Document:

EX-4.1

 Exhibit 4.1 
  

 
 WILLIAM LYON HOMES, INC., 

as Issuer 
 THE GUARANTORS named
herein, 
 and 
 U.S. BANK
NATIONAL ASSOCIATION, 
 as Trustee 
  

 
 INDENTURE 

 
  

Dated as of March 31, 2014 

5.75% Senior Notes Due 2019 
  

 

 CROSS-REFERENCE TABLE 
  

					
	 TIA

Section
	 	 	 	 Indenture
Section

			
	310(a)(1)	 		 	7.10
			
	(a)(2)	 		 	7.10
			
	(a)(3)	 		 	N.A.
			
	(a)(4)	 		 	N.A.
			
	(b)	 		 	7.08; 7.10
			
	(c)	 		 	N.A.
			
	311(a)	 		 	7.11
			
	(b)	 		 	7.11
			
	(c)	 		 	N.A.
			
	312(a)	 		 	2.05
			
	(b)	 		 	11.03
			
	(c)	 		 	11.03
			
	313(a)	 		 	7.06
			
	(b)(1)	 		 	N.A.
			
	(b)(2)	 		 	7.06
			
	(c)	 		 	11.02
			
	(d)	 		 	7.06
			
	314(a)	 		 	4.02;
			
		 		 	4.12; 11.02
			
	(b)	 		 	N.A.
			
	(c)(1)	 		 	11.04
			
	(c)(2)	 		 	11.04
			
	(c)(3)	 		 	N.A.
			
	(d)	 		 	N.A.
			
	(e)	 		 	11.05

					
	 TIA

Section
	 	 	 	 Indenture
Section

			
	(f)	 		 	4.12
			
	315(a)	 		 	7.01
			
	(b)	 		 	7.05; 11.02
			
	(c)	 		 	7.01
			
	(d)	 		 	7.01
			
	(e)	 		 	6.11
			
	316(a) (last sentence)	 		 	11.0
			
	(a)(1)(A)	 		 	6.05
			
	(a)(1)(B)	 		 	6.04
			
	(a)(2)	 		 	N.A.
			
	(b)	 		 	6.07
			
	317(a)(1)	 		 	6.08
			
	(a)(2)	 		 	6.09
			
	(b)	 		 	2.04
			
	318(a)	 		 	11.01

 N.A. means Not Applicable. 

 
 Note: This Cross-Reference Table shall not,
for any purpose, be deemed to be part of this Indenture. 

  
 3 

 TABLE OF CONTENTS 
  

							
	 	 	 	  	Page	 
	
	ARTICLE 1	  
	
	DEFINITIONS AND INCORPORATION BY REFERENCE	  
			
	SECTION 1.01.	 	 Definitions
	  	 	1	  
	SECTION 1.02.	 	 Other Definitions
	  	 	28	  
	SECTION 1.03.	 	 Incorporation by Reference of Trust Indenture Act
	  	 	29	  
	SECTION 1.04.	 	 Rules of Construction
	  	 	29	  
	
	ARTICLE 2	  
	
	THE SECURITIES	  
			
	SECTION 2.01.	 	 Form and Dating
	  	 	30	  
	SECTION 2.02.	 	 Execution and Authentication
	  	 	30	  
	SECTION 2.03.	 	 Registrar and Paying Agent
	  	 	31	  
	SECTION 2.04.	 	 Paying Agent To Hold Money in Trust
	  	 	31	  
	SECTION 2.05.	 	 Securityholder Lists
	  	 	31	  
	SECTION 2.06.	 	 Transfer and Exchange
	  	 	32	  
	SECTION 2.07.	 	 Replacement Securities
	  	 	32	  
	SECTION 2.08.	 	 Outstanding Securities
	  	 	32	  
	SECTION 2.09.	 	 Temporary Securities
	  	 	32	  
	SECTION 2.10.	 	 Cancellation
	  	 	33	  
	SECTION 2.11.	 	 Defaulted Interest
	  	 	33	  
	SECTION 2.12.	 	 CUSIP Numbers, ISINs, etc.
	  	 	33	  
	SECTION 2.13.	 	 Issuance of Additional Securities
	  	 	33	  
	
	ARTICLE 3	  
	
	REDEMPTION	  
			
	SECTION 3.01.	 	 Notices to Trustee
	  	 	34	  
	SECTION 3.02.	 	 Selection of Securities to Be Redeemed
	  	 	34	  
	SECTION 3.03.	 	 Notice of Redemption
	  	 	34	  
	SECTION 3.04.	 	 Effect of Notice of Redemption
	  	 	35	  
	SECTION 3.05.	 	 Deposit of Redemption Price
	  	 	35	  
	SECTION 3.06.	 	 Securities Redeemed in Part
	  	 	36	  
	
	ARTICLE 4	  
	
	COVENANTS	  
			
	SECTION 4.01.	 	 Payment of Securities
	  	 	36	  
	SECTION 4.02.	 	 Reports to Holders
	  	 	36	  

  
 i 

							
	SECTION 4.03.	 	 Limitations on Additional Indebtedness
	  	 	37	  
	SECTION 4.04.	 	 Limitations on Restricted Payments
	  	 	39	  
	SECTION 4.05.	 	 Limitations on Dividend and Other Restrictions Affecting Restricted Subsidiaries
	  	 	41	  
	SECTION 4.06.	 	 Limitations on Asset Sales
	  	 	43	  
	SECTION 4.07.	 	 Limitations on Transactions with Affiliates
	  	 	45	  
	SECTION 4.08.	 	 Effectiveness of Covenants
	  	 	46	  
	SECTION 4.09.	 	 Conduct of Business.
	  	 	47	  
	SECTION 4.10.	 	 Change of Control
	  	 	47	  
	SECTION 4.11.	 	 Limitations on Designation of Unrestricted Subsidiaries
	  	 	49	  
	SECTION 4.12.	 	 Limitations on Liens
	  	 	50	  
	SECTION 4.13.	 	 Additional Security Guarantees
	  	 	50	  
	SECTION 4.14.	 	 Compliance Certificate
	  	 	50	  
	SECTION 4.15.	 	 Further Instruments and Acts
	  	 	50	  
	
	ARTICLE 5	  
	
	SUCCESSOR COMPANY	  
			
	SECTION 5.01.	 	 When Company May Merge or Transfer Assets
	  	 	51	  
	
	ARTICLE 6	  
	
	DEFAULTS AND REMEDIES	  
			
	SECTION 6.01.	 	 Events of Default
	  	 	52	  
	SECTION 6.02.	 	 Acceleration
	  	 	54	  
	SECTION 6.03.	 	 Other Remedies
	  	 	55	  
	SECTION 6.04.	 	 Waiver of Past Defaults
	  	 	55	  
	SECTION 6.05.	 	 Control by Majority
	  	 	55	  
	SECTION 6.06.	 	 Limitation on Suits
	  	 	55	  
	SECTION 6.07.	 	 Rights of Holders to Receive Payment
	  	 	56	  
	SECTION 6.08.	 	 Collection Suit by Trustee
	  	 	56	  
	SECTION 6.09.	 	 Trustee May File Proofs of Claim
	  	 	56	  
	SECTION 6.10.	 	 Priorities
	  	 	56	  
	SECTION 6.11.	 	 Undertaking for Costs
	  	 	57	  
	SECTION 6.12.	 	 Waiver of Stay or Extension Laws
	  	 	57	  
	
	ARTICLE 7	  
	
	TRUSTEE	  
			
	SECTION 7.01.	 	 Duties of Trustee
	  	 	57	  
	SECTION 7.02.	 	 Rights of Trustee
	  	 	58	  
	SECTION 7.03.	 	 Individual Rights of Trustee
	  	 	59	  
	SECTION 7.04.	 	 Trustee’s Disclaimer
	  	 	59	  
	SECTION 7.05.	 	 Notice of Defaults
	  	 	59	  

  
 ii 

							
	SECTION 7.06.	 	 Reports by Trustee to Holders
	  	 	60	  
	SECTION 7.07.	 	 Compensation and Indemnity
	  	 	60	  
	SECTION 7.08.	 	 Replacement of Trustee
	  	 	61	  
	SECTION 7.09.	 	 Successor Trustee by Merger
	  	 	61	  
	SECTION 7.10.	 	 Eligibility; Disqualification
	  	 	62	  
	SECTION 7.11.	 	 Preferential Collection of Claims Against Company
	  	 	62	  
	
	ARTICLE 8	  
	
	SATISFACTION AND DISCHARGE OF INDENTURE; DEFEASANCE	  
			
	SECTION 8.01.	 	 Discharge of Liability on Securities; Defeasance
	  	 	62	  
	SECTION 8.02.	 	 Conditions to Defeasance
	  	 	63	  
	SECTION 8.03.	 	 Application of Trust Money
	  	 	64	  
	SECTION 8.04.	 	 Repayment to Company
	  	 	64	  
	SECTION 8.05.	 	 Indemnity for Government Obligations
	  	 	65	  
	SECTION 8.06.	 	 Reinstatement
	  	 	65	  
	
	ARTICLE 9	  
	
	AMENDMENTS	  
			
	SECTION 9.01.	 	 Without Consent of Holders
	  	 	65	  
	SECTION 9.02.	 	 With Consent of Holders
	  	 	66	  
	SECTION 9.03.	 	 Compliance with Trust Indenture Act
	  	 	67	  
	SECTION 9.04.	 	 Revocation and Effect of Consents and Waivers
	  	 	67	  
	SECTION 9.05.	 	 Notation on or Exchange of Securities
	  	 	67	  
	SECTION 9.06.	 	 Trustee To Sign Amendments
	  	 	67	  
	SECTION 9.07.	 	 Payments for Consent
	  	 	68	  
	
	ARTICLE 10	  
	
	GUARANTEES	  
			
	SECTION 10.01.	 	 Guarantees
	  	 	68	  
	SECTION 10.02.	 	 Limitation on Liability
	  	 	69	  
	SECTION 10.03.	 	 Successors and Assigns
	  	 	70	  
	SECTION 10.04.	 	 No Waiver
	  	 	70	  
	SECTION 10.05.	 	 Modification
	  	 	70	  
	SECTION 10.06.	 	 Execution and Delivery of Security Guarantee
	  	 	70	  
	SECTION 10.07.	 	 Release of Guarantor
	  	 	71	  
	SECTION 10.08.	 	 Contribution
	  	 	71	  
	
	ARTICLE 11	  
	
	MISCELLANEOUS	  
			
	SECTION 11.01.	 	 Trust Indenture Act Controls
	  	 	72	  

  
 iii 

							
	SECTION 11.02.	 	 Notices
	  	 	72	  
	SECTION 11.03.	 	 Communication by Holders with Other Holders
	  	 	73	  
	SECTION 11.04.	 	 Certificate and Opinion as to Conditions Precedent
	  	 	73	  
	SECTION 11.05.	 	 Statements Required in Certificate or Opinion
	  	 	73	  
	SECTION 11.06.	 	 When Securities Disregarded
	  	 	73	  
	SECTION 11.07.	 	 Rules by Trustee, Paying Agent and Registrar
	  	 	74	  
	SECTION 11.08.	 	 Legal Holidays
	  	 	74	  
	SECTION 11.09.	 	 Governing Law
	  	 	74	  
	SECTION 11.10.	 	 No Recourse Against Others
	  	 	74	  
	SECTION 11.11.	 	 Successors
	  	 	74	  
	SECTION 11.12.	 	 Multiple Originals
	  	 	74	  
	SECTION 11.13.	 	 Table of Contents; Headings
	  	 	74	  

 Rule 144A/Regulation S Appendix 
  

			
	Exhibit 1 –	  	Form of Initial Security
		
	Exhibit A –	  	Form of Exchange Security or Private Exchange Security
		
	Exhibit B –	  	Form of Notation of Guarantee

  
 iv 

 INDENTURE dated as of March 31, 2014, among WILLIAM LYON HOMES, INC., a California
corporation (the “Company”), the Guarantors (as hereinafter defined) that from time to time become parties to this Indenture and U.S. BANK NATIONAL ASSOCIATION (the “Trustee”). 

Each party agrees as follows for the benefit of the other parties and for the equal and ratable benefit of the Holders of the Initial
Securities, Exchange Securities, Private Exchange Securities and any Additional Securities: 
 ARTICLE 1 

DEFINITIONS AND INCORPORATION BY REFERENCE 

SECTION 1.01. Definitions. 

“Acquired Indebtedness” means (1) with respect to any Person that becomes a Restricted Subsidiary after the Issue Date,
Indebtedness of such Person and its Subsidiaries existing at the time such Person becomes a Restricted Subsidiary that was not incurred in connection with, or in contemplation of, such Person becoming a Restricted Subsidiary and (2) with
respect to the Parent or any Restricted Subsidiary, any Indebtedness of a Person (other than the Parent or a Restricted Subsidiary) existing at the time such Person is merged with or into the Parent or a Restricted Subsidiary, or Indebtedness
expressly assumed by the Parent or any Restricted Subsidiary in connection with the acquisition of an asset or assets from another Person, which Indebtedness was not, in any case, incurred by such other Person in connection with, or in contemplation
of, such merger or acquisition. 
 “Additional Assets” means (1) any property, plant or equipment used in a Permitted
Business; (2) the Capital Stock of a Person that becomes a Restricted Subsidiary as a result of the acquisition of such Capital Stock by the Company or another Restricted Subsidiary; or (3) Capital Stock constituting a minority interest in
any Person that at such time is a Restricted Subsidiary; provided, however, that any such Restricted Subsidiary described in clause (2) or (3) of this definition is primarily engaged in a Permitted Business. 

“Additional Securities” means Securities issued under this Indenture after the Issue Date and in compliance with Sections
2.13 and 4.03, it being understood that any Securities issued in exchange for or replacement of any Initial Security issued on the Issue Date shall not be an Additional Security, including any such Securities issued pursuant to the Registration
Rights Agreement. 
 “Adjusted Treasury Rate” means, with respect to any redemption date, (1) the yield, under the
heading which represents the average for the immediately preceding week, appearing in the most recently published statistical release designated “H.15(519)” or any successor publication which is published weekly by the Board of Governors
of the Federal Reserve System and which establishes yields on actively traded United States Treasury securities adjusted to constant maturity under the caption “Treasury Constant Maturities”, for the maturity corresponding to the
Comparable Treasury Issue (if no maturity is within three months before or after November 15, 2016, yields for the two published maturities most closely corresponding to 

 
the Comparable Treasury Issue shall be determined and the Adjusted Treasury Rate shall be interpolated or extrapolated from such yields on a straight line basis, rounding to the nearest month) or
(2) if such release (or any successor release) is not published during the week preceding the calculation date or does not contain such yields, the rate per year equal to the semi-annual equivalent yield to maturity of the Comparable Treasury
Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such redemption date, in each case calculated on the third Business Day immediately preceding the redemption date, in each case, plus 0.50%. 

“Affiliate” of any Person means any other Person which directly or indirectly controls or is controlled by, or is under
direct or indirect common control with, the referent Person. For purposes of Sections 4.04, 4.06 and 4.07, Affiliates shall be deemed to include, with respect to any Person, any other Person (1) which beneficially owns or holds, directly
or indirectly, 10% or more of any class of the Voting Stock of the referent Person, (2) of which 10% or more of the Voting Stock is beneficially owned or held, directly or indirectly, by the referent Person or (3) with respect to an
individual, any immediate family member of such Person. For purposes of this definition, “control” of a Person shall mean the power to direct the management and policies of such Person, directly or indirectly, whether through the ownership
of voting securities, by contract or otherwise. 
 “Applicable Premium” means with respect to a Security at any redemption
date, the greater of (1) 1.00% of the principal amount of such Security and (2) the excess of (A) the present value at such redemption date of (i) the redemption price of such Security on April 15, 2016 (such redemption
price being described in Section 5 of the Securities, exclusive of any accrued interest) plus (ii) all required remaining scheduled interest payments due on such Security through April 15, 2016 (but excluding accrued and unpaid
interest to the redemption date), computed using a discount rate equal to the Adjusted Treasury Rate, over (B) the principal amount of such Security on such redemption date. 

“Asset Acquisition” means (1) an Investment by the Parent or any Restricted Subsidiary in any other Person if, as a
result of such Investment, such Person shall become a Restricted Subsidiary or shall be merged with or into the Parent or any Restricted Subsidiary or (2) the acquisition by the Parent or any Restricted Subsidiary of all or substantially all of
the assets of any other Person or any division or line of business of any other Person. 
 “Asset Sale” means any sale,
issuance, conveyance, transfer, lease, assignment or other disposition by the Parent or any Restricted Subsidiary to any Person other than the Parent or any Restricted Subsidiary (including by means of a Sale and Leaseback Transaction or a merger or
consolidation) (collectively, for purposes of this definition, a “transfer”), in one transaction or a series of related transactions, of any assets (including Equity Interests) of the Parent or any of its Restricted Subsidiaries other than
in the ordinary course of business. For purposes of this definition, the term “Asset Sale” shall not include: 

(1) transfers of cash or Cash Equivalents; 

(2) transfers of assets (including Equity Interests) that are governed by, and made in accordance with, Section 5.01; 

  
 2 

 (3) Permitted Investments and Restricted Payments permitted under
Section 4.04; 
 (4) the creation or realization of any Permitted Lien; 

(5) transactions in the ordinary course of business, including dedications and other donations to governmental authorities,
sales (directly or indirectly), leases, sales and leasebacks and other dispositions of (A) homes, improved land and unimproved land, whether in single or multiple lots, (B) real estate (including related amenities and improvements),
whether in single or multiple lots and (C) Equity Interests of a Subsidiary, the assets of which consist entirely of amenities and improvements related to real estate, such as golf courses, and real estate underlying such amenities and
improvements; 
 (6) dispositions of mortgage loans and related assets and mortgage-backed securities in the ordinary course
of a mortgage lending business; 
 (7) any transfer or series of related transfers that, but for this clause, would be Asset
Sales, if after giving effect to such transfers, the aggregate Fair Market Value of the assets transferred in such transaction or any such series of related transactions does not exceed $5,000,000; 

(8) the surrender or waiver of contractual rights or the settlement, release or surrender of contract, tort or other claims of
any kind; 
 (9) the disposition of assets or property that are obsolete or that are no longer useful in the conduct of the
business of the Company and/or any Restricted Subsidiaries; and 
 (10) an issuance of Equity Interests by a Restricted
Subsidiary to the Company, Parent or to a Restricted Subsidiary. 
 “Attributable Indebtedness”, when used with respect to
any Sale and Leaseback Transaction, means, as at the time of determination, the present value (discounted at a rate equivalent to the Company’s then-current weighted average cost of funds for borrowed money as at the time of determination,
compounded on a semi-annual basis) of the total obligations of the lessee for rental payments during the remaining term of any Capitalized Lease included in any such Sale and Leaseback Transaction. 

“Board of Directors” means the board of directors of the Company or any committee thereof duly authorized to act on behalf
of such board or, in the case of a Person that is not a corporation, the group exercising the authority generally vested in a board of directors of a corporation. 

“Business Day” means a day other than a Saturday, Sunday or other day on which banking institutions in New York are
authorized or required by law to close. 

  
 3 

 “Capitalized Lease” means a lease required to be capitalized for financial
reporting purposes in accordance with GAAP. 
 “Capitalized Lease Obligations” of any Person means the obligations of such
Person to pay rent or other amounts under a Capitalized Lease, and the amount of such obligation shall be the capitalized amount thereof determined in accordance with GAAP. 

“Capital Stock” of any Person means any and all shares, interests (including partnership interests), rights to purchase,
warrants, options, participations or other equivalents of or interests in (however designated) equity of such Person, including any Preferred Stock, but excluding any debt securities convertible into such equity. 

“Cash Equivalents” means (1) marketable obligations with a maturity of one year or less issued or directly and fully
guaranteed or insured by the United States of America or any agency or instrumentality thereof; (2) demand and time deposits and certificates of deposit or acceptances with a maturity of one year or less of any financial institution that is a
member of the Federal Reserve System having combined capital and surplus and undivided profits of not less than $500,000,000 and is assigned at least a “B” rating by Thomson Financial BankWatch; (3) commercial paper maturing no more
than 180 days from the date of creation thereof issued by a corporation that is not the Parent or an Affiliate of the Parent, and is organized under the laws of any State of the United States of America or the District of Columbia and rated at least
A-1 by Standard & Poor’s or at least P-1 by Moody’s; (4) repurchase obligations with a term of not more than ten days for underlying securities of the types described in clause (1) of this definition entered into with
any commercial bank meeting the specifications of clause (2) of this definition; and (5) investments in money market or other mutual funds substantially all of whose assets comprise securities of the types described in clauses
(1) through (4) of this definition. 
 “Change of Control” means the occurrence of any of the following events:

 (1) any “person” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act), other than the
Permitted Holders, is or becomes the “beneficial owner” (as defined in Rules 13d-3 and 13d-5 under the Exchange Act, except that for purposes of this clause (1) such person shall be deemed to have “beneficial ownership” of
all shares that any such person has the right to acquire, whether such right is exercisable immediately or only after the passage of time), directly or indirectly, of more than 50% of the total voting power of the Voting Stock of the Parent (for the
purposes of this clause (1), such other person shall be deemed to beneficially own any Voting Stock of a Person held by any other Person (the “parent entity”), if such other person is the beneficial owner (as defined above in this
clause (1)), directly or indirectly, of more than 50% of the voting power of the Voting Stock of such parent entity); 
 (2)
the stockholders of the Parent adopt a plan of liquidation or dissolution of the Parent; provided that a liquidation or dissolution of Parent which is part of a transaction that does not constitute a Change of Control pursuant to the proviso
contained in clause (3) of this definition shall not constitute a Change of Control; 

  
 4 

 (3) the merger or consolidation of the Parent with or into another Person or the
merger of another Person with or into the Parent, or the sale of all or substantially all the assets of the Parent and its Restricted Subsidiaries (determined on a consolidated basis) to another Person; provided that a transaction following which
(A) in the case of a merger or consolidation transaction, one or more holders of securities that represented 100% of the Voting Stock of the Parent immediately prior to such transaction (or other securities into which such securities are
converted as part of such merger or consolidation transaction) own directly or indirectly at least a majority of the voting power of the Voting Stock of the surviving Person in such merger or consolidation transaction immediately after such
transaction or (B) in the case of a sale of assets transaction, each transferee is or becomes an obligor in respect of the Securities and a Subsidiary of the transferor of such assets shall not constitute a Change of Control; or 

(4) the Parent ceases to own 100% of the Voting Stock of the Company. 

“Code” means the Internal Revenue Code of 1986, as amended. 

“Company” means the party named as such in this Indenture until a successor replaces it and, thereafter, means the successor
and, for purposes of any provision contained herein and required by the TIA, each other obligor on the indenture securities. 

“Comparable Treasury Issue” means the United States Treasury security selected by the Quotation Agent as having a maturity
comparable to the remaining term of the Securities from the redemption date to April 15, 2016, that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt
securities of a maturity most nearly equal to April 15, 2016. 
 “Comparable Treasury Price” means, with respect to
any redemption date, if clause (2) of the Adjusted Treasury Rate definition is applicable, the average of three, or such lesser number as is obtained by the Trustee, Reference Treasury Dealer Quotations for such redemption date. 

“Consolidated Amortization Expense” for any period means the amortization expense of the Parent and the Restricted
Subsidiaries for such period, determined on a consolidated basis in accordance with GAAP. 
 “Consolidated Cash Flow Available for
Fixed Charges” for any period means, without duplication, the sum of the amounts for such period of 
 (1) Consolidated Net
Income, plus 
 (2) in each case only to the extent (and in the same proportion) deducted in determining Consolidated Net Income and
with respect to the portion of Consolidated Net Income attributable to any Restricted Subsidiary (other than the Company) only if a corresponding amount would be permitted at the date of determination to be distributed to the Parent by such
Restricted Subsidiary without prior approval (that has not been obtained), pursuant to the terms of its charter and all agreements, instruments, judgments, decrees, orders, statutes, rules and governmental regulations applicable to such Restricted
Subsidiary or its stockholders, 

  
 5 

 (a) Consolidated Income Tax Expense, 

(b) Consolidated Amortization Expense (but only to the extent not included in Consolidated Interest Expense), 

(c) Consolidated Depreciation Expense, 

(d) Consolidated Interest Expense and interest and other charges amortized to “cost of sales— homes” or “cost of
sales—lots, land and other”, 
 (e) all other non-cash items reducing the Consolidated Net Income (excluding any non-cash charge
that results in an accrual of a reserve for cash charges in any future period) for such period, 
 (f) any expenses or charges related to
any equity offering of Parent, non-ordinary course Permitted Investments, acquisition, disposition, recapitalization or the incurrence of Indebtedness permitted to be incurred by this Indenture (including the issuance of the Securities), including a
refinancing thereof (whether or not successful) or the early extinguishment of such Indebtedness and any amendment or modification to the terms of any such transactions, 

(g) any charges resulting from the application of Accounting Standards Codification Topic 805 “Business Combinations,” Accounting
Standards Codification Topic 350 “Intangibles—Goodwill and Other,” Accounting Standards Codification Topic 360-10-35-15 “Impairment or Disposal of Long-Lived Assets” (other than with respect to impairments or write-offs of
inventory), Accounting Standards Codification Topic 480-10-25-4 “Distinguishing Liabilities from Equity—Overall—Recognition” or Accounting Standards Codification Topic 820 “Fair Value Measurements and Disclosures,” 

(h) any unrealized net gain or loss resulting in such period from Hedging Obligations or other derivative instruments, 

(i) any non-cash impairment charge or asset write-off (other than with respect to inventory), in each case pursuant to GAAP; and 

(j) any (a) non-cash compensation charges, (b) non-cash costs or expenses resulting from stock option plans, employee benefit
plans, compensation charges or post-employment benefit plans, or grants or awards of stock, stock appreciation or similar rights, stock options, restricted stock, preferred stock or other rights and (c) write-offs or write-downs of goodwill,

 in each case determined on a consolidated basis in accordance with GAAP, minus 

(3) the aggregate amount of all non-cash items, determined on a consolidated basis, to the extent such items increased Consolidated Net
Income for such period. 

  
 6 

 “Consolidated Depreciation Expense” for any period means the depreciation expense of
the Parent and the Restricted Subsidiaries for such period, determined on a consolidated basis in accordance with GAAP. 

“Consolidated Fixed Charge Coverage Ratio” means the ratio of Consolidated Cash Flow Available for Fixed Charges during the
most recent four consecutive full fiscal quarters for which internal financial statements are available (the “Four-Quarter Period”) ending on or prior to the date of the transaction giving rise to the need to calculate the
Consolidated Fixed Charge Coverage Ratio (the “Transaction Date”) to Consolidated Interest Incurred for the Four-Quarter Period. For purposes of this definition, Consolidated Cash Flow Available for Fixed Charges and Consolidated
Interest Incurred shall be calculated after giving effect on a pro forma basis for the period of such calculation to: 
 (1)
the incurrence of any Indebtedness, the inclusion of any Indebtedness on the balance sheet or the issuance of any preferred stock, in each case of the Parent or any Restricted Subsidiary (and the application of the proceeds thereof) and any
repayment, repurchase, defeasance or other discharge or the assumption by another Person that is not an Affiliate (collectively, “repayment”) of other Indebtedness or redemption of other preferred stock (other than the incurrence or
repayment of Indebtedness in the ordinary course of business for working capital purposes pursuant to any revolving credit arrangement) occurring during the Four-Quarter Period or at any time subsequent to the last day of the Four-Quarter Period and
on or prior to the Transaction Date, as if such incurrence, repayment, issuance or redemption, as the case may be (and the application of the proceeds thereof), occurred on the first day of the Four-Quarter Period; 

(2) any Asset Sale or Asset Acquisition (including any Asset Acquisition giving rise to the need to make such calculation as a
result of the Parent or any Restricted Subsidiary (including any Person who becomes a Restricted Subsidiary as a result of such Asset Acquisition) incurring Acquired Indebtedness and also including any Consolidated Cash Flow Available for Fixed
Charges (including any pro forma expense and cost reductions calculated on a basis consistent with Regulation S-X under the Securities Exchange Act of 1934, as amended) associated with any such Asset Acquisition) occurring during the Four-Quarter
Period or at any time subsequent to the last day of the Four-Quarter Period and on or prior to the Transaction Date, as if such Asset Sale or Asset Acquisition or other disposition (including the incurrence of, or assumption or liability for, any
such Indebtedness or Acquired Indebtedness) occurred on the first day of the Four-Quarter Period; 
 (3) any Person that is a
Restricted Subsidiary on the Transaction Date will be deemed to have been a Restricted Subsidiary at all times during such Four-Quarter Period; 

(4) any Person that is not a Restricted Subsidiary on the Transaction Date will be deemed not to have been a Restricted
Subsidiary at any time during such Four-Quarter Period; and 
 (5) the Consolidated Cash Flow Available for Fixed Charges and
the Consolidated Interest Expense attributable to discontinued operations, as determined in accordance with GAAP shall be excluded. 

  
 7 

 If the Parent or any Restricted Subsidiary directly or indirectly guarantees Indebtedness of a
third Person (other than a Restricted Subsidiary, in the case of the Parent, or the Parent or another Restricted Subsidiary, in the case of a Restricted Subsidiary), the preceding sentence shall give effect to the incurrence of such guaranteed
Indebtedness as if the Parent or such Restricted Subsidiary had directly incurred or otherwise assumed such guaranteed Indebtedness. 
 In
calculating Consolidated Interest Incurred for purposes of determining the denominator (but not the numerator) of this Consolidated Fixed Charge Coverage Ratio: 

(1) interest on outstanding Indebtedness determined on a fluctuating basis as of the Transaction Date and which will continue
to be so determined thereafter shall be deemed to have accrued at a fixed rate per annum equal to the rate of interest on this Indebtedness in effect on the Transaction Date; 

(2) if interest on any Indebtedness actually incurred on the Transaction Date may optionally be determined at an interest rate
based upon a factor of a prime or similar rate, a Eurocurrency interbank offered rate, or other rates, then the interest rate in effect on the Transaction Date will be deemed to have been in effect during the Four-Quarter Period; and 

(3) notwithstanding the immediately preceding clauses (1) and (2), interest on Indebtedness determined on a fluctuating
basis, to the extent such interest is covered by agreements with a term of at least one year after the Transaction Date relating to Hedging Obligations, shall be deemed to accrue at the rate per annum resulting after giving effect to the operation
of these agreements. 
 “Consolidated Income Tax Expense” for any period means the provision for taxes of the Parent and
the Restricted Subsidiaries, determined on a consolidated basis in accordance with GAAP. 
 “Consolidated Indebtedness”
means, as of any date, the total Indebtedness of the Parent and the Restricted Subsidiaries as of such date, determined on a consolidated basis. 

“Consolidated Interest Expense” for any period means the sum, without duplication, of the total interest expense (other than
interest and other charges amortized to “cost of sales—homes” or “cost of sales—lots, land and other”) of the Parent and the Restricted Subsidiaries for such period, determined on a consolidated basis in accordance with
GAAP and including, without duplication, 
 (1) imputed interest on Capitalized Lease Obligations and Attributable
Indebtedness, 
 (2) commissions, discounts and other fees and charges owed with respect to letters of credit securing
financial obligations, bankers’ acceptance financing and receivables financings, 

  
 8 

 (3) the net costs associated with Hedging Obligations, 

(4) amortization of debt issuance costs, debt discount or premium and other financing fees and expenses, 

(5) the interest portion of any deferred payment obligations, 

(6) all other non-cash interest expense; provided, however, that any non-cash interest expense or income attributable to
the movement in the mark-to-market valuation of Hedging Obligations or other derivative instrument pursuant to GAAP shall be excluded from the calculation of Consolidated Interest Expense, 

(7) the product of (a) all dividend payments on any series of Disqualified Equity Interests of the Parent or any preferred
stock of any Restricted Subsidiary (other than any such Disqualified Equity Interests or any preferred stock held by the Parent or a Wholly Owned Restricted Subsidiary), multiplied by (b) a fraction, the numerator of which is one and the
denominator of which is one minus the then current combined federal, state and local statutory tax rate of the Parent and the Restricted Subsidiaries, expressed as a decimal, 

(8) all interest payable with respect to discontinued operations, and 

(9) all interest on any Indebtedness of any other Person (other than a Restricted Subsidiary, in the case of the Parent, or the
Parent or another Restricted Subsidiary, in the case of a Restricted Subsidiary) guaranteed by the Parent or any Restricted Subsidiary. 

“Consolidated Interest Incurred” for any period means the sum, without duplication, of (1) Consolidated Interest
Expense and (2) interest capitalized for such period (including interest capitalized with respect to discontinued operations but not including interest or other charges amortized to “cost of sales—homes” or “cost of
sales—lots, land and other”). 
 “Consolidated Net Income” for any period means the net income (or loss) of the
Parent and the Restricted Subsidiaries for such period determined on a consolidated basis in accordance with GAAP; provided that there shall be excluded from such net income (to the extent otherwise included therein), without duplication: 

(1) the net income (or loss) of any Person (other than a Restricted Subsidiary) in which any Person other than the Parent or
any of its Restricted Subsidiaries has an ownership interest, except to the extent that cash in an amount equal to any such income has actually been received by the Parent or any of its Restricted Subsidiaries during such period; 

(2) except to the extent includible in the consolidated net income of the Parent pursuant to the clause (1) of this
definition, the net income (or loss) of any Person that accrued prior to the date that (a) such Person becomes a Restricted Subsidiary or is merged into or consolidated with the Parent or any Restricted Subsidiary or (b) the assets of such
Person are acquired by the Parent or any Restricted Subsidiary; 

  
 9 

 (3) the net income of any Restricted Subsidiary (other than the Company) during
such period to the extent that the declaration or payment of dividends or similar distributions by such Restricted Subsidiary of that income is not permitted by operation of the terms of its charter or any agreement, instrument, judgment, decree,
order, statute, rule or governmental regulation applicable to that Subsidiary during such period; 
 (4) that portion of the
net income of any Restricted Subsidiary (other than the Company) that is not a Guarantor and is not a Wholly Owned Restricted Subsidiary attributable to the portion of the Equity Interests of such Restricted Subsidiary that is not owned by the
Parent or the Restricted Subsidiaries; 
 (5) for the purposes of calculating the Restricted Payments Basket only, in the
case of a successor to the Parent or the Company by consolidation, merger or transfer of its assets, any income (or loss) of the successor prior to such merger, consolidation or transfer of assets; 

(6) any gain (or loss), together with any related provisions for taxes on any such gain (or the tax effect of any such loss),
realized during such period by the Parent or any Restricted Subsidiary upon (a) the acquisition of any securities, or the extinguishment of any Indebtedness, of the Parent or any Restricted Subsidiary or (b) any Asset Sale by the Parent or
any Restricted Subsidiary; and 
 (7) any extraordinary gain (or extraordinary loss), together with any related provision for
taxes on any such extraordinary gain (or the tax effect of any such extraordinary loss), realized by the Parent or any Restricted Subsidiary during such period. 

In addition, any return of capital with respect to an Investment that increased the Restricted Payments Basket pursuant to Section 4.04(a)(3)(d) or
decreased the amount of Investments outstanding pursuant to clause (14) of the definition of “Permitted Investments” shall be excluded from Consolidated Net Income for purposes of calculating the Restricted Payments Basket. 

“Consolidated Net Worth” means, with respect to any Person as of any date, the consolidated stockholders’ equity of
such Person, determined on a consolidated basis in accordance with GAAP, less (without duplication) (1) any amounts thereof attributable to Disqualified Equity Interests of such Person or its Subsidiaries or any amount attributable to
Unrestricted Subsidiaries (other than Cerro Plata Associates, LLC and 242 Cerro Plata, LLC) and (2) all write-ups (other than write-ups resulting from foreign currency translations and write-ups of tangible assets of a going concern business
made within twelve months after the acquisition of such business) subsequent to the Issue Date in the book value of any asset owned by such Person or a Subsidiary of such Person. 

“Consolidated Tangible Assets” means, as of any date, the total amount of assets of the Parent and the Restricted
Subsidiaries on a consolidated basis at the end of the fiscal quarter immediately preceding such date, as determined in accordance with GAAP, less (1) Intangible Assets and (2) any assets securing Non-Recourse Indebtedness. 

  
 10 

 “Consolidated Tangible Net Worth” means, with respect to any Person as of any
date, the Consolidated Net Worth of such Person as of such date less (without duplication) all Intangible Assets of such Person as of such date. 

“Credit Facilities” means one or more debt facilities, indentures or commercial paper facilities, in each case, with banks
or other lenders or investors or credit providers or a trustee providing for the revolving credit loans, term loans, receivables financing (including through the sale of receivables to such lenders or to special purpose entities formed to borrow
from such lenders against such receivables), bankers acceptances, letters of credit or issuances of debt securities, including any related notes, guarantees, collateral documents, instruments, documents and agreements executed in connection
therewith and in each case, as amended, restated, modified, renewed, extended, supplemented, restructured, refunded, replaced in any manner (whether upon or after termination or otherwise) or in part from time to time, in one or more instances and
including any amendment increasing the amount of Indebtedness incurred or available to be borrowed thereunder, extending the maturity of any Indebtedness incurred thereunder or contemplated thereby or deleting, adding or substituting one or more
parties thereto (whether or not such added or substituted parties are banks or other institutional lenders), including one or more separate instruments or facilities, in each case, whether any such amendment, restatement, modification, renewal,
extension, supplement, restructuring, refunding, replacement or refinancing occurs simultaneously or not with the termination or repayment of a prior Credit Facility. 

“Default” means (1) any Event of Default or (2) any event, act or condition that, after notice or the passage of
time or both, would be an Event of Default. 
 “Directly Related Assets” means, with respect to any particular property,
assets directly related thereto or derived therefrom, such as proceeds (including insurance proceeds), products, rents, and profits thereof and improvements and accessions thereto. 

“Disqualified Equity Interests” of any Person means any class of Equity Interests of such Person that, by their terms, or by
the terms of any related agreement or of any security into which they are convertible, puttable or exchangeable, are, or upon the happening of any event or the passage of time would be, required to be redeemed by such Person, whether or not at the
option of the holder thereof, or mature or are mandatorily redeemable, pursuant to a sinking fund obligation or otherwise, in whole or in part, on or prior to the date which is 91 days after the final maturity date of the Securities;
provided, however, that any class of Equity Interests of such Person that, by its terms, authorizes such Person to satisfy in full its obligations with respect to the payment of dividends or upon maturity, redemption (pursuant to a
sinking fund or otherwise) or repurchase thereof or otherwise by the delivery of Equity Interests that are not Disqualified Equity Interests, and that are not convertible, puttable or exchangeable for Disqualified Equity Interests or Indebtedness,
will not be deemed to be Disqualified Equity Interests so long as such Person satisfies its obligations with respect thereto solely by the delivery of Equity Interests that are not Disqualified Equity Interests; provided further,
however, that any Equity Interests that would constitute Disqualified Equity Interests but for provisions thereof giving holders thereof (or the holders of any security into or for which such Equity Interests are convertible, exchangeable or
exercisable) the right to require the Company to redeem such Equity Interests upon the occurrence of a change in control occurring prior to the final maturity date of the 

  
 11 

 
Securities shall not constitute Disqualified Equity Interests if the change in control provisions applicable to such Equity Interests are no more favorable to such holders than the provisions in
Section 4.10 and such Equity Interests specifically provide that the Company will not redeem any such Equity Interests pursuant to such provisions prior to the Company’s purchase of the Securities as required pursuant to Section 4.10.

 “Equity Interests” of any Person means (1) any and all shares or other equity interests (including common stock,
preferred stock, limited liability company interests and partnership interests) in such Person and (2) all rights to purchase, warrants or options (whether or not currently exercisable), participations or other equivalents of or interests in
(however designated) such shares or other interests in such Person but excluding from all of the foregoing any debt securities convertible into Equity Interests. 

“Equity Offering” means public or private equity offering or sale after the Issue Date of Qualified Equity Interests. 

“Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended. 

“Fair Market Value” means, with respect to any asset, the price (after taking into account any liabilities relating to such
assets) that would reasonably expected to be negotiated in an arm’s-length transaction for cash between a willing seller and a willing and able buyer, neither of which is under any compulsion to complete the transaction, as such price is
determined in good faith by the board of directors of the Parent or a duly authorized committee thereof, as evidenced by a resolution of such board or committee. 

“Final Offering Circular” means the final offering circular dated March 26, 2014 for the sale of the Securities by the
Company. 
 “GAAP” means generally accepted accounting principles set forth in the opinions and pronouncements of the
Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such other entity as may be approved by a significant
segment of the accounting profession of the United States, as in effect from time to time. 
 “GP Indebtedness” means as
of any date the amount of the liability of Parent or any of its Restricted Subsidiaries in its capacity as a general partner for the Indebtedness of a partnership or Joint Venture after subtracting the Fair Market Value as of such date of the assets
of such partnership or Joint Venture that secure such Indebtedness. 
 “guarantee” means a direct or indirect guarantee by
any Person of any Indebtedness of any other Person and includes any obligation, direct or indirect, contingent or otherwise, of such Person: (1) to purchase or pay (or advance or supply funds for the purchase or payment of) Indebtedness of such
other Person (whether arising by virtue of partnership arrangements, or by agreements to keep-well, to purchase assets, goods, securities or services (unless such purchase arrangements are on arm’s-length terms and are entered into in the
ordinary course of business), to take-or-pay, or to maintain financial statement conditions or otherwise); or (2) entered into for purposes of assuring in any other manner the obligee of such Indebtedness of the payment thereof or to protect
such obligee against loss in respect thereof (in whole or in part). “guarantee,” when used as a verb, and “guaranteed” have correlative meanings. 

  
 12 

 “Guarantors” means the Parent and each Restricted Subsidiary of the Parent
(other than the Company), and each other Person that is required to become a Guarantor by the terms of this Indenture, in each case, until such Person is released from its Security Guarantee. 

“Hedging Obligations” of any Person means the obligations of such Person pursuant to (1) any interest rate swap
agreement, interest rate collar agreement or other similar agreement or arrangement designed to protect such Person against fluctuations in interest rates, (2) agreements or arrangements designed to protect such Person against fluctuations in
foreign currency exchange rates in the conduct of its operations, or (3) any forward contract, commodity swap agreement, commodity option agreement or other similar agreement or arrangement designed to protect such Person against fluctuations
in commodity prices, in each case entered into in the ordinary course of business for bona fide hedging purposes and not for the purpose of speculation. 

“Holder” or “Securityholder” means any registered holder, from time to time, of the Securities. 

“incur” means, with respect to any Indebtedness or obligation, incur, create, issue, assume, guarantee or otherwise become
directly or indirectly liable, contingently or otherwise, with respect to such Indebtedness or obligation; provided that (1) the Indebtedness of a Person existing at the time such Person became a Restricted Subsidiary or at the time such Person
merged with or into the Parent or a Restricted Subsidiary shall be deemed to have been incurred at such time and (2) neither the accrual of interest nor the accretion of original issue discount shall be deemed to be an incurrence of
Indebtedness. 
 “Indebtedness” of any Person at any date means, without duplication: 

(1) all liabilities, contingent or otherwise, of such Person for borrowed money (whether or not the recourse of the lender is
to the whole of the assets of such Person or only to a portion thereof); 
 (2) all obligations of such Person evidenced by
bonds, debentures, notes or other similar instruments; 
 (3) all obligations of such Person in respect of letters of credit
or other similar instruments (or reimbursement obligations with respect thereto); 
 (4) all obligations of such Person to
pay the deferred and unpaid purchase price of property or services, except trade payables and accrued expenses incurred by such Person in the ordinary course of business in connection with obtaining goods, materials or services; 

(5) the maximum fixed redemption or repurchase price of all Disqualified Equity Interests of such Person; 

  
 13 

 (6) all Capitalized Lease Obligations of such Person; 

(7) all Indebtedness of others secured by a Lien on any asset of such Person, whether or not such Indebtedness is assumed by
such Person; 
 (8) all Indebtedness of others guaranteed by such Person to the extent of such guarantee; provided that
(i) Indebtedness of the Parent or its Subsidiaries that is guaranteed by the Parent or the Parent’s Subsidiaries shall be counted only once in the calculation of the amount of Indebtedness of the Parent and its Subsidiaries on a
consolidated basis and (ii) only the liabilities relating to any such guarantee that are recorded as liabilities, or required (in accordance with GAAP) to be recorded as liabilities, on the balance sheet of such Person shall be considered
Indebtedness of such Person (it being understood that any increase in liabilities recorded or required to be recorded on such Person’s balance sheet shall be deemed to be an “incurrence” of Indebtedness by such Person at the time of
such increase); 
 (9) all Attributable Indebtedness; 

(10) to the extent not otherwise included in this definition, Hedging Obligations of such Person; 

(11) all obligations of such Person under conditional sale or other title retention agreements relating to assets purchased by
such Person; and 
 (12) the liquidation value of preferred stock of a Subsidiary of such Person issued and outstanding and
held by any Person other than such Person (or one of its Wholly Owned Restricted Subsidiaries). 
 Notwithstanding the foregoing the following shall not be
considered Indebtedness: (a) earn-outs or similar profit sharing or participation arrangements provided for in acquisition agreements which are determined on the basis of future operating earnings or other similar performance criteria (which
are not determinable at the time of acquisition) of the acquired assets or entities, (b) accrued expenses, trade payables, customer deposits or deferred income taxes arising in the ordinary course of business, (c) completion guarantees
entered into in the ordinary course of business, (d) obligations in respect of district improvement bonds pertaining to roads, sewers and other infrastructure and (e) Indebtedness that has been discharged or defeased in accordance with its
governing documents. 
 The amount of Indebtedness of any Person at any date shall be the outstanding balance at such date of all
unconditional obligations as described in this definition, the maximum liability of such Person for any such contingent obligations at such date and, in the case of clause (7) of this definition, the lesser of (a) the Fair Market Value of
any asset subject to a Lien securing the Indebtedness of others on the date that the Lien attaches and (b) the amount of the Indebtedness secured; provided, however, that the amount outstanding at any time of any Indebtedness
issued with original issue discount shall be deemed to be the face amount of such Indebtedness less the remaining unamortized portion of the original issue discount of such Indebtedness at such time, as determined in accordance with GAAP. For
purposes of clause (5) of this definition, the “maximum fixed redemption or repurchase price” of any Disqualified 

  
 14 

 
Equity Interests that do not have a fixed redemption or repurchase price shall be calculated in accordance with the terms of such Disqualified Equity Interests as if such Disqualified Equity
Interests were redeemed on any date on which an amount of Indebtedness outstanding shall be required to be determined pursuant to this Indenture. 

“Indenture” means this Indenture as amended or supplemented from time to time. 

“Independent Director” means a director of the Parent who 

(1) is independent with respect to the transaction at issue; 

(2) does not have any material financial interest in the Parent or any of its Affiliates (other than as a result of holding securities of the
Parent); and 
 (3) has not and whose Affiliates or affiliated firm has not, at any time during the twelve months prior to the taking of
any action hereunder, directly or indirectly, received, or entered into any understanding or agreement to receive, compensation, payment or other benefit, of any type or form, from the Parent or any of its Affiliates, other than customary
directors’ fees and indemnity and insurance arrangements for serving on the board of directors of the Parent or any Affiliate and reimbursement of out-of-pocket expenses for attendance at the Parent’s or Affiliate’s board and board
committee meetings. 
 “Independent Financial Advisor” means an accounting, appraisal or investment banking firm of
nationally recognized standing that is, in the reasonable judgment of the Parent’s board of directors, qualified to perform the task for which it has been engaged and disinterested and independent with respect to the Parent and its Affiliates;
provided, however, that the prior rendering of service to the Parent or an Affiliate of the Parent shall not, by itself, disqualify the advisor. 

“Intangible Assets” means, with respect to any Person, all unamortized debt discount and expense, unamortized deferred
charges, goodwill, patents, trademarks, service marks, trade names, copyrights, write-ups of assets over their carrying value (other than write-ups which occurred prior to the Issue Date and other than, in connection with the acquisition of an
asset, the write-up of the value of such asset to its Fair Market Value in accordance with GAAP on the date of acquisition) and all other items which would be treated as intangibles on the consolidated balance sheet of such Person prepared in
accordance with GAAP. 
 “interest” means, with respect to the Securities, interest on the Securities. 

“Investment Grade Rating” means a rating equal to or higher than Baa3 (or the equivalent) by Moody’s Investors Service,
Inc. and BBB- (or the equivalent) by Standard & Poor’s Ratings Group, Inc., or any other equivalent investment grade rating by any Rating Agency. 

“Investments” of any Person means, without duplication: 

(1) all direct or indirect investments by such Person in any other Person in the form of loans, advances or capital
contributions or other credit extensions constituting Indebtedness of such other Person, and any guarantee of Indebtedness of any other Person; 

  
 15 

 (2) all purchases (or other acquisitions for consideration) by such Person of
Indebtedness, Equity Interests or other securities of any other Person; 
 (3) all other items that would be classified as
investments on a balance sheet of such Person prepared in accordance with GAAP; and 
 (4) the Designation of any Subsidiary
as an Unrestricted Subsidiary. 
 Except as otherwise expressly specified in this definition, the amount of any Investment (other than an
Investment made in cash) shall be the Fair Market Value thereof on the date such Investment is made. The amount of any Investment pursuant to clause (4) of this definition shall be the Designation Amount determined in accordance with
Section 4.11. If the Parent or any Restricted Subsidiary sells or otherwise disposes of any Equity Interests of any direct or indirect Restricted Subsidiary such that, after giving effect to any such sale or disposition, such Person is no
longer a Restricted Subsidiary, the Parent shall be deemed to have made an Investment on the date of any such sale or other disposition equal to the Fair Market Value of the Equity Interests of and all other Investments in such Restricted Subsidiary
not sold or disposed of, which amount shall be determined by the board of directors of the Parent. Notwithstanding the foregoing, redemptions of Equity Interests of the Parent shall be deemed not to be Investments. 

“Issue Date” means March 31, 2014. 

“Joint Venture” means a corporation, limited liability company, partnership or other entity engaged in a Permitted Business
(other than an entity constituting a Subsidiary of the Parent) in which the Parent or any of its Restricted Subsidiaries owns, directly or indirectly, at least 20% of the Equity Interests. 

“Legal Holiday” means a Saturday, a Sunday or a day on which banking institutions are not required to be open in the State
of New York. 
 “Lien” means, with respect to any asset, any mortgage, deed of trust, lien (statutory or other), pledge,
lease, easement, restriction, covenant, charge, security interest or other encumbrance of any kind or nature in respect of such asset, whether or not filed, recorded or otherwise perfected under applicable law, including any conditional sale or
other title retention agreement, and any lease in the nature thereof, any option or other agreement to sell, and any filing of, or agreement to give, any financing statement under the Uniform Commercial Code (or equivalent statutes) of any
jurisdiction (other than cautionary filings in respect of operating leases). 
 “Net Available Proceeds” means, with
respect to any Asset Sale, the proceeds thereof in the form of cash or Cash Equivalents, net of 
 (1) brokerage commissions
and other fees and expenses (including fees and expenses of legal counsel, accountants and investment banks) of such Asset Sale; 

  
 16 

 (2) provisions for taxes payable as a result of such Asset Sale (after taking
into account any available tax credits or deductions and any tax sharing arrangements); 
 (3) amounts required to be paid to
any Person (other than the Parent or any Restricted Subsidiary) owning a beneficial interest in the assets subject to the Asset Sale or having a Lien thereon; 

(4) payments of unassumed liabilities (not constituting Indebtedness) relating to the assets sold at the time of, or within 30
days after the date of, such Asset Sale; and 
 (5) appropriate amounts to be provided by the Parent or any Restricted
Subsidiary, as the case may be, as a reserve required in accordance with GAAP against any liabilities associated with such Asset Sale and retained by the Parent or any Restricted Subsidiary, as the case may be, after such Asset Sale, including
pensions and other postemployment benefit liabilities, liabilities related to environmental matters and liabilities under any indemnification obligations associated with such Asset Sale; provided, however, that any amounts remaining after
adjustments, revaluations or liquidations of such reserves shall constitute Net Available Proceeds. 
 “Non-Recourse
Indebtedness” with respect to any Person means Indebtedness of such Person for which (1) the sole legal recourse for collection of principal and interest on such Indebtedness is against the specific property identified in the
instruments evidencing or securing such Indebtedness and such property was acquired with the proceeds of such Indebtedness or such Indebtedness was incurred within 365 days after the acquisition of such property and (2) no other assets of such
Person may be realized upon in collection of principal or interest on such Indebtedness. Indebtedness that is otherwise Non-Recourse Indebtedness will not lose its character as Non-Recourse Indebtedness because there is recourse for
(a) environmental warranties or indemnities, indemnities for and liabilities arising from fraud, misrepresentation, misapplication or non-payment of rents, profits, insurance and condemnation proceeds and other sums actually received by the
obligor from secured assets to be paid to the lender, waste and mechanics liens or (c) similar customary “bad-boy” guarantees. 

“Obligations” means with respect to any Indebtedness, all obligations for principal, premium, interest, penalties, fees,
indemnifications, reimbursements, and other amounts payable pursuant to the documentation governing such Indebtedness. 

“Officer” of any Person means any of the following of such Person: the Chairman of the board of directors, the Chief
Executive Officer, the Chief Financial Officer, the President, any Vice President, the Treasurer or the Secretary. 

“Officers’ Certificate” of any Person means a certificate signed by two Officers of such Person. 

“Opinion of Counsel” means a written opinion from legal counsel who is reasonably acceptable to the Trustee. The counsel may
be an employee of or counsel to the Company or the Trustee. 
 “Parent” means William Lyon Homes, a Delaware corporation,
and its successors. 

  
 17 

 “Pari Passu Indebtedness” means any Indebtedness of the Company or any
Guarantor that ranks pari passu as to payment with the Securities or the Security Guarantee of such Guarantor, as applicable. 

“Permitted Business” means the businesses engaged in by the Parent and its Subsidiaries on the Issue Date and businesses
that are reasonably related thereto or reasonable extensions thereof. 
 “Permitted Business Investments” means
Investments and expenditures made in the ordinary course of a Permitted Business as a means of acquiring or developing land or constructing residential communities through agreements, transactions, interests or arrangements that, among other things,
permit a Person to share (or have the effect of sharing) risks or costs, to participate in (or have the effect of participating in) the economics of residential development projects or to comply with any regulatory agreements or requirements
Investments in the form of or pursuant to joint development agreements, partnership agreements, limited liability company agreements, trust agreements, joint venture agreements or other similar agreements with third parties. 

“Permitted Holders” means 

(i) Luxor Capital Group LP, Paulson & Co. and their respective Affiliates and all investment funds managed by any of
the foregoing (excluding, for the avoidance of doubt, their respective portfolio companies or other operating companies affiliated with Luxor Capital Group LP and Paulson & Co.), 

(ii) General William Lyon, his spouse and lineal descendants (including adopted children and their lineal descendants) or any
Person controlled, directly or indirectly, by, or trust or similar estate planning vehicle established exclusively for the benefit of, any of such Persons, 

(iii) any Person or any of the Persons who were a group (within the meaning of Section 13(d)(3) or Section 14(d)(2)
of the Exchange Act, or any successor provision) whose ownership of assets or Voting Stock has triggered a Change of Control in respect of which a Change of Control Offer has been made and all Securities that were tendered therein have been accepted
and paid, 
 (iv) any group (within the meaning of Section 13(d)(3) or Section 14(d)(2) of the Exchange Act or any
successor provision) of which any of the foregoing beneficially own, without giving effect to the existence of such group or any other group, more than 50.0% of the total voting power of the aggregate Voting Stock of the Parent held directly or
indirectly by such group and 
 (v) any members of a group described in clause (iv) of this definition for so long as
such Person is a member of such group. 

  
 18 

 “Permitted Investment” means: 

(1) Investments by the Parent or any Restricted Subsidiary in (a) the Company or any Guarantor or (b) in any Person
that is or will become immediately after such Investment a Restricted Subsidiary or that will merge or consolidate into the Company or a Restricted Subsidiary; 

(2) Investments in the Parent by any Restricted Subsidiary; 

(3) loans and advances to directors, employees and officers of the Parent and the Restricted Subsidiaries for bona fide
business purposes and to purchase Equity Interests of the Parent not in excess of $2,000,000 at any one time outstanding; 

(4) Hedging Obligations incurred pursuant to Section 4.03(b)(4); 

(5) Cash Equivalents; 

(6) receivables owing to the Parent or any Restricted Subsidiary if created or acquired in the ordinary course of business and
payable or dischargeable in accordance with customary trade terms; provided, however, that such trade terms may include such concessionary trade terms as the Parent or any such Restricted Subsidiary deems reasonable under the
circumstances; 
 (7) Investments received pursuant to any plan of reorganization or similar arrangement, including
foreclosure, perfection or enforcement of any Lien, upon the bankruptcy or insolvency of such trade creditors or customers; 

(8) Investments made by the Parent or any Restricted Subsidiary as a result of consideration received in connection with an
Asset Sale made in compliance with Section 4.06; 
 (9) lease, utility and other similar deposits in the ordinary course
of business; 
 (10) Investments made by the Parent or a Restricted Subsidiary for consideration consisting only of Qualified
Equity Interests; 
 (11) stock, obligations or securities received in settlement of debts created in the ordinary course of
business and owing to the Parent or any Restricted Subsidiary or in satisfaction of judgments; 
 (12) Investments in
existence on the Issue Date and any extension, modification or renewal of such Investments or any Investments made with the proceeds of any disposition of any such Investments, but only to the extent not involving additional advances, contributions
or other Investments of cash or other assets or other increases thereof (other than as a result of the appreciation, accrual or accretion of interest or original issue discount or the issuance of pay-in-kind securities, in each case, pursuant to the
terms of such Investment as in effect on the Issue Date); 
 (13) completion guarantees entered into in the ordinary course
of business; 

  
 19 

 (14) the Designation of a Subsidiary as an Unrestricted Subsidiary in accordance
with Section 4.11; and 
 (15) Permitted Business Investments so long as immediately after giving effect to such
Investment, the Parent could incur at least $1.00 of additional Indebtedness pursuant to the Ratio Exception. 
 “Permitted
Liens” means the following types of Liens: 
 (1) (a) statutory Liens of landlords and Liens of carriers,
warehousemen, mechanics, suppliers, materialmen, repairmen and other Liens imposed by law incurred in the ordinary course of business and (b) Liens for taxes, assessments or governmental or quasi-governmental charges or claims, in either case,
for sums not yet delinquent or being contested in good faith, if such reserve or other appropriate provision, if any, as shall be required by GAAP shall have been made in respect thereof; 

(2) Liens incurred or deposits made in the ordinary course of business in connection with workers’ compensation,
unemployment insurance and other types of social security, or to secure the performance of tenders, statutory obligations, surety and appeal bonds, bids, leases, government contracts, performance and return-of-money bonds, development obligations,
progress payments, utility services, developer’s or other obligations to make on-site or off-site improvements and other similar obligations (exclusive of obligations for the payment of borrowed money); 

(3) Liens upon specific items of inventory or other goods and proceeds of any Person securing such Person’s obligations in
respect of bankers’ acceptances issued or created for the account of such Person to facilitate the purchase, shipment or storage of such inventory or other goods; 

(4) Liens securing reimbursement obligations with respect to commercial letters of credit which encumber documents, goods
covered thereby and other assets relating to such letters of credit and products and proceeds thereof; 
 (5) Liens
encumbering deposits made to secure obligations arising from statutory, regulatory, contractual or warranty requirements of the Parent or any Restricted Subsidiary, including rights of offset and setoff; 

(6) bankers’ Liens, rights of setoff and other similar Liens existing solely with respect to cash and Cash Equivalents on
deposit in one or more accounts maintained by the Parent or any Restricted Subsidiary, in each case granted in the ordinary course of business in favor of the bank or banks with which such accounts are maintained, securing amounts owing to such bank
with respect to cash management and operating account arrangements, including those involving pooled accounts and netting arrangements; provided that in no case shall any such Liens secure (either directly or indirectly) the repayment of any
Indebtedness; 
 (7) leases or subleases, licenses or sublicenses, (or any Liens related thereto) granted to others that do
not materially interfere with the ordinary course of business of the Parent or any Restricted Subsidiary; 

  
 20 

 (8) Liens arising from filing Uniform Commercial Code financing statements regarding leases; 

(9) Liens securing all of the Securities and Liens securing any Security Guarantee; 

(10) Liens in favor of the Trustee under and as permitted by this Indenture; 

(11) Liens existing on the Issue Date securing Indebtedness outstanding on the Issue Date; 

(12) Liens in favor of the Company or a Guarantor; 

(13) Liens securing Permitted Indebtedness incurred pursuant to and outstanding under Section 4.03(b)(1); 

(14) Liens securing Indebtedness in an amount not to exceed the greater of (x) $15.0 million and (y) 1.5% of Consolidated Tangible
Assets at the time of incurrence; 
 (15) Liens securing Non-Recourse Indebtedness of the Parent or any Restricted Subsidiary permitted to be
incurred under this Indenture; provided, that such Liens apply only to (a) the property financed out of the net proceeds of such Non-Recourse Indebtedness within 365 days after the incurrence of such Non-Recourse Indebtedness and
(b) Directly Related Assets; 
 (16) Liens securing Purchase Money Indebtedness permitted to be incurred under this Indenture; provided
that such Liens apply only to (a) the property acquired, constructed or improved with the proceeds of such Purchase Money Indebtedness within 365 days after the incurrence of such Purchase Money Indebtedness and (b) Directly Related
Assets; 
 (17) Liens securing Acquired Indebtedness permitted to be incurred under this Indenture; provided that the Liens do not extend to
assets not subject to such Lien at the time of acquisition (other than Directed Related Assets) and are no more favorable to the lienholders than those securing such Acquired Indebtedness prior to the incurrence of such Acquired Indebtedness by the
Parent or a Restricted Subsidiary; 
 (18) Liens on assets of a Person existing at the time such Person is acquired or merged with or into or
consolidated with the Parent or any such Restricted Subsidiary (and not created in anticipation or contemplation thereof); 
 (19) Liens to
secure Attributable Indebtedness permitted to be incurred under this Indenture; provided that any such Lien shall not extend to or cover any assets of the Parent or any Restricted Subsidiary other than (a) the assets which are the subject of
the Sale and Leaseback Transaction in which the Attributable Indebtedness is incurred and (b) Directly Related Assets; 

  
 21 

 (20) Liens securing Indebtedness of Parent or its Restricted Subsidiaries in respect of
Indebtedness of a Joint Venture permitted to be incurred under this Indenture; provided that, with respect to such Indebtedness, such Liens do not extend to assets of Parent or its Restricted Subsidiaries other than (x) assets of the Joint
Venture or (y) the Equity Interests held by Parent or a Restricted Subsidiary in such Joint Venture to the extent that such Liens secure Indebtedness in respect of such Joint Venture owing to lenders who have also been granted Liens on assets
of such Joint Venture to secure Indebtedness of such Joint Venture; 
 (21) Liens to secure Refinancing Indebtedness which is incurred to
refinance any Indebtedness which has been secured by a Lien permitted under this Indenture and which has been incurred in accordance with the provisions of this Indenture; provided that in each case such Liens do not extend to any additional assets
(other than Directly Related Assets); 
 (22) attachment or judgment Liens not giving rise to a Default and which are being contested in good
faith by appropriate proceedings; 
 (23) easements, rights-of-way, dedications, covenants, conditions, restrictions, reservations,
assessment district and other similar charges or encumbrances not materially interfering with the ordinary course of business of the Parent and its Subsidiaries; 

(24) zoning restrictions, licenses, restrictions on the use of real property or minor irregularities in title thereto, which do not materially
impair the use of such real property in the ordinary course of business of the Parent and its Subsidiaries or the value of such real property for the purpose of such business; 

(25) Liens on Equity Interests in an Unrestricted Subsidiary to the extent that such Liens secure Indebtedness of such Unrestricted Subsidiary
owing to lenders who have also been granted Liens on assets of such Unrestricted Subsidiary to secure such Indebtedness; 
 (26) any right of
first refusal, right of first offer, option, contract or other agreement to sell an asset; provided such sale is not otherwise prohibited under this Indenture; 

(27) Liens for homeowner and property owner association developments and assessments; 

(28) Licenses of intellectual property granted in the ordinary course of business and not interfering in any material respect with the ordinary
conduct of business of the Parent or any Restricted Subsidiary; 

  
 22 

 (29) pledges, deposits and other Liens existing under, or required to be made in connection with
(i) earnest money obligations, escrows or similar purpose undertakings or indemnifications in connection with any purchase and sale agreement, (ii) development agreements or other contracts entered into with governmental authorities (or an
entity sponsored by a governmental authority), in connection with the entitlement of real property or (iii) agreements for the funding of infrastructure, including in respect of the issuance of community facility district bonds, metro district
bonds, mello-roos bonds and subdivision improvement bonds, and similar bonding requirements arising in the ordinary course of business of a homebuilder 

(30) Liens, encumbrances or other restrictions not securing Indebtedness contained in any joint venture agreement entered into by the Parent or
any Restricted Subsidiary with respect to the equity interests issued by the relevant joint venture or the assets of such joint venture; 

(31) assignments of insurance or condemnation proceeds provided to landlords (or their mortgagees) pursuant to the terms of any lease of
property leased by the Parent or any Restricted Subsidiary, in each case with respect to the property so leased, and customary Liens and rights reserved in any lease for rent or for compliance with the terms of such lease; and 

(32) Liens on cash pledged to secure deductibles, retentions and other obligations to insurance providers in the ordinary course of business.

 “Person” means any individual, corporation, partnership, limited liability company, joint venture, incorporated or
unincorporated association, joint-stock company, trust, unincorporated organization or government or other agency or political subdivision thereof or other entity of any kind. 

“Plan of Liquidation” with respect to any Person, means a plan that provides for, contemplates or the effectuation of which
is preceded or accompanied by (whether or not substantially contemporaneously, in phases or otherwise): (1) the sale, lease, conveyance or other disposition of all or substantially all of the assets of such Person otherwise than as an entirety
or substantially as an entirety; and (2) the distribution of all or substantially all of the proceeds of such sale, lease, conveyance or other disposition of all or substantially all of the remaining assets of such Person to creditors and
holders of Equity Interests of such Person. 
 “Preferred Stock”, as applied to the Capital Stock of any Person, means
Capital Stock of any class or classes (however designated) which is preferred as to the payment of dividends or distributions, or as to the distribution of assets upon any voluntary or involuntary liquidation or dissolution of such Person, over
shares of Capital Stock of any other class of such Person. 
 “principal” means, with respect to the Securities, the
principal of, and premium, if any, on the Securities. 

  
 23 

 “Purchase Money Indebtedness” means Indebtedness, including Capitalized Lease
Obligations, of the Parent or any Restricted Subsidiary incurred for the purpose of financing all or any part of the purchase price of property, plant or equipment used in the business of the Parent or any Restricted Subsidiary or the cost of
installation, construction or improvement thereof; provided, however, that (1) the amount of such Indebtedness shall not exceed such purchase price or cost (including financing costs), (2) such Indebtedness shall not be secured by
any asset other than the specified asset being financed or, in the case of real property or fixtures, including additions and improvements, the real property to which such asset is attached and Directly Related Assets and (3) such Indebtedness
shall be incurred within 365 days after such acquisition of such asset by the Parent or such Restricted Subsidiary or such installation, construction or improvement. 

“Qualified Equity Interests” means Equity Interests of the Parent other than Disqualified Equity Interests. 

“Quotation Agent” means the Reference Treasury Dealer selected by the Trustee after consultation with the Company. 

“Rating Agency” means each of Standard & Poor’s Ratings Group, Inc. and Moody’s Investors Service, Inc.
or, if Standard & Poor’s Ratings Group, Inc. or Moody’s Investors Service, Inc. or both shall cease to rate the Securities, a nationally recognized statistical rating agency or agencies, as the case may be, selected by the Company
(as certified by a resolution of the Board of Directors) which shall be substituted for Standard & Poor’s Ratings Group, Inc. or Moody’s Investors Service, Inc. or both, as the case may be. 

“redeem” means to redeem, repurchase, purchase, defease, retire, discharge or otherwise acquire or retire for value; and
“redemption” shall have a correlative meaning. 
 “Reference Treasury Dealer” means Credit Suisse Securities
(USA) LLC and its successors and assigns and two other nationally recognized investment banking firms selected by the Company that are primary U.S. Government securities dealers. 

“Reference Treasury Dealer Quotations” means with respect to each Reference Treasury Dealer and any redemption date, the
average, as determined by the Trustee, of the bid and asked prices for the Comparable Treasury Issue, expressed in each case as a percentage of its principal amount, quoted in writing to the Trustee by such Reference Treasury Dealer at 5:00 p.m.,
New York City time, on the third Business Day immediately preceding such redemption date. 
 “Refinancing Indebtedness”
means Indebtedness of the Parent or a Restricted Subsidiary issued in exchange for, or the proceeds from the issuance and sale or disbursement of which are used substantially concurrently to redeem or refinance in whole or in part, or constituting
an amendment of, any Indebtedness of the Parent or any Restricted Subsidiary (the “Refinanced Indebtedness”) in a principal amount not in excess of the principal amount of the Refinanced Indebtedness so repaid or amended (plus the
amount of any premium paid, accrued and unpaid interest and the amount of expenses incurred by the Parent or any Restricted Subsidiary in connection with such repayment or amendment) (or, if such Refinancing

  
 24 

 
Indebtedness refinances Indebtedness under a revolving credit facility or other agreement providing a commitment for subsequent borrowings, with a maximum commitment not to exceed the maximum
commitment under such revolving credit facility or other agreement); provided that: 
 (1) if the Refinanced Indebtedness was
subordinated to or pari passu with the Securities or the Security Guarantees, as the case may be, then such Refinancing Indebtedness, by its terms, is expressly pari passu with (in the case of Refinanced Indebtedness that was pari passu with) or
subordinated in right of payment to (in the case of Refinanced Indebtedness that was subordinated to) the Securities or the Security Guarantees, as the case may be, at least to the same extent as the Refinanced Indebtedness; 

(2) the Refinancing Indebtedness is scheduled to mature either (a) no earlier than the Refinanced Indebtedness being repaid or amended
or (b) after the maturity date of the Securities; 
 (3) the portion, if any, of the Refinancing Indebtedness that is scheduled to
mature on or prior to the maturity date of the Securities has a Weighted Average Life to Maturity at the time such Refinancing Indebtedness is incurred that is equal to or greater than the Weighted Average Life to Maturity of the portion of the
Refinanced Indebtedness being repaid that is scheduled to mature on or prior to the maturity date of the Securities; and 
 (4) the
Refinancing Indebtedness is secured only to the extent, if at all, and by the assets, that the Refinanced Indebtedness being repaid, extended or amended is secured. 

“Restricted Payment” means any of the following: 

(1) the declaration or payment of any dividend or any other distribution on Equity Interests of the Parent or any Restricted
Subsidiary or any payment made to the direct or indirect holders (in their capacities as such) of Equity Interests of the Parent or any Restricted Subsidiary, including any payment in connection with any merger or consolidation involving the Parent
or the Company, but excluding (a) dividends or distributions payable solely in Qualified Equity Interests and (b) in the case of Restricted Subsidiaries, dividends or distributions payable to the Parent or to a Restricted Subsidiary and
pro rata dividends or distributions payable to minority stockholders of any Restricted Subsidiary; 
 (2) the redemption of
any Equity Interests of the Parent or any Restricted Subsidiary, including any payment in connection with any merger or consolidation involving the Parent or the Company, but excluding any such Equity Interests held by the Parent or any Restricted
Subsidiary; 
 (3) any Investment other than a Permitted Investment; or 

(4) any payment on or with respect to, or redemption of, any Subordinated Indebtedness of the Company or any Subsidiary
Guarantor (excluding any intercompany Indebtedness between or among the Parent and any of its Restricted Subsidiaries), except (i) a payment of interest or principal at the Stated Maturity thereof or (ii) the redemption

  
 25 

 
of any such Subordinated Indebtedness purchased in anticipation of satisfying a sinking fund obligation, principal installment or payment at final maturity, in each case due within one year of
the date of purchase, repurchase or other acquisition 
 “Restricted Subsidiary” means any Subsidiary of the Parent other
than an Unrestricted Subsidiary. 
 “Sale and Leaseback Transaction” means, with respect to any Person, an arrangement
with any bank, insurance company or other lender or investor or to which such lender or investor is a party, providing for the leasing by such Person of any asset of such Person which has been or is being sold or transferred by such Person to such
lender or investor or to any Person to whom funds have been or are to be advanced by such lender or investor on the security of such asset. 

“SEC” means the U.S. Securities and Exchange Commission. 

“Secretary’s Certificate” means a certificate signed by the Secretary of the Parent. 

“Securities Act” means the U.S. Securities Act of 1933, as amended. 

“Security Guarantee” means the guarantee of the Securities executed by each Guarantor and the notation thereof executed
pursuant to the provisions of this Indenture. 
 “Significant Subsidiary” means (1) any Restricted Subsidiary (other
than the Company) that would be a “significant subsidiary” as defined in Regulation S-X promulgated pursuant to the Securities Act as such Regulation is in effect on the Issue Date and (2) any Restricted Subsidiary (other than the
Company) that, when aggregated with all other Restricted Subsidiaries (other than the Company) that are not otherwise Significant Subsidiaries and as to which any event described in Section 6.01(7) or (8) has occurred and is continuing,
would constitute a Significant Subsidiary under clause (1) of this definition. 
 “Stated Maturity” means, with
respect to any security, the date specified in such security as the fixed date on which the final payment of principal of such security is due and payable, including pursuant to any mandatory redemption provision (but excluding any provision
providing for the repurchase of such security at the option of the holder thereof upon the happening of any contingency beyond the control of the issuer unless such contingency has occurred). 

“Subordinated Indebtedness” means Indebtedness of the Company or any Guarantor that is subordinated in right of payment to
the Securities or the Security Guarantees, respectively. 
 “Subsidiary” means, with respect to any Person, any
corporation, limited liability company, partnership, association or other business entity that is or is required to be consolidated in the consolidated financial statements of such Person in accordance with GAAP. Unless otherwise specified,
“Subsidiary” refers to a Subsidiary of the Parent. 
 “Subsidiary Guarantor” means any Guarantor other than the
Parent. 

  
 26 

 “TIA” means the Trust Indenture Act of 1939 (15 U.S.C.
§§ 77aaa-77bbbb) as in effect on the date of this Indenture. 
 “Trustee” means the party named as such in
this Indenture until a successor replaces it and, thereafter, means the successor. 
 “Trust Officer” means the Chairman
of the Board, the President or any other officer or assistant officer of the Trustee assigned by the Trustee to administer its corporate trust matters. 

“Uniform Commercial Code” means the New York Uniform Commercial Code as in effect from time to time. 

“Unrestricted Subsidiary” means (1) any Subsidiary that at the time of determination shall be designated an
Unrestricted Subsidiary by the Board of Directors of the Parent in accordance with Section 4.11 and (2) any Subsidiary of an Unrestricted Subsidiary. 

“U.S. Government Obligations” means direct non-callable obligations of, or obligations guaranteed by, the United States of
America for the payment of which guarantee or obligations the full faith and credit of the United States is pledged. 
 “Voting
Stock” with respect to any Person, means securities of any class of Equity Interests of such Person entitling the holders thereof (whether at all times or only so long as no senior class of stock or other relevant equity interest has voting
power by reason of any contingency) to vote in the election of members of the board of directors of such Person. 
 “Weighted
Average Life to Maturity” when applied to any Indebtedness at any date, means the number of years obtained by dividing (1) the sum of the products obtained by multiplying (a) the amount of each then remaining installment, sinking
fund, serial maturity or other required payment of principal, including payment at final maturity, in respect thereof by (b) the number of years (calculated to the nearest one-twelfth) that will elapse between such date and the making of such
payment by (2) the then outstanding principal amount of such Indebtedness. 
 “Wholly Owned Restricted Subsidiary”
means a Restricted Subsidiary of which 100% of the Equity Interests (except for directors’ qualifying shares or certain minority interests owned by other Persons solely due to local law requirements that there be more than one stockholder, but
which interest is not in excess of what is required for such purpose) are owned directly by the Parent or through one or more Wholly-Owned Restricted Subsidiaries. 

“Wholly Owned Subsidiary” means a Subsidiary of which 100% of the Equity Interests (except for directors’ qualifying
shares or certain minority interests owned by other Persons solely due to local law requirements that there be more than one stockholder, but which interest is not in excess of what is required for such purpose) are owned directly by the Parent or
through one or more Wholly-Owned Subsidiaries. 
  

  
 27 

 SECTION 1.02. Other Definitions. 

 

			
	 Term
	  	 Defined in
Section

		
	 “Affiliate Transaction”
	  	4.07(a)
		
	 “Asset Sale Offer”
	  	4.06(c)
		
	 “Bankruptcy Law”
	  	6.01
		
	 “Change of Control Offer”
	  	4.10(b)
		
	 “covenant defeasance option”
	  	8.01(b)
		
	 “Custodian”
	  	6.01
		
	 “Designation”
	  	4.11
		
	 “Designation Amount”
	  	4.11
		
	 “Event of Default”
	  	6.01
		
	 “Excess Proceeds”
	  	4.06(c)
		
	 “Guaranteed Obligations”
	  	10.01
		
	 “legal defeasance option”
	  	8.01(b)
		
	 “Mortgage Subsidiary”
	  	4.03(b)(13)
		
	 “Paying Agent”
	  	2.03
		
	 “Permitted Indebtedness”
	  	4.03(b)
		
	 “Ratio Exception”
	  	4.03(a)
		
	 “Redesignation”
	  	4.11
		
	 “Registrar”
	  	2.03
		
	 “Reinstatement Date”
	  	4.08(b)
		
	 “Restricted Payments Basket”
	  	4.04(a)(3)
		
	 “Suspension Date”
	  	4.08(a)
		
	 “Successor”
	  	5.01(a)(1)
		
	“Triggering Lien”	  	4.12

  
 28 

 SECTION 1.03. Incorporation by Reference of Trust Indenture Act. This Indenture is
subject to the mandatory provisions of the TIA which are incorporated by reference in and made a part of this Indenture. The following TIA terms have the following meanings: 

“Commission” means the SEC; 

“indenture securities” means the Securities and the Security Guarantees; 

“indenture security holder” means a Securityholder; 

“indenture to be qualified” means this Indenture; 

“indenture trustee” or “institutional trustee” means the Trustee; and 

“obligor” on the indenture securities means the Company, each Guarantor and any other obligor on the Securities. 

All other TIA terms used in this Indenture that are defined by the TIA, defined by TIA reference to another statute or defined by SEC rule
have the meanings assigned to them by such definitions. 
 SECTION 1.04. Rules of Construction. Unless the context otherwise
requires: 
 (1) a term has the meaning assigned to it; 

(2) an accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP; 

(3) “or” is not exclusive; 

(4) “including” means including without limitation; 

(5) words in the singular include the plural and words in the plural include the singular; 

(6) Indebtedness shall not be considered subordinate in right of payment to any other Indebtedness solely by virtue of being
unsecured, secured with a subset of the collateral securing such other Indebtedness or with different collateral, secured to a lesser extent or secured with lower priority, by virtue of structural subordination, by virtue of maturity date, order of
payment or order of application of funds, or by virtue of not being guaranteed by all guarantors of such other Indebtedness, and any subordination in right of payment must be pursuant to a written agreement or instrument; 

  
 29 

 (7) the principal amount of any noninterest bearing or other discount security at
any date shall be the principal amount thereof that would be shown on a balance sheet of the issuer dated such date prepared in accordance with GAAP; 

(8) the principal amount of any Preferred Stock shall be (A) the maximum liquidation value of such Preferred Stock or
(B) the maximum mandatory redemption or mandatory repurchase price with respect to such Preferred Stock, whichever is greater; and 

(9) all references to the date the Securities were originally issued shall refer to the Issue Date. 

ARTICLE 2 
 THE SECURITIES

 SECTION 2.01. Form and Dating. Provisions relating to the Initial Securities, the Private Exchange Securities and the Exchange
Securities are set forth in the Rule 144A/Regulation S Appendix attached hereto (the “Appendix”) which is hereby incorporated in, and expressly made part of, this Indenture. The Initial Securities and the Trustee’s
certificate of authentication shall be substantially in the form of Exhibit 1 to the Appendix which is hereby incorporated in, and expressly made a part of, this Indenture. The Exchange Securities, the Private Exchange Securities and the
Trustee’s certificate of authentication shall be substantially in the form of Exhibit A, which is hereby incorporated in and expressly made a part of this Indenture. The Securities may have notations, legends or endorsements required by law,
stock exchange rule, agreements to which the Company is subject, if any, or usage (provided that any such notation, legend or endorsement is in a form acceptable to the Company). Each Security shall be dated the date of its authentication. The terms
of the Securities set forth in the Appendix and Exhibit A are part of the terms of this Indenture. 
 SECTION 2.02. Execution
and Authentication. Two Officers shall sign the Securities for the Company by manual or facsimile signature. 
 If an Officer whose
signature is on a Security no longer holds that office at the time the Trustee authenticates the Security, the Security shall be valid nevertheless. 

A Security shall not be valid until an authorized signatory of the Trustee manually signs the certificate of authentication on the Security.
The signature shall be conclusive evidence that the Security has been authenticated under this Indenture. 
 On the Issue Date, the Trustee
shall authenticate and deliver $150,000,000 of 5.75% Senior Notes Due 2019 and, at any time and from time to time thereafter, the Trustee shall authenticate and deliver Securities for original issue in an aggregate principal amount specified in such
order, in each case upon a written order of the Company signed by two Officers or by an Officer and either an Assistant Treasurer or an Assistant Secretary of the Company. Such order shall specify the amount of the Securities to be authenticated and
the date on which the original issue of Securities is to be authenticated and, in the case of an issuance of Additional Securities pursuant to Section 2.13 after the Issue Date, shall certify that such issuance is in compliance with
Section 4.03. 

  
 30 

 The Trustee may appoint an authenticating agent reasonably acceptable to the Company to
authenticate the Securities. Unless limited by the terms of such appointment, an authenticating agent may authenticate Securities whenever the Trustee may do so. Each reference in this Indenture to authentication by the Trustee includes
authentication by such agent. An authenticating agent has the same rights as any Registrar, Paying Agent or agent for service of notices and demands. 

SECTION 2.03. Registrar and Paying Agent. The Company shall maintain an office or agency where Securities may be presented for
registration of transfer or for exchange (the “Registrar”) and an office or agency where Securities may be presented for payment (the “Paying Agent”). The Registrar shall keep a register of the Securities and of
their transfer and exchange. The Company may have one or more co-registrars and one or more additional paying agents. The term “Paying Agent” includes any additional paying agent. 

The Company shall enter into an appropriate agency agreement with any Registrar, Paying Agent or co-registrar not a party to this Indenture,
which shall incorporate the terms of the TIA. The agreement shall implement the provisions of this Indenture that relate to such agent. The Company shall notify the Trustee of the name and address of any such agent. If the Company fails to maintain
a Registrar or Paying Agent, the Trustee shall act as such and shall be entitled to appropriate compensation therefor pursuant to Section 7.07. The Company or any Wholly Owned Restricted Subsidiary incorporated or organized within The United
States of America may act as Paying Agent, Registrar, co-registrar or transfer agent. 
 The Company initially appoints the Trustee as
Registrar and Paying Agent in connection with the Securities. 
 SECTION 2.04. Paying Agent To Hold Money in Trust. Prior to each
due date of the principal and interest on any Security, the Company shall deposit with the Paying Agent a sum sufficient to pay such principal and interest when so becoming due. The Company shall require each Paying Agent (other than the Trustee) to
agree in writing that the Paying Agent shall hold in trust for the benefit of Securityholders or the Trustee all money held by the Paying Agent for the payment of principal of or interest on the Securities and shall notify the Trustee of any default
by the Company in making any such payment. If the Company or a Subsidiary acts as Paying Agent, it shall segregate the money held by it as Paying Agent and hold it as a separate trust fund. The Company at any time may require a Paying Agent to pay
all money held by it to the Trustee and to account for any funds disbursed by the Paying Agent. Upon complying with this Section 2.04, the Paying Agent shall have no further liability for the money delivered to the Trustee. 

SECTION 2.05. Securityholder Lists. The Trustee shall preserve in as current a form as is reasonably practicable the most recent list
available to it of the names and addresses of Securityholders. If the Trustee is not the Registrar, the Company shall furnish, or cause the Registrar to furnish, to the Trustee, in writing at least five Business Days before each interest payment
date and at such other times as the Trustee may request in writing, a list in such form and as of such date as the Trustee may reasonably require of the names and addresses of Securityholders. 

  
 31 

 SECTION 2.06. Transfer and Exchange. The Securities shall be issued in registered form
and shall be transferable only upon the surrender of a Security for registration of transfer. When a Security is presented to the Registrar or a co-registrar with a request to register a transfer, the Registrar shall register the transfer as
requested if the requirements of this Indenture and Section 8-401(1) of the Uniform Commercial Code are met. When Securities are presented to the Registrar or a co-registrar with a request to exchange them for an equal principal amount of
Securities of other denominations, the Registrar shall make the exchange as requested if the same requirements are met. Without the prior consent of the Company, the Registrar is not required (1) to register the transfer of or exchange any
Security selected for redemption, (2) to register the transfer of or exchange any Security for a period of 15 days before a selection of Securities to be redeemed or (3) to register the transfer or exchange of a Security between a record
date and the next succeeding interest payment date. 
 SECTION 2.07. Replacement Securities. If a mutilated Security is surrendered
to the Registrar or if the Holder of a Security claims that the Security has been lost, destroyed or wrongfully taken, the Company shall issue and the Trustee shall authenticate a replacement Security if the requirements of Section 8-405 of the
Uniform Commercial Code are met and the Holder satisfies any other reasonable requirements of the Trustee. If required by the Trustee or the Company, such Holder shall furnish an indemnity bond sufficient in the judgment of the Company and the
Trustee to protect the Company, the Trustee, the Paying Agent, the Registrar and any co-registrar from any loss which any of them may suffer if a Security is replaced. The Company and the Trustee may charge the Holder for their expenses in replacing
a Security. 
 Every replacement Security is an additional Obligation of the Company. 

SECTION 2.08. Outstanding Securities. Securities outstanding at any time are all Securities authenticated by the Trustee except for
those canceled by it, those delivered to it for cancellation and those described in this Section as not outstanding. A Security does not cease to be outstanding because the Company or an Affiliate of the Company holds the Security. 

If a Security is replaced pursuant to Section 2.07, it ceases to be outstanding unless the Trustee and the Company receive proof
satisfactory to them that the replaced Security is held by a protected purchaser (as defined in Section 8-303 of the Uniform Commercial Code). 

If the Paying Agent segregates and holds in trust, in accordance with this Indenture, on a redemption date or maturity date money sufficient
to pay all principal and interest payable on that date with respect to the Securities (or portions thereof) to be redeemed or maturing, as the case may be, then on and after that date such Securities (or portions thereof) cease to be outstanding and
interest on them ceases to accrue. 
 SECTION 2.09. Temporary Securities. Until definitive Securities are ready for delivery, the
Company may prepare and the Trustee shall authenticate temporary Securities. Temporary Securities shall be substantially in the form of definitive Securities but may have 

  
 32 

 
variations that the Company considers appropriate for temporary Securities. Without unreasonable delay, the Company shall prepare and the Trustee shall authenticate definitive Securities and
deliver them in exchange for temporary Securities. 
 SECTION 2.10. Cancellation. The Company at any time may deliver Securities to
the Trustee for cancellation. The Registrar and the Paying Agent shall forward to the Trustee any Securities surrendered to them for registration of transfer, exchange or payment. The Trustee and no one else shall cancel and destroy (subject to the
record retention requirements of the Exchange Act) all Securities surrendered for registration of transfer, exchange, payment or cancellation and deliver a certificate of such destruction to the Company unless the Company directs the Trustee to
deliver canceled Securities to the Company. The Company may not issue new Securities to replace Securities it has redeemed, paid or delivered to the Trustee for cancellation. 

SECTION 2.11. Defaulted Interest. If the Company defaults in a payment of interest on the Securities, the Company shall pay defaulted
interest (plus interest on such defaulted interest to the extent lawful) in any lawful manner. The Company may pay the defaulted interest to the Persons who are Securityholders on a subsequent special record date. The Company shall fix or cause to
be fixed any such special record date and payment date to the reasonable satisfaction of the Trustee and shall promptly mail to each Securityholder a notice that states the special record date, the payment date and the amount of defaulted interest
to be paid. 
 SECTION 2.12. CUSIP Numbers, ISINs, etc. The Company in issuing the Securities may use “CUSIP” numbers,
ISINs and “Common Code” numbers (in each case if then generally in use) and, if so, the Trustee shall use “CUSIP” numbers, ISINs and “Common Code” numbers in notices of redemption as a convenience to Holders;
provided, however, that any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Securities or as contained in any notice of a redemption and that reliance
may be placed only on the other identification numbers printed on the Securities, and any such redemption shall not be affected by any defect in or omission of such numbers. The Company shall advise the Trustee in writing of any change in any
“CUSIP” numbers, ISINs or “Common Code” numbers applicable to the Securities. 
 SECTION 2.13. Issuance of
Additional Securities. After the Issue Date, the Company shall be entitled, subject to its compliance with Section 4.03, to issue Additional Securities under this Indenture, which Securities shall have identical terms as the Initial
Securities issued on the Issue Date, other than with respect to the date of issuance and issue price. All the Securities issued under this Indenture shall be treated as a single class for all purposes of this Indenture including waivers, amendments,
redemptions and offers to purchase. 

  
 33 

 With respect to any Additional Securities, the Company shall set forth in a resolution of the
Board of Directors and an Officers’ Certificate, a copy of each which shall be delivered to the Trustee, the following information: 

(1) the aggregate principal amount of such Additional Securities to be authenticated and delivered pursuant to this Indenture
and the provision of Section 4.03 that the Company is relying on to issue such Additional Securities; 
 (2) the issue
price, the issue date and the CUSIP number of such Additional Securities; provided, however, that a separate CUSIP number will be issued for any Additional Securities unless the Securities and the Additional Securities
are fungible for U.S. federal income tax purposes; and 
 (3) whether such Additional Securities shall be Initial Securities
or shall be issued in the form of Exchange Securities as set forth in Exhibit A. 
 ARTICLE 3 

REDEMPTION 
 SECTION
3.01. Notices to Trustee. If the Company elects to redeem Securities pursuant to paragraph 5 of the Securities, it shall notify the Trustee in writing of the redemption date, the principal amount of Securities to be redeemed and the
paragraph of the Securities pursuant to which the redemption will occur. 
 The Company shall give each notice to the Trustee provided for
in this Section at least 60 days before the redemption date unless the Trustee consents to a shorter period. Such notice shall be accompanied by an Officers’ Certificate and an Opinion of Counsel from the Company to the effect that such
redemption will comply with the conditions herein. 
 SECTION 3.02. Selection of Securities to Be Redeemed. If fewer than all the
Securities are to be redeemed, the Trustee shall select the Securities to be redeemed in compliance with the requirements of the principal national securities exchange, if any, on which the Securities are listed; or if the Securities are not then
listed on a national security exchange, on a pro rata basis, by lot or by such method as the Trustee shall deem fair and appropriate. The Trustee shall make the selection from outstanding Securities not previously called for redemption. The Trustee
may select for redemption portions of the principal of Securities that have denominations larger than $2,000. Securities and portions of them the Trustee selects shall be in principal amounts of $2,000 or any greater integral multiple of $1,000
thereof. Provisions of this Indenture that apply to Securities called for redemption also apply to portions of Securities called for redemption. The Trustee shall notify the Company promptly of the Securities or portions of Securities to be
redeemed. 
 SECTION 3.03. Notice of Redemption. At least 30 days but not more than 60 days before a date for redemption of
Securities, the Company shall mail a notice of redemption by first-class mail to each Holder of Securities to be redeemed at such Holder’s registered address, except that redemption notices may be mailed more than 60 days prior to the
redemption date if the notice is issued in connection with a defeasance of the Securities or a satisfaction and discharge of this Indenture. Any inadvertent defect in the notice of redemption, including an inadvertent failure to give notice, to any
Holder selected for redemption shall not impair or affect the validity of the redemption of any other Security redeemed in accordance with provisions of this Indenture. 

  
 34 

 The notice shall identify the Securities to be redeemed and shall state: 

(1) the redemption date; 

(2) the redemption price; 

(3) the name and address of the Paying Agent; 

(4) that Securities called for redemption must be surrendered to the Paying Agent to collect the redemption price; 

(5) if fewer than all the outstanding Securities are to be redeemed, the identification and principal amounts of the particular
Securities to be redeemed; 
 (6) that, unless the Company defaults in making such redemption payment, interest on Securities
(or portion thereof) called for redemption ceases to accrue on and after the redemption date; 
 (7) the “CUSIP”
number, ISIN or “Common Code” number, if any, printed on the Securities being redeemed; and 
 (8) that no
representation is made as to the correctness or accuracy of the “CUSIP” number, ISIN, or “Common Code” number, if any, listed in such notice or printed on the Securities. 

At the Company’s request, the Trustee shall give the notice of redemption in the Company’s name and at the Company’s expense.
In such event, the Company shall provide the Trustee with the information required by this Section. 
 SECTION 3.04. Effect of Notice of
Redemption. Once notice of redemption is mailed, Securities called for redemption become due and payable on the redemption date and at the redemption price stated in the notice. Upon surrender to the Paying Agent, such Securities shall be paid
at the redemption price stated in the notice, plus accrued interest to the redemption date (subject to the right of Holders of record on the relevant record date to receive interest due on the related interest payment date), and such Securities
shall be canceled by the Trustee. Failure to give notice or any defect in the notice to any Holder shall not affect the validity of the notice to any other Holder. 

SECTION 3.05. Deposit of Redemption Price. Prior to the redemption date, the Company shall deposit with the Paying Agent (or, if the
Company or a Subsidiary is the Paying Agent, shall segregate and hold in trust) money sufficient to pay the redemption price of and accrued interest on all Securities to be redeemed on that date other than Securities or portions of Securities called
for redemption which have been delivered by the Company to the Trustee for cancellation. 

  
 35 

 SECTION 3.06. Securities Redeemed in Part. Upon surrender of a Security that is redeemed
in part, the Company shall execute and the Trustee shall authenticate for the Holder (at the Company’s expense) a new Security equal in principal amount to the unredeemed portion of the Security surrendered. 

ARTICLE 4 
 COVENANTS 

SECTION 4.01. Payment of Securities. The Company shall promptly pay the principal of and interest on the Securities on the dates and
in the manner provided in the Securities and in this Indenture. Principal and interest shall be considered paid on the date due if on such date the Trustee or the Paying Agent holds in accordance with this Indenture money sufficient to pay all
principal and interest then due. 
 The Company shall pay interest on overdue principal at the rate specified therefor in the Securities,
and it shall pay interest on overdue installments of interest at the same rate to the extent lawful. 
 SECTION 4.02. Reports to
Holders. Whether or not required by the SEC, the Parent shall furnish to the Holders of Securities, within the time periods specified in the SEC’s rules and regulations (including any grace periods or extensions permitted by the SEC):
(1) all quarterly and annual financial information that would be required to be contained in a filing with the SEC on Forms 10-Q and 10-K if the Parent were required to file these Forms, including a “Management’s Discussion and
Analysis of Financial Condition and Results of Operations” and, with respect to the annual information only, an audit report on the annual financial statements by the Parent’s certified independent accountants and (2) all current
reports that would be required to be filed with the SEC on Form 8-K if the Parent were required to file these reports. 
 In addition,
whether or not required by the SEC, the Parent shall file a copy of all of the information and reports referred to in clauses (1) and (2) of this Section 4.02 with the SEC for public availability within the time periods specified in
the SEC’s rules and regulations (unless the SEC will not accept the filing) and make the information available to securities analysts and prospective investors upon request. 

At any time that there shall be one or more Unrestricted Subsidiaries that, in the aggregate, hold more than 15.0% of Consolidated Tangible
Assets, the quarterly and annual financial information required by the preceding paragraph shall include a reasonably detailed presentation, either on the face of the financial statements or in the footnotes thereto of the financial condition and
results of operations of the Parent and its Restricted Subsidiaries separate from the financial condition and results of operations of the Unrestricted Subsidiaries. 

In addition, for so long as any Securities remain outstanding, if at any time the Parent is not required to file with the SEC the reports
required by the preceding paragraphs, it shall furnish to the Holders of the Securities and prospective investors, upon their request, the information required to be delivered pursuant to Rule 144A(d)(4) under the Securities Act. 

  
 36 

 In addition, the Parent shall: (1) hold a quarterly conference call to discuss the
information contained in the reports not later than ten business days from the time Parent furnishes the reports to the trustee and (2) no fewer than three business days prior to the date of the conference call required to be held in accordance
with clause (1) of this Section 4.02, issue a press release to the appropriate U.S. wire services announcing the time and date of such conference call and directing the holders or beneficial owners of, and prospective investors in, the
securities and securities analysts and market makers to contact an individual at the Parent (for whom contact information shall be provided in such press release) to obtain the reports and information on how to access such conference call. 

The Company will also deliver to the Trustee, within 90 days after the end of each fiscal year, an Officers’ Certificate stating that,
to the signing Officers’ knowledge, no Default has occurred under this Indenture, or, if a Default has occurred, what action the Company and/or Guarantors are taking or propose to take with respect thereto. 

SECTION 4.03. Limitations on Additional Indebtedness. (a) The Parent shall not, and shall not permit any Restricted Subsidiary
to, directly or indirectly, incur any Indebtedness; provided, however, Parent, the Company or any Subsidiary Guarantor may incur additional Indebtedness (including Acquired Indebtedness) if no Default shall have occurred and be
continuing at the time of or as a consequence of the incurrence of the Indebtedness and if, after giving effect thereto, either (a) the Consolidated Fixed Charge Coverage Ratio would be at least 2.00 to 1.00 or (b) the ratio of
Consolidated Indebtedness to Consolidated Tangible Net Worth would be less than 3.00 to 1.00 (either (a) or (b), the “Ratio Exception”)).  

(b) Notwithstanding Section 4.03(a), so long as no Default shall have occurred and be continuing at the time of or as a consequence of
the incurrence of the following Indebtedness, each of the following shall be permitted (the “Permitted Indebtedness”): 

(1) the incurrence by the Company or any Subsidiary Guarantor (and the Guarantee thereof by the Parent, the Company or any such
Subsidiary Guarantor) of Indebtedness (including Refinancing Indebtedness) under Credit Facilities in an aggregate principal amount at any one time outstanding under this Section 4.03(b)(1) (with letters of credit being deemed to have a
principal amount equal to the maximum potential liability of the Company and its Restricted Subsidiaries thereunder) not to exceed the greater of $200,000,000 and 20% of Consolidated Tangible Assets; 

(2) the Securities and the Security Guarantees issued on the Issue Date and the Exchange Securities and Security Guarantees
issued in exchange therefor; 
 (3) Indebtedness of the Parent, the Company and the Guarantors to the extent outstanding on
the Issue Date (other than Indebtedness referred to in Section 4.03(b) (1) and (2)) ; 
 (4) Indebtedness of
the Parent and the Restricted Subsidiaries under Hedging Obligations; provided that (a) such Hedging Obligations relate to payment obligations on Indebtedness otherwise permitted to be incurred by this Section 4.03, and (b) the
notional principal amount of such Hedging Obligations at the time incurred does not exceed the principal amount of the Indebtedness to which such Hedging Obligations relate; 

  
 37 

 (5) Indebtedness of the Parent owed to a Restricted Subsidiary and Indebtedness
of any Restricted Subsidiary owed to the Parent or any other Restricted Subsidiary; provided, however, that (a) any Indebtedness of the Parent or the Company owed to a Restricted Subsidiary that is not a Subsidiary Guarantor is
unsecured and subordinated, pursuant to a written agreement, to the Parent or the Company’s obligations under this Indenture and the Securities and (b) upon any such Restricted Subsidiary ceasing to be a Restricted Subsidiary or such
Indebtedness being owed to any Person other than the Parent or a Restricted Subsidiary, such Restricted Subsidiary shall be deemed to have incurred Indebtedness not permitted by this Section 4.03(b)(5); 

(6) Indebtedness in respect of bid, performance or surety bonds issued for the account of the Parent or any Restricted
Subsidiary in the ordinary course of business, including guarantees or obligations of the Parent or any Restricted Subsidiary with respect to letters of credit supporting such bid, performance or surety obligations (in each case other than for an
obligation for money borrowed); 
 (7) Purchase Money Indebtedness incurred by the Parent or any Restricted Subsidiary, in an
aggregate amount not to exceed at any time outstanding $25,000,000; 
 (8) Non-Recourse Indebtedness of the Parent or any
Restricted Subsidiary incurred for the acquisition, development and/or improvement of real property and secured by Liens only on such real property and Directly Related Assets; 

(9) Indebtedness arising from the honoring by a bank or other financial institution of a check, draft or similar instrument
inadvertently (except in the case of daylight overdrafts) drawn against insufficient funds in the ordinary course of business; provided, however, that such Indebtedness is extinguished within five Business Days of incurrence; 

(10) Indebtedness arising in connection with endorsement of instruments for deposit in the ordinary course of business; 

(11) Refinancing Indebtedness with respect to Indebtedness incurred pursuant to the Ratio Exception, Section 4.03(b)
(2) or (3) or this Section 4.03(b)(11); 
 (12) the guarantee by the Parent or any Restricted Subsidiary of
Indebtedness (other than Indebtedness incurred pursuant to Section 4.03(b)(8), (13) or (16) or, in the case of the guarantee by a Restricted Subsidiary that is not a Guarantor, pursuant to the Ratio Exception or
Section 4.03(b)(1)) of a Restricted Subsidiary, in the case of the Parent, or of the Parent, Company or another Restricted Subsidiary, in the case of a Restricted Subsidiary, in either case, that was permitted to be incurred by another
provision of this Section 4.03; 
 (13) Indebtedness of any Restricted Subsidiary engaged primarily in the mortgage
origination and lending business (a “Mortgage Subsidiary”) under warehouse 

  
 38 

 
lines of credit and repurchase agreements, and Indebtedness secured by mortgage loans and related assets of such Restricted Subsidiary, in each case incurred in the ordinary course of such
business; provided that the only legal recourse for collection of obligations owing on such Indebtedness is against such Restricted Subsidiary, any other Mortgage Subsidiary and their respective assets; 

(14) (x) Indebtedness of the Parent, the Company or any Subsidiary Guarantor incurred to finance an acquisition or merger
or (y) Acquired Indebtedness of the Parent, the Company or any Restricted Subsidiary; provided, however, that in either case, after giving effect to the transactions that result in the incurrence or issuance thereof, on a pro
forma basis, (a) the Parent would have been able to incur at least $1.00 of additional Indebtedness pursuant to the Ratio Exception, (b) the Consolidated Fixed Charge Coverage Ratio of the Parent is greater than such ratio immediately
prior to such acquisition or merger, or (c) the ratio of Consolidated Indebtedness to Consolidated Tangible Net Worth of the Parent is less than such ratio immediately prior to such acquisition or merger; 

(15) Indebtedness of the Parent, Company or any Subsidiary Guarantor in an aggregate amount not to exceed the greater of
$40,000,000 and 4.0% of Consolidated Tangible Assets at any time outstanding; and 
 (16) (x) Security Guarantees by
Parent or any of its Restricted Subsidiaries in respect of Indebtedness incurred by Joint Ventures, and (y) GP Indebtedness of Parent or its Restricted Subsidiaries in respect of Joint Ventures, in an aggregate amount at any time outstanding
under this Section 4.03(b)(16) not to exceed the greater of $40,000,000 and 4% of Consolidated Tangible Assets at the time of incurrence. 

(c) For purposes of determining compliance with this Section 4.03, in the event that an item of Indebtedness meets the criteria of more
than one of the categories of Permitted Indebtedness described in Section 4.03(b)(1) through (16) or is entitled to be incurred pursuant to the Ratio Exception, the Parent shall, in its sole discretion, classify such item of Indebtedness
and may divide and classify such Indebtedness in more than one of the types of Indebtedness described. 
 SECTION 4.04. Limitations on
Restricted Payments. (a) The Parent shall not, and shall not permit any Restricted Subsidiary to, directly or indirectly, make any Restricted Payment unless: 

(1) no Default or Event of Default shall have occurred and be continuing at the time of or immediately after giving effect to
such Restricted Payment; 
 (2) immediately after giving effect to such Restricted Payment, the Parent could incur at least
$1.00 of additional Indebtedness pursuant to the Ratio Exception; and 

  
 39 

 (3) the amount of such Restricted Payment, when added to the aggregate amount of
all other Restricted Payments made after November 8, 2012 (other than Restricted Payments made pursuant to Section 4.04(b) (2), (3), (4), (5), (6), or (7)), does not exceed the sum (the “Restricted Payments Basket”) of
(without duplication): 
 (A) 50% of Consolidated Net Income for the period (taken as one accounting period) from
October 1, 2012 to and including the last day of the fiscal quarter ended immediately prior to the date of such calculation for which consolidated financial statements are available (or, if such Consolidated Net Income shall be a deficit, minus
100% of such aggregate deficit), plus 
 (B) 100% of the aggregate net cash proceeds or the Fair Market Value (as determined
by the Board of Directors of Parent) of any assets to be used in a Permitted Business received by the Parent either (x) as contributions to the common equity of the Parent after November 8, 2012 or (y) from the issuance and sale of
Qualified Equity Interests after November 8, 2012, plus 
 (C) the aggregate amount by which Indebtedness of the Parent
or any Restricted Subsidiary is reduced on the Parent’s balance sheet upon the conversion or exchange (other than by a Subsidiary of the Parent) of Indebtedness issued subsequent to November 8, 2012 into Qualified Equity Interests (less
the amount of any cash, or the fair value of assets, distributed by the Parent or any Restricted Subsidiary upon such conversion or exchange), plus 

(D) in the case of the disposition or repayment of or return on any Investment that was treated as a Restricted Payment made
after November 8, 2012, an amount (to the extent not included in the computation of Consolidated Net Income) equal to the lesser of (i) the return of capital with respect to such Investment and (ii) the amount of such Investment that
was treated as a Restricted Payment, in either case, less the cost of the disposition of such Investment and net of taxes, plus 

(E) upon a Redesignation of an Unrestricted Subsidiary as a Restricted Subsidiary, the lesser of (i) the Fair Market
Value of the Parent’s proportionate interest in such Subsidiary immediately following such Redesignation, and (ii) the aggregate amount of the Parent’s Investments in such Subsidiary to the extent such Investments reduced the amount
available for subsequent Restricted Payments under this Section 4.04(a)(E) and were not previously repaid or otherwise reduced, plus 

(F) 100% of the principal amount of, or, if issued at a discount, the accreted value of, any guarantee by the Parent or any
Restricted Subsidiary incurred after November 8, 2012 that is subsequently released (other than due to a payment on such guarantee), but only to the extent that such guarantee was treated as a Restricted Payment pursuant to this paragraph
(a) when made. 
 (b) The provisions of Section 4.04(a) shall not prohibit: 

(1) the payment by the Parent or any Restricted Subsidiary of any dividend or similar distribution within 60 days after the
date of declaration thereof, if on the date of declaration the payment would have complied with the provisions of this Indenture; 

  
 40 

 (2) the making of any Restricted Payment in exchange for, or out of the proceeds
of the substantially concurrent issuance and sale of, Qualified Equity Interests (other than to the Parent or any of its Subsidiaries); 

(3) the repurchase, redemption, defeasance or other acquisition or retirement for value of Subordinated Indebtedness of the
Parent or any Restricted Subsidiary in exchange for, or out of the proceeds of the substantially concurrent incurrence of, Refinancing Indebtedness permitted to be incurred under Section 4.03 and the other terms of this Indenture; 

(4) the repurchase, redemption, defeasance or other acquisition or retirement for value of Equity Interests of the Parent held
by officers, directors or employees or former officers, directors or employees (or their transferees, estates or beneficiaries under their estates), upon their bankruptcy or petition for bankruptcy, death, disability, retirement, severance or
termination of employment or service or any other repurchase event set forth in a written agreement between Parent and such individual evidencing such Equity Interest as of the Issue Date; provided that the aggregate cash consideration paid
for all such redemptions shall not exceed $4,000,000 during any calendar year; 
 (5) repurchases of Equity Interests deemed
to occur upon the exercise of stock options or stock appreciation rights if the Equity Interests represents a portion of the exercise price thereof; 

(6) the repurchase of Equity Interests upon vesting of restricted stock, restricted stock units, performance share units or
similar equity incentives to satisfy tax withholding or similar tax obligations with respect thereto; or 
 (7) Restricted
Payments in an aggregate amount, when taken together with all Restricted Payments made pursuant to this Section 4.04(b)(7) and then outstanding, does not exceed $20,000,000. 

provided that no issuance and sale of Qualified Equity Interests pursuant to Section 4.04(b)(2) or (3) shall increase the Restricted Payments
Basket, except to the extent the proceeds thereof exceed the amounts used to effect the transactions described therein. 
 The amount of all
Restricted Payments (other than cash) will be the Fair Market Value on the date of the Restricted Payment of the asset(s) or securities proposed to be transferred or issued by the Parent or a Restricted Subsidiary of the Parent, as the case may be,
pursuant to the Restricted Payment. 
 SECTION 4.05. Limitations on Dividend and Other Restrictions Affecting Restricted
Subsidiaries. The Parent shall not, and shall not permit any Restricted Subsidiary to, directly or indirectly, create or otherwise cause or permit to exist or become effective any consensual encumbrance or consensual restriction on the ability
of any Restricted Subsidiary (other than the Company) to: 
 (1) pay dividends or make any other distributions on or in
respect of its Equity Interests; 

  
 41 

 (2) make loans or advances or pay any Indebtedness or other obligation owed to
the Parent or any other Restricted Subsidiary; or 
 (3) transfer any of its assets to the Parent or any other Restricted
Subsidiary; 
 except for: 

(A) encumbrances or restrictions existing under or by reason of applicable law; 

(B) encumbrances or restrictions existing under this Indenture, the Securities and the Security Guarantees; 

(C) non-assignment provisions of any contract or any lease entered into in the ordinary course of business; 

(D) encumbrances or restrictions existing under agreements existing on the Issue Date as in effect on the Issue Date and
encumbrances or restrictions applicable to Restricted Subsidiaries existing under any Credit Facility pursuant to which Indebtedness has been incurred under Section 4.03(b)(1); 

(E) restrictions on the transfer of assets subject to any Lien permitted under this Indenture imposed by the holder of such
Lien; 
 (F) restrictions on the transfer of assets imposed under any agreement to sell such assets permitted under this
Indenture to any Person pending the closing of such sale; 
 (G) any instrument governing Acquired Indebtedness, which
encumbrance or restriction is not applicable to any Person, or the assets of any Person, other than the Person or the assets so acquired; 

(H) encumbrances or restrictions arising in connection with Refinancing Indebtedness; provided, however, that
any such encumbrances and restrictions are not materially more restrictive than those contained in the agreements creating or evidencing the Indebtedness being refinanced; 

(I) customary provisions in leases, licenses, partnership agreements, limited liability company organizational governance
documents, joint venture agreements and other similar agreements entered into in the ordinary course of business that restrict the transfer of leasehold interests or ownership interests in such partnership, limited liability company, joint venture
or similar Person; 
 (J) Purchase Money Indebtedness incurred in compliance with Section 4.03 to the extent they
impose restrictions of the nature described in Section 4.05(3) on the assets acquired; 

  
 42 

 (K) Non-Recourse Indebtedness incurred in compliance with Section 4.03 to
the extent they impose restrictions of the nature described in Section 4.05(3) on the assets secured by such Non-Recourse Indebtedness or on the Equity Interests in the Person holding such assets; 

(L) customary restrictions in other Indebtedness incurred in compliance with Section 4.03; provided that such
restrictions, taken as a whole, are, in the good faith judgment of the Parent’s board of directors, no more materially restrictive with respect to such encumbrances and restrictions than those contained in the existing agreements referenced in
clause (D) of this Section 4.05; 
 (M) restrictions on cash or other deposits or net worth imposed by customers under
contracts entered into in the ordinary course of business; and 
 (N) any encumbrances or restrictions imposed by any
amendments or refinancings of the contracts, instruments or obligations referred to in clauses (A) through (M) of this Section 4.05; provided that such amendments or refinancings are, in the good faith judgment of the
Parent’s board of directors, no more materially restrictive with respect to such encumbrances and restrictions than those prior to such amendment or refinancing. 

SECTION 4.06. Limitations on Asset Sales. (a) The Parent shall not, and shall not permit any Restricted Subsidiary to, directly
or indirectly, consummate any Asset Sale unless: (1) the Parent or such Restricted Subsidiary receives consideration at the time of such Asset Sale at least equal to the Fair Market Value of the assets included in such Asset Sale and
(2) at least 70% of the total consideration received in such Asset Sale or series of related Asset Sales consists of cash or Cash Equivalents. 

For the purposes of this Section 4.06(a), the following are deemed to be cash: (i) the amount (without duplication) of any
Indebtedness (other than Subordinated Indebtedness) of the Parent or such Restricted Subsidiary that is expressly assumed by the transferee in such Asset Sale and with respect to which the Parent or such Restricted Subsidiary, as the case may be, is
unconditionally released by the holder of such Indebtedness; (ii) the amount of any obligations received from such transferee that are within 90 days converted by the Parent or such Restricted Subsidiary to cash (to the extent of the cash
actually so received); and (iii) the Fair Market Value of any assets (other than securities, unless such securities represent Equity Interests in an entity engaged solely in a Permitted Business, such entity becomes a Restricted Subsidiary and
the Parent or a Restricted Subsidiary acquires voting and management control of such entity) received by the Parent or any Restricted Subsidiary to be used by it in the Permitted Business. If at any time any non-cash consideration received by the
Parent or any Restricted Subsidiary, as the case may be, in connection with any Asset Sale is repaid or converted into or sold or otherwise disposed of for cash (other than interest received with respect to any such non-cash consideration), then the
date of such repayment, conversion or disposition shall be deemed to constitute the date of an Asset Sale hereunder and the Net Available Proceeds thereof shall be applied in accordance with this Section 4.06. 

  
 43 

 (b) In the event that the Parent or any Restricted Subsidiary engages in an Asset Sale, the
Parent or such Restricted Subsidiary shall, no later than 360 days following the receipt of the Net Available Proceeds, apply all or any of the Net Available Proceeds therefrom (1) to permanently repay, prepay, redeem or repurchase
(x) Obligations under Indebtedness secured by Permitted Liens pursuant to clauses (13), (14), (16), and (17) of the definition of “Permitted Liens” (whose commitments shall be correspondingly reduced permanently upon such
repayment or prepayment), (y) Obligations under the Securities or any other Pari Passu Indebtedness of the Parent or any Restricted Subsidiary of the Company; provided that if the Parent or any such Restricted Subsidiary shall so repay
or prepay any such other Pari Passu Indebtedness, the Parent will reduce Obligations under the Securities on a pro rata basis (based on the amount so applied to such repayments or prepayments) by, at their option, (A) redeeming notes as
described under Section 5 of the Securities, (B) making an offer (in accordance with the procedures set forth in Section 4.06(c) and (d) for an Asset Sale Offer) to all Holders to purchase their Securities at least 100% of the
principal amount thereof, plus the amount of accrued but unpaid interest, if any, thereon up to the principal amount of Securities to be repurchased or (C) purchasing Securities through privately negotiated transactions or open market
purchases, in a manner that complies with this Indenture and applicable securities law, at a price not less than 100% of the principal amount thereof, plus the amount of accrued but unpaid interest, if any, thereon; or (z) Indebtedness of a
Restricted Subsidiary of the Company that is not a Guarantor, other than Indebtedness owed to the Company or another Restricted Subsidiary of the Company; (2) to acquire all or substantially all of the assets of, or any Capital Stock of,
another Permitted Business, if, after giving effect to any such acquisition of Capital Stock, the Permitted Business is or becomes a Restricted Subsidiary of the Company; (3) to make a capital expenditure; (4) to acquire Additional Assets
or improve or develop existing assets to be used in a Permitted Business; or (5) to make any combination of the foregoing payments, redemptions, repurchases or investments. Pending the final application of any Net Available Proceeds, the
Company may temporarily reduce revolving credit borrowings or otherwise invest the Net Available Proceeds in any manner that is not prohibited by this Indenture. 

(c) Any Net Available Proceeds from Asset Sales that are not applied or invested as provided in Section 4.06(b) will constitute
“Excess Proceeds.” When the aggregate amount of Excess Proceeds exceeds $15,000,000, the Parent shall, or shall cause the Company to, make an Asset Sale Offer to all Holders of Securities and if the Company elects (or is required by the
terms of such other Pari Passu Indebtedness), all holders of other Pari Passu Indebtedness (an “Asset Sale Offer”) to purchase the maximum aggregate principal amount of Securities and such Pari Passu Indebtedness, in denominations of
$2,000 initial principal amount and multiples of $1,000 in excess thereof, that may be purchased with an amount equal to the Excess Proceeds at an offer price in cash in an amount not less than 100% of the principal amount thereof, or, in the case
of Pari Passu Indebtedness represented by securities sold at a discount, not less than the amount of the accreted value thereof at such time, plus accrued and unpaid interest to the date fixed for the closing of such offer, in accordance with the
procedures set forth in this Indenture. In the event that the Parent or any Restricted Subsidiary of the Company prepays any Pari Passu Indebtedness that is outstanding under a revolving credit or other committed loan facility pursuant to an Asset
Sale Offer, the Parent or such Restricted Subsidiary shall cause the related loan commitment to be reduced in an amount equal to the principal amount so prepaid. After the completion of an Asset Sale, the Parent and its Restricted Subsidiaries may
make an Asset Sale Offer prior to the time they are required to do so by the 

  
 44 

 
first sentence of this paragraph. If the Parent or any Restricted Subsidiary completes such an Asset Sale Offer with respect to any Net Available Proceeds, the Company and its Restricted
Subsidiaries shall be deemed to have complied with this Section 4.06 with respect to the application of such Net Available Proceeds, and any such Net Available Proceeds remaining after completion of such Asset Sale Offer may be used by the
Parent and its Restricted Subsidiaries for any purpose not prohibited by this Indenture. If any Excess Proceeds remain after consummation of an Asset Sale Offer, the Parent and its Restricted Subsidiaries may use those Excess Proceeds for any
purpose not provided by this Indenture. If the aggregate principal amount of Securities and other Pari Passu Indebtedness tendered into such Asset Sale Offer exceeds the amount of Excess Proceeds, the trustee will select the Securities and such
other Pari Passu Indebtedness to be purchased on a pro rata basis based on the aggregate principal amount of the Securities and the other Pari Passu Indebtedness to be purchased validly tendered and not withdrawn. Upon completion of each
Asset Sale Offer, the amount of Excess Proceeds will be reset at zero. 
 (d) The Parent shall comply with the requirements of Rule 14e-1
under the Exchange Act and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with each repurchase of Securities pursuant to an Asset Sale Offer. To the extent that the
provisions of any securities laws or regulations conflict with this Section 4.06, the Parent shall comply with the applicable securities laws and regulations and will not be deemed to have breached their obligations under this Section 4.06
by virtue of such compliance. 
 SECTION 4.07. Limitations on Transactions with Affiliates. (a) The Parent shall not, and shall
not permit any Restricted Subsidiary to, directly or indirectly, in one transaction or a series of related transactions, sell, lease, transfer or otherwise dispose of any of its assets to, or purchase any assets from, or enter into any contract,
agreement, understanding, loan, advance or guarantee with, or for the benefit of, any Affiliate (an “Affiliate Transaction”), unless: (1) such Affiliate Transaction is on terms that are no less favorable to the Parent or the
relevant Restricted Subsidiary than those that could be obtained in a comparable transaction at such time on an arm’s-length basis by the Parent or that Restricted Subsidiary from a Person that is not an Affiliate of the Parent or that
Restricted Subsidiary and (2) the Parent delivers to the Trustee: (a) with respect to any Affiliate Transaction involving aggregate value expended or received by the Parent or any Restricted Subsidiary in excess of $7,500,000, an
Officers’ Certificate of the Parent certifying that such Affiliate Transaction complies with Section 4.07(a)(1) and a Secretary’s Certificate which sets forth and authenticates a resolution that has been adopted by the Independent
Directors approving such Affiliate Transaction; and (b) with respect to any Affiliate Transaction involving aggregate value expended or received by the Parent or any Restricted Subsidiary of $25,000,000 or more, the certificates described in
4.07(a)(2)(a) and (x) a written opinion as to the fairness of such Affiliate Transaction to the Parent or such Restricted Subsidiary from a financial point of view or (y) a written appraisal supporting the value of such Affiliate
Transaction, in either case, issued by an Independent Financial Advisor. 
 (b) The provisions of Section 4.07(a) shall not apply to
(1) transactions exclusively between or among (a) the Parent and one or more Restricted Subsidiaries or (b) Restricted Subsidiaries; provided, in each case, that no Affiliate of the Parent (other than another

  
 45 

 
Restricted Subsidiary) owns Equity Interests of any such Restricted Subsidiary; (2) reasonable director, officer, employee and consultant compensation (including bonuses) and other benefits
(including retirement, health, stock and other benefit plans) and indemnification and insurance arrangements; (3) the allocation of employee services among the Parent, its Subsidiaries and the Joint Ventures on a fair and equitable basis in the
ordinary course of business; provided that, in the case of any such Subsidiary or Joint Venture, no officer, director or stockholder of the Parent beneficially owns any Equity Interests in such Subsidiary or Joint Venture (other than
indirectly through ownership of Equity Interests in the Parent); (4) any Permitted Investment (other than any Permitted Investment made in accordance with clause (1)(b), clause (14) or clause (15) of the definition of “Permitted
Investments” to the extent that such Permitted Investment under clause (14) or clause (15) is in a Joint Venture or Unrestricted Subsidiary of which any officer, director or stockholder of the Parent beneficially owns any Equity
Interests (other than indirectly through ownership of Equity Interests in the Parent)); (5) any agreement as in effect as of the Issue Date or any extension, amendment or modification thereto (so long as any such extension, amendment or
modification satisfies the requirements set forth in Section 4.07(a)(1)) or any transaction contemplated thereby; (6) Restricted Payments which are made in accordance with Section 4.04(a) or Section 4.04(b)(1), (4)-(7);
(7) licensing of trademarks to, and allocation of overhead, sales and marketing, travel and like expenses among, the Parent, its Subsidiaries and the Joint Ventures on a fair and equitable basis in the ordinary course of business;
provided that, in the case of any such Subsidiary or Joint Venture, no officer, director or stockholder of the Parent beneficially owns any Equity Interests in such Subsidiary or Joint Venture (other than indirectly through ownership of
Equity Interests in the Parent); or (8) issuances, sales or other dispositions of Qualified Equity Interests for cash by the Parent to an Affiliate. 

SECTION 4.08. Effectiveness of Covenants. 

(a) The first day (such date, a “Suspension Date”) on which: 

(1) the Notes have an Investment Grade Rating from both of the Rating Agencies; and 

(2) no Default has occurred and is continuing under the Indenture, the covenants listed below will be suspended and the Parent,
the Company and their Restricted Subsidiaries will not be subject to the provisions of Section 4.03, 4.04, 4.05, 4.06, 4.07, 4.11, 4.13 (but only with respect to any Person that is required to become a Guarantor on or after the date of the
commencement of the applicable Suspension Date), and 5.01(a)(3) (collectively, the “Suspended Covenants”). 
 (b) If at
any time the Notes’ credit rating is below an Investment Grade Rating by any Rating Agency, then the Suspended Covenants will thereafter be reinstated as if such covenants had never been suspended (the “Reinstatement Date”) and
be applicable pursuant to the terms of the Indenture (including in connection with performing any calculation or assessment to determine compliance with the terms of the Indenture), unless and until the Notes subsequently attain an Investment Grade
Rating from both of the Rating Agencies and no Default is in existence and continuing at such time (in which event the Suspended Covenants shall no longer be in effect for such time that the Notes maintain an Investment Grade Rating from both of the
Rating Agencies); provided, however, that no Default or breach of any kind 

  
 46 

 
shall be deemed to exist under the Indenture, the Notes or the Note Guarantees with respect to the Suspended Covenants based on, and none of the Parent, the Company nor any of their Subsidiaries
shall bear any liability for, any actions taken or events occurring during the Suspension Period (as defined below), regardless of whether such actions or events would have been permitted if the applicable Suspended Covenants had remained in effect
during such period. The period of time between the Suspension Date and the Reinstatement Date is referred to as the “Suspension Period.” 

(c) On the Reinstatement Date, all Indebtedness incurred during the Suspension Period will be classified to have been incurred pursuant to
Section 4.03(a) or 4.03(b) (in each case to the extent such Indebtedness would be permitted to be incurred thereunder as of the Reinstatement Date and after giving effect to Indebtedness incurred prior to the Suspension Period and outstanding
on the Reinstatement Date). To the extent such Indebtedness would not be so permitted to be incurred pursuant to Section 4.03(a) or (b), such Indebtedness will be deemed to have been outstanding on the Issue Date, so that it is classified under
Section 4.03(b)(3). Calculations made after the Reinstatement Date of the amount available to be made as Restricted Payments under Section 4.04 will be made as though the covenant described under Section 4.04 had been in effect since
the Issue Date and throughout the Suspension Period. Accordingly, Restricted Payments made during the Suspension Period will reduce the amount available to be made as Restricted Payments under Section 4.04(a). Notwithstanding the foregoing, no
default or Event of Default will be deemed to have occurred solely by reason of a Restricted Payment made during the Suspension Period. 

(d) During any period when the Suspended Covenants are suspended, the Board of Directors of the Parent may not designate any of the
Parent’s Subsidiaries as Unrestricted Subsidiaries pursuant to this Indenture. 
 (e) Promptly following the occurrence of any
Suspension Date or Reinstatement Date, the Parent will provide an Officers’ Certificate to the Trustee regarding such occurrence. The Trustee shall have no obligation to independently determine or verify if a Suspension Date or Reinstatement
Date has occurred or notify the Holders of any Suspension Date or Reinstatement Date. The Trustee may provide a copy of such Officers’ Certificate to any Holder of the Notes upon written request. 

SECTION 4.09. Conduct of Business. The Parent shall not, and shall not permit any Restricted Subsidiary, to engage in any business
other than the Permitted Business and businesses necessary, reasonably related or ancillary thereto. 
 SECTION 4.10. Change of
Control. (a) Upon the occurrence of a Change of Control, each Holder shall have the right to require that the Company repurchase such Holder’s Securities at a purchase price in cash equal to 101% of the principal amount thereof on the
date of purchase plus accrued and unpaid interest, if any, to the date of purchase (subject to the right of holders of record on the relevant record date to receive interest due on the relevant interest payment date), in accordance with the terms
contemplated in Section 4.10(b). 

  
 47 

 (b) Within 30 days following any Change of Control, the Company shall mail a notice to each
Holder with a copy to the Trustee (the “Change of Control Offer”) stating: 
 (1) that a Change of Control
has occurred and that such Holder has the right to require the Company to purchase such Holder’s Securities at a purchase price in cash equal to 101% of the principal amount thereof on the date of purchase, plus accrued and unpaid interest, if
any, to the date of purchase (subject to the right of Holders of record on the relevant record date to receive interest on the relevant interest payment date); 

(2) the circumstances and relevant facts regarding such Change of Control (including information with respect to pro
forma historical income, cash flow and capitalization, in each case after giving effect to such Change of Control); 

(3) the purchase date (which shall be no earlier than 30 days nor later than 60 days from the date such notice is
mailed); and 
 (4) the instructions, as determined by the Company, consistent with this Section, that a Holder must follow
in order to have its Securities purchased. 
 (c) Holders electing to have a Security purchased will be required to surrender the Security,
with an appropriate form duly completed, to the Company at the address specified in the notice at least three Business Days prior to the purchase date. Holders will be entitled to withdraw their election if the Trustee or the Company receives not
later than one Business Day prior to the purchase date, a facsimile transmission or letter setting forth the name of the Holder, the principal amount of the Security which was delivered for purchase by the Holder and a statement that such Holder is
withdrawing its election to have such Security purchased. 
 (d) On the purchase date, all Securities purchased by the Company under this
Section shall be delivered by the Company to the Trustee for cancellation, and the Company shall pay the purchase price plus accrued and unpaid interest, if any, to the Holders entitled thereto. 

(e) Notwithstanding any other provision of this Indenture, the Company shall not be required to make a Change of Control Offer following a
Change of Control if a third party makes the Change of Control Offer in the manner, at the times and otherwise in compliance with the requirements set forth in this Section applicable to a Change of Control Offer made by the Company and purchases
all Securities validly tendered and not withdrawn under such Change of Control Offer or if notice of redemption has been given pursuant to Section 5 of the Securities. 

(f) A Change of Control Offer may be made in advance of a Change of Control, conditional upon such Change of Control, if a definitive
agreement is in place for the Change of Control at the time of making of the Change of Control Offer. 
 (g) The Company shall comply, to
the extent applicable, with the requirements of Section 14(e) of the Exchange Act and any other securities laws or regulations in connection with the repurchase of Securities pursuant to this Section 4.10. To the extent that the provisions
of any securities laws or regulations conflict with provisions of this Section 4.10, the Company shall comply with the applicable securities laws and regulations and shall not be deemed to have breached its obligations under this
Section 4.10 by virtue of its compliance with such securities laws or regulations. 

  
 48 

 SECTION 4.11. Limitations on Designation of Unrestricted Subsidiaries. The Parent may
designate any Subsidiary of the Parent (other than the Company) as an “Unrestricted Subsidiary” under this Indenture (a “Designation”) only if (1) no Default shall have occurred and be continuing at the time of or
after giving effect to such Designation and (2) the Parent would be permitted to make, at the time of such Designation, (a) a Permitted Investment or (b) an Investment pursuant to Section 4.04, in either case, in an amount (the
“Designation Amount”) equal to the Fair Market Value of the Parent’s proportionate interest in such Subsidiary on such date. 

No Subsidiary shall be Designated as an “Unrestricted Subsidiary” unless: (1) neither the Company nor any of its other
Subsidiaries (other than Unrestricted Subsidiaries) (x) provides any direct or indirect credit support for any Indebtedness of such Subsidiary (including any undertaking, agreement or instrument evidencing such Indebtedness) or (y) is
directly or indirectly liable for any Indebtedness of such Subsidiary other than, in each case, such Investments as are permitted pursuant to Section 4.04; (2) such Subsidiary is not party to any agreement, contract, arrangement or
understanding with the Parent or any Restricted Subsidiary unless the terms of the agreement, contract, arrangement or understanding (x) are no less favorable to the Parent or the Restricted Subsidiary than those that would be reasonably
expected to be obtained at the time from Persons who are not Affiliates of the Parent or such Restricted Subsidiary or (y) would be permitted as (a) an Affiliate Transaction under and in compliance with Section 4.07, (b) an Asset
Sale under and in compliance with Section 4.06, (c) a Permitted Investment or (d) an Investment under and in compliance with Section 4.04; (3) such Subsidiary is a Person with respect to which neither the Parent nor any
Restricted Subsidiary has any direct or indirect obligation (x) to subscribe for additional Equity Interests or (y) to maintain or preserve the Person’s financial condition or to cause the Person to achieve any specified levels of
operating results; and (4) such Subsidiary has not guaranteed or otherwise directly or indirectly provided credit support for any Indebtedness of the Parent or any Restricted Subsidiary, except for any guarantee given solely to support the
pledge by the Parent or any Restricted Subsidiary of the Equity Interest of such Unrestricted Subsidiary, which guarantee is not recourse to the Parent or any Restricted Subsidiary, and except to the extent the amount thereof constitutes a
Restricted Payment permitted pursuant to Section 4.04. 
 If, at any time after the Designation, any Unrestricted Subsidiary fails to
meet the requirements set forth in the preceding paragraph, it shall thereafter cease to be an Unrestricted Subsidiary for purposes of this Indenture and any Indebtedness of the Subsidiary and any Liens on assets of such Subsidiary shall be deemed
to be incurred by a Restricted Subsidiary as of the date and, if the Indebtedness is not permitted to be incurred under Section 4.03 or the Lien is not permitted under Section 4.12, the Parent shall be in default of the applicable
covenant. 
 The Parent may not Designate the Company as an Unrestricted Subsidiary. As of the Issue Date, the Parent shall be deemed to
have Designated Duxford Title Reinsurance Company, Cerro Plata Associates, LLC, Silver Creek Preserve, Nobar Water Company, Horsethief Canyon Partners and Lyon Mission, LLC as Unrestricted Subsidiaries. 

The Parent may redesignate an Unrestricted Subsidiary as a Restricted Subsidiary (a “Redesignation”) only if (1) no
Default shall have occurred and be continuing at the time of and after giving effect to such Redesignation and (2) all Liens, Indebtedness and Investments of 

  
 49 

 
such Unrestricted Subsidiary outstanding immediately following such Redesignation would, if incurred or made at such time, have been permitted to be incurred or made for all purposes of this
Indenture. 
 All Designations and Redesignations must be evidenced by resolutions of the Board of Directors of the Parent delivered to the
Trustee and certifying compliance with the foregoing provisions. 
 SECTION 4.12. Limitations on Liens. The Parent shall not, and
shall not permit any Restricted Subsidiary to, directly or indirectly, create, incur, assume or permit or suffer to exist any Lien (a “Triggering Lien”) of any nature whatsoever against any assets now owned or hereafter acquired by
the Parent or such Restricted Subsidiary (including Equity Interests of a Restricted Subsidiary), or any proceeds, income or profits therefrom securing any Indebtedness, except Permitted Liens, unless all payments due under this indenture and the
Securities (or under a Security Guarantee in the case of Liens of a Guarantor) are secured on an equal and ratable basis (or on a superior basis, in the event the other Indebtedness is Subordinated Indebtedness) with the obligations so secured until
such time as such obligations are no longer secured by a Triggering Lien. 
 SECTION 4.13. Additional Security Guarantees. If, after
the Issue Date, (a) the Parent or any Restricted Subsidiary shall acquire or create another Wholly Owned Restricted Subsidiary (other than (i) a Subsidiary that has been designated an Unrestricted Subsidiary, and (ii) any Subsidiary
that is a project-financed special purpose entity) or (b) any Unrestricted Subsidiary is redesignated a Wholly Owned Restricted Subsidiary, then, in each such case, to the extent such Wholly Owned Subsidiary has guaranteed any Indebtedness of
Parent, Company or any Subsidiary Guarantor and such Security Guarantee is then outstanding, the Parent shall cause such Restricted Subsidiary to (1) execute and deliver to the Trustee (a) a supplemental indenture in form and substance
satisfactory to the Trustee pursuant to which such Restricted Subsidiary shall unconditionally guarantee all of the Company’s obligations under the Securities and this Indenture and (b) a notation of guarantee in respect of its Security
Guarantee; and (2) deliver to the Trustee one or more opinions of counsel that such supplemental indenture (a) has been duly authorized, executed and delivered by such Restricted Subsidiary and (b) constitutes a valid and legally
binding obligation of such Restricted Subsidiary in accordance with its terms. 
 SECTION 4.14. Compliance Certificate. The Company
shall deliver to the Trustee within 90 days after the end of each fiscal year of the Company an Officers’ Certificate stating that, to the signing Officers’ knowledge, no Default has occurred under this Indenture, or, if a Default has
occurred, what action the Company and/or the Guarantors are taking or propose to take with respect thereto. The Company also shall comply with TIA § 314(a)(4). 

SECTION 4.15. Further Instruments and Acts. Upon request of the Trustee, the Parent or Company will execute and deliver such further
instruments and do such further acts as may be reasonably necessary or proper to carry out more effectively the purpose of this Indenture. 

  
 50 

 ARTICLE 5 

SUCCESSOR COMPANY 

SECTION 5.01. When Company May Merge or Transfer Assets. (a) Neither the Parent nor the Company will, directly or indirectly, in
a single transaction or a series of related transactions, (a) consolidate or merge with or into any Person (other than a merger that satisfies the requirements of Section 5.01(a)(1) with a Wholly Owned Restricted Subsidiary solely for the
purpose of changing the Parent’s or the Company’s jurisdiction of incorporation, as the case may be, to another State of the United States), or sell, lease, transfer, convey or otherwise dispose of or assign all or substantially all of the
assets of the Parent or the Parent and the Restricted Subsidiaries (taken as a whole) or the Company or the Company and the Restricted Subsidiaries that are Subsidiaries of the Company (taken as a whole), as the case may be, to any Person or
(b) adopt a Plan of Liquidation unless, in either case: 
 (1) Either (a) the Parent or the Company, as the case
may be, will be the surviving or continuing Person or (b) the Person formed by or surviving such consolidation or merger or to which such sale, lease, conveyance or other disposition shall be made (or, in the case of a Plan of Liquidation, any
Person to which assets are transferred) (collectively, the “Successor”) is a corporation or limited liability company organized and existing under the laws of any State of the United States of America or the District of Columbia,
and the Successor expressly assumes, by supplemental indenture in form and substance satisfactory to the Trustee, all of the obligations of the Company or the Parent, as the case may be, under the Securities or the Parent’s Security Guarantee,
as applicable, and this Indenture; provided that, in the case of the Company, at any time the Successor is a limited liability company, there shall be a co-issuer of the Securities that is a corporation organized and existing under the laws
of any State of the United States of America or the District of Columbia; 
 (2) immediately prior to and immediately after
giving effect to such transaction and the assumption (if applicable) of the obligations as set forth in Section 5.01(a)(1)(b) and the incurrence of any Indebtedness to be incurred in connection therewith, no Default shall have occurred and be
continuing; and 
 (3) immediately after and giving effect to such transaction and the assumption (if applicable) of the
obligations set forth in Section 5.01(a)(1)(b) and the incurrence of any Indebtedness to be incurred in connection therewith, and the use of any net proceeds therefrom on a pro forma basis, (a) the Parent or the Successor, as the case may
be, could incur $1.00 of additional Indebtedness pursuant to the Ratio Exception, (b) the Consolidated Fixed Charge Coverage Ratio of the Parent or the Successor is greater than such ratio for Parent immediately prior to such transaction, or
(c) the ratio of Consolidated Indebtedness to Consolidated Tangible Net Worth of the Parent or the Successor is less than such ratio for Parent immediately prior to such transaction. 

For purposes of this Section 5.01, any Indebtedness of the Successor which was not Indebtedness of the Parent or the Company, as the
case may be, immediately prior to the transaction shall be deemed to have been incurred in connection with such transaction. 

  
 51 

 (b) No Subsidiary Guarantor may consolidate with or merge with or into (whether or not such
Subsidiary Guarantor is the surviving Person) another Person, whether or not affiliated with such Subsidiary Guarantor, unless (1) either, (a) such Subsidiary Guarantor will be the surviving or continuing Person or (b) the Person
formed by or surviving any such consolidation or merger assumes, by supplemental indenture in form and substance satisfactory to the Trustee, all of the obligations of such Subsidiary Guarantor under the Security Guarantee of such Subsidiary
Guarantor and this Indenture; and (2) immediately after giving effect to such transaction no Default shall have occurred and be continuing. 

Notwithstanding the foregoing, (a) any Restricted Subsidiary (other than the Company) may merge into the Parent or another Restricted
Subsidiary and (b) the requirements of the immediately preceding paragraph will not apply to any transaction pursuant to which such Guarantor is permitted to be released from its Security Guarantee in accordance with the provisions described
under Section 10.07. 
 For purposes of this Section 5.01, the transfer (by lease, assignment, sale or otherwise, in a single
transaction or series of transactions) of all or substantially all of the assets of one or more Restricted Subsidiaries, the Equity Interests of which constitute all or substantially all of the assets of the Parent or the Company, will be deemed to
be the transfer of all or substantially all of the assets of the Parent or the Company, as the case may be. 
 Upon any consolidation,
combination or merger of the Company or a Guarantor, or any transfer of all or substantially all of the assets of the Parent or the Company in accordance with the foregoing, in which the Company or such Guarantor is not the continuing obligor under
the Securities or its Security Guarantee, the surviving entity formed by such consolidation or into which the Company or such Guarantor is merged or to which the conveyance, lease or transfer is made will succeed to, and be substituted for, and may
exercise every right and power of, the Company or such Guarantor under this Indenture, the Securities and the Security Guarantees with the same effect as if such surviving entity had been named therein as the Company or such Guarantor and, except in
the case of a conveyance, transfer or lease, the Company or such Guarantor, as the case may be, will be released from the obligation to pay the principal of and interest on the Securities or in respect of its Security Guarantee, as the case may be,
and all of the Company’s or such Guarantor’s other obligations and covenants under the Securities, this Indenture and its Security Guarantee, if applicable. 

ARTICLE 6 
 DEFAULTS AND
REMEDIES 
 SECTION 6.01. Events of Default. Each of the following is an “Event of Default”: 

(1) failure by the Company to pay interest on any of the Securities when it becomes due and payable and the continuance of any
such failure for 30 days; 

  
 52 

 (2) failure by the Company to pay the principal on any of the Securities when it
becomes due and payable, whether at stated maturity, upon redemption, upon purchase, upon acceleration or otherwise; 
 (3)
failure by the Parent or the Company to comply with any of its agreements or covenants described in Section 5.01; 
 (4)
failure by the Parent or the Company to comply with any other agreement or covenant in this Indenture and continuance of this failure for 60 days after written notice of the failure has been given to the Company by the Trustee or by the Holders of
at least 25% of the aggregate principal amount of the Securities then outstanding; 
 (5) default under any mortgage,
indenture or other instrument or agreement under which there may be issued or by which there may be secured or evidenced Indebtedness (other than Non-Recourse Indebtedness) of the Parent or any Restricted Subsidiary, whether such Indebtedness now
exists or is incurred after the Issue Date, which default (a) is caused by a failure to pay when due principal on such Indebtedness within the applicable express grace period, or (b) results in the acceleration of such Indebtedness prior
to its express final maturity, and in each case the principal amount of such Indebtedness, together with any other Indebtedness with respect to which an event described in 6.01(5) (a) or (b) has occurred and is continuing, aggregates
$20,000,000 or more; provided, however, that if any such default is cured or waived or any acceleration rescinded or such Indebtedness is repaid within a period of ten (10) days from the continuation of such default beyond any
applicable grace period or the occurrence of such acceleration, as the case may be, such Event of Default under this Indenture and any consequential acceleration of the Securities shall automatically be rescinded so long as such rescission does not
conflict with any judgment or decree; 
 (6) one or more judgments or orders that exceed $20,000,000 in the aggregate (net of
amounts covered by insurance or bonded) for the payment of money have been entered by a court or courts of competent jurisdiction against the Parent or any Restricted Subsidiary and such judgment or judgments have not been satisfied, stayed,
annulled or rescinded within 60 days of being entered; 
 (7) the Parent, the Company or any Significant Subsidiary pursuant
to or within the meaning of any Bankruptcy Law: 
 (A) commences a voluntary case; 

(B) consents to the entry of an order for relief against it in an involuntary case; 

(C) consents to the appointment of a Custodian of it or for all or substantially all of its assets; or 

(D) makes a general assignment for the benefit of its creditors. 

  
 53 

 (8) a court of competent jurisdiction enters an order or decree under any
Bankruptcy Law that: 
 (A) is for relief against the Parent, the Company or any Significant Subsidiary as debtor in
an involuntary case; 
 (B) appoints a Custodian of the Parent, the Company or any Significant Subsidiary or a Custodian for
all or substantially all of the assets of the Parent, the Company or any Significant Subsidiary; or 
 (C) orders the
liquidation of the Parent, the Company or any Significant Subsidiary, and the order or decree remains unstayed and in effect for 60 days; or 

(9) the Security Guarantee of the Parent or any Security Guarantee of any Significant Subsidiary ceases to be in full force and
effect (other than in accordance with the terms of such Security Guarantee and this Indenture) or is declared null and void and unenforceable or found to be invalid or any Guarantor denies its liability under its Security Guarantee (other than by
reason of release of a Guarantor from its Security Guarantee in accordance with the terms of this Indenture and the Security Guarantee). 

The foregoing will constitute Events of Default whatever the reason for any such Event of Default and whether it is voluntary or involuntary
or is effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental body. 

The term “Bankruptcy Law” means Title 11 of the United States Code, as amended, or any similar federal or state law for the relief
of debtors. The term “Custodian” means any receiver, trustee, assignee, liquidator, or similar official under any Bankruptcy Law. 

The Company shall deliver to the Trustee annually a statement regarding compliance with this Indenture, and upon any Officer of the Company
becoming aware of any Default, a statement specifying such Default and what action the Company is taking or proposes to take with respect thereto. 

SECTION 6.02. Acceleration. If an Event of Default (other than an Event of Default specified in Section 6.01(7) or (8) with
respect to the Company) occurs and is continuing, the Trustee by written notice to the Company, or the Holders of at least 25% in aggregate principal amount of the Securities then outstanding by written notice to the Company and the Trustee, may
declare all amounts owing under the Securities to be due and payable immediately. Upon such declaration of acceleration, the aggregate principal of and accrued and unpaid interest on the outstanding Securities shall immediately become due and
payable; provided, however, that after such acceleration, but before a judgment or decree based on acceleration, the Holders of a majority in aggregate principal amount of such outstanding Securities may rescind and annul such
acceleration. If an Event of Default specified in Section 6.01(7) or (8) with respect to the Company occurs, all outstanding Securities shall become due and payable without any further action or notice. 

  
 54 

 SECTION 6.03. Other Remedies. If an Event of Default occurs and is continuing, the
Trustee may pursue any available remedy to collect the payment of principal of or interest on the Securities or to enforce the performance of any provision of the Securities or this Indenture. 

The Trustee may maintain a proceeding even if it does not possess any of the Securities or does not produce any of them in the proceeding. A
delay or omission by the Trustee or any Securityholder in exercising any right or remedy accruing upon an Event of Default shall not impair the right or remedy or constitute a waiver of or acquiescence in the Event of Default. No remedy is exclusive
of any other remedy. All available remedies are cumulative. 
 SECTION 6.04. Waiver of Past Defaults. The Holders of a majority in
principal amount of the Securities by notice to the Trustee may waive an existing Default and its consequences except (a) a Default in the payment of the principal of or interest on a Security (b) a Default arising from the failure to
redeem or purchase any Security when required pursuant to this Indenture or (c) a Default in respect of a provision that under Section 9.02 cannot be amended without the consent of each Securityholder affected. When a Default is waived, it
is deemed cured, but no such waiver shall extend to any subsequent or other Default or impair any consequent right. 
 SECTION 6.05.
Control by Majority. The Holders of a majority in principal amount of the Securities may direct the time, method and place of conducting any proceeding for any remedy available to the Trustee or of exercising any trust or power conferred on
the Trustee. However, the Trustee may refuse to follow any direction that conflicts with law or this Indenture or, subject to Section 7.01, that the Trustee determines is unduly prejudicial to the rights of other Securityholders or would
involve the Trustee in personal liability; provided, however, that the Trustee may take any other action deemed proper by the Trustee that is not inconsistent with such direction. Prior to taking any action hereunder, the Trustee shall
be entitled to indemnification satisfactory to it in its sole discretion against all losses and expenses caused by taking or not taking such action. 

SECTION 6.06. Limitation on Suits. Except to enforce the right to receive payment of principal, premium (if any) or interest when due,
no Securityholder may pursue any remedy with respect to this Indenture or the Securities unless: 
 (1) the Holder gives to
the Trustee written notice stating that an Event of Default is continuing; 
 (2) the Holders of at least 25% in principal
amount of the Securities make a written request to the Trustee to pursue the remedy; 
 (3) such Holder or Holders offer to
the Trustee reasonable security or indemnity against any loss, liability or expense; 
 (4) the Trustee does not comply with
the request within 60 days after receipt of the request and the offer of security or indemnity; and 
 (5) the Holders of a
majority in principal amount of the Securities do not give the Trustee a direction inconsistent with the request during such 60-day period. 

  
 55 

 A Securityholder may not use this Indenture to prejudice the rights of another Securityholder or
to obtain a preference or priority over another Securityholder. In the event that the Definitive Securities are not issued to any beneficial owner promptly after the Registrar has received a request from the Holder of a Global Security to issue such
Definitive Securities to such beneficial owner of its nominee, the Company expressly agrees and acknowledges, with respect to the right of any Holder to pursue a remedy pursuant to this Indenture, the right of such beneficial holder of Securities to
pursue such remedy with respect to the portion of the Global Security that represents such beneficial holder’s Securities as if such Definitive Securities had been issued. 

SECTION 6.07. Rights of Holders to Receive Payment. Notwithstanding any other provision of this Indenture, the right of any Holder to
receive payment of principal of and interest on the Securities held by such Holder, on or after the respective due dates expressed in the Securities, or to bring suit for the enforcement of any such payment on or after such respective dates, shall
not be impaired or affected without the consent of such Holder. 
 SECTION 6.08. Collection Suit by Trustee. If an Event of Default
specified in Section 6.01(1) or (2) occurs and is continuing, the Trustee may recover judgment in its own name and as trustee of an express trust against the Company for the whole amount then due and owing (together with interest on any
unpaid interest to the extent lawful) and the amounts provided for in Section 7.07. 
 SECTION 6.09. Trustee May File Proofs of
Claim. The Trustee may file such proofs of claim and other papers or documents as may be necessary or advisable in order to have the claims of the Trustee and the Securityholders allowed in any judicial proceedings relative to the Company, its
creditors or its property and, unless prohibited by law or applicable regulations, may vote on behalf of the Holders in any election of a trustee in bankruptcy or other Person performing similar functions, and any Custodian in any such judicial
proceeding is hereby authorized by each Holder to make payments to the Trustee and, in the event that the Trustee shall consent to the making of such payments directly to the Holders, to pay to the Trustee any amount due it for the reasonable
compensation, expenses, disbursements and advances of the Trustee, its agents and its counsel, and any other amounts due the Trustee under Section 7.07. 

SECTION 6.10. Priorities. If the Trustee collects any money or property pursuant to this Article 6, it shall pay out the money or
property in the following order: 
 FIRST: to the Trustee for amounts due under Section 7.07; 

SECOND: to Securityholders for amounts due and unpaid on the Securities for principal and interest, ratably, without preference
or priority of any kind, according to the amounts due and payable on the Securities for principal and interest, respectively; and 

THIRD: to the Company. 

  
 56 

 The Trustee may fix a record date and payment date for any payment to Securityholders pursuant
to this Section. At least 15 days before such record date, the Company shall mail to each Securityholder and the Trustee a notice that states the record date, the payment date and amount to be paid. 

SECTION 6.11. Undertaking for Costs. In any suit for the enforcement of any right or remedy under this Indenture or in any suit
against the Trustee for any action taken or omitted by it as Trustee, a court in its discretion may require the filing by any party litigant in the suit of an undertaking to pay the costs of the suit, and the court in its discretion may assess
reasonable costs, including reasonable attorneys’ fees, against any party litigant in the suit, having due regard to the merits and good faith of the claims or defenses made by the party litigant. This Section does not apply to a suit by the
Trustee, a suit by a Holder pursuant to Section 6.07 or a suit by Holders of more than 10% in aggregate principal amount of the Securities. 

SECTION 6.12. Waiver of Stay or Extension Laws. The Company (to the extent it may lawfully do so) shall not at any time insist upon,
or plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay or extension law wherever enacted, now or at any time hereafter in force, which may affect the covenants or the performance of this Indenture; and the Company
(to the extent that it may lawfully do so) hereby expressly waives all benefit or advantage of any such law, and shall not hinder, delay or impede the execution of any power herein granted to the Trustee, but shall suffer and permit the execution of
every such power as though no such law had been enacted. 
 ARTICLE 7 

TRUSTEE 
 SECTION 7.01.
Duties of Trustee. (a) If an Event of Default actually known to a Trust Officer has occurred and is continuing, the Trustee shall exercise such of the rights and powers vested in it by this Indenture and use the same degree of care and
skill in their exercise as a prudent Person would exercise or use under the same circumstances in the conduct of his or her own affairs. 

(b) Except during the continuance of an Event of Default: 

(1) the Trustee undertakes to perform such duties and only such duties as are specifically set forth in this Indenture and no
implied covenants or obligations shall be read into this Indenture against the Trustee; and 
 (2) in the absence of bad
faith on its part, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon certificates or opinions furnished to the Trustee and conforming to the requirements of this
Indenture. However, the Trustee shall examine the certificates and opinions to determine whether or not they conform to the requirements of this Indenture (but need not confirm or investigate the accuracy of mathematical calculations or other facts
stated therein). 

  
 57 

 (c) The Trustee may not be relieved from liability for its own negligent action, its own
negligent failure to act or its own wilful misconduct, except that: 
 (1) this paragraph does not limit the effect of
paragraph (b) of this Section; 
 (2) the Trustee shall not be liable for any error of judgment made in good faith by a
Trust Officer unless it is proved that the Trustee was negligent in ascertaining the pertinent facts; and 
 (3) the Trustee
shall not be liable with respect to any action it takes or omits to take in good faith in accordance with a direction received by it pursuant to Section 6.05. 

(a) Every provision of this Indenture that in any way relates to the Trustee is subject to paragraphs (a), (b) and (c) of this
Section. 
 (b) The Trustee shall not be liable for interest on any money received by it except as the Trustee may agree in writing with
the Company. 
 (c) Money held in trust by the Trustee need not be segregated from other funds except to the extent required by law. 

(d) No provision of this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur financial liability in the
performance of any of its duties hereunder or in the exercise of any of its rights or powers, if it shall have reasonable grounds to believe that repayment of such funds or adequate indemnity against such risk or liability is not reasonably assured
to it. 
 (e) Every provision of this Indenture relating to the conduct or affecting the liability of or affording protection to the
Trustee shall be subject to the provisions of this Section and to the provisions of the TIA. 
 SECTION 7.02. Rights of Trustee.
(a) The Trustee may rely on any document believed by it to be genuine and to have been signed or presented by the proper person. The Trustee need not investigate any fact or matter stated in the document. 

(b) Before the Trustee acts or refrains from acting, it may require an Officers’ Certificate or an Opinion of Counsel. The Trustee shall
not be liable for any action it takes or omits to take in good faith in reliance on the Officers’ Certificate or Opinion of Counsel. 

(c) The Trustee may act through agents and shall not be responsible for the misconduct or negligence of any agent appointed with due care.

 (d) The Trustee shall not be liable for any action it takes or omits to take in good faith which it believes to be authorized or within
its rights or powers; provided, however, that the Trustee’s conduct does not constitute wilful misconduct or negligence. 

  
 58 

 (e) The Trustee may consult with counsel, and the advice or opinion of counsel with respect to
legal matters relating to this Indenture and the Securities shall be full and complete authorization and protection from liability in respect to any action taken, omitted or suffered by it hereunder in good faith and in accordance with the advice or
opinion of such counsel. 
 (f) Except with respect to Sections 4.01 and 4.02, the Trustee shall have no duty to inquire as to the
performance of the Company’s covenants in Article Four hereof. In addition, the Trustee shall not be deemed to have knowledge of any Default or Event of Default except (1) any Event of Default occurring pursuant to Sections 6.01(1) and
6.01(2) or (ii) any Default or Event of Default of which the Trustee shall have received written notice in the manner set forth in this Indenture or a Trust Officer shall have obtained actual knowledge. Delivery of reports, information and
documents to the Trustee under Section 4.02 is for informational purposes only and the Trustee’s receipt of the foregoing shall not constitute constructive notice of any information contained therein or determinable from information
contained therein, including the Company’s compliance with any of its covenants thereunder (as to which the Trustee is entitled to rely exclusively on an Officers’ Certificate). 

(g) The Trustee shall not be responsible or liable for any failure or delay in the performance of its obligations under this Indenture
arising out of or caused, directly or indirectly, by circumstances beyond its reasonable control, including acts of God; earthquakes; fire; flood; terrorism; wars and other military disturbances; sabotage; epidemics; riots; interruptions; loss or
malfunctions of utilities, computer (hardware or software) or communication services; accidents; labor disputes; acts of civil or military authority and governmental action, it being understood that the Trustee shall use reasonable best efforts
which are consistent with accepted practices in the banking industry to resume performance as soon as practicable under the circumstances. 

(h) Anything in this Indenture notwithstanding, in no event shall the Trustee be liable for special, indirect, punitive or consequential loss
or damage of any kind whatsoever (including but not limited to loss of profit), even if the Company has been advised as to the likelihood of such loss or damage and regardless of the form of action. 

SECTION 7.03. Individual Rights of Trustee. The Trustee in its individual or any other capacity may become the owner or pledgee of
Securities and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. Any Paying Agent, Registrar, co-registrar or co-paying agent may do the same with like rights. However, the Trustee must
comply with Sections 7.10 and 7.11. 
 SECTION 7.04. Trustee’s Disclaimer. The Trustee shall not be responsible for and makes
no representation as to the validity or adequacy of this Indenture or the Securities, it shall not be accountable for the Company’s use of the proceeds from the Securities, and it shall not be responsible for any statement of the Company in
this Indenture or in any document issued in connection with the sale of the Securities or in the Securities other than the Trustee’s certificate of authentication. 

SECTION 7.05. Notice of Defaults. If a Default occurs, is continuing and is known to the Trustee, the Trustee shall give notice of the
Default to each Securityholder within 

  
 59 

 
90 days after it occurs. Except in the case of a Default in the payment of principal of or interest on any Security (including payments pursuant to the mandatory redemption provisions of such
Security, if any) or a Default in complying with Section 5.01, the Trustee may withhold the notice if and so long as a committee of its Trust Officers in good faith determines that withholding the notice is not opposed to the interests of the
Securityholders. 
 SECTION 7.06. Reports by Trustee to Holders. As promptly as practicable after each May 15 beginning with
the May 15 following the date of this Indenture, and in any event prior to July 15 in each year, the Trustee shall mail to each Securityholder a brief report dated as of May 15 that complies with TIA § 313(a). The Trustee
also shall comply with TIA § 313(b). 
 A copy of each report at the time of its mailing to Securityholders shall be filed with
the SEC and each stock exchange (if any) on which the Securities are listed. The Company agrees to notify promptly the Trustee whenever the Securities become listed on any stock exchange and of any delisting thereof. 

SECTION 7.07. Compensation and Indemnity. The Company shall pay to the Trustee from time to time reasonable compensation for its
services. The Trustee’s compensation shall not be limited by any law on compensation of a trustee of an express trust. The Company shall reimburse the Trustee upon request for all reasonable out-of-pocket expenses incurred or made by it,
including costs of collection, in addition to the compensation for its services. Such expenses shall include the reasonable compensation and expenses, disbursements and advances of the Trustee’s agents, counsel, accountants and experts. The
Company shall indemnify each of the Trustee and any predecessor Trustee for, and hold each of them harmless against, any and all loss, damage, claim, liability or expense, including taxes (other than taxes based on the income of the Trustee) and
reasonable attorneys’ fees and expenses incurred by each of them in connection with acceptance or performance of its duties under this Indenture including the reasonable costs and expenses of enforcing this Indenture against the Company
(including this Section 7.07) and defending itself against any claim (whether asserted by the Company, any Holder or any other Person) or liability in connection with the exercise or performance of any of its powers or duties hereunder
(including settlement costs). The Trustee shall notify the Company promptly of any claim for which it may seek indemnity. Failure by the Trustee to so notify the Company shall not relieve the Company of its obligations hereunder. The Company shall
defend the claim and the Trustee may have separate counsel and the Company shall pay the fees and expenses of such counsel. The Company need not reimburse any expense or indemnify against any loss, liability or expense incurred by the Trustee
through the Trustee’s own wilful misconduct, negligence or bad faith. 
 To secure the Company’s payment obligations in this
Section, the Trustee shall have a lien prior to the Securities on all money or property held or collected by the Trustee other than money or property held in trust to pay principal of and interest on particular Securities. 

The Company’s payment obligations pursuant to this Section shall survive the resignation or removal of the Trustee and the satisfaction,
discharge or other termination of this Indenture, including any termination or rejection hereof under any Bankruptcy Law. When the Trustee incurs expenses after the occurrence of a Default specified in Section 6.01(7) or (8) with respect
to the Company, the expenses are intended to constitute expenses of administration under the Bankruptcy Law. 

  
 60 

 SECTION 7.08. Replacement of Trustee. The Trustee may resign at any time by so notifying
the Company. The Holders of a majority in principal amount of the Securities may remove the Trustee by so notifying the Trustee and may appoint a successor Trustee. The Company shall remove the Trustee if: 

(1) the Trustee fails to comply with Section 7.10; 

(2) the Trustee is adjudged bankrupt or insolvent; 

(3) a receiver or other public officer takes charge of the Trustee or its property; or 

(4) the Trustee otherwise becomes incapable of acting. 

If the Trustee resigns, is removed by the Company or by the Holders of a majority in principal amount of the Securities and such Holders do
not reasonably promptly appoint a successor Trustee, or if a vacancy exists in the office of Trustee for any reason (the Trustee in such event being referred to herein as the retiring Trustee), the Company shall promptly appoint a successor Trustee.

 A successor Trustee shall deliver a written acceptance of its appointment to the retiring Trustee and to the Company. Thereupon the
resignation or removal of the retiring Trustee shall become effective, and the successor Trustee shall have all the rights, powers and duties of the Trustee under this Indenture. The successor Trustee shall mail a notice of its succession to
Securityholders. The retiring Trustee shall promptly transfer all property held by it as Trustee to the successor Trustee, subject to the lien provided for in Section 7.07. 

If a successor Trustee does not take office within 60 days after the retiring Trustee resigns or is removed, the retiring Trustee or the
Holders of 10% in principal amount of the Securities may petition any court of competent jurisdiction for the appointment of a successor Trustee. 

If the Trustee fails to comply with Section 7.10, any Securityholder may petition any court of competent jurisdiction for the removal of
the Trustee and the appointment of a successor Trustee. 
 Notwithstanding the replacement of the Trustee pursuant to this Section, the
Company’s obligations under Section 7.07 shall continue for the benefit of the retiring Trustee. 
 SECTION 7.09. Successor
Trustee by Merger. If the Trustee consolidates with, merges or converts into, or transfers all or substantially all its corporate trust business or assets to, another corporation or banking association, the resulting, surviving or transferee
corporation without any further act shall be the successor Trustee. 

  
 61 

 In case at the time such successor or successors by merger, conversion or consolidation to the
Trustee shall succeed to the trusts created by this Indenture any of the Securities shall have been authenticated but not delivered, any such successor to the Trustee may adopt the certificate of authentication of any predecessor trustee, and
deliver such Securities so authenticated; and in case at that time any of the Securities shall not have been authenticated, any successor to the Trustee may authenticate such Securities either in the name of any predecessor hereunder or in the name
of the successor to the Trustee; and in all such cases such certificates shall have the full force which it is anywhere in the Securities or in this Indenture provided that the certificate of the Trustee shall have. 

SECTION 7.10. Eligibility; Disqualification. The Trustee shall at all times satisfy the requirements of TIA § 310(a). The
Trustee shall have a combined capital and surplus of at least $50,000,000 as set forth in its most recent published annual report of condition. The Trustee shall comply with TIA § 310(b); provided, however, that there shall
be excluded from the operation of TIA § 310(b)(1) any indenture or indentures under which other securities or certificates of interest or participation in other securities of the Company are outstanding if the requirements for such
exclusion set forth in TIA § 310(b)(1) are met. 
 SECTION 7.11. Preferential Collection of Claims
Against Company. The Trustee shall comply with TIA § 311(a), excluding any creditor relationship listed in TIA § 311(b). A Trustee who has resigned or been removed shall be subject to TIA § 311(a) to the extent
indicated. 
 ARTICLE 8 

SATISFACTION AND DISCHARGE OF INDENTURE; DEFEASANCE 

SECTION 8.01. Discharge of Liability on Securities; Defeasance. (a) The Company may terminate its obligations and the
obligations of the Guarantors under the Securities, the Security Guarantees and this Indenture, except the obligations referred to in 8.01(c), if (1) all the Securities that have been authenticated and delivered (except lost, stolen or
destroyed Securities which have been replaced or paid and Securities for whose payment money has been deposited in trust or segregated and held in trust by the Company and thereafter repaid to the Company or discharged from this trust) have been
delivered to the Trustee for cancellation or (2) (i) all Securities not delivered to the Trustee for cancellation otherwise have become due and payable by reason of the mailing of a notice of redemption or otherwise or will become due and
payable within one year and the Company has irrevocably deposited or caused to be deposited with the Trustee trust funds in trust in an amount of money sufficient to pay and discharge the entire Indebtedness (including all principal and accrued
interest) on the Securities not theretofore delivered to the Trustee for cancellation, (ii) the Company has paid all sums payable by it under this Indenture, (iii) the Company has delivered irrevocable instructions to the Trustee to apply
the deposited money toward the payment of the Securities at maturity or on the date of redemption, as the case may be, and (iv) the Trustee, for the benefit of the Holders, has a valid, perfected, exclusive security interest in this trust. In
addition, the Company must deliver an Officers’ Certificate and an Opinion of Counsel (as to legal matters) stating that all conditions precedent to satisfaction and discharge have been complied with. After such delivery, the Trustee shall
acknowledge in writing the discharge of the Company’s and the Guarantors’ obligations under the Securities, the Security Guarantees and this Indenture except for those surviving obligations specified in Section 8.01(c). 

  
 62 

 (b) Subject to Sections 8.01(c) and 8.02, the Company at any time may terminate (1) all its
obligations under the Securities and this Indenture (“legal defeasance option”) or (2) its obligations under Sections 4.02, 4.03, 4.04, 4.05, 4.06, 4.07, 4.09, 4.10, 4.11 and 4.12 and the operation of Sections 6.01(5)
and 6.01(6) and the limitations contained in Section 5.01(a)(3) (“covenant defeasance option”). The Company may exercise its legal defeasance option notwithstanding its prior exercise of its covenant defeasance option. 

If the Company exercises its legal defeasance option, payment of the Securities may not be accelerated because of an Event of Default with
respect thereto. If the Company exercises its covenant defeasance option, payment of the Securities may not be accelerated because of an Event of Default specified in Sections 6.01(5) and 6.01(6) or because of the failure of the Company to
comply with Section 5.01(a)(3). 
 Upon satisfaction of the conditions set forth herein and upon request of the Company, the Trustee
shall acknowledge in writing the discharge of those obligations that the Company terminates. 
 (c) Notwithstanding
Section 8.01 (a) and (b) , the Company’s obligations in Sections 2.03, 2.04, 2.05, 2.06, 2.07, 2.08, 7.07 and 7.08 and in this Article 8 shall survive until the Securities have been paid in full. Thereafter, the
Company’s obligations in Sections 7.07, 8.04 and 8.05 shall survive. 
 SECTION 8.02. Conditions to Defeasance. The Company may
exercise its legal defeasance option or its covenant defeasance option only if: 
 (1) the Company irrevocably deposits with
the Trustee, in trust, for the benefit of the Holders, U.S. legal tender, U.S. Government Obligations or a combination thereof, in such amounts as will be sufficient (without reinvestment) in the opinion of a nationally recognized firm of
independent public accountants selected by the Company, to pay the principal of and interest on the Securities on the stated date for payment or on the redemption date of the principal or installment of principal of or interest on the Securities,
and the Trustee must have a valid, perfected, exclusive security interest in such trust; 
 (2) in the case of Legal
Defeasance, the Company delivers to the Trustee an opinion of counsel in the United States reasonably acceptable to the Trustee confirming that (a) the Company has received from, or there has been published by the Internal Revenue Service, a
ruling, or (b) since the date of this Indenture, there has been a change in the applicable U.S. federal income tax law, in either case to the effect that, the Holders will not recognize income, gain or loss for U.S. federal income tax purposes
as a result of the Legal Defeasance and will be subject to U.S. federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such Legal Defeasance had not occurred; 

  
 63 

 (3) in the case of Covenant Defeasance, the Company delivers to the Trustee an
opinion of counsel in the United States reasonably acceptable to the Trustee confirming that the Holders will not recognize income, gain or loss for U.S. federal income tax purposes as a result of such Covenant Defeasance and will be subject to U.S.
federal income tax on the same amounts, in the same manner and at the same times as would have been the case if the Covenant Defeasance had not occurred; 

(4) no Default has occurred and is continuing on the date of such deposit (other than a Default resulting from the borrowing of
funds to be applied to such deposit and the grant of any Lien securing such borrowing); 
 (5) the Legal Defeasance or
Covenant Defeasance does not result in a breach or violation of, or constitute a default under, this Indenture or any other material agreement or instrument to which the Parent or any of its Subsidiaries is a party or by which the Parent or any of
its Subsidiaries is bound (other than a default resulting from the borrowing of funds to be applied to such deposit and the grant of any Lien securing such borrowing); 

(6) the Company delivers to the Trustee an Officers’ Certificate stating that the deposit was not made by it with the
intent of preferring the Holders over any other of its creditors or with the intent of defeating, hindering, delaying or defrauding any other of its creditors or others; and 

(7) the Company delivers to the Trustee an Officers’ Certificate and an opinion of counsel, each stating that the
conditions provided for in, in the case of the Officers’ Certificate, Section 8.02(1) - (6) and, in the case of the opinion of counsel, Section 8.02 (1) (with respect to the validity and perfection of the security interest),
(2) and/or (3) and (5) have been complied with. 
 Before or after a deposit, the Company may make arrangements satisfactory
to the Trustee for the redemption of Securities at a future date in accordance with Article 3. 
 SECTION 8.03. Application of Trust
Money. The Trustee shall hold in trust money or U.S. Government Obligations deposited with it pursuant to this Article 8. It shall apply the deposited money and the money from U.S. Government Obligations through the Paying Agent
and in accordance with this Indenture to the payment of principal of and interest on the Securities. 
 SECTION 8.04. Repayment to
Company. The Trustee and the Paying Agent shall promptly turn over to the Company upon request any excess money or securities held by them at any time. 

Subject to any applicable abandoned property law, the Trustee and the Paying Agent shall pay to the Company upon request any money held by
them for the payment of principal or interest that remains unclaimed for two years, and, thereafter, Securityholders entitled to the money must look to the Company for payment as general creditors. 

  
 64 

 SECTION 8.05. Indemnity for Government Obligations. The Company shall pay and shall
indemnify the Trustee against any tax, fee or other charge imposed on or assessed against deposited U.S. Government Obligations or the principal and interest received on such U.S. Government Obligations. 

SECTION 8.06. Reinstatement. If the Trustee or Paying Agent is unable to apply any money or U.S. Government Obligations in
accordance with this Article 8 by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, the Company’s and each
Guarantor’s obligations under this Indenture, each Security Guarantee and the Securities shall be revived and reinstated as though no deposit had occurred pursuant to this Article 8 until such time as the Trustee or Paying Agent is permitted to
apply all such money or U.S. Government Obligations in accordance with this Article 8; provided, however, that, if the Company has made any payment of interest on or principal of any Securities because of the reinstatement of
its obligations, the Company shall be subrogated to the rights of the Holders of such Securities to receive such payment from the money or U.S. Government Obligations held by the Trustee or Paying Agent. If the funds deposited with the Trustee to
effect Covenant Defeasance are insufficient to pay the principal of and interest on the Securities when due, then the obligations of the Company and the Guarantors under this Indenture will be revived and no such defeasance will be deemed to have
occurred. 
 ARTICLE 9 

AMENDMENTS 
 SECTION
9.01. Without Consent of Holders. The Company, the Guarantors and the Trustee may amend this Indenture, the Security Guarantees or the Securities without notice to or consent of any Securityholder: 

(1) to cure any ambiguity, defect or inconsistency; 

(2) to provide for the assumption of the Company’s or any Guarantor’s obligations to the Holders in the case of a
merger or acquisition; 
 (3) to provide for uncertificated Securities in addition to or in place of certificated Securities;
provided, however, that the uncertificated Securities are issued in registered form for purposes of Section 163(f) of the Code or in a manner such that the uncertificated Securities are described in Section 163(f)(2)(B) of
the Code; 
 (4) to allow any Guarantor to execute a supplemental indenture or a Security Guarantee with respect to the
Securities; 
 (5) to release any Guarantor from any of its obligations under its Security Guarantee or this Indenture (to
the extent permitted by this Indenture); 
 (6) to make any change that would provide any additional rights or benefits
(including the addition of collateral) to the holders of Securities or that does not adversely affect in any material respect the legal rights under this indenture of any such holder; 

  
 65 

 (7) to comply with SEC rules and regulations or changes to applicable law; 

(8) to conform the text of this Indenture, the Securities or any Security Guarantee to any provision of the “Description
of the Notes” section of the Final Offering Circular; 
 (9) to provide for the issuance of Additional Securities in
accordance with the limitations set forth in this Indenture as of the Issue Date; or 
 (10) to comply with the rules of any
applicable securities depository. 
 After an amendment under this Section becomes effective, the Company shall mail to Securityholders a
notice briefly describing such amendment. The failure to give such notice to all Securityholders, or any defect therein, shall not impair or affect the validity of an amendment under this Section. 

SECTION 9.02. With Consent of Holders. The Company, the Guarantors and the Trustee may amend this Indenture or the Securities with the
written consent of the Holders of at least a majority in principal amount of the Securities then outstanding (including consents obtained in connection with a tender offer or exchange for the Securities) and any past default or compliance with any
provisions may also be waived with the consent of the Holders of at least a majority in principal amount of the Securities then outstanding. However, without the consent of each Securityholder affected thereby, an amendment or waiver may not: 

(1) change the maturity of any Security; 

(2) reduce the amount, extend the due date or otherwise affect the terms of any scheduled payment of interest on or principal
of the Securities; 
 (3) reduce any premium payable upon optional redemption of the Securities, change the date on which any
Securities are subject to redemption or otherwise alter the provisions with respect to the redemption of the Securities (other than provisions specifying the notice periods for effecting a redemption); 

(4) make any Security payable in money or currency other than that stated in the Securities; 

(5) modify or change any provision of this Indenture or the related definitions to subordinate the Securities or any Security
Guarantee in right of payment to other Indebtedness in a manner that adversely affects the Holders; 
 (6) reduce the
percentage of Holders necessary to consent to an amendment or waiver to this Indenture or the Securities; 
 (7) impair the
rights of Holders to receive payments of principal of or interest on the Securities; 

  
 66 

 (8) release the Parent from any of its obligations under its Security
Guarantee or this Indenture, except as permitted by this Indenture; or 
 (9) make any change in Section 9.01 or
9.02. 
 It shall not be necessary for the consent of the Holders under this Section to approve the particular form of any proposed
amendment, but it shall be sufficient if such consent approves the substance thereof. 
 After an amendment under this Section becomes
effective, the Company shall mail to Securityholders a notice briefly describing such amendment. The failure to give such notice to all Securityholders, or any defect therein, shall not impair or affect the validity of an amendment under this
Section. 
 SECTION 9.03. Compliance with Trust Indenture Act. Every amendment to this Indenture or the Securities shall comply with
the TIA as then in effect. 
 SECTION 9.04. Revocation and Effect of Consents and Waivers. A consent to an amendment or a waiver by
a Holder of a Security shall bind the Holder and every subsequent Holder of that Security or portion of the Security that evidences the same debt as the consenting Holder’s Security, even if notation of the consent or waiver is not made on the
Security. However, any such Holder or subsequent Holder may revoke the consent or waiver as to such Holder’s Security or portion of the Security if the Trustee receives the notice of revocation before the date the amendment or waiver becomes
effective. After an amendment or waiver becomes effective, it shall bind every Securityholder. An amendment or waiver becomes effective upon the execution of such amendment or waiver by the Trustee. 

The Company may, but shall not be obligated to, fix a record date for the purpose of determining the Securityholders entitled to give their
consent or take any other action described in this Article 9 or required or permitted to be taken pursuant to this Indenture. If a record date is fixed, then notwithstanding the immediately preceding paragraph, those Persons who were Securityholders
at such record date (or their duly designated proxies), and only those Persons, shall be entitled to give such consent or to revoke any consent previously given or to take any such action, whether or not such Persons continue to be Holders after
such record date. No such consent shall be valid or effective for more than 120 days after such record date. 
 SECTION 9.05. Notation
on or Exchange of Securities. If an amendment changes the terms of a Security, the Trustee may require the Holder of the Security to deliver it to the Trustee. The Trustee may place an appropriate notation on the Security regarding the changed
terms and return it to the Holder. Alternatively, if the Company or the Trustee so determines, the Company in exchange for the Security shall issue and the Trustee shall authenticate a new Security that reflects the changed terms. Failure to make
the appropriate notation or to issue a new Security shall not affect the validity of such amendment. 
 SECTION 9.06. Trustee To Sign
Amendments. The Trustee shall sign any amendment authorized pursuant to this Article 9 if the amendment does not adversely affect the rights, duties, liabilities or immunities of the Trustee. If it does, the Trustee may but need not sign it. In
signing such amendment the Trustee shall be entitled to receive indemnity reasonably 

  
 67 

 
satisfactory to it and to receive, and (subject to Section 7.01) shall be fully protected in relying upon, an Officers’ Certificate and an Opinion of Counsel stating that such amendment
is authorized or permitted by this Indenture. 
 SECTION 9.07. Payments for Consent. The Parent shall not, and shall not permit any
Restricted Subsidiary to, directly or indirectly, pay or cause to be paid any consideration, to any Holder of Securities for or as an inducement to any consent, waiver or amendment of any of the terms or provisions of this Indenture or the
Securities unless such consideration is offered to be paid or agreed to be paid to all Holders of the Securities that consent, waive or agree to amend in the time frame set forth in solicitation documents relating to such consent, waiver or
agreement. 
 ARTICLE 10 

GUARANTEES 
 SECTION
10.01. Guarantees. Each Guarantor hereby unconditionally and irrevocably guarantees, jointly and severally, to each Holder and to the Trustee and its successors and assigns (a) the full and punctual payment of principal of and interest
on the Securities when due, whether at maturity, by acceleration, by redemption or otherwise, and all other monetary obligations of the Company under this Indenture and the Securities and (b) the full and punctual performance within applicable
grace periods of all other obligations of the Company under this Indenture and the Securities (all the foregoing being hereinafter collectively called the “Guaranteed Obligations”). Each Guarantor further agrees that the Guaranteed
Obligations may be extended or renewed, in whole or in part, without notice or further assent from such Guarantor and that such Guarantor will remain bound under this Article 10 notwithstanding any extension or renewal of any Obligation. 

Each Guarantor waives presentation to, demand of, payment from and protest to the Company of any of the Guaranteed Obligations and also
waives notice of protest for nonpayment. Each Guarantor waives notice of any default under the Securities or the Guaranteed Obligations. The obligations of each Guarantor hereunder shall not be affected by (1) the failure of any Holder or the
Trustee to assert any claim or demand or to enforce any right or remedy against the Company or any other Person (including any Guarantor) under this Indenture, the Securities or any other agreement or otherwise; (2) any extension or renewal of
any thereof; (3) any rescission, waiver, amendment or modification of any of the terms or provisions of this Indenture, the Securities or any other agreement; (4) the release of any security held by any Holder or the Trustee for the
Guaranteed Obligations or any of them; (5) the failure of any Holder or the Trustee to exercise any right or remedy against any other guarantor of the Guaranteed Obligations; or (6) except as set forth in Section 10.07, any change in
the ownership of such Guarantor. 
 Each Guarantor further agrees that its Security Guarantee herein constitutes a guarantee of payment,
performance and compliance when due (and not a guarantee of collection) and waives any right to require that any resort be had by any Holder or the Trustee to any security held for payment of the Guaranteed Obligations. 

  
 68 

 Except as expressly set forth in Sections 8.01(b), 10.02 and 10.07, the obligations of each
Guarantor hereunder shall not be subject to any reduction, limitation, impairment or termination for any reason, including any claim of waiver, release, surrender, alteration or compromise, and shall not be subject to any defense of setoff,
counterclaim, recoupment or termination whatsoever or by reason of the invalidity, illegality or unenforceability of the Guaranteed Obligations or otherwise. Without limiting the generality of the foregoing, the obligations of each Guarantor herein
shall not be discharged or impaired or otherwise affected by the failure of any Holder or the Trustee to assert any claim or demand or to enforce any remedy under this Indenture, the Securities or any other agreement, by any waiver or modification
of any thereof, by any default, failure or delay, willful or otherwise, in the performance of the obligations, or by any other act or thing or omission or delay to do any other act or thing which may or might in any manner or to any extent vary the
risk of such Guarantor or would otherwise operate as a discharge of such Guarantor as a matter of law or equity. 
 Each Guarantor further
agrees that its Security Guarantee herein shall continue to be effective or be reinstated, as the case may be, if at any time payment, or any part thereof, of principal of or interest on any Obligation is rescinded or must otherwise be restored by
any Holder or the Trustee upon the bankruptcy or reorganization of the Company or otherwise. 
 In furtherance of the foregoing and not in
limitation of any other right which any Holder or the Trustee has at law or in equity against any Guarantor by virtue hereof, upon the failure of the Company to pay the principal of or interest on any Obligation when and as the same shall become
due, whether at maturity, by acceleration, by redemption or otherwise, or to perform or comply with any other Obligation, each Guarantor hereby promises to and shall, upon receipt of written demand by the Trustee, forthwith pay, or cause to be paid,
in cash, to the Holders or the Trustee an amount equal to the sum of (A) the unpaid amount of such Guaranteed Obligations, (B) accrued and unpaid interest on such Guaranteed Obligations (but only to the extent not prohibited by law) and
(C) all other monetary Guaranteed Obligations of the Company to the Holders and the Trustee. 
 Each Guarantor agrees that, as between
it, on the one hand, and the Holders and the Trustee, on the other hand, (i) the maturity of the Guaranteed Obligations hereby may be accelerated as provided in Article 6 for the purposes of such Guarantor’s Security Guarantee herein,
notwithstanding any stay, injunction or other prohibition preventing such acceleration in respect of the Guaranteed Obligations guaranteed hereby, and (ii) in the event of any declaration of acceleration of such Guaranteed Obligations as
provided in Article 6, such Guaranteed Obligations (whether or not due and payable) shall forthwith become due and payable by such Guarantor for the purposes of this Section. 

Each Guarantor also agrees to pay any and all costs and expenses (including reasonable attorneys’ fees) incurred by the Trustee or any
Holder in enforcing any rights under this Section. 
 SECTION 10.02. Limitation on Liability. Each Guarantor, and by its acceptance
of the Securities, each Holder, hereby confirms that it is the intention of all such parties that the Security Guarantee of such Guarantor not constitute a fraudulent transfer or conveyance for purposes of Bankruptcy Law, the Uniform Fraudulent
Conveyance Act, the 

  
 69 

 
Uniform Fraudulent Transfer Act or any similar federal or state law to the extent applicable to any Security Guarantee. To effectuate the foregoing intention, the Trustee, the Holders and the
Guarantors hereby irrevocably agree that, any term or provision of this Indenture to the contrary notwithstanding, the maximum aggregate amount of the Guaranteed Obligations guaranteed hereunder by any Guarantor shall not exceed the maximum amount
that can be hereby guaranteed without rendering this Indenture, as it relates to such Guarantor, voidable under applicable law relating to fraudulent conveyance or fraudulent transfer or similar laws affecting the rights of creditors generally. 

SECTION 10.03. Successors and Assigns. This Article 10 shall be binding upon each Guarantor and its successors and assigns and
shall enure to the benefit of the successors and assigns of the Trustee and the Holders and, in the event of any transfer or assignment of rights by any Holder or the Trustee, the rights and privileges conferred upon that party in this Indenture and
in the Securities shall automatically extend to and be vested in such transferee or assignee, all subject to the terms and conditions of this Indenture. 

SECTION 10.04. No Waiver. Neither a failure nor a delay on the part of either the Trustee or the Holders in exercising any right,
power or privilege under this Article 10 shall operate as a waiver thereof, nor shall a single or partial exercise thereof preclude any other or further exercise of any right, power or privilege. The rights, remedies and benefits of the Trustee and
the Holders herein expressly specified are cumulative and not exclusive of any other rights, remedies or benefits which either may have under this Article 10 at law, in equity, by statute or otherwise. 

SECTION 10.05. Modification. No modification, amendment or waiver of any provision of this Article 10, nor the consent to any
departure by any Guarantor therefrom, shall in any event be effective unless the same shall be in writing and signed by the Trustee, and then such waiver or consent shall be effective only in the specific instance and for the purpose for which
given. No notice to or demand on any Guarantor in any case shall entitle such Guarantor to any other or further notice or demand in the same, similar or other circumstances. 

SECTION 10.06. Execution and Delivery of Security Guarantee 

To evidence its Security Guarantee set forth in Section 10.01 hereof, each Guarantor hereby agrees that a notation of such Security
Guarantee substantially in the form attached as Exhibit B hereto will be endorsed by an Officer of such Guarantor on Securities authenticated and delivered by the Trustee and that this Indenture will be executed on behalf of such Guarantor by one of
its Officers. 
 Each Guarantor hereby agrees that its Security Guarantee set forth in Section 10.01 hereof will remain in full force
and effect notwithstanding any failure to endorse on such Security a notation of such Security Guarantee. 
 If an Officer whose signature
is on this Indenture or on the Security Guarantee no longer holds that office at the time the Trustee authenticates the Securities on which a Security Guarantee is endorsed, the Security Guarantee will be valid nevertheless. 

  
 70 

 The delivery of any Global Security by the Trustee, after the authentication thereof hereunder,
will constitute due delivery of the Security Guarantee set forth in this Indenture on behalf of the Guarantors. 
 In the event that the
Parent or any Restricted Subsidiary creates or acquires any Wholly Owned Restricted Subsidiary (other than (i) a Subsidiary that has been designated an Unrestricted Subsidiary, and (ii) any Subsidiary that is a project-financed special
purpose entity) after the date of this Indenture, if required by Section 4.13 hereof, the Company will cause such Wholly Owned Restricted Subsidiary to comply with the provisions of Section 4.13 hereof and this Article 10, to the extent
applicable 
 SECTION 10.07. Release of Guarantor. A Subsidiary Guarantor will be released from its obligations under this Article
10 (other than any obligation that may have arisen under Section 10.08) 
 (1) upon any consolidation with or merger
with or into, any Person by such Subsidiary Guarantor pursuant to Section 5.01(b); 
 (2) upon the disposition of all or
a portion of the Capital Stock of such Subsidiary Guarantor such that such Subsidiary Guarantor ceases to be a Subsidiary, if the sale or other disposition does not violate Section 4.06; 

(3) upon the designation of such Subsidiary Guarantor as an Unrestricted Subsidiary in accordance with the terms of this
Indenture; 
 (4) at such time as such Subsidiary Guarantor does not have any Security Guarantees outstanding that would have
required such Subsidiary Guarantor to enter into a Security Guarantee pursuant to Section 4.13; 
 (5) upon defeasance
of the Securities pursuant to Article 8; or 
 (6) upon the full satisfaction of the Company’s obligations under this
Indenture; 
 provided, however, that in the case of Section 10.07(1) , if such other Person is not a Subsidiary of the
Parent then (i) such merger or consolidation must otherwise be permitted by this Indenture and (ii) the Company must provide an Officers’ Certificate to the Trustee to the effect that the Company will comply with its obligations under
Section 4.06. 
 At the request of the Company, the Trustee shall execute and deliver an appropriate instrument evidencing such release. 

SECTION 10.08. Contribution. Each Subsidiary Guarantor that makes a payment under its Security Guarantee shall be entitled upon
payment in full of all Guaranteed Obligations under this Indenture to a contribution from each other Subsidiary Guarantor in an amount equal to such other Subsidiary Guarantor’s pro rata portion of such payment based on the
respective net assets of all the Subsidiary Guarantors at the time of such payment determined in accordance with GAAP. 

  
 71 

 ARTICLE 11 

MISCELLANEOUS 
 SECTION
11.01. Trust Indenture Act Controls. If any provision of this Indenture limits, qualifies or conflicts with another provision which is required to be included in this Indenture by the TIA, the required provision shall control. 

SECTION 11.02. Notices. Any notice or communication shall be in writing and delivered in person or mailed by first-class mail
addressed as follows: 
 If to the Company or any Guarantor: 

WILLIAM LYON HOMES, INC. 
 4695
MacArthur Court, 8th Floor 
 Newport Beach, CA 92660 

Attention: Chief Financial Officer 

Fax Number: (949) 252-2575 

with a copy to (which shall not constitute notice): 

LATHAM & WATKINS LLP 

650 Town Center Drive 
 20th Floor Costa Mesa, CA 92626 
 Attention: Cary K. Hyden and Michael Treska 

Fax Number: (714) 755-8290 

If to the Trustee: 
 U.S. BANK
NATIONAL ASSOCIATION 
 EP-MN-WS3C 

60 Livingston Avenue 
 St. Paul,
MN 55107 
 Attention: Corporate Trust Department 

Fax Number: (651) 495-8097 

The Company, any Guarantor or the Trustee by notice to the other may designate additional or different addresses for subsequent notices or
communications. 
 Any notice or communication mailed to a Securityholder shall be mailed to the Securityholder at the
Securityholder’s address as it appears on the registration books of the Registrar and shall be sufficiently given if so mailed within the time prescribed. 

Failure to mail a notice or communication to a Securityholder or any defect in it shall not affect its sufficiency with respect to other
Securityholders. If a notice or communication is mailed in the manner provided in this Section 11.02, it is duly given, whether or not the addressee receives it. 

  
 72 

 Notwithstanding any other provision of this Indenture or any Note, where this Indenture or any
Note provides for notice of any event (including any notice of redemption or repurchase) to a Holder (whether by mail or otherwise), such notice shall be sufficiently given if given to the Depository (or its designee) pursuant to the standing
instructions from the Depository or its designee, including by electronic mail in accordance with accepted practices or procedures at the Depository. 

SECTION 11.03. Communication by Holders with Other Holders. Securityholders may communicate pursuant to TIA § 312(b) with other
Securityholders with respect to their rights under this Indenture or the Securities. The Company, any Guarantor, the Trustee, the Registrar and anyone else shall have the protection of TIA § 312(c). 

SECTION 11.04. Certificate and Opinion as to Conditions Precedent. Upon any request or application by the Company to the Trustee to
take or refrain from taking any action under this Indenture, the Company shall furnish to the Trustee: 
 (1) an
Officers’ Certificate in form and substance reasonably satisfactory to the Trustee stating that, in the opinion of the signers, all conditions precedent, if any, provided for in this Indenture relating to the proposed action have been complied
with; and 
 (2) an Opinion of Counsel in form and substance reasonably satisfactory to the Trustee stating that, in the
opinion of such counsel, all such conditions precedent have been complied with. 
 SECTION 11.05. Statements Required in Certificate or
Opinion. Each certificate or opinion with respect to compliance with a covenant or condition provided for in this Indenture shall include: 

(1) a statement that the individual making such certificate or opinion has read such covenant or condition; 

(2) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions
contained in such certificate or opinion are based; 
 (3) a statement that, in the opinion of such individual, he has made
such examination or investigation as is necessary to enable him to express an informed opinion as to whether or not such covenant or condition has been complied with; and 

(4) a statement as to whether or not, in the opinion of such individual, such covenant or condition has been complied with.

 SECTION 11.06. When Securities Disregarded. In determining whether the Holders of the required principal amount of Securities
have concurred in any direction, waiver or 

  
 73 

 
consent, Securities owned by the Company or by any Person directly or indirectly controlling or controlled by or under direct or indirect common control with the Company shall be disregarded and
deemed not to be outstanding, except that, for the purpose of determining whether the Trustee shall be protected in relying on any such direction, waiver or consent, only Securities which the Trustee knows are so owned shall be so disregarded. Also,
subject to the foregoing, only Securities outstanding at the time shall be considered in any such determination. 
 SECTION 11.07. Rules
by Trustee, Paying Agent and Registrar. The Trustee may make reasonable rules for action by or a meeting of Securityholders. The Registrar and the Paying Agent may make reasonable rules for their functions. 

SECTION 11.08. Legal Holidays. If a payment date is a Legal Holiday, payment shall be made on the next succeeding day that is not a
Legal Holiday, and no interest shall accrue for the intervening period. If a regular record date is a Legal Holiday, the record date shall not be affected. 

SECTION 11.09. Governing Law. This Indenture and the Securities shall be governed by, and construed in accordance with, the laws of
the State of New York. 
 SECTION 11.10. No Recourse Against Others. No director, officer, employee, incorporator or
stockholder of the Parent or any Restricted Subsidiary shall have any liability for any obligations of the Company under the Securities or the Indenture or any Guarantor under its Security Guarantee or for any claim based on, in respect of or by
reason of such obligations or their creation. By accepting a Security, each Securityholder waives and releases all such liability. The waiver and release are part of the consideration for the issuance of the Securities and the Security Guarantees.

 SECTION 11.11. Successors. All agreements of the Company in this Indenture and the Securities shall bind its successors. All
agreements of the Trustee in this Indenture shall bind its successors. 
 SECTION 11.12. Multiple Originals. The parties may sign
any number of copies of this Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. One signed copy is enough to prove this Indenture. 

SECTION 11.13. Table of Contents; Headings. The table of contents, cross-reference sheet and headings of the Articles and Sections of
this Indenture have been inserted for convenience of reference only, are not intended to be considered a part hereof and shall not modify or restrict any of the terms or provisions hereof. 

  
 74 

 IN WITNESS WHEREOF, the parties have caused this Indenture to be duly executed as of the date
first written above. 
  

			
	WILLIAM LYON HOMES, INC.
		
	By:	 	 Matthew R. Zaist

	Name:	 	Matthew R. Zaist
	Title:	 	President and Chief Operating Officer
	
	GUARANTORS:
	
	WILLIAM LYON HOMES
		
	By:	 	 Matthew R. Zaist

	Name:	 	Matthew R. Zaist
	Title:	 	President and Chief Operating Officer
	
	 PH-LP VENTURES

DUXFORD FINANCIAL, INC.
 SYCAMORE CC, INC.

PRESLEY CMR, INC.
 WILLIAM LYON SOUTHWEST, INC.

PH-RIELLY VENTURES
 PH VENTURES-SAN JOSE

PRESLEY HOMES

		
	By:	 	 Matthew R. Zaist

	Name:	 	Matthew R. Zaist
	Title:	 	President and Chief Operating Officer
	
	WLH ENTERPRISES
		
	By:	 	William Lyon Homes, Inc.
	Its:	 	General Partner
		
	By:	 	 Matthew R. Zaist

	Name:	 	Matthew R. Zaist
	Title:	 	President and Chief Operating Officer

  
 75 

			
	By:	 	Presley CMR, Inc.
	Its:	 	General Partner
		
	By:	 	 Matthew R. Zaist

	Name:	 	Matthew R. Zaist
	Title:	 	President and Chief Operating Officer
	
	LYON EAST GARRISON COMPANY I, LLC
		
	By:	 	William Lyon Homes, Inc.
	Its:	 	Sole Member
		
	By:	 	 Matthew R. Zaist

	Name:	 	Matthew R. Zaist
	Title:	 	President and Chief Operating Officer
	
	LYON WATERFRONT, LLC
		
	By:	 	William Lyon Homes, Inc.
	Its:	 	Sole Member
		
	By:	 	 Matthew R. Zaist

	Name:	 	Matthew R. Zaist
	Title:	 	President and Chief Operating Officer
	
	CIRCLE G AT THE CHURCH FARM NORTH JOINT VENTURE, LLC
		
	By:	 	William Lyon Homes, Inc.
	Its:	 	Manager
		
	By:	 	 Matthew R. Zaist

	Name:	 	Matthew R. Zaist
	Title:	 	President and Chief Operating Officer
	
	MOUNTAIN FALLS, LLC
		
	By:	 	William Lyon Homes, Inc.
	Its:	 	Sole Member
		
	By:	 	 Matthew R. Zaist

	Name:	 	Matthew R. Zaist
	Title:	 	President and Chief Operating Officer

  
 76 

					
	MOUNTAIN FALLS GOLF COURSE, LLC
		
	By:	 	WLH Enterprises
	Its:	 	Managing Member
			
		 	By:	 	William Lyon Homes, Inc.
		 	Its:	 	General Partner
			
		 	By:	 	 Matthew R. Zaist

		 	Name:	 	Matthew R. Zaist
		 	Title:	 	President and Chief Operating Officer
			
		 	By:	 	Presley CMR, Inc.
		 	Its:	 	General Partner
			
		 	By:	 	 Matthew R. Zaist

		 	Name:	 	Matthew R. Zaist
		 	Title:	 	President and Chief Operating Officer
	
	CALIFORNIA EQUITY FUNDING, INC.
	
	HSP, INC.
		
	By:	 	 Matthew R. Zaist

	Name:	 	Matthew R. Zaist
	Title:	 	Executive Vice President

  
 77 

			
	U.S. BANK NATIONAL ASSOCIATION
		
	By:	 	 Donald Hurrelbrink

	Name:	 	Donald Hurrelbrink
	Title:	 	Vice President

  
 78 

 RULE 144A/REGULATION S APPENDIX 

PROVISIONS RELATING TO INITIAL SECURITIES, 

PRIVATE EXCHANGE SECURITIES 

AND EXCHANGE SECURITIES 

1. Definitions 
 1.1
Definitions 
 For the purposes of this Appendix the following terms shall have the meanings indicated below: 

“Applicable Procedures” means, with respect to any transfer or transaction involving a Temporary Regulation S Global
Security or beneficial interest therein, the rules and procedures of the Depository for such a Temporary Regulation S Global Security, to the extent applicable to such transaction and as in effect from time to time. 

“Definitive Security” means a certificated Initial Security or Exchange Security or Private Exchange Security bearing, if
required, the appropriate restricted securities legend set forth in Section 2.3(e). 
 “Depository” means The
Depository Trust Company, its nominees and their respective successors. 
 “Distribution Compliance Period”, with respect
to any Securities, means the period of 40 consecutive days beginning on and including the later of (i) the day on which such Securities are first offered to Persons other than distributors (as defined in Regulation S under the Securities Act)
in reliance on Regulation S and (ii) the issue date with respect to such Securities. 
 “Exchange Securities” means
(1) the 5.75% Senior Notes Due 2019 issued pursuant to this Indenture in connection with a Registered Exchange Offer pursuant to the Registration Rights Agreement and (2) Additional Securities, if any, issued pursuant to a registration
statement filed with the SEC under the Securities Act. 
 “Initial Purchasers” means (1) with respect to the Initial
Securities issued on the Issue Date, Credit Suisse Securities (USA) LLC, Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Comerica Securities, Inc., Moelis & Company LLC and Zelman Partners LLC and (2) with respect to each
issuance of Additional Securities, the Persons purchasing such Additional Securities under the related Purchase Agreement. 

“Initial Securities” means (1) $150,000,000 aggregate principal amount of 5.75% Senior Notes Due 2019 issued on
the Issue Date and (2) Additional Securities, if any, issued in a transaction exempt from the registration requirements of the Securities Act. 

“Private Exchange” means the offer by the Company, pursuant to a Registration Rights Agreement, to the Initial Purchasers to
issue and deliver to each Initial Purchaser, in exchange for the Initial Securities held by the Initial Purchaser as part of its initial distribution, a like aggregate principal amount of Private Exchange Securities. 

 “Private Exchange Securities” means any 5.75% Senior Notes Due 2019 issued in
connection with a Private Exchange. 
 “Purchase Agreement” means (1) with respect to the Initial Securities issued
on the Issue Date, the Purchase Agreement dated March 26, 2014, among the Company, the guarantors party thereto and Credit Suisse Securities (USA) LLC as representative of the Initial Purchasers, and (2) with respect to each issuance of
Additional Securities, the purchase agreement or underwriting agreement among the Company and the Persons purchasing such Additional Securities. 

“QIB” means a “qualified institutional buyer” as defined in Rule 144A. 

“Registered Exchange Offer” means the offer by the Company, pursuant to a Registration Rights Agreement, to certain Holders
of Initial Securities, to issue and deliver to such Holders, in exchange for the Initial Securities, a like aggregate principal amount of Exchange Securities registered under the Securities Act. 

“Registration Rights Agreement” means (1) with respect to the Initial Securities issued on the Issue Date, the
Registration Rights Agreement dated as of the date hereof, among the Company, the guarantors party thereto and Credit Suisse Securities (USA) LLC as representative of the Initial Purchasers and (2) with respect to each issuance of Additional
Securities issued in a transaction exempt from the registration requirements of the Securities Act, the registration rights agreement, if any, among the Company and the Persons purchasing such Additional Securities under the related Purchase
Agreement. 
 “Rule 144A Securities” means all Securities offered and sold to QIBs in reliance on Rule 144A. 

“Securities” means the Initial Securities, the Exchange Securities and the Private Exchange Securities, treated as a single
class. 
 “Securities Act” means the Securities Act of 1933. 

“Securities Custodian” means the custodian with respect to a Global Security (as appointed by the Depository), or any
successor Person thereto and shall initially be the Trustee. 
 “Shelf Registration Statement” means the registration
statement issued by the Company in connection with the offer and sale of Initial Securities or Private Exchange Securities pursuant to the Registration Rights Agreement. 

“Transfer Restricted Securities” means Securities that bear or are required to bear the legend relating to restrictions on
transfer relating to the Securities Act set forth in Section 2.3(e) hereto. 

  
 2 

 1.2 Other Definitions 

 

			
	 Term
	  	Defined
in
Section:
		
	 “Agent Members”
	  	2.1(b)
		
	 “Global Securities”
	  	2.1(a)
		
	 “Permanent Regulation S Global Security”
	  	2.1(a)
		
	 “Regulation S”
	  	2.1(a)
		
	 “Regulation S Global Security”
	  	2.1(a)
		
	 “Rule 144A”
	  	2.1(a)
		
	 “Rule 144A Global Security”
	  	2.1(a)
	“Temporary Regulation S Global Security”	  	2.1(a)

 2. The Securities. 

2.1(a) Form and Dating. The Initial Securities will be offered and sold by the Company pursuant to a Purchase Agreement. The
Initial Securities will be resold initially only to (i) QIBs in reliance on Rule 144A under the Securities Act (“Rule 144A”) and (ii) Persons other than U.S. Persons (as defined in Regulation S) in reliance on
Regulation S under the Securities Act (“Regulation S”). Initial Securities may thereafter be transferred to, among others, QIBs and purchasers in reliance on Regulation S, subject to the restrictions on transfer set forth
herein. Initial Securities initially resold pursuant to Rule 144A shall be issued initially in the form of one or more permanent global Securities in definitive, fully registered form (collectively, the “Rule 144A Global
Security”) and Initial Securities initially resold pursuant to Regulation S shall be issued initially in the form of one or more temporary global securities in fully registered form (collectively, the “Temporary Regulation S Global
Security”), in each case without interest coupons and with the global securities legend and the applicable restricted securities legend set forth in Exhibit 1 hereto, which shall be deposited on behalf of the purchasers of the Initial
Securities represented thereby with the Securities Custodian and registered in the name of the Depository or a nominee of the Depository, duly executed by the Company and authenticated by the Trustee as provided in this Indenture. Except as set
forth in this Section 2.1(a), beneficial ownership interests in the Temporary Regulation S Global Security will not be exchangeable for interests in the Rule 144A Global Security, a permanent global security (the “Permanent Regulation S
Global Security”, and together with the Temporary Regulation S Global Security, the “Regulation S Global Security”) or any other Security prior to the expiration of the Distribution Compliance Period and then, after the
expiration of the Distribution Compliance Period, may be exchanged for interests in a Rule 144A Global Security or the Permanent 

  
 3 

 
Regulation S Global Security only upon certification in form reasonably satisfactory to the Trustee that beneficial ownership interests in such Temporary Regulation S Global Security are
owned either by non-U.S. persons or U.S. persons who purchased such interests in a transaction that did not require registration under the Securities Act. 

Beneficial interests in Temporary Regulation S Global Securities may be exchanged for interests in Rule 144A Global Securities if
(1) such exchange occurs in connection with a transfer of Securities in compliance with Rule 144A and (2) the transferor of the beneficial interest in the Temporary Regulation S Global Security first delivers to the Trustee a written
certificate (in a form satisfactory to the Trustee) to the effect that the beneficial interest in the Temporary Regulation S Global Security is being transferred to a Person (a) who the transferor reasonably believes to be a QIB,
(b) purchasing for its own account or the account of a QIB in a transaction meeting the requirements of Rule 144A, and (c) in accordance with all applicable securities laws of the States of the United States and other jurisdictions. 

Beneficial interests in a Rule 144A Global Security may be transferred to a Person who takes delivery in the form of an interest in a
Regulation S Global Security, whether before or after the expiration of the Distribution Compliance Period, only if the transferor first delivers to the Trustee a written certificate (in the form provided in this Indenture) to the effect that
such transfer is being made in accordance with Rule 903 or 904 of Regulation S or Rule 144 (if applicable). 
 The Rule 144A
Global Security, the Temporary Regulation S Global Security and the Permanent Regulation S Global Security are collectively referred to herein as “Global Securities”. The aggregate principal amount of the Global Securities may from time to
time be increased or decreased by adjustments made on the records of the Trustee and the Depository or its nominee as hereinafter provided. 

(b) Book-Entry Provisions. This Section 2.1(b) shall apply only to a Global Security deposited with or on behalf of the
Depository. 
 The Company shall execute and the Trustee shall, in accordance with this Section 2.1(b), authenticate and deliver
initially one or more Global Securities that (a) shall be registered in the name of the Depository for such Global Security or Global Securities or the nominee of such Depository and (b) shall be delivered by the Trustee to such Depository
or pursuant to such Depository’s instructions or held by the Trustee as custodian for the Depository. 
 Members of, or participants
in, the Depository (“Agent Members”) shall have no rights under this Indenture with respect to any Global Security held on their behalf by the Depository or by the Trustee as the custodian of the Depository or under such Global
Security, and the Company, the Trustee and any agent of the Company or the Trustee shall be entitled to treat the Depository as the absolute owner of such Global Security for all purposes whatsoever. Notwithstanding the foregoing, nothing herein
shall prevent the Company, the Trustee or any agent of the Company or the Trustee from giving effect to any written certification, proxy or other authorization furnished by the Depository or impair, as between the Depository and its Agent Members,
the operation of customary practices of such Depository governing the exercise of the rights of a holder of a beneficial interest in any Global Security. 

  
 4 

 (c) Definitive Securities. Except as provided in this Section 2.1 or
Section 2.3 or 2.4, owners of beneficial interests in Global Securities shall not be entitled to receive physical delivery of Definitive Securities. 

2.2 Authentication. The Trustee shall authenticate and deliver: (1) on the Issue Date, an aggregate principal amount of
$150,000,000 5.75% Senior Notes Due 2019, (2) any Additional Securities for an original issue in an aggregate principal amount specified in the written order of the Company pursuant to Section 2.02 of this Indenture and (3) Exchange
Securities or Private Exchange Securities for issue only in a Registered Exchange Offer or a Private Exchange, respectively, pursuant to a Registration Rights Agreement, for a like principal amount of Initial Securities, in each case upon a written
order of the Company signed by two Officers or by an Officer and either an Assistant Treasurer or an Assistant Secretary of the Company. Such order shall specify the amount of the Securities to be authenticated and the date on which the original
issue of Securities is to be authenticated and, in the case of any issuance of Additional Securities pursuant to Section 2.13 of this Indenture, shall certify that such issuance is in compliance with Section 4.03 of this Indenture. 

2.3 Transfer and Exchange. 

(a) Transfer and Exchange of Definitive Securities. When Definitive Securities are presented to the Registrar with a request: 

 

	 	(x)	to register the transfer of such Definitive Securities; or 

  

	 	(y)	to exchange such Definitive Securities for an equal principal amount of Definitive Securities of other authorized denominations, 

the Registrar shall register the transfer or make the exchange as requested if its reasonable requirements for such transaction are met; provided,
however, that the Definitive Securities surrendered for transfer or exchange: 
 (i) shall be duly endorsed or
accompanied by a written instrument of transfer in form reasonably satisfactory to the Company and the Registrar, duly executed by the Holder thereof or its attorney duly authorized in writing; and 

(ii) if such Definitive Securities are required to bear a restricted securities legend, they are being transferred or exchanged
pursuant to an effective registration statement under the Securities Act, pursuant to Section 2.3(b) or pursuant to clause (A), (B) or (C) below, and are accompanied by the following additional information and documents, as
applicable: 
 (A) if such Definitive Securities are being delivered to the Registrar by a Holder for registration in the
name of such Holder, without transfer, a certification from such Holder to that effect; or 
 (B) if such Definitive
Securities are being transferred to the Company, a certification to that effect; or 
 (C) if such Definitive Securities are
being transferred (x) pursuant to an exemption from registration in accordance with Rule 144A, Regulation S or Rule 144 under the Securities Act; or (y) in reliance upon another exemption from the requirements of the Securities Act:
(i) a certification to that effect (in the form set forth on the reverse of the Security) and (ii) if the Company so requests, an opinion of counsel or other evidence reasonably satisfactory to it as to the compliance with the restrictions
set forth in the legend set forth in Section 2.3(e)(i). 

  
 5 

 (b) Restrictions on Transfer of a Definitive Security for a Beneficial Interest in a Global
Security. A Definitive Security may not be exchanged for a beneficial interest in a Rule 144A Global Security or a Permanent Regulation S Global Security except upon satisfaction of the requirements set forth below. Upon receipt by the
Trustee of a Definitive Security, duly endorsed or accompanied by appropriate instruments of transfer, in form satisfactory to the Trustee, together with: 

(i) certification, in the form set forth on the reverse of the Security, that such Definitive Security is either
(A) being transferred to a QIB in accordance with Rule 144A or (B) being transferred after expiration of the Distribution Compliance Period by a Person who initially purchased such Security in reliance on Regulation S to a buyer who elects
to hold its interest in such Security in the form of a beneficial interest in the Permanent Regulation S Global Security; and 

(ii) written instructions directing the Trustee to make, or to direct the Securities Custodian to make, an adjustment on its
books and records with respect to such Rule 144A Global Security (in the case of a transfer pursuant to clause (b)(i)(A)) or Permanent Regulation S Global Security (in the case of a transfer pursuant to clause (b)(i)(B)) to reflect an increase in
the aggregate principal amount of the Securities represented by the Rule 144A Global Security or Permanent Regulation S Global Security, as applicable, such instructions to contain information regarding the Depository account to be credited with
such increase, 
 then the Trustee shall cancel such Definitive Security and cause, or direct the Securities Custodian to cause, in accordance with the
standing instructions and procedures existing between the Depository and the Securities Custodian, the aggregate principal amount of Securities represented by the Rule 144A Global Security or Permanent Regulation S Global Security, as applicable, to
be increased by the aggregate principal amount of the Definitive Security to be exchanged and shall credit or cause to be credited to the account of the Person specified in such instructions a beneficial interest in the Rule 144A Global Security or
Permanent Regulation S Global Security, as applicable, equal to the principal amount of the Definitive Security so canceled. If no Rule 144A Global Securities or Permanent Regulation S Global Securities, as applicable, are then outstanding, the
Company shall issue and the Trustee shall authenticate, upon written order of the Company in the form of an Officers’ Certificate of the Company, a new Rule 144A Global Security or Permanent Regulation S Global Security, as applicable, in the
appropriate principal amount. 

  
 6 

 (c) Transfer and Exchange of Global Securities. 

(i) The transfer and exchange of Global Securities or beneficial interests therein shall be effected through the Depository,
in accordance with this Indenture (including applicable restrictions on transfer set forth herein, if any) and the procedures of the Depository therefor. A transferor of a beneficial interest in a Global Security shall deliver to the Registrar a
written order given in accordance with the Depository’s procedures containing information regarding the participant account of the Depository to be credited with a beneficial interest in the Global Security. The Registrar shall, in accordance
with such instructions instruct the Depository to credit to the account of the Person specified in such instructions a beneficial interest in the Global Security and to debit the account of the Person making the transfer the beneficial interest in
the Global Security being transferred. 
 (ii) If the proposed transfer is a transfer of a beneficial interest in one Global
Security to a beneficial interest in another Global Security, the Registrar shall reflect on its books and records the date and an increase in the principal amount of the Global Security to which such interest is being transferred in an amount equal
to the principal amount of the interest to be so transferred, and the Registrar shall reflect on its books and records the date and a corresponding decrease in the principal amount of the Global Security from which such interest is being
transferred. 
 (iii) Notwithstanding any other provisions of this Appendix (other than the provisions set forth in
Section 2.4), a Global Security may not be transferred as a whole except by the Depository to a nominee of the Depository or by a nominee of the Depository to the Depository or another nominee of the Depository or by the Depository or any such
nominee to a successor Depository or a nominee of such successor Depository. 
 (iv) In the event that Global Security is
exchanged for Definitive Securities to Section 2.4 of this Appendix, prior to the consummation of a Registered Exchange Offer or the effectiveness of a Shelf Registration Statement with respect to such Securities, such Securities may be
exchanged only in accordance with such procedures as are substantially consistent with the provisions of this Section 2.3 (including the certification requirements set forth on the reverse of the Initial Securities intended to ensure that such
transfers comply with Rule 144A, Regulation S or another applicable exemption under the Securities Act, as the case may be) and such other procedures as may from time to time be adopted by the Company. 

(d) Restrictions on Transfer of Temporary Regulation S Global Securities. During the Distribution Compliance Period, beneficial
ownership interests in Temporary Regulation S Global Securities may only be sold, pledged or transferred in accordance with the Applicable Procedures and only (i) to the Company, (ii) in an offshore transaction in accordance with
Regulation S (other than a transaction resulting in an exchange for an interest in a Permanent Regulation S Global Security), or (iii) pursuant to an effective registration statement under the Securities Act, in each case in accordance with any
applicable securities laws of any State of the United States. 

  
 7 

 (e) Legend. 

(i) Except as permitted by the following paragraphs (ii), (iii) and (iv), each Security certificate evidencing the
Global Securities (and all Securities issued in exchange therefor or in substitution thereof), in the case of Securities offered otherwise than in reliance on Regulation S shall bear a legend in substantially the following form: 

THIS SECURITY (OR ITS PREDECESSOR) WAS ORIGINALLY ISSUED IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER THE UNITED STATES SECURITIES ACT OF
1933, AS AMENDED (THE “SECURITIES ACT”), AND THIS SECURITY MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN APPLICABLE EXEMPTION THEREFROM. EACH PURCHASER OF THIS SECURITY IS HEREBY NOTIFIED THAT
THE SELLER OF THIS SECURITY MAY BE RELYING ON THE EXEMPTION FROM THE PROVISIONS OF SECTION 5 OF THE SECURITIES ACT PROVIDED BY RULE 144A THEREUNDER. 

THE HOLDER OF THIS SECURITY AGREES FOR THE BENEFIT OF THE COMPANY THAT (A) THIS SECURITY MAY BE OFFERED, RESOLD, PLEDGED OR OTHERWISE
TRANSFERRED, ONLY (I) IN THE UNITED STATES TO A PERSON WHOM THE SELLER REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER (AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT) IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A,
(II) OUTSIDE THE UNITED STATES IN AN OFFSHORE TRANSACTION IN ACCORDANCE WITH RULE 904 UNDER THE SECURITIES ACT, (III) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER (IF
AVAILABLE) OR (IV) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, IN EACH OF CASES (I) THROUGH (IV) IN ACCORDANCE WITH ANY APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES, AND (B) THE HOLDER
WILL, AND EACH SUBSEQUENT HOLDER IS REQUIRED TO, NOTIFY ANY PURCHASER OF THIS SECURITY FROM IT OF THE RESALE RESTRICTIONS REFERRED TO IN (A) ABOVE. 

  
 8 

 Each certificate evidencing a Security offered in reliance on Regulation S shall,
in addition to the foregoing, bear a legend in substantially the following form: 
 THIS SECURITY (OR ITS PREDECESSOR) WAS ORIGINALLY ISSUED
IN A TRANSACTION ORIGINALLY EXEMPT FROM REGISTRATION UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND MAY NOT BE TRANSFERRED IN THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, ANY U.S. PERSON EXCEPT
PURSUANT TO AN AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND ALL APPLICABLE STATE SECURITIES LAWS. TERMS USED ABOVE HAVE THE MEANINGS GIVEN TO THEM IN REGULATION S UNDER THE SECURITIES ACT. 

Each Definitive Security shall also bear the following additional legend: 

IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH
TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS. 
 (ii) Upon
any sale or transfer of a Transfer Restricted Security (including any Transfer Restricted Security represented by a Global Security) pursuant to Rule 144 under the Securities Act, the Registrar shall permit the transferee thereof to exchange such
Transfer Restricted Security for a certificated Security that does not bear the legend set forth above and rescind any restriction on the transfer of such Transfer Restricted Security, if the transferor thereof certifies in writing to the Registrar
that such sale or transfer was made in reliance on Rule 144 (such certification to be in the form set forth on the reverse of the Security). 

(iii) After a transfer of any Initial Securities or Private Exchange Securities pursuant to and during the period of the
effectiveness of a Shelf Registration Statement with respect to such Initial Securities or Private Exchange Securities, as the case may be, all requirements pertaining to legends on such Initial Security or such Private Exchange Security will cease
to apply, the requirements requiring any such Initial Security or such Private Exchange Security issued to certain Holders be issued in global form will cease to apply, and a certificated Initial Security or Private Exchange Security or an Initial
Security or Private Exchange Security in global form, in each case without restrictive transfer legends, will be available to the transferee of the Holder of such Initial Securities or Private Exchange Securities upon exchange of such transferring
Holder’s certificated Initial Security or Private Exchange Security or directions to transfer such Holder’s interest in the Global Security, as applicable. 

(iv) Upon the consummation of a Registered Exchange Offer with respect to the Initial Securities, all requirements pertaining
to such Initial 

  
 9 

 
Securities that Initial Securities issued to certain Holders be issued in global form will still apply with respect to Holders of such Initial Securities that do not exchange their Initial
Securities, and Exchange Securities in certificated or global form, in each case without the restricted securities legend set forth in Exhibit 1 hereto will be available to Holders that exchange such Initial Securities in such Registered
Exchange Offer. 
 (v) Upon the consummation of a Private Exchange with respect to the Initial Securities, all requirements
pertaining to such Initial Securities that Initial Securities issued to certain Holders be issued in global form will still apply with respect to Holders of such Initial Securities that do not exchange their Initial Securities, and Private Exchange
Securities in global form with the global securities legend and the applicable restricted securities legend set forth in Exhibit 1 hereto will be available to Holders that exchange such Initial Securities in such Private Exchange. 

(f) Cancellation or Adjustment of Global Security. At such time as all beneficial interests in a Global Security have either been
exchanged for Definitive Securities, redeemed, purchased or canceled, such Global Security shall be returned to the Depository for cancellation or retained and canceled by the Trustee. At any time prior to such cancellation, if any beneficial
interest in a Global Security is exchanged for certificated Securities, redeemed, purchased or canceled, the principal amount of Securities represented by such Global Security shall be reduced and an adjustment shall be made on the books and records
of the Trustee (if it is then the Securities Custodian for such Global Security) with respect to such Global Security, by the Trustee or the Securities Custodian, to reflect such reduction. 

(g) No Obligation of the Trustee. 

(i) The Trustee shall have no responsibility or obligation to any beneficial owner of a Global Security, a member of, or a
participant in the Depository or other Person with respect to the accuracy of the records of the Depository or its nominee or of any participant or member thereof, with respect to any ownership interest in the Securities or with respect to the
delivery to any participant, member, beneficial owner or other Person (other than the Depository) of any notice (including any notice of redemption) or the payment of any amount, under or with respect to such Securities. All notices and
communications to be given to the Holders and all payments to be made to Holders under the Securities shall be given or made only to or upon the order of the registered Holders (which shall be the Depository or its nominee in the case of a Global
Security). The rights of beneficial owners in any Global Security shall be exercised only through the Depository subject to the applicable rules and procedures of the Depository. The Trustee may rely and shall be fully protected in relying upon
information furnished by the Depository with respect to its members, participants and any beneficial owners. 
 (ii) The
Trustee shall have no obligation or duty to monitor, determine or inquire as to compliance with any restrictions on transfer imposed under this 

  
 10 

 
Indenture or under applicable law with respect to any transfer of any interest in any Security (including any transfers between or among Depository participants, members or beneficial owners in
any Global Security) other than to require delivery of such certificates and other documentation or evidence as are expressly required by, and to do so if and when expressly required by, the terms of this Indenture, and to examine the same to
determine substantial compliance as to form with the express requirements hereof. 
 2.4 Definitive Securities. 

(a) A Global Security deposited with the Depository or with the Trustee as Securities Custodian for the Depository pursuant to
Section 2.1 shall be transferred to the beneficial owners thereof in the form of Definitive Securities in an aggregate principal amount equal to the principal amount of such Global Security, in exchange for such Global Security, only if such
transfer complies with Section 2.3 hereof and (i) the Depository notifies the Company that it is unwilling or unable to continue as Depository for such Global Security and the Depository fails to appoint a successor depository or if at any
time such Depository ceases to be a “clearing agency” registered under the Exchange Act, in either case, and a successor depository is not appointed by the Company within 90 days of such notice, (ii) an Event of Default has
occurred and is continuing or (iii) the Company, in its sole discretion, notifies the Trustee in writing that it elects to cause the issuance of Definitive Securities under this Indenture. 

(b) Any Global Security that is transferable to the beneficial owners thereof pursuant to this Section 2.4 shall be surrendered by the
Depository to the Trustee located at its principal corporate trust office in the Borough of Manhattan, The City of New York, to be so transferred, in whole or from time to time in part, without charge, and the Trustee shall authenticate and deliver,
upon such transfer of each portion of such Global Security, an equal aggregate principal amount of Definitive Securities of authorized denominations. Any portion of a Global Security transferred pursuant to this Section 2.4 shall be executed,
authenticated and delivered only in minimum denominations of $2,000 principal amount and any greater integral multiple of $1,000 thereof and registered in such names as the Depository shall direct. Any Definitive Security delivered in exchange for
an interest in the Transfer Restricted Security shall, except as otherwise provided by Section 2.3(e) hereof, bear the applicable restricted securities legend and definitive securities legend set forth in Exhibit 1 hereto. 

(c) Subject to the provisions of Section 2.4(b) hereof, the registered Holder of a Global Security shall be entitled to grant proxies
and otherwise authorize any Person, including Agent Members and Persons that may hold interests through Agent Members, to take any action which a Holder is entitled to take under this Indenture or the Securities. 

(d) In the event of the occurrence of one of the events specified in Section 2.4(a) hereof, the Company shall promptly make available to
the Trustee a reasonable supply of Definitive Securities in definitive, fully registered form without interest coupons. In the event that such Definitive Securities are not issued, the Company expressly acknowledges, with respect to the right of any
Holder to pursue a remedy pursuant to Section 6.06 of this Indenture, the right of any beneficial owner of Securities to pursue such remedy with respect to the portion of the Global Security that represents such beneficial owner’s
Securities as if such Definitive Securities had been issued. 

  
 11 

 EXHIBIT 1 

to 
 RULE 144A/REGULATION S APPENDIX

 [FORM OF FACE OF INITIAL SECURITY] 

[Global Securities Legend] 

UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION
(“DTC”), NEW YORK, NEW YORK, TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED
REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC) ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL
INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 
 TRANSFERS OF THIS GLOBAL SECURITY SHALL BE LIMITED
TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH
IN THE INDENTURE REFERRED TO ON THE REVERSE HEREOF. 
 [[FOR REGULATION S GLOBAL SECURITY ONLY] UNTIL 40 DAYS AFTER THE LATER OF
COMMENCEMENT OR COMPLETION OF THE OFFERING, AN OFFER OR SALE OF SECURITIES WITHIN THE UNITED STATES BY A DEALER (AS DEFINED IN THE SECURITIES ACT) MAY VIOLATE THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT IF SUCH OFFER OR SALE IS MADE
OTHERWISE THAN IN ACCORDANCE WITH RULE 144A THEREUNDER.] 
 [Restricted Securities Legend for Securities offered otherwise than in Reliance
on Regulation S) 
 THIS SECURITY (OR ITS PREDECESSOR) WAS ORIGINALLY ISSUED IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER THE UNITED
STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND THIS SECURITY MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN APPLICABLE EXEMPTION THEREFROM. EACH PURCHASER OF THIS SECURITY
IS HEREBY NOTIFIED THAT THE SELLER OF THIS SECURITY MAY BE RELYING ON THE EXEMPTION FROM THE PROVISIONS OF SECTION 5 OF THE SECURITIES ACT PROVIDED BY RULE 144A THEREUNDER. 

THE HOLDER OF THIS SECURITY AGREES FOR THE BENEFIT OF THE COMPANY THAT (A) THIS SECURITY MAY BE OFFERED, RESOLD, PLEDGED OR

 
OTHERWISE TRANSFERRED, ONLY (I) IN THE UNITED STATES TO A PERSON WHOM THE SELLER REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER (AS DEFINED IN RULE 144A UNDER THE SECURITIES
ACT) IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A, (II) OUTSIDE THE UNITED STATES IN AN OFFSHORE TRANSACTION IN ACCORDANCE WITH RULE 904 UNDER THE SECURITIES ACT, (III) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER
THE SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER (IF AVAILABLE) OR (IV) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, IN EACH OF CASES (I) THROUGH (IV) IN ACCORDANCE WITH ANY APPLICABLE SECURITIES LAWS OF
ANY STATE OF THE UNITED STATES, AND (B) THE HOLDER WILL, AND EACH SUBSEQUENT HOLDER IS REQUIRED TO, NOTIFY ANY PURCHASER OF THIS SECURITY FROM IT OF THE RESALE RESTRICTIONS REFERRED TO IN (A) ABOVE. 

[Restricted Securities Legend for Securities Offered in Reliance on Regulation S.] 

THIS SECURITY (OR ITS PREDECESSOR) WAS ORIGINALLY ISSUED IN A TRANSACTION ORIGINALLY EXEMPT FROM REGISTRATION UNDER THE U.S. SECURITIES ACT
OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND MAY NOT BE TRANSFERRED IN THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, ANY U.S. PERSON EXCEPT PURSUANT TO AN AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE
SECURITIES ACT AND ALL APPLICABLE STATE SECURITIES LAWS. TERMS USED ABOVE HAVE THE MEANINGS GIVEN TO THEM IN REGULATION S UNDER THE SECURITIES ACT. 

[Temporary Regulation S Global Security Legend] 

EXCEPT AS SET FORTH BELOW, BENEFICIAL OWNERSHIP INTERESTS IN THIS TEMPORARY REGULATION S GLOBAL SECURITY WILL NOT BE EXCHANGEABLE FOR
INTERESTS IN THE PERMANENT REGULATION S GLOBAL SECURITY OR ANY OTHER SECURITY REPRESENTING AN INTEREST IN THE SECURITIES REPRESENTED HEREBY WHICH DO NOT CONTAIN A LEGEND CONTAINING RESTRICTIONS ON TRANSFER, UNTIL THE EXPIRATION OF THE
“40-DAY DISTRIBUTION COMPLIANCE PERIOD” (WITHIN THE MEANING OF RULE 903(b)(2) OF REGULATION S UNDER THE SECURITIES ACT) AND THEN ONLY UPON CERTIFICATION IN FORM REASONABLY SATISFACTORY TO THE TRUSTEE THAT SUCH BENEFICIAL INTERESTS ARE
OWNED EITHER BY NON-U.S. PERSONS OR U.S. PERSONS WHO PURCHASED SUCH INTERESTS IN A TRANSACTION THAT DID NOT REQUIRE REGISTRATION UNDER THE SECURITIES ACT. DURING SUCH 40-DAY DISTRIBUTION COMPLIANCE PERIOD, BENEFICIAL OWNERSHIP INTERESTS IN THIS
TEMPORARY REGULATION S GLOBAL SECURITY MAY ONLY BE SOLD, PLEDGED OR TRANSFERRED (I) TO THE COMPANY, (II) OUTSIDE THE UNITED STATES IN A TRANSACTION IN ACCORDANCE WITH RULE 904 OF REGULATION S UNDER THE SECURITIES ACT, OR
(III) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, IN EACH OF CASES (I) THROUGH (III) IN ACCORDANCE WITH ANY APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES. HOLDERS OF INTERESTS IN THIS

  
 2 

 
TEMPORARY REGULATION S GLOBAL SECURITY WILL NOTIFY ANY PURCHASER OF THIS SECURITY OF THE RESALE RESTRICTIONS REFERRED TO ABOVE, IF THEN APPLICABLE. 

AFTER THE EXPIRATION OF THE DISTRIBUTION COMPLIANCE PERIOD BENEFICIAL INTERESTS IN THIS TEMPORARY REGULATION S GLOBAL SECURITY MAY BE
EXCHANGED FOR INTERESTS IN A RULE 144A GLOBAL SECURITY ONLY IF (1) SUCH EXCHANGE OCCURS IN CONNECTION WITH A TRANSFER OF THE SECURITIES IN COMPLIANCE WITH RULE 144A AND (2) THE TRANSFEROR OF THE REGULATION S GLOBAL SECURITY FIRST DELIVERS
TO THE TRUSTEE A WRITTEN CERTIFICATE (IN THE FORM ATTACHED TO THIS CERTIFICATE) TO THE EFFECT THAT THE REGULATION S GLOBAL SECURITY IS BEING TRANSFERRED (A) TO A PERSON WHO THE TRANSFEROR REASONABLY BELIEVES TO BE A QUALIFIED INSTITUTIONAL
BUYER WITHIN THE MEANING OF RULE 144A, (B) TO A PERSON WHO IS PURCHASING FOR ITS OWN ACCOUNT OR THE ACCOUNT OF A QUALIFIED INSTITUTIONAL BUYER IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A, AND (C) IN ACCORDANCE WITH ALL
APPLICABLE SECURITIES LAWS OF THE STATES OF THE UNITED STATES AND OTHER JURISDICTIONS. 
 BENEFICIAL INTERESTS IN A RULE 144A GLOBAL
SECURITY MAY BE TRANSFERRED TO A PERSON WHO TAKES DELIVERY IN THE FORM OF AN INTEREST IN THE REGULATION S GLOBAL SECURITY, WHETHER BEFORE OR AFTER THE EXPIRATION OF THE 40-DAY DISTRIBUTION COMPLIANCE PERIOD, ONLY IF THE TRANSFEROR FIRST DELIVERS TO
THE TRUSTEE A WRITTEN CERTIFICATE (IN THE FORM ATTACHED TO THIS CERTIFICATE) TO THE EFFECT THAT SUCH TRANSFER IS BEING MADE IN ACCORDANCE WITH RULE 903 OR 904 OF REGULATION S OR RULE 144 (IF AVAILABLE). 

[Definitive Securities Legend] 

IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH
TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS. 

  
 3 

			
	No.        	  	$        

 5.75% Senior Notes Due 2019 

William Lyon Homes, Inc., a California corporation, promises to pay to Cede & Co., or registered assigns, the principal sum of
$             Dollars on April 15, 2019. 
 Interest Payment Dates:
April 15 and October 15. 
 Record Dates: April 1 and October 1. 

Additional provisions of this Security are set forth on the other side of this Security. 

Dated:             

  
 4 

 
			
	WILLIAM LYON HOMES, INC.
		
	By:	 	  

	Name:	 	Matthew R. Zaist
	Title:	 	President and Chief Operating Officer

  
 5 

							
	 TRUSTEE’S CERTIFICATE OF AUTHENTICATION

	
	U.S. BANK NATIONAL ASSOCIATION
	 as Trustee, certifies that this is one of the Securities referred to in the Indenture.

				
		 		 	By	 	
		
		 	  

		 		 		 	Authorized Signatory

  
 6 

 [FORM OF REVERSE SIDE OF INITIAL SECURITY] 

5.75% Senior Note Due 2019 
  

	 	1.	Interest 

 William Lyon Homes, Inc., a California corporation (such corporation, and its
successors and assigns under the Indenture hereinafter referred to, being herein called the “Company”), promises to pay interest on the principal amount of this Security at the rate per annum shown above; provided, however,
that if a Registration Default (as defined in the Registration Rights Agreement) occurs, additional interest will accrue on this Security at a rate of 0.25% per annum (increasing by an additional 0.25% per annum after each subsequent
90-day period that occurs until all Registration defaults have been cured, up to a maximum additional interest rate of 1.00%) from and including the date on which any such Registration Default shall occur to but excluding the date on which all
Registration Defaults have been cured. The Company will pay interest semiannually on April 15 and October 15 of each year, commencing October 15, 2014. Interest on the Securities will accrue from the most recent date to which interest
has been paid or, if no interest has been paid, from the Issue Date. Interest will be computed on the basis of a 360-day year of twelve 30-day months. The Company will pay interest on overdue principal at the
rate borne by this Security plus 1.0% per annum, and it will pay interest on overdue installments of interest at the same rate to the extent lawful. 
  

	 	2.	Method of Payment 

 The Company will pay interest on the Securities (except defaulted
interest) to the Persons who are registered holders of Securities at the close of business on the April 1 or October 1 next preceding the interest payment date even if Securities are canceled after the record date and on or before the
interest payment date. Holders must surrender Securities to a Paying Agent to collect principal payments. The Company will pay principal and interest in money of the United States that at the time of payment is legal tender for payment of public and
private debts. If a Holder has given wire transfer instructions to the Company at least ten Business days prior to the applicable payment date, the Company will make all payments on the Holder’s Securities in accordance with those instructions.
Otherwise, payments on the Securities will be made at the office or agency of the Paying Agent and Registrar unless the Company elects to make interest payments by check mailed to the Holder entitled thereto at the address indicated on the register
maintained by the Registrar for the Securities. 
  

	 	3.	Paying Agent and Registrar 

 Initially, U.S. Bank National Association (the
“Trustee”) will act as Paying Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or co-registrar without notice. The Company or any of its domestically incorporated Wholly Owned Subsidiaries may act
as Paying Agent, Registrar or co-registrar. 
  

	 	4.	Indenture 

 The Company issued the Securities under an Indenture dated as of
March 31, 2014 (“Indenture”), among William Lyon Homes, a Delaware Corporation (the “Parent”), the 

  
 7 

 
Company, the Subsidiary Guarantors and the Trustee. The terms of the Securities include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act
of 1939 (15 U.S.C. §§ 77aaa-77bbbb) (the “Act”), as amended from time to time. Terms defined in the Indenture and not defined herein have the meanings ascribed thereto in the Indenture. The Securities are
subject to all such terms, and Securityholders are referred to the Indenture and the Act for a statement of those terms. 
 The Securities
are general unsecured obligations of the Company. The Company shall be entitled, subject to its compliance with Section 4.03 of the Indenture, to issue Additional Securities pursuant to Section 2.13 of the Indenture. The Initial Securities
issued on the Issue Date, any Additional Securities and all Exchange Securities or Private Exchange Securities issued in exchange therefor will be treated as a single class for all purposes under the Indenture. The Indenture contains covenants that
limit the ability of the Company and its subsidiaries to incur additional indebtedness or issue certain equity interests; pay dividends or distributions on, or redeem or repurchase capital stock; make certain investments; engage in transactions with
affiliates; incur liens; transfer or sell assets; guarantee indebtedness; restrict dividends or other payments of subsidiaries; consolidate, merge or transfer all or substantially all of its assets and the assets of its subsidiaries; and create
unrestricted subsidiaries. These covenants are subject to important exceptions and qualifications. 
  

	 	5.	Optional Redemption 

 Except as set forth below, the Company shall not be entitled to
redeem the Securities. 
 On and after April 15, 2016, the Company shall be entitled at its option to redeem all or a portion of the
Securities, at the redemption prices (expressed in percentages of principal amount on the redemption date), plus accrued interest to the redemption date (subject to the right of Holders of record on the relevant record date to receive interest due
on the relevant interest payment date), if redeemed on or after the dates set forth below: 
  

					
	 Period
	  	Redemption
Price	 
		
	 April 15, 2016
	  	 	104.313	% 
		
	 October 15, 2016
	  	 	102.875	% 
		
	 April 15, 2017
	  	 	101.438	% 
		
	 April 15, 2018 and thereafter
	  	 	100.000	% 

 In addition, at any time prior to April 15, 2016, the Company shall be entitled at its option on one or
more occasions to redeem Securities (which includes Additional Securities, if any) in an aggregate principal amount not to exceed 35% of the aggregate principal amount of 

  
 8 

 
the Securities (which includes Additional Securities, if any) issued prior to such date at a redemption price (expressed as a percentage of principal amount of 105.75%, plus accrued and unpaid
interest to the redemption date (subject to the right of Holders of record on the relevant record date to receive interest due on the relevant interest payment date), with an amount equal to the net cash proceeds from one or more Equity Offerings;
provided, however, that (1) at least 65% of such aggregate principal amount of Securities (which includes Additional Securities, if any) remains outstanding immediately after the occurrence of each such redemption (with Securities held,
directly or indirectly, by the Company or its Affiliates being deemed to be not outstanding for purposes of such calculation); and (2) notice of such redemption has been given within 90 days after the date of the related Equity Offering.

 Prior to April 15, 2016, the Company shall be entitled at its option to redeem all or a portion of the Securities at a redemption
price equal to 100% of the principal amount of the Securities plus the Applicable Premium as of, and accrued and unpaid interest to, the redemption date (subject to the right of Holders on the relevant record date to receive interest due on the
relevant interest payment date). 
  

	 	6.	Notice of Redemption 

 Notice of redemption shall be sent at least 30 days but not more
than 60 days before the redemption date to each Holder of Securities to be redeemed at its registered address, except that redemption notices may be sent more than 60 days prior to the redemption date if the notice is issued in connection with a
defeasance of the Securities or a satisfaction and discharge of the Indenture. Any inadvertent defect in the notice of redemption, including an inadvertent failure to give notice, to any Holder selected for redemption shall not impair or affect the
validity of the redemption of any other Security redeemed in accordance with the provisions of the Indenture. Securities in denominations larger than $2,000 principal amount may be redeemed in part but only in whole multiples of $1,000. If money
sufficient to pay the redemption price of and accrued interest on all Securities (or portions thereof) to be redeemed on the redemption date is deposited with the Paying Agent on or before the redemption date and certain other conditions are
satisfied, on and after such date interest ceases to accrue on such Securities (or such portions thereof) called for redemption. 
  

	 	7.	Put Provisions 

 Upon a Change of Control, each Holder of Securities shall have the
right to require the Company to repurchase all or any part of the Securities of such Holder at a repurchase price equal to 101% of the principal amount of the Securities to be repurchased plus accrued interest to the date of repurchase (subject to
the right of holders of record on the relevant record date to receive interest due on the related interest payment date) as provided in, and subject to the terms of, the Indenture. 

The Indenture provides that, under certain circumstances, the Parent shall, or shall cause the Company to, use the Excess Proceeds from Asset
Sales to make an offer to all Holders to purchase Securities at an offer price in cash in an amount not less than 100% of the principal amount thereof, plus accrued and unpaid interest. 

  
 9 

	 	8.	Guarantee 

 The payment by the Company of the principal of, and premium and interest on,
the Securities is fully and unconditionally guaranteed on a joint and several senior basis by each of the Guarantors to the extent set forth in the Indenture. 
  

	 	9.	Denominations; Transfer; Exchange 

 The Securities are in registered form without
coupons in minimum denominations of $2,000 principal amount and integral multiples of $1,000 in excess thereof. A Holder may transfer or exchange Securities in accordance with the Indenture. The Registrar may require a Holder, among other things, to
furnish appropriate endorsements or transfer documents and to pay any taxes and fees required by law or permitted by the Indenture. Without the prior consent of the Company, the Registrar is not required (1) to register the transfer of or
exchange any Security selected for redemption, (2) to register the transfer of or exchange any Security for a period of 15 days before a selection of Security to be redeemed or (3) to register the transfer or exchange of a Security between
a record date and the next succeeding interest payment date. 
  

	 	10.	Persons Deemed Owners 

 The registered Holder of this Security may be treated as the
owner of it for all purposes. 
  

	 	11.	Unclaimed Money 

 If money for the payment of principal or interest remains unclaimed
for two years, the Trustee or Paying Agent shall pay the money back to the Company at its request unless an abandoned property law designates another Person. After any such payment, Holders entitled to the money must look only to the Company and not
to the Trustee for payment. 
  

	 	12.	Discharge and Defeasance 

 Subject to certain conditions, the Company at any time shall
be entitled to terminate some or all of its obligations under the Securities and the Indenture if the Company deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Securities to redemption or
maturity, as the case may be. 
  

	 	13.	Amendment; Waiver 

 Subject to certain exceptions set forth in the Indenture,
(a) the Indenture and the Securities may be amended with the written consent of the Holders of at least a majority in principal amount outstanding of the Securities and (b) any default or noncompliance with any provision may be waived with
the written consent of the Holders of a majority in principal amount outstanding of the Securities. Subject to certain exceptions set forth in the Indenture, without the consent of any Securityholder, the Company, the Guarantors and the Trustee
shall be entitled to amend the Indenture, the Security Guarantees or the Securities to cure any ambiguity, 

  
 10 

 
defect or inconsistency, or to provide for uncertificated Securities in addition to or in place of certificated Securities, or to provide for the assumption of the Company’s or any
Guarantor’s obligations to the Holders in the case of a merger or acquisition, or to release any Guarantor from any of its obligations under its Security Guarantee or the Indenture (to the extent permitted by the Indenture), or to make any
change that would provide any additional rights or benefits (including the addition of collateral) to the holders of Securities or that does not adversely affect in any material respect the legal rights under the indenture of any such holder, or to
comply with SEC rules and regulations or changes to applicable law, or to conform the text of the Indenture, the Security Guarantees or the Securities to any provision of the “Description of Notes” section of the Final Offering Circular,
or to provide for the issuance of Additional Securities in accordance with the limitations set forth in the Indenture as of the Issue Date, or to allow any Guarantor to execute a supplemental indenture or a Security Guarantee with respect to the
Securities, or to comply with the rules of any applicable securities depository. 
  

	 	14.	Defaults and Remedies 

 Under the Indenture, Events of Default include (a) default
for 30 days in payment of interest on the Securities; (b) default in payment of principal on the Securities at maturity, upon redemption, upon purchase, upon acceleration or otherwise, or failure by the Company to redeem or purchase
Securities when required; (c) failure by the Parent or Company to comply with other agreements in the Indenture or the Securities, in certain cases subject to notice and lapse of time; (d) certain accelerations (including failure to pay
within any grace period after final maturity) of other Indebtedness of the Parent or any Restricted Subsidiary if the amount accelerated (or so unpaid) exceeds $20 million; (e) certain events of bankruptcy or insolvency with respect to the
Parent, Company or any Significant Subsidiary; (f) certain judgments or decrees for the payment of money in excess of $20 million; and (g) certain defaults with respect to Security Guarantees of the Parent or any Significant
Subsidiary. If an Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in principal amount of the Securities may declare all the Securities to be due and payable immediately. Certain events of bankruptcy or
insolvency are Events of Default that will result in the Securities being due and payable immediately upon the occurrence of such Events of Default. 

Securityholders may not enforce the Indenture or the Securities except as provided in the Indenture. The Trustee may refuse to enforce the
Indenture or the Securities unless it receives indemnity or security satisfactory to it. Subject to certain limitations, Holders of a majority in principal amount of the Securities may direct the Trustee in its exercise of any trust or power. The
Trustee may withhold from Securityholders notice of any continuing Default (except a Default in payment of principal or interest or a Default in complying with Section 5.01 of the Indenture) if it determines that withholding notice is in the
interest of the Holders. 
  

	 	15.	Trustee Dealings with the Company 

 Subject to certain limitations imposed by the Act,
the Trustee under the Indenture, in its individual or any other capacity, may become the owner or pledgee of Securities and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the
Company or its Affiliates with the same rights it would have if it were not Trustee. 

  
 11 

	 	16.	No Recourse Against Others 

 No director, officer, employee, incorporator or stockholder
of the Parent or any Restricted Subsidiary shall have any liability for any obligations of the Company under the Securities or the Indenture or any Guarantor under its Security Guarantee or for any claim based on, in respect of or by reason of such
obligations or their creation. By accepting a Security, each Securityholder waives and releases all such liability. The waiver and release are part of the consideration for the issuance of the Securities and the Security Guarantees. 

 

	 	17.	Authentication 

 This Security shall not be valid until an authorized signatory of the
Trustee (or an authenticating agent) manually signs the certificate of authentication on the other side of this Security. 
  

	 	18.	Abbreviations 

 Customary abbreviations may be used in the name of a Securityholder or
an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants by the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). 

 

	 	19.	CUSIP Numbers 

 Pursuant to a recommendation promulgated by the Committee on Uniform
Security Identification Procedures the Company has caused CUSIP numbers to be printed on the Securities and has directed the Trustee to use CUSIP numbers in notices of redemption as a convenience to Securityholders. No representation is made as to
the accuracy of such numbers either as printed on the Securities or as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. 

 

	 	20.	Holders’ Compliance with Registration Rights Agreement 

 Each Holder of a Security,
by acceptance hereof, acknowledges and agrees to the provisions of the Registration Rights Agreement, including the obligations of the Holders with respect to a registration and the indemnification of the Company to the extent provided therein. 

 

	 	21.	Governing Law 

 THIS SECURITY SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH,
THE LAWS OF THE STATE OF NEW YORK. 

  
 12 

 The Company will furnish to any Securityholder upon written request and without charge to the
Security holder a copy of the Indenture which has in it the text of this Security in larger type. Requests may be made to: 
 WILLIAM LYON
HOMES, INC. 
 4695 MacArthur Court, 8th Floor 

Newport Beach, CA 92660 
 Attention:
Chief Financial Officer 

  
 13 

 ASSIGNMENT FORM 

To assign this Security, fill in the form below: 
 I or we
assign and transfer this Security to 
 (Print or type assignee’s name, address and zip code) 

(Insert assignee’s soc. sec. or tax I.D. No.) 

and irrevocably appoint                      agent to
transfer this Security on the books of the Company. The agent may substitute another to act for him. 
  

									
	  

					
	Date:	 	  
	 		 	Your Signature:	 	  

	
	  

 Sign exactly as your name appears on the other side of this Security. 

In connection with any transfer of any of the Securities evidenced by this certificate occurring prior to the expiration of the period referred to in
Rule 144(k) under the Securities Act after the later of the date of original issuance of such Securities and the last date, if any, on which such Securities were owned by the Company or any Affiliate of the Company, the undersigned
confirms that such Securities are being transferred in accordance with its terms: 
 CHECK ONE BOX BELOW 

 

					
	(1)	  	 ̈	  	to the Company; or
			
	(2)	  	 ̈	  	pursuant to an effective registration statement under the Securities Act of 1933; or
			
	(3)	  	 ̈	  	inside the United States to a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act of 1933) that purchases for its own account or for the account of a qualified institutional buyer to
whom notice is given that such transfer is being made in reliance on Rule 144A, in each case pursuant to and in compliance with Rule 144A under the Securities Act of 1933; or
			
	(4)	  	 ̈	  	outside the United States in an offshore transaction within the meaning of Regulation S under the Securities Act in compliance with Rule 904 under the Securities Act of 1933; or
			
	(5)	  	 ̈	  	pursuant to the exemption from registration provided by Rule 144 under the Securities Act of 1933.

  
 14 

 Unless one of the boxes is checked, the Trustee will refuse to register any of the Securities
evidenced by this certificate in the name of any person other than the registered holder thereof; provided, however, that if box (5) is checked, the Trustee shall be entitled to require, prior to registering any such transfer of the
Securities, such legal opinions, certifications and other information as the Company has reasonably requested to confirm that such transfer is being made pursuant to an exemption from, or in a transaction not subject to, the registration
requirements of the Securities Act of 1933, such as the exemption provided by Rule 144 under such Act. 
  

							
	  
	 		 	
				
		 	Signature	 		 	

 Signature Guarantee: 
  

									
	  
	 		 	  

					
		 	Signature must be guaranteed	 		 		 	Signature

 Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the
Registrar, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in addition to,
or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended. 

  
 15 

 TO BE COMPLETED BY PURCHASER IF (2) ABOVE IS CHECKED. 

The undersigned represents and warrants that it is purchasing this Security for its own account or an account with respect to which it
exercises sole investment discretion and that it and any such account is a “qualified institutional buyer” within the meaning of Rule 144A under the Securities Act of 1933, and is aware that the sale to it is being made in reliance on
Rule 144A and acknowledges that it has received such information regarding the Company as the undersigned has requested pursuant to Rule 144A or has determined not to request such information and that it is aware that the transferor is
relying upon the undersigned’s foregoing representations in order to claim the exemption from registration provided by Rule 144A. 
  

									
	Dated:	 	  
	 		 		 	  

					
		 		 		 	Notice:	 	To be executed byan executive officer

  
 16 

 [TO BE ATTACHED TO GLOBAL SECURITIES] 

SCHEDULE OF INCREASES OR DECREASES IN GLOBAL SECURITY 

The following increases or decreases in this Global Security have been made: 

 

									
	Date of Exchange	  	Amount of decrease in
Principal amount of this
Global Security	  	Amount of increase in
Principal amount of this
Global Security	  	Principal amount of this
Global Security following
such decrease or increase)	  	Signature of authorized
officer of Trustee or
Securities Custodian
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	

  
 17 

 OPTION OF HOLDER TO ELECT PURCHASE 

If you want to elect to have this Security purchased by the Company pursuant to Section 4.06 or 4.10 of the Indenture, check the box:  ̈ 
  ̈ If you want to elect to have only part of
this Security purchased by the Company pursuant to Section 4.06 or 4.10 of the Indenture, state the amount in principal amount: $ 
  

											
		 	Dated:	 	  
	 		 	Your Signature:	 	  

						
		 		 		 		 		 	(Sign exactly as your name appears on the other side of this Security.)

  

					
		 	Signature Guarantee:	 	  

			
		 		 	(Signature must be guaranteed)

 Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the
Registrar, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in addition to,
or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended. 

  
 18 

 EXHIBIT A 

[FORM OF FACE OF EXCHANGE SECURITY 

OR PRIVATE EXCHANGE SECURITY]*/**/ 

 

	*/	If the Security is to be issued in global form add the Global Securities Legend from Exhibit 1 to Appendix A and the attachment from such Exhibit 1 captioned “[TO BE ATTACHED TO GLOBAL SECURITIES] - SCHEDULE OF
INCREASES OR DECREASES IN GLOBAL SECURITY”. 

	**/	If the Security is a Private Exchange Security issued in a Private Exchange to an Initial Purchaser holding an unsold portion of its initial allotment, add the Restricted Securities Legend from Exhibit 1 to Appendix A
and replace the Assignment Form included in this Exhibit A with the Assignment Form included in such Exhibit 1. 

			
	No.            	  	$        

 5.75% Senior Notes Due 2019 

William Lyon Homes, Inc., a California corporation, promises to pay to Cede & Co., or registered assigns, the principal sum of
                     Dollars on April 15, 2019. 

Interest Payment Dates: April 15 and October 15. 

Record Dates: April 1 and October 1. 

Additional provisions of this Security are set forth on the other side of this Security. 

Dated: 
  

									
		 		 	WILLIAM LYON HOMES, INC.
					
		 		 		 	by	 	
			
		 		 	  

		 		 		 		 	Name:
					
		 		 		 		 	Title:
		
		 	 TRUSTEE’S CERTIFICATE OF AUTHENTICATION

		
		 	U.S. BANK NATIONAL ASSOCIATION
		 	 as Trustee, certifies that this is one of the Securities referred to in the Indenture.

					
		 		 		 	by	 	
			
		 		 	  

		 		 		 		 	Authorized Signatory

  
 2 

 [FORM OF REVERSE SIDE OF EXCHANGE SECURITY 

OR PRIVATE EXCHANGE SECURITY] 

5.75% Senior Note Due 2019 
  

	 	1.	Interest 

 William Lyon Homes, Inc., a California corporation (such corporation, and its
successors and assigns under the Indenture hereinafter referred to, being herein called the “Company”), promises to pay interest on the principal amount of this Security at the rate per annum shown above; provided, however,
that if a Registration Default (as defined in the Registration Rights Agreement) occurs, additional interest will accrue on this Security at a rate of 0.25% per annum (increasing by an additional 0.25% per annum after each subsequent
90-day period that occurs until all Registration defaults have been cured, up to a maximum additional interest rate of 1.00%) from and including the date on which any such Registration Default shall occur to but excluding the date on which all
Registration Defaults have been cured. The Company will pay interest semiannually on April 15 and October 15 of each year, commencing October 15, 2014. Interest on the Securities will accrue from the most recent date to which interest
has been paid or, if no interest has been paid, from the Issue Date. Interest will be computed on the basis of a 360-day year of twelve 30-day months. The Company will pay interest on overdue principal at the
rate borne by this Security plus 1.0% per annum, and it will pay interest on overdue installments of interest at the same rate to the extent lawful. 
  

	 	2.	Method of Payment 

 The Company will pay interest on the Securities (except defaulted
interest) to the Persons who are registered holders of Securities at the close of business on the April 1 or October 1 next preceding the interest payment date even if Securities are canceled after the record date and on or before the
interest payment date. Holders must surrender Securities to a Paying Agent to collect principal payments. The Company will pay principal and interest in money of the United States that at the time of payment is legal tender for payment of public and
private debts. If a Holder has given wire transfer instructions to the Company at least ten Business days prior to the applicable payment date, the Company will make all payments on the Holder’s Securities in accordance with those instructions.
Otherwise, payments on the Securities will be made at the office or agency of the Paying Agent and Registrar unless the Company elects to make interest payments by check mailed to the Holder entitled thereto at the address indicated on the register
maintained by the Registrar for the Securities. 
  

	 	3.	Paying Agent and Registrar 

 Initially, U.S. Bank National Association (the
“Trustee”), will act as Paying Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or co-registrar without notice. The Company or any of its domestically incorporated Wholly Owned Subsidiaries may act
as Paying Agent, Registrar or co-registrar. 

  
 3 

	 	4.	Indenture 

 The Company issued the Securities under an Indenture dated as of
March 31, 2014 (“Indenture”), among William Lyon Homes, a Delaware Corporation (the “Parent”), the Company, the Subsidiary Guarantors and the Trustee. The terms of the Securities include those stated in the
Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. §§ 77aaa-77bbbb) (the “Act”). Terms defined in the Indenture and not defined herein have the meanings
ascribed thereto in the Indenture. The Securities are subject to all such terms, and Securityholders are referred to the Indenture and the Act for a statement of those terms. 

The Securities are general unsecured obligations of the Company. The Company shall be entitled, subject to its compliance with
Section 4.03 of the Indenture, to issue Additional Securities pursuant to Section 2.13 of the Indenture. The Initial Securities issued on the Issue Date, any Additional Securities and all Exchange Securities or Private Exchange Securities
issued in exchange therefor will be treated as a single class for all purposes under the Indenture. The Indenture contains covenants that limit the ability of the Company and its subsidiaries to incur additional indebtedness or issue certain equity
interests; pay dividends or distributions on, or redeem or repurchase capital stock; make certain investments; engage in transactions with affiliates; incur liens; transfer or sell assets; guarantee indebtedness; restrict dividends or other payments
of subsidiaries; consolidate, merge or transfer all or substantially all of its assets and the assets of its subsidiaries; and create unrestricted subsidiaries. These covenants are subject to important exceptions and qualifications. 

 

	 	5.	Optional Redemption 

 Except as set forth below, the Company shall not be entitled to
redeem the Securities. 
 On and after April 15, 2016, the Company shall be entitled at its option to redeem all or a portion of the
Securities, at the redemption prices (expressed in percentages of principal amount on the redemption date), plus accrued interest to the redemption date (subject to the right of Holders of record on the relevant record date to receive interest due
on the relevant interest payment date), if redeemed on or after the following dates: 
  

					
	 Period
	  	Redemption
Price	 
		
	 April 15, 2016
	  	 	104.313	% 
		
	 October 15, 2016
	  	 	102.875	% 
		
	 April 15, 2017
	  	 	101.438	% 
		
	 April 15, 2018 and thereafter
	  	 	100.000	% 

  
 4 

 In addition, at any time prior to April 15, 2016, the Company shall be entitled at its
option on one or more occasions to redeem Securities (which includes Additional Securities, if any) in an aggregate principal amount not to exceed 35% of the aggregate principal amount of the Securities (which includes Additional Securities, if any)
issued prior to such date at a redemption price (expressed as a percentage of principal amount of 105.75% plus accrued and unpaid interest to the redemption date (subject to the right of Holders of record on the relevant record date to receive
interest due on the relevant interest payment date), with an amount equal to the net cash proceeds from one or more Equity Offerings; provided, however, that (1) at least 65% of such aggregate principal amount of Securities (which
includes Additional Securities, if any) remains outstanding immediately after the occurrence of each such redemption (with Securities held, directly or indirectly, by the Company or its Affiliates being deemed to be not outstanding for purposes of
such calculation); and (2) notice of such redemption has been given within 90 days after the date of the related Equity Offering. 

Prior to April 15, 2016, the Company shall be entitled at its option to redeem all or a portion of the Securities at a redemption price
equal to 100% of the principal amount of the Securities plus the Applicable Premium as of, and accrued and unpaid interest to, the redemption date (subject to the right of Holders on the relevant record date to receive interest due on the relevant
interest payment date). 
  

	 	6.	Notice of Redemption 

 Notice of redemption shall be sent at least 30 days but not more
than 60 days before the redemption date to each Holder of Securities to be redeemed at its registered address, except that redemption notices may be sent more than 60 days prior to the redemption date if the notice is issued in connection with a
defeasance of the Securities or a satisfaction and discharge of the Indenture. Any inadvertent defect in the notice of redemption, including an inadvertent failure to give notice, to any Holder selected for redemption shall not impair or affect the
validity of the redemption of any other Security redeemed in accordance with the provisions of the Indenture. Securities in denominations larger than $2,000 principal amount may be redeemed in part but only in whole multiples of $1,000. If money
sufficient to pay the redemption price of and accrued interest on all Securities (or portions thereof) to be redeemed on the redemption date is deposited with the Paying Agent on or before the redemption date and certain other conditions are
satisfied, on and after such date interest ceases to accrue on such Securities (or such portions thereof) called for redemption. 
  

	 	7.	Put Provisions 

 Upon a Change of Control, each Holder of Securities shall have the right
to require the Company to repurchase all or any part of the Securities of such Holder at a repurchase price equal to 101% of the principal amount of the Securities to be repurchased plus accrued interest to the date of repurchase (subject to the
right of holders of record on the relevant record date to receive interest due on the related interest payment date) as provided in, and subject to the terms of, the Indenture. 

The Indenture provides that, under certain circumstances, the Parent shall, or shall cause the Company to, use the Excess Proceeds from Asset
Sales to make an offer to all Holders to purchase Securities at an offer price in cash in an amount not less than 100% of the principal amount thereof, plus accrued and unpaid interest 

  
 5 

	 	8.	Guarantee 

 The payment by the Company of the principal of, and premium and interest on,
the Securities is fully and unconditionally guaranteed on a joint and several senior basis by each of the Guarantors to the extent set forth in the Indenture. 
  

	 	9.	Denominations; Transfer; Exchange 

 The Securities are in registered form without coupons
in minimum denominations of $2,000 principal amount and integral multiples of $1,000 in excess thereof. A Holder may transfer or exchange Securities in accordance with the Indenture. The Registrar may require a Holder, among other things, to furnish
appropriate endorsements or transfer documents and to pay any taxes and fees required by law or permitted by the Indenture. Without the prior consent of the Company, the Registrar is not required (1) to register the transfer of or exchange any
Security selected for redemption, (2) to register the transfer of or exchange any Security for a period of 15 days before a selection of Security to be redeemed or (3) to register the transfer or exchange of a Security between a record
date and the next succeeding interest payment date. 
  

	 	10.	Persons Deemed Owners 

 The registered Holder of this Security may be treated as the
owner of it for all purposes. 
  

	 	11.	Unclaimed Money 

 If money for the payment of principal or interest remains unclaimed for
two years, the Trustee or Paying Agent shall pay the money back to the Company at its request unless an abandoned property law designates another Person. After any such payment, Holders entitled to the money must look only to the Company and not to
the Trustee for payment. 
  

	 	12.	Discharge and Defeasance 

 Subject to certain conditions, the Company at any time shall
be entitled to terminate some or all of its obligations under the Securities and the Indenture if the Company deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Securities to redemption or
maturity, as the case may be. 
  

	 	13.	Amendment; Waiver 

 Subject to certain exceptions set forth in the Indenture,
(a) the Indenture and the Securities may be amended with the written consent of the Holders of at least a majority in principal amount outstanding of the Securities and (b) any default or noncompliance with any provision may be waived with
the written consent of the Holders of a majority in principal amount outstanding of the Securities. Subject to certain exceptions set forth in the Indenture, without the consent of any Securityholder, the Company, the Guarantors and the Trustee
shall be entitled to amend the Indenture, the Security Guarantees or the Securities to cure any ambiguity, 

  
 6 

 
defect or inconsistency, or to provide for uncertificated Securities in addition to or in place of certificated Securities, or to provide for the assumption of the Company’s or any
Guarantor’s obligations to the Holders in the case of a merger or acquisition, or to release any Guarantor from any of its obligations under its Security Guarantee or the Indenture (to the extent permitted by the Indenture), or to make any
change that would provide any additional rights or benefits (including the addition of collateral) to the holders of Securities or that does not adversely affect in any material respect the legal rights under the indenture of any such holder, or to
comply with SEC rules and regulations or changes to applicable law, or to conform the text of the Indenture, the Security Guarantees or the Securities to any provision of the “Description of Notes” section of the Final Offering Circular,
or to provide for the issuance of Additional Securities in accordance with the limitations set forth in the Indenture as of the Issue Date, or to allow any Guarantor to execute a supplemental indenture or a Security Guarantee with respect to the
Securities, or to comply with the rules of any applicable securities depository. 
  

	 	14.	Defaults and Remedies 

 Under the Indenture, Events of Default include (a) default
for 30 days in payment of interest on the Securities; (b) default in payment of principal on the Securities at maturity, upon redemption, upon purchase, upon acceleration or otherwise, or failure by the Company to redeem or purchase
Securities when required; (c) failure by the Parent or Company to comply with other agreements in the Indenture or the Securities, in certain cases subject to notice and lapse of time; (d) certain accelerations (including failure to pay
within any grace period after final maturity) of other Indebtedness of the Parent or any Restricted Subsidiary if the amount accelerated (or so unpaid) exceeds $20 million; (e) certain events of bankruptcy or insolvency with respect to the
Parent, Company or any Significant Subsidiary; (f) certain judgments or decrees for the payment of money in excess of $20 million; and (g) certain defaults with respect to Security Guarantees of the Parent or any Significant
Subsidiary. If an Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in principal amount of the Securities may declare all the Securities to be due and payable immediately. Certain events of bankruptcy or
insolvency are Events of Default that will result in the Securities being due and payable immediately upon the occurrence of such Events of Default. 

Securityholders may not enforce the Indenture or the Securities except as provided in the Indenture. The Trustee may refuse to enforce the
Indenture or the Securities unless it receives indemnity or security satisfactory to it. Subject to certain limitations, Holders of a majority in principal amount of the Securities may direct the Trustee in its exercise of any trust or power. The
Trustee may withhold from Securityholders notice of any continuing Default (except a Default in payment of principal or interest or a Default in complying with Section 5.01 of the Indenture) if it determines that withholding notice is in the
interest of the Holders. 
  

	 	15.	Trustee Dealings with the Company 

 Subject to certain limitations imposed by the Act,
the Trustee under the Indenture, in its individual or any other capacity, may become the owner or pledgee of Securities and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the
Company or its Affiliates with the same rights it would have if it were not Trustee. 

  
 7 

	 	16.	No Recourse Against Others 

 No director, officer, employee, incorporator or stockholder
of the Parent or any Restricted Subsidiary shall have any liability for any obligations of the Company under the Securities or the Indenture or any Guarantor under its Security Guarantee or for any claim based on, in respect of or by reason of such
obligations or their creation. By accepting a Security, each Securityholder waives and releases all such liability. The waiver and release are part of the consideration for the issuance of the Securities and the Security Guarantees. 

 

	 	17.	Authentication 

 This Security shall not be valid until an authorized signatory of the
Trustee (or an authenticating agent) manually signs the certificate of authentication on the other side of this Security. 
  

	 	18.	Abbreviations 

 Customary abbreviations may be used in the name of a Securityholder or
an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants by the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). 

 

	 	19.	CUSIP Numbers 

 Pursuant to a recommendation promulgated by the Committee on Uniform
Security Identification Procedures the Company has caused CUSIP numbers to be printed on the Securities and has directed the Trustee to use CUSIP numbers in notices of redemption as a convenience to Securityholders. No representation is made as to
the accuracy of such numbers either as printed on the Securities or as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. 

 

	 	20.	Holders’ Compliance with Registration Rights Agreement 

 Each Holder of a Security,
by acceptance hereof, acknowledges and agrees to the provisions of the Registration Rights Agreement, including the obligations of the Holders with respect to a registration and the indemnification of the Company to the extent provided therein. 

 

	 	21.	Governing Law 

 THIS SECURITY SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH,
THE LAWS OF THE STATE OF NEW YORK. 
 The Company will furnish to any Securityholder upon written request and without charge to
the Security holder a copy of the Indenture which has in it the text of this Security in larger type. Requests may be made to: 

  
 8 

 WILLIAM LYON HOMES, INC. 

4695 MacArthur Court, 8th Floor 

Newport Beach, CA 92660 
 Attention:
Chief Financial Officer 
  

  
 9 

 ASSIGNMENT FORM 

To assign this Security, fill in the form below: 
 I or we
assign and transfer this Security to 
 (Print or type assignee’s name, address and zip code) 

(Insert assignee’s soc. sec. or tax I.D. No.) 

and irrevocably appoint agent to transfer this Security on the books of the Company. The agent may substitute another to act for him. 

 

									
	  

					
	Date:	 	  
	 		 	Your Signature:	 	  

	
	  

 Sign exactly as your name appears on the other side of this Security. 

  
 10 

 OPTION OF HOLDER TO ELECT PURCHASE 

If you want to elect to have this Security purchased by the Company pursuant to Section 4.06 or 4.10 of the Indenture, check the box:  ̈ 
  ̈ If you want to elect to have only part of
this Security purchased by the Company pursuant to Section 4.06 or 4.10 of the Indenture, state the amount in principal amount: $ 
  

											
		 	Dated:	 	  
	 		 	Your Signature:	 	  

						
		 		 		 		 		 	(Sign exactly as your name appears on the other side of this Security.)

  

					
		 	Signature Guarantee:	 	  

			
		 		 	(Signature must be guaranteed)

 Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Registrar,
which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in addition to, or in
substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended. 

 EXHIBIT 2 to Rule 144A/REGULATION S APPENDIX 

Form of 
 Transferee Letter of
Representation 
 William Lyon Homes, Inc. 
 In care of 

U.S. Bank National Association 

[            ] 

[            ] 

Ladies and Gentlemen: 
 This certificate is
delivered to request a transfer of $[    ] principal amount of the 5.75% Senior Notes due 2019 (the “Securities”) of William Lyon Homes, Inc. (the “Company”). 

Upon transfer, the Securities would be registered in the name of the new beneficial owner as follows: 

 

			
	Name:	 	  

			
		
	Address:	 	  

			
		
	Taxpayer ID Number:	 	  

The undersigned represents and warrants to you that: 

1. We are an institutional “accredited investor” (as defined in Rule 501(a)(1), (2), (3) or (7) under the Securities Act
of 1933, as amended (the “Securities Act”)), purchasing for our own account or for the account of such an institutional “accredited investor” at least $250,000 principal amount of the Securities, and we are acquiring the
Securities not with a view to, or for offer or sale in connection with, any distribution in violation of the Securities Act. We have such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks
of our investment in the Securities, and we invest in or purchase securities similar to the Securities in the normal course of our business. We, and any accounts for which we are acting, are each able to bear the economic risk of our or its
investment. 
 2. We understand that the Securities have not been registered under the Securities Act and, unless so registered, may not be
sold except as permitted in the following sentence. We agree on our own behalf and on behalf of any investor account for which we are purchasing Securities to offer, sell or otherwise transfer such Securities prior to the date that is two years
after the later of the date of original issue and the last date on which the Company or any affiliate of the Company was the owner of such Securities (or any predecessor thereto) (the “Resale

 
Restriction Termination Date”) only (i) to the Company, (ii) in the United States to a person whom the seller reasonably believes is a qualified institutional buyer in a
transaction meeting the requirements of Rule 144A, (iii) to an institutional “accredited investor” within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act that is an institutional accredited
investor purchasing for its own account or for the account of an institutional accredited investor, in each case in a minimum principal amount of the Securities of $250,000, (iv) outside the United States in a transaction complying with the
provisions of Rule 904 under the Securities Act, (v) pursuant to an exemption from registration under the Securities Act provided by Rule 144 (if available) or (vi) pursuant to an effective registration statement under the Securities Act,
in each of cases (i) through (vi) subject to any requirement of law that the disposition of our property or the property of such investor account or accounts be at all times within our or their control and in compliance with any applicable
state securities laws. The foregoing restrictions on resale will not apply subsequent to the Resale Restriction Termination Date. If any resale or other transfer of the Securities is proposed to be made pursuant to clause (iii) above prior to
the Resale Restriction Termination Date, the transferor shall deliver a letter from the transferee substantially in the form of this letter to the Company and the Trustee, which shall provide, among other things, that the transferee is an
institutional “accredited investor” within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act and that it is acquiring such Securities for investment purposes and not for distribution in violation of the
Securities Act. Each purchaser acknowledges that the Company and the Trustee reserve the right prior to the offer, sale or other transfer prior to the Resale Restriction Termination Date of the Securities pursuant to clause (iii),
(iv) or (v) above to require the delivery of an opinion of counsel, certifications or other information satisfactory to the Company and the Trustee. 

 

					
	TRANSFEREE:                    ,
			
		 	by:	 	 
		 		 	

 EXHIBIT B 

FORM OF NOTATION OF GUARANTEE 
 For value
received, each Guarantor (which term includes any successor Person under the Indenture) has, jointly and severally, unconditionally guaranteed, to the extent set forth in the Indenture and subject to the provisions in the Indenture dated as of
March 31, 2014 (the “Indenture”), among William Lyon Homes, Inc., a California corporation (the “Company”), the Guarantors party thereto and U.S. Bank National Association, as Trustee, (a) the due and
punctual payment of the principal of, premium on, if any, and interest, if any, on, the Securities, whether at maturity, by acceleration, redemption or otherwise, the due and punctual payment of interest on overdue principal of, premium on, if any,
and interest, if any, on, the Securities, if any, if lawful, and the due and punctual performance of all other obligations of the Company to the Holders or the Trustee all in accordance with the terms of the Indenture and (b) in case of any
extension of time of payment or renewal of any Securities or any of such other obligations, that the same will be promptly paid in full when due or performed in accordance with the terms of the extension or renewal, whether at stated maturity, by
acceleration or otherwise. The obligations of the Guarantors to the Holders of Securities and to the Trustee pursuant to the Security Guarantee and the Indenture are expressly set forth in Article 10 of the Indenture and reference is hereby made to
the Indenture for the precise terms of the Security Guarantee. 
 Capitalized terms used but not defined herein have the meanings given to them in the
Indenture. 

 
			
	WILLIAM LYON HOMES
		
	By:	 	  

	Name:	 	Matthew R. Zaist
	Title:	 	President and Chief Operating Officer
	
	PH-LP VENTURES
	DUXFORD FINANCIAL, INC.
	SYCAMORE CC, INC.
	PRESLEY CMR, INC.
	WILLIAM LYON SOUTHWEST, INC.
	PH-RIELLY VENTURES
	PH VENTURES-SAN JOSE
	PRESLEY HOMES
		
	By:	 	  

	Name:	 	Matthew R. Zaist
	Title:	 	President and Chief Operating Officer
	
	WLH ENTERPRISES
		
	By:	 	William Lyon Homes, Inc.
	Its:	 	General Partner
		
	By:	 	  

	Name:	 	Matthew R. Zaist
	Title:	 	President and Chief Operating Officer
		
	By:	 	Presley CMR, Inc.
	Its:	 	General Partner
		
	By:	 	  

	Name:	 	Matthew R. Zaist
	Title:	 	President and Chief Operating Officer
	
	LYON EAST GARRISON COMPANY I, LLC
		
	By:	 	William Lyon Homes, Inc.
	Its:	 	Sole Member
		
	By:	 	  

	Name:	 	Matthew R. Zaist
	Title:	 	President and Chief Operating Officer

 
					
	LYON WATERFRONT, LLC
		
	By:	 	William Lyon Homes, Inc.
	Its:	 	Sole Member
		
	By:	 	  

	Name:	 	Matthew R. Zaist
	Title:	 	President and Chief Operating Officer
	
	CIRCLE G AT THE CHURCH FARM NORTH JOINT VENTURE, LLC
		
	By:	 	William Lyon Homes, Inc.
	Its:	 	Manager
		
	By:	 	  

	Name:	 	Matthew R. Zaist
	Title:	 	President and Chief Operating Officer
	
	MOUNTAIN FALLS, LLC
		
	By:	 	William Lyon Homes, Inc.
	Its:	 	Sole Member
		
	By:	 	  

	Name:	 	Matthew R. Zaist
	Title:	 	President and Chief Operating Officer
	
	MOUNTAIN FALLS GOLF COURSE, LLC
		
	By:	 	WLH Enterprises
	Its:	 	Managing Member
			
		 	By:	 	William Lyon Homes, Inc.
		 	Its:	 	General Partner
			
		 	By:	 	  

		 	Name:	 	Matthew R. Zaist
		 	Title:	 	President and Chief Operating Officer
			
		 	By:	 	Presley CMR, Inc.
		 	Its:	 	General Partner
			
		 	By:	 	  

		 	Name:	 	Matthew R. Zaist
		 	Title:	 	President and Chief Operating Officer

 
			
	CALIFORNIA EQUITY FUNDING, INC.
	HSP, INC.
		
	By:	 	  

	Name:	 	Matthew R. Zaist
	Title:	 	Executive Vice PresidentEX-10.1

 Exhibit 10.1 

EXECUTION VERSION 
 THIRD
OMNIBUS AMENDMENT 
 This THIRD OMNIBUS AMENDMENT is made as of March 31, 2014 (this “Amendment”), among
CHS RECEIVABLES FUNDING, LLC, a Delaware limited liability company (“Receivables Funding”), as Borrower and as the Company, THE BANK OF NOVA SCOTIA (“Scotia”), as a Committed Lender and as a Managing Agent,
CRÉDIT AGRICOLE CORPORATE AND INVESTMENT BANK (“CA-CIB”), as a Committed Lender, as a Managing Agent and as Administrative Agent, THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.
(“BTMU”), as a Committed Lender and as a Managing Agent, ATLANTIC ASSET SECURITIZATION LLC (“Atlantic”), as a Conduit Lender, LIBERTY STREET FUNDING LLC (“Liberty Street”), as a Conduit Lender, VICTORY
RECEIVABLES CORPORATION (“Victory”), as a Conduit Lender, COMMUNITY HEALTH SYSTEMS PROFESSIONAL SERVICES CORPORATION (“Professional Services”), a Delaware corporation, as Collection Agent under each of the
Receivables Loan Agreement, Contribution Agreement, and Sale Agreement, and as Authorized Representative (as defined in the Sale Agreement, the “Authorized Representative”), CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation
(“CHS”), as Transferor, as Buyer and individually (as the provider of a performance undertaking), NANTICOKE HOSPITAL COMPANY, LLC, a Delaware limited liability company, as the Removed Originator (as defined below) and EACH OF THE
OTHER PERSONS IDENTIFIED AS ORIGINATORS ON THE SIGNATURE PAGES HERETO AFFILIATED WITH CHS/COMMUNITY HEALTH SYSTEMS, INC., as Originators. All capitalized terms used herein without reference shall have the meanings assigned to such terms in the
Receivables Loan Agreement, Contribution Agreement or Sale Agreement (as each is defined below), as applicable, in each case after giving effect to this Amendment. 

WHEREAS, Receivables Funding, as Borrower, Scotia, as a Committed Lender and as a Managing Agent, CA-CIB, as a Committed Lender, as a Managing
Agent and as Administrative Agent, BTMU, as a Committed Lender and as a Managing Agent, the other Lenders party thereto and Professional Services, as Collection Agent, have entered into the Receivables Loan Agreement, dated as of March 21, 2012
(as amended, restated, supplemented or otherwise modified prior to the date hereof, the “Receivables Loan Agreement”); 

WHEREAS, CHS, as Transferor, Receivables Funding, as the Company, and Professional Services, as Collection Agent thereunder, have entered into
the Receivables Purchase and Contribution Agreement, dated as of March 21, 2012 (as amended, restated, supplemented or otherwise modified prior to the date hereof, the “Contribution Agreement”); 

WHEREAS, the Originators party to the Sale Agreement (as defined below) as of the Second Omnibus Amendment Effective Date (the
“Existing Originators”), Professional Services, as Collection Agent and Authorized Representative thereunder, and CHS, as Buyer, have entered into the Receivables Sale Agreement, dated as of March 21, 2012 (as amended,
restated, supplemented or otherwise modified prior to the date hereof, the “Sale Agreement”); 
 WHEREAS, each of the
Supplemental Originators (as defined below) has agreed to join and be bound by the Sale Agreement and each other applicable Facility Document as an Originator thereunder; 

 WHEREAS, the Collection Agent has requested the Removed Originator (as defined below) be removed
from the Sale Agreement and each other applicable Facility Document as an Originator thereunder and the Removed Originator has agreed to be so removed; and 

WHEREAS, the parties hereto desire to amend certain provisions of the Receivables Loan Agreement, the Contribution Agreement and the Sale
Agreement, pursuant to Section 10.01 of the Receivables Loan Agreement, Section 9.01 of the Contribution Agreement and Section 9.01 of the Sale Agreement, and take the other actions set forth herein, and have agreed to do so subject
to the terms and conditions of this Amendment. 
 NOW, THEREFORE, in consideration of the agreements hereinafter set forth, and for other
good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto agree as follows: 
 SECTION
1. Supplemental Originators. On the Amendment Effective Date, and pursuant to Section 9.14(a) of the Sale Agreement, each of the parties listed on Schedule I hereto (collectively, the “Supplemental
Originators”, and each, a “Supplemental Originator”) shall be added as Originators under the Sale Agreement, subject to the satisfaction of the conditions listed in Section 9.14(a) of the Sale Agreement, including the
execution and delivery by each Supplemental Originator of a joinder agreement in the form of Annex A hereto. Each such addition is hereby agreed and consented to by the Required Lenders, Buyer and the Administrative Agent, as the
Buyer’s assignee under the Assignment of Agreements. 
 SECTION 2. Removal of Originator. On the Amendment Effective Date, and
pursuant to Section 9.14(b) of the Sale Agreement, Nanticoke Hospital Company, LLC, a Delaware limited liability company and Originator under the Sale Agreement prior to its Removal on the date hereof shall be removed as an Originator under the
Sale Agreement, subject to the satisfaction of the conditions listed in Section 9.14(b) of the Sale Agreement (such Originator, the “Removed Originator”). The Removed Originator hereby consents to its Removal as an Originator
under the Sale Agreement on the Amendment Effective Date and confirms and agrees the provisions of Article VIII of the Sale Agreement (and the representations and warranties with respect thereto) shall, with respect to the Removed Originator,
survive such Removal for all claims arising prior to such Removal. The parties hereto hereby agree that any report, notice or other information delivered under any Facility Document following the Amendment Effective Date (including any Monthly
Report) shall not include the Removed Originator or any Receivables generated by the Removed Originator for any period commencing on or after March 1, 2014. The Removed Originator hereby acknowledges and consents to the amendments to the Sale
Agreement contemplated hereby and agrees that it shall have no further rights under or interests with respect to the Sale Agreement or any of the other Facility Documents on and after its Removal, other than any such rights or interests that
specifically survive such Removal or termination of the Sale Agreement or the applicable Facility Document. 
 SECTION 3. Amendments to
Receivables Loan Agreement. Subject to all of the terms and conditions set forth in this Amendment: 
 (a) The cover page to the
Receivables Loan Agreement is hereby amended by replacing the dollar amount “$500,000,000” appearing on such cover page with “$700,000,000”. 

  
 2 

 (b) Section 1.01 of the Receivables Loan Agreement is amended as by inserting the following
definitions in the appropriate alphabetical order: 
 “Conforming Funding Period” means any period in the
Revolving Period other than during a Deferred Funding Period. 
 “Conforming Lender” means a Committed
Lender other than a Deferred Funding Lender. 
 “Conforming Lender Group” means a Lender Group other than a
Deferred Funding Lender Group. 
 “Deferred Funding Advance Shortfall” means the amount of the Advance that
a Deferred Funding Lender Group was requested to fund in a Funding Notice and was not funded on the related Funding Date as a result of the provisions set forth in Section 2.01(h) with respect to Deferred Funding Lenders. 

“Deferred Funding Amount” means, with respect to any Deferred Funding Lender and determined as of any
Deferred Funding Settlement Date, an amount equal to the Deferred Funding Advance Shortfall. 
 “Deferred Funding
Certificate” means an Officer’s Certificate delivered by a Managing Agent to the Collection Agent and the Administrative Agent certifying that a Lender in (or an Affiliate of) such Managing Agent’s Lender Group: (i) is
incurring (or expects to incur) charges with respect to its Commitment hereunder in connection with the calculation of the “liquidity coverage ratio” under Basel III, and (ii) is in good faith seeking to exercise or has exercised
a delayed funding option in transactions similar to the transactions contemplated hereunder. 
 “Deferred Funding
Date” means a Funding Date during a Deferred Funding Period. 
 “Deferred Funding De-Designation
Date” has the meaning assigned to that term in Section 2.01(h)(i). 
 “Deferred Funding De-Designation
Notice” has the meaning assigned to that term in Section 2.01(h)(i). 
 “Deferred Funding
Lender” means a Committed Lender that delivers a Deferred Funding Certificate in accordance with to Section 2.01(h)(i). 

“Deferred Funding Lender Agent” means the Managing Agent of a Deferred Funding Lender Group. 

“Deferred Funding Lender Group” means any Lender Group that includes a Deferred Funding Lender. 

  
 3 

 “Deferred Funding Period” means a period in the Revolving Period
during which one or more Lender Groups is then currently a Deferred Funding Lender Group. 
 “Deferred Funding
Settlement Date” means, with respect to unpaid Deferred Funding Amounts of any Deferred Funding Lender Group, the earlier to occur of (i) a Business Day selected by the applicable Deferred Funding Lender Agent and indicated in its
Deferred Funding Certificate that is 32 days (or, if such 32nd day is not a Business Day, not more than the number of days to the next Business Day following such 32nd day) from the applicable Deferred Funding Date (even if such date occurs following the end of the Revolving Period); and (ii) the Deferred Funding De-Designation Date applicable to such
Deferred Funding Lender Group. 
 “HHS Compliance Date” the date established by the United States
Department of Health and Human Services on and after which certain health care entities, including the CHS Parties, are required to have implemented the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) for diagnosis coding, including the Official ICD-10-CM Guidelines for Coding and Reporting, and the International
Classification of Diseases, 10th Revision, Procedure Coding System (ICD-10-PCS) for inpatient hospital procedure coding, including the Official ICD-10-PCS Guidelines for Coding and Reporting. 

“ratable”, “ratable share”, “ratably” (and similar terms) means, the
ratable interest of each Lender Group as determined by reference to its Lender Group Percentage. 
 “Temporary
Relief Period” means, solely to the extent that the HHS Compliance Date occurs on or before October 1, 2014, the following periods: (i) with respect to the Default Ratio for a single Collection Period, the period comprised of the
five consecutive Collection Periods from February 2015 through and including June 2015, (ii) with respect to the Delinquency Ratio for a single Collection Period, the period comprised of the five consecutive Collection Periods from February
2015 through and including June 2015, (iii) with respect to the Payment Denial Rate for a single Collection Period, the period comprised of the four consecutive Collection Periods from April 2015 through and including July 2015, (iv) with
respect to the average of the Default Ratio for a Collection Period and the two prior Collection Periods, the period comprised of the five consecutive Collection Periods from March 2015 through and including July 2015, (v) with respect to the
average of the Delinquency Ratio for a Collection Period and the two prior Collection Periods, the period comprised of the five consecutive Collection Periods from March 2015 through and including July 2015, and (vi) with respect to the DSO for
a single Collection Period, the period comprised of the three consecutive Collection Periods from February 2015 through and 

  
 4 

 including April 2015; provided, that if the HHS Compliance Date occurs after
October 1, 2014, the “Temporary Relief Period” hereunder shall consist of such periods, if any, and pursuant to such terms as the Administrative Agent and the Managing Agents each agrees in writing in its respective sole discretion.

 “Third Omnibus Amendment” means that certain Third Omnibus Amendment, made as of the Third Omnibus
Amendment Effective Date, among the Borrower, as Borrower and as the Company, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed Lender, BTMU, as a Managing Agent and as a Committed Lender,
CA-CIB, as a Managing Agent, as a Committed Lender and as Administrative Agent, the Collection Agent, as Collection Agent under each of this Agreement, the Contribution Agreement, and the Sale Agreement, and
as Authorized Representative (as defined in the Sale Agreement), CHS, as Transferor, as Buyer and individually (as a performance undertaking party), each of the Originators party to the Sale Agreement as of the Third Omnibus Amendment Effective
Date, as Originators, and such other parties as are named therein. 
 “Third Omnibus Amendment Effective
Date” means March 31, 2014. 
 (c) The definition of “Collection Account Bank” in Section 1.01 of the
Receivables Loan Agreement is hereby amended and restated in its entirety to read as follows: 
 “Collection Account
Bank” means a bank or other financial institution holding one or more Collection Accounts, which on the Closing Date shall be Bank of America, N.A., and on both the Second Omnibus Amendment Effective Date and Third Omnibus Amendment
Effective Date shall be Bank of America, N.A., or Fifth Third Bank, as context requires. 
 (d) The definition of “Commitment” in
Section 1.01 of the Receivables Loan Agreement is hereby amended by deleting the last sentence thereof and inserting in lieu thereof the following: 

As of the Third Omnibus Amendment Effective Date, the aggregate amount of the Commitments is $700,000,000. 

(e) The definition of “Contribution Agreement” in Section 1.01 of the Receivables Loan Agreement is hereby amended and restated
in its entirety to read as follows: 
 “Contribution Agreement” means that certain Receivables Purchase and
Contribution Agreement dated as of the Closing Date, among the Transferor, the Company and the Collection Agent, as amended by the First Omnibus Amendment, the Second Omnibus Amendment, and the Third Omnibus Amendment and as the same may be further
amended, restated, supplemented or otherwise modified from time to time in accordance with the terms thereof and hereof, together with all instruments, documents and agreements executed by any of the CHS Parties party thereto in connection
therewith, in each case, as the same may be amended, restated, supplemented or otherwise modified from time to time in accordance with the terms thereof and hereof. 

  
 5 

 (f) The definition of “Facility Limit” in Section 1.01 of the Receivables Loan
Agreement is hereby amended by replacing the dollar amount “$500,000,000” appearing in such definition with “$700,000,000”. 

(g) The definition of “Sale Agreement” in Section 1.01 of the Receivables Loan Agreement is hereby amended and restated in its
entirety to read as follows: 
 “Sale Agreement” means that certain Receivables Sale Agreement, dated as of
the Closing Date, among the Originators, the Buyer and the Collection Agent, as amended by the First Omnibus Amendment, the Second Omnibus Amendment and the Third Omnibus Amendment and as the same may be further amended, restated, supplemented or
otherwise modified from time to time in accordance with the terms thereof and hereof, together with all instruments, documents and agreements executed by any of the Originators in connection therewith, in each case, as the same may be amended,
restated, supplemented or otherwise modified from time to time in accordance with the terms thereof and hereof. 
 (h) The definition of
“Scheduled Termination Date” in Section 1.01 of the Receivables Loan Agreement is hereby amended and restated in its entirety to read as follows: 

“Scheduled Termination Date” means March 21, 2016, as such date may be extended thereafter in accordance
with Section 2.03(a). 
 (i) The definition of “Second Omnibus Amendment” in Section 1.01 of the Receivables Loan
Agreement is hereby amended and restated in its entirety to read as follows: 
 “Second Omnibus Amendment”
means that certain Second Omnibus Amendment, made as of the Second Omnibus Amendment Effective Date, among the Borrower, as Borrower and as the Company, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed Lender, BTMU, as a Managing
Agent and as a Committed Lender, CA-CIB, as a Managing Agent, as a Committed Lender and as Administrative Agent, the Collection Agent, as Collection Agent under each of this Agreement, the Contribution
Agreement, and the Sale Agreement, and as Authorized Representative (as defined in the Sale Agreement), CHS, as Transferor, as Buyer and individually (as a performance undertaking party), and each of the Originators party to the Sale Agreement as of
the Second Omnibus Amendment Effective Date, as Originators. 
 (j) The definition of “Specified Originators” in Section 1.01
of the Receivables Loan Agreement is hereby amended and restated in its entirety to read as follows: 
 “Specified
Originators” means the Originators listed on Schedule VI, which Schedule also sets forth the percentage ownership of the issued and outstanding equity interests of each such Originator that is held by CHS and its subsidiaries as
of the Third Omnibus Amendment Effective Date. 

  
 6 

 (k) The definition of “Supplemental Originators” in Section 1.01 of the
Receivables Loan Agreement is hereby deleted. 
 (l) Section 2.01(c) of the Receivables Loan Agreement is hereby amended by adding the
words “by Lenders not part of a Deferred Lending Group” immediately following the words “requested to be made” appearing in the third line thereof. 

(m) Section 2.01(e) of the Receivables Loan Agreement is hereby amended and restated in its entirety to read as follows: 

(e) The applicable portion of the Advance (i) may be made by the related Conduit Lender, in its sole discretion or
(ii) if the related Conduit Lender does not fund, shall be made by the related Committed Lender, in each case, in accordance with its individual Commitment, if applicable, and its Lender Group Percentage (subject to, during a Deferred Funding
Period, the provisions of Section 2.01(h) below with respect to Deferred Funding Lenders). Notwithstanding anything contained in this Section 2.01 or elsewhere in this Agreement to the contrary, no Lender shall be obligated
to make any Advance in an amount that would result in the aggregate Advances then funded by the related Lender Group exceeding such Lender Group’s Lender Group Limit then in effect. 

(n) Section 2.01(g) of the Receivables Loan Agreement is hereby amended and restated in its entirety to read as follows: 

(g) On each Funding Date during a Conforming Period, following the satisfaction of the applicable conditions set forth in this
Section 2.01 and Article III, each Lender shall make available to its related Managing Agent, for deposit to the account of the Borrower or its designee in same day funds, at the account specified in the Funding Request, an
amount equal to such Lender’s ratable share of the Advance then being made. During a Deferred Funding Period, following the satisfaction of the applicable conditions set forth in this Section 2.01 and Article III
(i) on each Deferred Funding Date, each Lender member of a Conforming Lender Group shall make available to its related Managing Agent, for deposit to the account of the Borrower or its designee in same day funds, at the account specified in the
Funding Request, an amount equal to such Lender’s ratable share of the Advance then being made, and (ii) on each Deferred Funding Settlement Date, each Deferred Funding Lender shall make available Advances in accordance with the provisions
of Section 2.01(h). Each Lender shall use commercially reasonable efforts to initiate each wire transfer of an Advance to the Borrower no later than 12:00 noon (New York City time) on the applicable Funding Date, Deferred Funding Date or
Deferred Funding Settlement Date, as applicable. Each Lender agrees that either (i) no portion of any Advance shall be funded or held with “plan assets” of any “benefit plan investor” within the meaning of Section 3(42)
of ERISA or (ii) the funding and 

  
 7 

 holding of any portion of any Advance shall not constitute or result in a non-exempt prohibited
transaction under Section 406 of ERISA or Section 4975 of the Code. 
 (o) Section 2.01 of the Receivables Loan Agreement is
hereby amended by adding a new clause (h) at the end thereof that reads as follows: 
 (h) Special Provisions for
Deferred Fundings. 
 (i) At any time, three Business Days after receipt by the Administrative Agent and the Collection
Agent of a Deferred Funding Certificate from a Managing Agent, the related Committed Lender shall become a “Deferred Funding Lender” and its related Lender Group shall become a “Deferred Funding Lender Group”. Such designation
shall remain in effect until such time as the related Deferred Funding Lender Agent issues a written notice to the Administrative Agent and the Collection Agent withdrawing such designation (a “Deferred Funding De-Designation
Notice”) effective as of the date such notice is delivered or as of such later date specified therein (such effective date, the “Deferred Funding De-Designation Date”). Effective as of the Deferred Funding De-Designation
Date, each Committed Lender that is a Deferred Funding Lender, and each related Lender Group that is a Deferred Funding Lender Group, shall cease to be a Deferred Funding Lender or a Deferred Funding Lender Group, as applicable, and shall, for all
purposes other than pursuant to the proviso hereto, be deemed to be a Conforming Lender and a Conforming Lender Group, as applicable; provided that in connection with any Advance outstanding as of the Deferred Funding De-Designation Date for
which any Deferred Funding Lender has not, as of such date, paid its Deferred Funding Amounts, such Deferred Funding De-Designation Date shall be deemed to be the Deferred Funding Settlement Date for such Advance and such Deferred Funding Lender
shall comply with its obligations pursuant to Section 2.01(h)(ii) and Section 2.01(h)(iii) for such Deferred Funding Settlement Date. 

(ii) On each Deferred Funding Settlement Date, each Deferred Funding Lender shall make available to its Managing Agent the
Deferred Funding Amount, which amount (1) if such Deferred Funding Settlement Date occurs prior to the occurrence and continuance of an Event of Default or Termination Date hereunder, shall be deposited in the account of the Borrower or its
designee as an Advance hereunder, and (2) if such Deferred Funding Settlement Date occurs following the occurrence and during the continuance of an Event of Default or Termination Date hereunder, shall be paid to the Administrative Agent for
distribution on the same Business Day to the Lenders (including such Deferred Lender) ratably (calculated presuming that all unfunded Deferred Funding Advance Shortfalls of any other Deferred Funding Lender Groups have been fully funded); provided
that such Deferred Funding Lender shall not fund to the Administrative Agent and shall instead net out of its ratable portion of the Deferred Funding Amount any amounts that it is entitled to receive from the Administrative Agent under this clause
(h)(ii)(2); provided, in no event shall any 

  
 8 

 
such payment reduce the Revolving Principal Balance of any Lender or Lender Group below zero. Upon the payment of the Deferred Funding Amount in accordance with the provisions of
clause (ii)(2) above and without any further action on the part of such Deferred Funding Lender making such payment, the Borrower, the Administrative Agent or the other Lenders, the Deferred Funding Lender making such payment will have
acquired, and each Lender receiving a distribution of a portion of such payment will have granted to such Deferred Funding Lender, without recourse or warranty, its portions of the Revolving Principal Balances that were reduced by application of the
distribution of such Deferred Funding Amount by the Administrative Agent. The Revolving Principal Balance owing to each Lender member of a Lender Group other than such Deferred Funding Lender’s Deferred Funding Lender Group shall be reduced by
the amount of any portion of such payment received by such Lender and the Revolving Principal Balance owing to the Deferred Funding Lender making such payment shall be increased by all amounts so paid such that the aggregate Revolving Principal
Balance of all Lenders outstanding hereunder immediately prior to such payment and distribution shall be unchanged and shall continue to equal to the aggregate Revolving Principal Balance of all Lenders outstanding hereunder immediately following
such payment and distribution. 
 (iii) The obligation of each Deferred Funding Lender to fund the Deferred Funding Amount
on the related Deferred Funding Settlement Date is subject to any valid and timely claims of a Deferred Funding Lender under clause (iv) below, but is otherwise absolute and unconditional and shall not be affected by any circumstance
whatsoever, including (1) any setoff, counterclaim, recoupment, defense or other right which such Deferred Funding Lender may have against the Administrative Agent, the other Lenders, the Borrower, or any other Person for any reason whatsoever;
(2) the occurrence or continuance of an Default, Event of Default or Termination Date; (3) the termination of the Revolving Period, (4) the reduction or termination of any Commitments; or (5) any other occurrence, event, or
condition, whether or not similar to any of the foregoing (in each case, so long as such Advance does not result in the aggregate Advances then funded by the related Deferred Funding Lender Group exceeding such Deferred Funding Lender Group’s
Lender Group Limit then in effect. The funding or failure to fund the Deferred Funding Amount will not relieve or otherwise impair the obligation of the Borrower to repay the Revolving Principal Balance of each Lender, together with interest as
provided in this Agreement. 
 (iv) A Deferred Funding Lender may not object to its funding obligation of Deferred Funding
Amounts under Section 2.01(g) and (h) on the basis of the failure of the Borrower to satisfy the conditions precedent set forth in this Section 2.01 and Article III as of the Deferred Funding Date so long
as all such conditions were satisfied as of the related Funding Date; provided that the absolute and unconditional funding obligations of a Deferred Funding Lender of Deferred Funding Amounts set forth in this Section 2.01 do not
constitute a waiver of any rights of such Deferred Funding Lender or of rights and remedies of the Administrative Agent and the Lenders (including such Deferred Funding Lender) against the Borrower, in each case, as set forth hereunder. 

  
 9 

 (v) Each Deferred Funding Lender acknowledges that the Conforming Lender Groups
have relied on the obligation of the Deferred Funding Lender to fund the Deferred Funding Amount in making Advances hereunder and is an intended beneficiary of such obligation. 

(p) Section 2.06(b) of the Receivables Loan Agreement is hereby amended and restated in its entirety to read as follows: 

(b) On the Third Omnibus Amendment Effective Date, the Borrower shall pay to the Administrative Agent for its own benefit and
the benefit of each Managing Agent and each Lender, as applicable, the fees set forth in the Fee Letter as amended and restated on such date that are due and payable on such date, including the upfront fee and reimbursement for all reasonable
out-of-pocket costs and expenses, including any legal fees and disbursements to the extent incurred, relating to the negotiation, preparation and closing of the Third Omnibus Amendment and the other Facility Documents. 

(q) The proviso set forth at the end of clause (dd) of Section 4.01 of the Receivables Loan Agreement is hereby amended by adding
the following language before the period at the end thereof: 
 and, if such violation is cured within such 15 day period, the cure of
such violation shall be effective to cure any breach of any covenant, representation or warranty by the Borrower under any Facility Document directly related to or directly arising from such violation without any further action 

(r) The proviso set forth at the end of clause (j) of Section 4.02 of the Receivables Loan Agreement is hereby amended by adding the
following language before the period at the end thereof: 
 and, if such violation is cured within such 15 day period, the cure of such
violation shall be effective to cure any breach of any covenant, representation or warranty by the Collection Agent under any Facility Document directly related to or directly arising from such violation without any further action 

(s) The proviso set forth at the end of clause (q) of Section 5.01 of the Receivables Loan Agreement is hereby amended by adding the
following language before the period at the end thereof: 
 and, if such violation is cured within such 15 day period, the cure of such
violation shall be effective to cure any breach of any covenant, representation or warranty by the Borrower under any Facility Document directly related to or directly arising from such violation without any further action 

  
 10 

 (t) The proviso set forth at the end of clause (i) of Section 5.02 of the Receivables
Loan Agreement is hereby amended by adding the following language before the period at the end thereof: 
 and, if such violation is cured
within such 15 day period, the cure of such violation shall be effective to cure any breach of any covenant, representation or warranty by the Collection Agent under any Facility Document directly related to or directly arising from such
violation without any further action 
 (u) Section 5.02 of the Receivables Loan Agreement is hereby amended by adding a new
clause (l) at the end thereof that reads as follows: 
 (l) Banc of America Leasing & Capital, LLC
Leases. The Collection Agent will utilize its best efforts to cause each of the existing lease agreements and the form for all future lease agreements between an Originator and Banc of America Leasing & Capital, LLC or any of its
affiliates to be amended to remove all references to “accounts” from the defined term “Collateral” identified thereunder as promptly as practicable and in any event within 90 days of the Third Omnibus Amendment Effective
Date; provided, that, to the extent any existing lease agreement or the form for any future lease agreement is not so amended within such 90 day period or any new lease agreement does not reflect such amendment, the Administrative Agent
shall have the right to deduct from the Borrowing Base amounts not exceeding the aggregate amount of all amounts payable under such lease agreements. 

(v) Clause (h) of Section 7.01 of the Receivables Loan Agreement is hereby amended and restated in its entirety to read as follows:

 (h) As of the last day of any Collection Period, (i) the Default Ratio (x) for any Collection Period occurring
during the Temporary Relief Period shall exceed 9.50% and (y) for all other Collection Periods shall exceed 9.00%, (ii) the Delinquency Ratio (x) for any Collection Period occurring during the Temporary Relief Period shall exceed
5.75% and (y) for all other Collection Periods, shall exceed 3.50%, (iii) the Payment Denial Rate (x) for any Collection Period occurring during the Temporary Relief Period shall exceed 1.50% and (y) for all other Collection
Periods shall exceed 1.25%, (iv) the average of the Default Ratio for each of such Collection Period and the two prior Collection Periods (x) for any Collection Period occurring during the Temporary Relief Period shall exceed 9.25% and
(y) for all other Collection Periods shall exceed 8.50%, or (v) the average of the Delinquency Ratio for each of such Collection Period and the two prior Collection Periods (x) for any Collection Period occurring during the Temporary
Relief Period shall exceed 5.25% and (y) for all other Collection Periods shall exceed 3.25%; or 

  
 11 

 (w) Clause (i) of Section 7.01 of the Receivables Loan Agreement is hereby amended and
restated in its entirety to read as follows: 
 (i) The DSO reported on any Monthly Report shall exceed, (x) if with
respect to a Collection Period occurring during the Temporary Relief Period, 60 days and (y) if with respect to a Collection Period occurring at any other time, 55 days; or 

(x) Clause (r) of Section 7.01 of the Receivables Loan Agreement is hereby amended and restated in its entirety to read as follows:

 (r) CHS or any subsidiary thereof shall fail to perform or observe any term, covenant or agreement contained in
Section 6.12 or Section 6.13 of the Parent Credit Agreement either as in effect on the Third Omnibus Amendment Effective Date or as in effect from time to time without regard to any waiver or modification to any of those provisions or any
of the defined terms used therein and such failure shall continue for a period of 10 Business Days after the date on which financial statements are required to be delivered with respect to the applicable fiscal quarter hereunder (the
“Financial Covenant Cure Period”); or 
 (y) CA-CIB’s and Atlantic’s signature pages to the Receivables Loan
Agreement are amended to replace the notice address set forth therein with the respective notice addresses as appear below CA-CIB’s and Atlantic’s signature lines and blocks hereto. 

(z) The Borrower and the Collection Agent’s signature pages to the Receivables Loan Agreement are amended to replace the notice address
set forth therein with the respective notice addresses as appear below the Borrower and the Collection Agent’s signature lines and blocks hereto. 

(aa) Schedule I of the Receivables Loan Agreement is hereby replaced with the Schedule I attached hereto as Annex B.

 (bb) Schedule VI of the Receivables Loan Agreement is hereby replaced with the Schedule VI attached hereto as
Annex C. 
 SECTION 4. Amendments to Contribution Agreement. Subject to all of the terms and conditions set forth in
this Amendment: 
 (a) Section 1.01 of the Contribution Agreement is amended as by inserting the following definitions in the
appropriate alphabetical order: 
 “Third Omnibus Amendment” means that certain Third Omnibus Amendment,
made as of the Third Omnibus Amendment Effective Date, among the Company, as Borrower and as the Company, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed Lender, BTMU, as a Managing Agent and as a Committed Lender, CA-CIB, as a Managing Agent, as a Committed Lender and as Administrative Agent, the Collection Agent, as Collection Agent under 

  
 12 

 
each of this Agreement, the Loan Agreement, and the Sale Agreement, and as Authorized Representative (as defined in the Sale Agreement), CHS, as Transferor, as Buyer and individually (as a
performance undertaking party), each of the Originators party to the Sale Agreement as of the Third Omnibus Amendment Effective Date, as Originators, and such other parties as are named therein. 

“Third Omnibus Amendment Effective Date” means March 31, 2014. 

(b) The definition of “Collection Account Bank” in Section 1.01 of the Contribution Agreement is hereby amended and restated in
its entirety to read as follows: 
 “Collection Account Bank” means a bank or other financial institution
holding one or more Collection Accounts, which on the Closing Date shall be Bank of America, N.A., and on both the Second Omnibus Amendment Effective Date and Third Omnibus Amendment Effective Date shall be Bank of America, N.A., or Fifth Third
Bank, as context requires. 
 (c) The definition of “Loan Agreement” in Section 1.01 of the Contribution Agreement is hereby
amended and restated in its entirety to read as follows: 
 “Loan Agreement” means that certain Receivables
Loan Agreement, dated as of the Closing Date, among the Company, Professional Services, in its capacity as Collection Agent, the Lenders party thereto from time to time, the Managing Agents party thereto from time to time and Credit Agricole
Corporate and Investment Bank, as Administrative Agent, as amended by the First Omnibus Amendment, the Second Omnibus Amendment and the Third Omnibus Amendment, as such agreement may be further amended, restated, supplemented or otherwise modified
from time to time in accordance with its terms. 
 (d) The definition of “Sale Agreement” in Section 1.01 of the Contribution
Agreement is hereby amended and restated in its entirety to read as follows: 
 “Sale Agreement” means that
certain Receivables Sale Agreement dated as of the Closing Date, among the Originators, the Buyer and the Collection Agent, as amended by the First Omnibus Amendment, the Second Omnibus Amendment and the Third Omnibus Amendment, and as the same may
be further amended, restated, supplemented or otherwise modified from time to time in accordance with the terms thereof, together with all instruments, documents and agreements executed by any of the Originators in connection therewith, in each
case, as the same may be amended, restated, supplemented or otherwise modified from time to time in accordance with the terms thereof. 

(e) The definition of “Second Omnibus Amendment” in Section 1.01 of the Contribution Agreement is hereby amended and restated
in its entirety to read as follows: 
 “Second Omnibus Amendment” means that certain Second Omnibus
Amendment, made as of the Second Omnibus Amendment Effective Date, among 

  
 13 

 
the Company, as Borrower and as the Company, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed Lender, BTMU, as a Managing Agent and as a Committed Lender, Credit Agricole
Corporate and Investment Bank, as a Managing Agent, as a Committed Lender and as Administrative Agent, the Collection Agent, as Collection Agent under each of this Agreement, the Sale Agreement, and the Loan Agreement, and as Authorized
Representative (as defined in the Sale Agreement), CHS, as Transferor, as Buyer and individually (as a performance undertaking party), and each of the Originators party to the Sale Agreement as of the Second Omnibus Amendment Effective Date, as
Originators. 
 (f) The definition of “Supplemental Originators” in Section 1.01 of the Contribution Agreement is hereby
deleted. 
 (g) Clause (d) of Section 2.01 of the Contribution Agreement is hereby amended by deleting the last sentence thereof
and inserting in lieu thereof the following: 
 If at any time contrary to the mutual intent of the Transferor and the Company a court
characterizes the transactions hereunder as loans by the Company to the Transferor, then the Transferor shall, effective as of the Closing Date, be deemed to have granted (and the Transferor hereby does grant) to the Company a first priority
security interest in all of its right and title to and interest in all Purchased Property and the proceeds thereof as security for such loans advanced to the Transferor hereunder with accrued interest thereon, and this Agreement shall be deemed to
be a security agreement. 
 (h) Clause (j) of Section 4.01 of the Contribution Agreement is hereby amended by replacing the
reference to “Second Omnibus Amendment Effective Date” appearing in such section with “Third Omnibus Amendment Effective Date”. 

(i) The proviso set forth at the end of clause (x) of Section 4.01 of the Contribution Agreement is hereby amended by adding the
following language before the period at the end thereof: 
 and, if such violation is cured within such 15 day period, the cure of such
violation shall be effective to cure any breach of any covenant, representation or warranty by the Transferor under any Facility Document directly related to or directly arising from such violation without any further action 

(j) The proviso set forth at the end of clause (i) of Section 5.01 of the Contribution Agreement is hereby amended by adding the
following language before the period at the end thereof: 
 and, if such violation is cured within such 15 day period, the cure of such
violation shall be effective to cure any breach of any covenant, representation or warranty by the Transferor under any Facility Document directly related to or directly arising from such violation without any further action 

  
 14 

 (k) The proviso set forth at the end of the second to last sentence of clause (b) of
Section 6.07 of the Contribution Agreement is hereby amended by adding the following language before the period at the end thereof: 

and, if such violation is cured within such 15 day period, the cure of such violation shall be effective to cure any breach of any
covenant, representation or warranty by the Transferor, the Company or the Collection Agent under any Facility Document directly related to or directly arising from such violation without any further action 

SECTION 5. Amendments to Sale Agreement. Subject to all of the terms and conditions set forth in this Amendment: 

(a) Section 1.01 of the Sale Agreement is amended as by inserting the following definitions in the appropriate alphabetical order: 

“Third Omnibus Amendment” means that certain Third Omnibus Amendment, made as of the Third Omnibus Amendment
Effective Date, among the Company, as Borrower and as the Company, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed Lender, BTMU, as a Managing Agent and as a Committed Lender, Credit Agricole Corporate and Investment Bank, as a
Managing Agent, as a Committed Lender and as Administrative Agent, the Collection Agent, as Collection Agent under each of this Agreement, the Contribution Agreement, and the Loan Agreement, and as Authorized Representative, CHS, as Transferor, as
Buyer and individually (as a performance undertaking party), each of the Originators party to this Agreement as of the Third Omnibus Amendment Effective Date, as Originators, and such other parties as are named therein. 

“Third Omnibus Amendment Effective Date” means March 31, 2014. 

(b) The definition of “Collection Account Bank” in Section 1.01 of the Sale Agreement is hereby amended and restated in its
entirety to read as follows: 
 “Collection Account Bank” means a bank or other financial institution
holding one or more Collection Accounts, which on the Closing Date shall be Bank of America, N.A., and on both the Second Omnibus Amendment Effective Date and Third Omnibus Amendment Effective Date shall be Bank of America, N.A., or Fifth Third
Bank, as context requires. 
 (c) The definition of “Contribution Agreement” in Section 1.01 of the Sale Agreement is hereby
amended and restated in its entirety to read as follows: 
 “Contribution Agreement” means that certain
Receivables Purchase and Contribution Agreement dated as of the Closing Date, among the Transferor, the Company and the Collection Agent, as amended by the First Omnibus Amendment, the Second Omnibus Amendment, and the Third Omnibus

  
 15 

 
Amendment, and as the same may be further amended, restated, supplemented or otherwise modified from time to time in accordance with the terms thereof and hereof, together with all instruments,
documents and agreements executed by any of the CHS Parties party thereto in connection therewith, in each case, as the same may be amended, restated, supplemented or otherwise modified from time to time in accordance with the terms thereof and
hereof. 
 (d) The definition of “Originator Notes” in Section 1.01 of the Sale Agreement is hereby amended and restated in
its entirety to read as follows: 
 “Originator Notes” means the subordinated promissory notes, each of
which is (i) payable to the Authorized Representative as the paying agent for one or more Originators and (ii) is substantially in the form of Exhibit B attached hereto, as each such note may be amended, restated, supplemented or
otherwise modified from time to time in accordance with its terms and the terms hereof. 
 (e) The definition of “Second Omnibus
Amendment” in Section 1.01 of the Sale Agreement is hereby amended and restated in its entirety to read as follows: 

“Second Omnibus Amendment” means that certain Second Omnibus Amendment, made as of the Second Omnibus
Amendment Effective Date, among the Company, as Borrower and as the Company, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed Lender, BTMU, as a Managing Agent and as a Committed Lender, Credit Agricole Corporate and Investment
Bank, as a Managing Agent, as a Committed Lender and as Administrative Agent, the Collection Agent, as Collection Agent under each of this Agreement, the Contribution Agreement, and the Loan Agreement, and as Authorized Representative, CHS, as
Transferor, as Buyer and individually (as a performance undertaking party), and each of the Originators party to this Agreement as of the Second Omnibus Amendment Effective Date, as Originators. 

(f) The definition of “Specified Originators” in Section 1.01 of the Sale Agreement is hereby amended and restated in its
entirety to read as follows: 
 “Specified Originators” means the Originators listed on
Schedule V, which Schedule also sets forth the percentage ownership of the issued and outstanding equity interests of each such Originator that is held by CHS and its subsidiaries as of the Third Omnibus Amendment Effective Date. 

(g) The definition of “Supplemental Originators” in Section 1.01 of the Sale Agreement is hereby deleted. 

(h) Clause (d) of Section 2.01 of the Sale Agreement is hereby amended by deleting the last sentence thereof and inserting in lieu
thereof the following: 
 If at any time contrary to the mutual intent of the Originators and the Buyer a court characterizes the
transactions hereunder as loans by the Buyer to the 

  
 16 

 
Originators, then each of the Originators shall, effective as of the Closing Date (with respect to Initial Originators) or effective as of the date of such Originator’s Addition (with
respect to Originators added as additional Originators hereunder after the Closing Date), be deemed to have granted (and each Originator hereby does grant) to the Buyer a first priority security interest in all of its right and title to and interest
in all Purchased Property and the proceeds thereof as security for such loans and for the repayment of all amounts advanced to the Originators hereunder with accrued interest thereon, and this Agreement shall be deemed to be a security agreement.

 (i) Clause (j) of Section 4.01 of the Sale Agreement is hereby amended by replacing the reference to “Second Omnibus
Amendment Effective Date” appearing in such section with “Third Omnibus Amendment Effective Date”. 
 (j) The proviso set
forth at the end of clause (x) of Section 4.01 of the Sale Agreement is hereby amended by adding the following language before the period at the end thereof: 

and, if such violation is cured within such 15 day period, the cure of such violation shall be effective to cure any breach of any
covenant, representation or warranty by any Originator under any Facility Document directly related to or directly arising from such violation without any further action. 

(k) The proviso set forth at the end of clause (l) of Section 5.01 of the Sale Agreement is hereby amended by adding the following
language before the period at the end thereof: 
 and, if such violation is cured within such 15 day period, the cure of such violation
shall be effective to cure any breach of any covenant, representation or warranty by any Originator under any Facility Document directly related to or directly arising from such violation without any further action. 

(l) The proviso set forth at the end of the second to last sentence of clause (b) of Section 6.07 of the Sale Agreement is hereby
amended by adding the following language before the period at the end thereof: 
 and, if such violation is cured within such 15 day
period, the cure of such violation shall be effective to cure any breach of any covenant, representation or warranty by any Originator or the Collection Agent under any Facility Document directly related to or directly arising from such violation
without any further action. 
 (m) Schedule I of the Sale Agreement is hereby replaced with the Schedule I attached hereto as
Annex D. 
 (n) Schedule III of the Sale Agreement is hereby replaced with the Schedule III attached hereto as
Annex E. 

  
 17 

 (o) Schedule V of the Sale Agreement is hereby replaced with the Schedule V attached
hereto as Annex F. 
 SECTION 6. Conditions to Effectiveness. This Amendment shall become effective upon the date
(the “Amendment Effective Date”) on which the following conditions have been satisfied (in form and substance reasonably acceptable to the Administrative Agent): 

(a) The Administrative Agent shall have received counterparts of this Amendment duly executed by each of the Borrower, the Company, the
Collection Agent (as Collection Agent under each of the Receivables Loan Agreement, the Contribution Agreement, and the Sale Agreement), the Authorized Representative, the Transferor, the Buyer, CHS individually, the Existing Originators (including
the Removed Originator, as Removed Originator), the Supplemental Originators, the Managing Agents, the Committed Lenders, the Conduit Lenders and the Administrative Agent. 

(b) The Administrative Agent shall have received the items listed in Schedule II. 

(c) All fees and expenses required to be paid prior to an Advance under the Receivables Loan Agreement (as amended by this Amendment) pursuant
to (i) the Receivables Loan Agreement (as amended by this Amendment) and (ii) the Fee Letter (as amended and restated on the date hereof) shall have been paid. 

(d) Each Managing Agent and the Administrative Agent shall have completed satisfactory due diligence and obtained the requisite credit
approvals. 
 SECTION 7. Representations and Warranties. 

(a) Each of the CHS Parties represents and warrants as of the date hereof that (i) it has taken all necessary action to authorize the
execution, delivery and performance of this Amendment and the performance of the Receivables Loan Agreement, Contribution Agreement, Sale Agreement and the other Facility Documents, each as amended hereby, and (ii) no consent, approval,
authorization or order of, or filing, registration or qualification with, any court or governmental authority or third party is required in connection with the execution, delivery or performance by such Person of this Amendment other than such as
has been met or obtained and are in full force and effect. 
 (b) Each of the CHS Parties represents and warrants as of the date hereof that
each of this Amendment and each Facility Document (as amended by this Amendment or otherwise as of the date hereof, as applicable) constitutes such Person’s legal, valid and binding obligation, enforceable against such person in accordance with
its terms, except as such enforceability may be subject to (A) bankruptcy, insolvency, reorganization, fraudulent conveyance or transfer, moratorium or similar laws affecting creditors’ rights generally and (B) general principles of
equity (regardless of whether such enforceability is considered in a proceeding at law or in equity). 
 (c) The Borrower hereby makes each
of the representations and warranties contained in Sections 4.01 and 4.03 of the Receivables Loan Agreement as of the date hereof, in each case after giving effect to this Amendment, except for those representations and warranties that refer to
specific dates, which are made as of the dates indicated therein. 

  
 18 

 (d) The Collection Agent hereby makes each of the representations and warranties contained in
Section 4.02 of the Receivables Loan Agreement as of the date hereof, in each case after giving effect to this Amendment, except for those representations and warranties that refer to specific dates, which are made as of the dates indicated
therein. 
 (e) Each of the Borrower and the Collection Agent further represents and warrants that, both before and after giving effect to
this Amendment, no event has occurred and is continuing which constitutes an Event of Default, or would, with the passage of time or the giving of notice, constitute an Event of Default. 

SECTION 8. Facility Document. This Amendment shall constitute a Facility Document under the terms of the Receivables Loan Agreement as
amended hereby. 
 SECTION 9. Further Assurances. The Borrower and the Collection Agent agree to promptly take such action, upon the
reasonable request of the Administrative Agent, as is necessary to carry out the intent of this Amendment. 
 SECTION 10. Confirmation of
Agreements. On and after the date hereof, all references to each of the Receivables Loan Agreement, the Contribution Agreement, and the Sale Agreement in the Facility Documents and the other documents and instruments delivered pursuant to or in
connection with such Facility Documents shall mean, respectively, (i) the Receivables Loan Agreement as amended by this Amendment, and as hereafter modified, amended or restated in accordance with its terms, (ii) the Contribution Agreement
as amended by this Amendment, and as hereafter modified, amended or restated in accordance with its terms, and (iii) the Sale Agreement as amended by this Amendment, and as hereafter modified, amended or restated in accordance with its terms.
Except as herein expressly amended, each of the Receivables Loan Agreement, the Contribution Agreement and the Sale Agreement are ratified and confirmed in all respects and shall remain in full force and effect in accordance with each
agreement’s respective terms. 
 SECTION 11. Confirmation of Undertaking. CHS, as undertaking party under the Collection Agent
Performance Undertaking, dated as of March 21, 2012 (as amended, restated, supplemented or otherwise modified prior to the date hereof, the “Performance Undertaking”), in favor of CA-CIB
as administrative agent on behalf of the Lenders, hereby consents to the amendments to (i) the Receivables Loan Agreement set forth in Section 3 of this Amendment, (ii) the Contribution Agreement set forth in Section 4 of this
Amendment, and (iii) the Sale Agreement set forth in Section 5 of this Amendment, and hereby confirms and agrees that, notwithstanding the effectiveness of this Amendment, the Performance Undertaking heretofore executed and delivered by it
is, and shall continue to be, in full force and effect in accordance with its terms and shall apply to the Receivables Loan Agreement, Contribution Agreement and Sale Agreement, each as amended by this Amendment, and the Performance Undertaking is
hereby so ratified and confirmed. 
 SECTION 12. GOVERNING LAW. THIS AMENDMENT SHALL, IN ACCORDANCE WITH SECTION 5-1401 OF THE GENERAL OBLIGATIONS LAW OF 

  
 19 

 
THE STATE OF NEW YORK, BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. EACH OF THE PARTIES HERETO HEREBY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE
AND FEDERAL COURTS OF THE UNITED STATES AND THE NON-EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN NEW YORK COUNTY, NEW YORK IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AMENDMENT, ANY OTHER FACILITY DOCUMENT,
ANY OTHER DOCUMENT DELIVERED PURSUANT HERETO OR THERETO, OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH OF THE PARTIES HERETO HEREBY WAIVES ANY OBJECTION BASED ON FORUM NON CONVENIENS THE MAINTENANCE OF ANY SUCH ACTION OR PROCEEDING AND
CONSENTS TO THE GRANTING OF SUCH LEGAL OR EQUITABLE RELIEF AS IS DEEMED APPROPRIATE BY SUCH COURT. 
 SECTION 13. Execution in
Counterparts. This Amendment may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together shall
constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Amendment by facsimile or by electronic mail in portable document format (pdf) shall be effective as delivery of a manually executed counterpart
of this Amendment. 
 SECTION 14. Severability of Provisions. Any provision of this Amendment which is prohibited or
unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof or affecting the validity or enforceability of such provision
in any other jurisdiction. 
 SECTION 15. Headings. Section headings used herein are for convenience of reference only, are not
part of this Amendment and shall not affect the construction of, or be taken into consideration in interpreting, this Amendment. 

[Signature Pages Follow] 

  
 20 

 IN WITNESS WHEREOF, this Amendment has been duly executed as of the date first written above.

  

			
	 CHS RECEIVABLES FUNDING, LLC,
 as
Borrower and as Company

		
	By:	 	/s/ James W. Doucette
		 	 Name: James W. Doucette
 Title: Senior Vice
President and Treasurer

	
	 CHS Receivables Funding, LLC
 4000
Meridian Boulevard
 Franklin, Tennessee 37067
 Attention:
Rachel A. Seifert
 Telephone No: (615) 465-7000
 Facsimile
No: (615) 373-9704
 Email: rachel_seifert@chs.net

	
	 COMMUNITY HEALTH SYSTEMS PROFESSIONAL SERVICES CORPORATION,

as Collection Agent under each of the Receivables Loan Agreement, Contribution Agreement and Sale Agreement and as Authorized Representative

		
	By: 	 	/s/ James W. Doucette
		 	 Name: James W. Doucette
 Title: Senior Vice
President and Treasurer

	
	 Community Health Systems Professional Services Corporation

4000 Meridian Boulevard
 Franklin, Tennessee 37067

Attention: Rachel A. Seifert
 Telephone No:
(615) 465-7000
 Facsimile No: (615) 373-9704
 Email:
rachel_seifert@chs.net

  
 Signature Page to Third
Omnibus Amendment 

 
			
	 CHS/COMMUNITY HEALTH SYSTEMS, INC.,

as Transferor, as Buyer and individually

		
	By:	 	/s/ James W. Doucette
		 	 Name: James W. Doucette
 Title: Senior Vice
President and Treasurer

  
 Signature Page to Third
Omnibus Amendment 

 
			
	 CRÉDIT AGRICOLE CORPORATE AND INVESTMENT BANK, as Administrative Agent,

as a Managing Agent and as a Committed Lender

		
	By:	 	/s/ Konstantina Kourmpetis
		 	 Name: Konstantina Kourmpetis
 Title: Managing
Director

		
	By:	 	/s/ Sam Pilcer
		 	 Name: Sam Pilcer

Title: Managing Director

	
	 Crédit Agricole CIB
 1301
Avenue of the Americas
 New York, NY 10019
 Attention: Roman
Burt
 Telephone No: (212) 261-3996
 Facsimile No:
(917) 849-5584
 Email: roman.burt@ca-cib.com

	
	 ATLANTIC ASSET SECURITIZATION LLC,

as a Conduit Lender

		
	By:	 	 CRÉDIT AGRICOLE CORPORATE AND
 INVESTMENT
BANK, as attorney-in-fact

		
	By:	 	/s/ Konstantina Kourmpetis
		 	 Name: Konstantina Kourmpetis
 Title: Managing
Director

		
	By:	 	/s/ Sam Pilcer
		 	 Name: Sam Pilcer
 Title: Managing
Director

	
	 Atlantic Asset Securitization
 c/o
Crédit Agricole CIB
 1301 Avenue of the Americas
 New
York, NY 10019
 Attention: Roman Burt
 Telephone No:
(212) 261-3996
 Facsimile No: (917) 849-5584
 Email:
roman.burt@ca-cib.com

  
 Signature Page to Third
Omnibus Amendment 

 
			
	 THE BANK OF NOVA SCOTIA, as a Managing

Agent and as a Committed Lender

		
	By:	 	/s/ John Frazell
		 	 Name: John Frazell
 Title:
Director

  

			
	 LIBERTY STREET FUNDING LLC,
 as a
Conduit Lender

		
	By:	 	/s/ Jill A. Russo
		 	 Name: Jill A. Russo
 Title: Vice
President

  
 Signature Page to Third
Omnibus Amendment 

 
			
	 THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.,

as a Managing Agent

		
	By:	 	/s/ Luna Mills
		 	 Name: Luna Mills
 Title:
Director

	
	 THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.,

as a Committed Lender

		
	By:	 	/s/ B. McNany
		 	 Name: B. McNany
 Title: Vice
President

	
	 VICTORY RECEIVABLES CORPORATION,
 as
a Conduit Lender

		
	By:	 	/s/ David V. DeAngelis
		 	 Name: David V. DeAngelis
 Title: Vice
President

  
 Signature Page to Third
Omnibus Amendment 

 
			
	 ORIGINATORS:
  

AFFINITY HOSPITAL, LLC
 BERWICK HOSPITAL COMPANY, LLC

BLUEFIELD HOSPITAL COMPANY, LLC
 BLUFFTON HEALTH SYSTEM LLC

BULLHEAD CITY HOSPITAL CORPORATION
 CARLSBAD MEDICAL CENTER,
LLC
 CLEVELAND TENNESSEE HOSPITAL COMPANY, LLC
 COATESVILLE
HOSPITAL CORPORATION
 CRESTVIEW HOSPITAL CORPORATION
 DEACONESS
HEALTH SYSTEM, LLC
 DHSC, LLC
 DUKES HEALTH SYSTEM, LLC

DYERSBURG HOSPITAL CORPORATION
 EMPORIA HOSPITAL CORPORATION

FOLEY HOSPITAL CORPORATION
 FRANKLIN HOSPITAL CORPORATION

GADSDEN REGIONAL MEDICAL CENTER, LLC
 GALESBURG HOSPITAL
CORPORATION
 GRANBURY HOSPITAL CORPORATION
 GRANITE CITY
ILLINOIS HOSPITAL COMPANY, LLC
 GREENBRIER VMC, LLC
 HOSPITAL
OF MORRISTOWN, INC.
 JACKSON, TENNESSEE HOSPITAL COMPANY, LLC

JOURDANTON HOSPITAL CORPORATION
 KAY COUNTY OKLAHOMA HOSPITAL
COMPANY, LLC

		
	By:	 	/s/ James W. Doucette
		 	 Name: James W. Doucette
 Title: Senior Vice
President and Treasurer

  
 Signature Page to Third
Omnibus Amendment 

 
			
	 ORIGINATORS (CONT.):
  

LAKE WALES HOSPITAL CORPORATION
 LANCASTER HOSPITAL
CORPORATION
 LAS CRUCES MEDICAL CENTER, LLC
 LEA REGIONAL
HOSPITAL, LLC
 MARTIN HOSPITAL CORPORATION
 MARY BLACK HEALTH
SYSTEM LLC
 MCKENZIE-WILLAMETTE REGIONAL MEDICAL CENTER ASSOCIATES, LLC

MCNAIRY HOSPITAL CORPORATION MCSA, L.L.C.
 MOBERLY HOSPITAL
COMPANY, LLC
 NATIONAL HEALTHCARE OF LEESVILLE, INC. NATIONAL HEALTHCARE OF MT. VERNON, INC.

NORTHAMPTON HOSPITAL COMPANY, LLC
 NORTHWEST HOSPITAL, LLC

ORO VALLEY HOSPITAL, LLC
 PAYSON HOSPITAL CORPORATION

PETERSBURG HOSPITAL COMPANY, LLC
 PHOENIXVILLE HOSPITAL COMPANY,
LLC
 POTTSTOWN HOSPITAL COMPANY, LLC
 PORTER HOSPITAL, LLC

QHG OF ENTERPRISE, INC.
 QHG OF SOUTH CAROLINA, INC.

ROSWELL HOSPITAL CORPORATION
 RUSTON LOUISIANA HOSPITAL
COMPANY, LLC

		
	By:	 	/s/ James W. Doucette
		 	 Name: James W. Doucette
 Title: Senior Vice
President and Treasurer

  
 Signature Page to Third
Omnibus Amendment 

 
			
	 ORIGINATORS (CONT.):
  

SAN MIGUEL HOSPITAL CORPORATION
 SCRANTON HOSPITAL COMPANY,
LLC
 SHELBYVILLE HOSPITAL CORPORATION
 SILOAM SPRINGS ARKANSAS
HOSPITAL COMPANY, LLC
 SPOKANE VALLEY WASHINGTON HOSPITAL COMPANY, LLC

SPOKANE WASHINGTON HOSPITAL COMPANY, LLC
 ST. JOSEPH HEALTH SYSTEM
LLC
 TOMBALL TEXAS HOSPITAL COMPANY, LLC
 TOOELE HOSPITAL
CORPORATION
 WARREN OHIO HOSPITAL COMPANY, LLC
 WARREN OHIO
REHAB HOSPITAL COMPANY, LLC
 WARSAW HEALTH SYSTEM LLC

WAUKEGAN ILLINOIS HOSPITAL COMPANY, LLC
 WEATHERFORD TEXAS
HOSPITAL COMPANY, LLC
 WESLEY HEALTH SYSTEM, LLC
 WEST
GROVE HOSPITAL COMPANY, LLC
 WILKES-BARRE HOSPITAL COMPANY, LLC

WOMEN & CHILDREN’S HOSPITAL, LLC
 YOUNGSTOWN OHIO
HOSPITAL COMPANY, LLC

		
	By:	 	/s/ James W. Doucette
		 	 Name: James W. Doucette
 Title: Senior Vice
President and Treasurer

  
 Signature Page to Third
Omnibus Amendment 

 
			
	 ORIGINATORS (CONT.):
  

ANNA HOSPITAL CORPORATION
 AUGUSTA HOSPITAL, LLC

BIG BEND HOSPITAL CORPORATION
 BIG SPRING HOSPITAL CORPORATION

BLUE RIDGE GEORGIA HOSPITAL COMPANY, LLC
 CENTRE HOSPITAL
CORPORATION
 CLINTON HOSPITAL CORPORATION
 DEMING HOSPITAL
CORPORATION
 EVANSTON HOSPITAL CORPORATION
 FALLBROOK HOSPITAL
CORPORATION
 FORREST CITY ARKANSAS HOSPITAL COMPANY, LLC
 FORT
PAYNE HOSPITAL CORPORATION
 GREENVILLE HOSPITAL CORPORATION HOSPITAL OF BARSTOW, INC.

HOSPITAL OF FULTON, INC.
 HOSPITAL OF LOUISA, INC.

KIRKSVILLE MISSOURI HOSPITAL COMPANY, LLC
 LEXINGTON HOSPITAL
CORPORATION
 LUTHERAN MUSCULOSKELETAL CENTER, LLC
 MARION
HOSPITAL CORPORATION
 MCKENZIE TENNESSEE HOSPITAL COMPANY, LLC

MMC OF NEVADA, LLC
 NATIONAL HEALTHCARE OF NEWPORT, INC.

OAK HILL HOSPITAL CORPORATION
 PHILLIPS HOSPITAL
CORPORATION

		
	By:	 	/s/ James W. Doucette
		 	 Name: James W. Doucette
 Title: Senior Vice
President and Treasurer

  
 Signature Page to Third
Omnibus Amendment 

 
			
	 ORIGINATORS (CONT.):
  

RED BUD ILLINOIS HOSPITAL COMPANY, LLC
 SALEM HOSPITAL
CORPORATION
 SCRANTON QUINCY HOSPITAL COMPANY, LLC

SUNBURY HOSPITAL COMPANY, LLC
 WATSONVILLE HOSPITAL
CORPORATION
 WILLIAMSTON HOSPITAL CORPORATION
 WOODWARD HEALTH
SYSTEM, LLC

		
	By:	 	/s/ James W. Doucette
		 	 Name: James W. Doucette
 Title: Senior Vice
President and Treasurer

  
 Signature Page to Third
Omnibus Amendment 

 
			
	 ORIGINATORS (CONT.):
  

BROWNWOOD HOSPITAL, L.P.

	By:	 	Brownwood Medical Center, LLC
	Its:	 	General Partner
		
	By:	 	/s/ James W. Doucette
		 	 Name: James W. Doucette
 Title: Senior Vice
President and Treasurer

	
	COLLEGE STATION HOSPITAL, L.P.
	By:	 	College Station Medical Center, LLC
	Its:	 	General Partner
		
	By:	 	/s/ James W. Doucette
		 	 Name: James W. Doucette
 Title: Senior Vice
President and Treasurer

	
	IOM HEALTH SYSTEM, L.P.
	By:	 	Lutheran Health Network Investors, LLC
	Its:	 	General Partner
		
	By:	 	/s/ James W. Doucette
		 	 Name: James W. Doucette
 Title: Senior Vice
President and Treasurer

  
 Signature Page to Third
Omnibus Amendment 

 
			
	 ORIGINATORS (CONT.):
  

LAREDO TEXAS HOSPITAL COMPANY, L.P.

	By:	 	Webb Hospital Corporation
	Its:	 	General Partner
		
	By:	 	/s/ James W. Doucette
		 	 Name: James W. Doucette
 Title: Senior Vice
President and Treasurer

	
	LONGVIEW MEDICAL CENTER, L.P.
	By:	 	Regional Hospital of Longview, LLC
	Its:	 	General Partner
		
	By:	 	/s/ James W. Doucette
		 	 Name: James W. Doucette
 Title: Senior Vice
President and Treasurer

	
	NAVARRO HOSPITAL, L.P.
	By:	 	Navarro Regional, LLC
	Its:	 	General Partner
		
	By:	 	/s/ James W. Doucette
		 	 Name: James W. Doucette
 Title: Senior Vice
President and Treasurer

  
 Signature Page to Third
Omnibus Amendment 

 
			
	 ORIGINATORS (CONT.):
  

PINEY WOODS HEALTHCARE SYSTEM, L.P.

	By:	 	Woodland Heights Medical Center, LLC
	Its:	 	General Partner
		
	By:	 	/s/ James W. Doucette
		 	 Name: James W. Doucette
 Title: Senior Vice
President and Treasurer

	
	REHAB HOSPITAL OF FORT WAYNE GENERAL PARTNERSHIP
	By:	 	Lutheran Health Network Investors, LLC
	Its:	 	General Partner
		
	By:	 	/s/ James W. Doucette
		 	 Name: James W. Doucette
 Title: Senior Vice
President and Treasurer

	
	SAN ANGELO HOSPITAL, L.P.
	By:	 	San Angelo Community Medical Center, LLC
	Its:	 	General Partner
		
	By:	 	/s/ James W. Doucette
		 	 Name: James W. Doucette
 Title: Senior Vice
President and Treasurer

	
	VICTORIA OF TEXAS, L.P.
	By:	 	Detar Hospital, LLC
	Its:	 	General Partner
		
	By:	 	/s/ James W. Doucette
		 	 Name: James W. Doucette
 Title: Senior Vice
President and Treasurer

  
 Signature Page to Third
Omnibus Amendment 

 
			
	 ORIGINATORS (CONT.):
  

ARMC, L.P.

	By:	 	Triad-ARMC, LLC
	Its:	 	General Partner
		
	By:	 	/s/ James W. Doucette
		 	 Name: James W. Doucette
 Title: Senior Vice
President and Treasurer

	
	CRESTWOOD HEALTHCARE, L.P.
	By:	 	Crestwood Hospital, LLC
	Its:	 	General Partner
		
	By:	 	/s/ James W. Doucette
		 	 Name: James W. Doucette
 Title: Senior Vice
President and Treasurer

  
 Signature Page to Third
Omnibus Amendment 

 
			
	 REMOVED ORIGINATOR:
  

NANTICOKE HOSPITAL COMPANY, LLC

		
	By:	 	/s/ James W. Doucette
		 	 Name: James W. Doucette
 Title: Senior Vice
President and Treasurer

  
 Signature Page to Third
Omnibus Amendment 

 Schedule I 

2014 Supplemental Originators 
  

							
	 Hospital Name
	  	 Legal Entity Name
	  	 Jurisdiction
	  	 Address

				
	Union County Hospital	  	Anna Hospital Corporation	  	IL	  	 517 North Main
 Anna, IL 62906

				
	Abilene Regional Medical Center	  	ARMC, L.P.	  	DE	  	 6250 Highway 83/84
 Abilene, TX
79606

				
	Trinity Hospital of Augusta	  	Augusta Hospital, LLC	  	DE	  	 2260 Wrightsboro Road
 Augusta, GA
30904

				
	Big Bend Regional Medical Center	  	Big Bend Hospital Corporation	  	TX	  	 2600 Highway 118 North
 Alpine, TX
79830

				
	Scenic Mountain Medical Center	  	Big Spring Hospital Corporation	  	TX	  	 1601 West Eleventh Place
 Big Spring, TX
79720

				
	Fannin Regional Hospital	  	Blue Ridge Georgia Hospital Company, LLC	  	DE	  	 2855 Old Highway 5, North
 Blue Ridge, GA
30513

				
	Cherokee Medical Center	  	Centre Hospital Corporation	  	AL	  	 400 Northwood Drive
 Centre, AL
35960

				
	Lock Haven Hospital	  	Clinton Hospital Corporation	  	PA	  	 24 Cree Drive
 Lock Haven, PA
17745

				
	Crestwood Medical Center	  	Crestwood Healthcare, L.P.	  	DE	  	 One Hospital Drive SW
 Huntsville, AL
35801

				
	Mimbres Memorial Hospital	  	Deming Hospital Corporation	  	NM	  	 900 W. Ash Street
 Deming, NM
88030

				
	Evanston Regional Hospital	  	Evanston Hospital Corporation	  	WY	  	 190 Arrowhead Drive
 Evanston, WY
82930

				
	Fallbrook Hospital	  	Fallbrook Hospital Corporation	  	DE	  	 624 East Elder
 Fallbrook, CA
92028

				
	Forrest City Medical Center	  	Forrest City Arkansas Hospital Company, LLC	  	AR	  	 1601 Newcastle Road
 Forrest City, AR
72335

  
 Schedules to Third
Omnibus Amendment 

							
	 Hospital Name
	  	 Legal Entity Name
	  	 Jurisdiction
	  	 Address

	DeKalb Regional Medical Center	  	Fort Payne Hospital Corporation	  	AL	  	 200 Medical Center Drive
 (P.O. Box 680778),

Fort Payne, AL 35968

				
	L.V. Stabler Memorial Hospital	  	Greenville Hospital Corporation	  	AL	  	 29 L.V. Stabler Drive
 Greenville, AL
36037

				
	Barstow Community Hospital	  	Hospital of Barstow, Inc.	  	DE	  	 820 East Mountain View Street
 Barstow, CA
92311

				
	Parkway Regional Hospital	  	Hospital of Fulton, Inc.	  	KY	  	 2000 Holiday Lane
 (P.O. Box 866)

Fulton, KY 42041

				
	Three Rivers Medical Center	  	Hospital of Louisa, Inc.	  	KY	  	 2483 Highway 644
 (P.O. Box 769)

Louisa, KY 41230

				
	Northeast Regional Medical Center	  	Kirksville Missouri Hospital Company, LLC	  	MO	  	 315 S. Osteopathy
 Kirksville, MO
63501

				
	Henderson County Community Hospital	  	Lexington Hospital Corporation	  	TN	  	 200 West Church St.
 Lexington, TN
38351

				
	The Orthopaedic Hospital of Lutheran Health Network	  	Lutheran Musculoskeletal Center, LLC	  	DE	  	 7952 W. Jefferson Blvd.
 Fort Wayne, IN
46804

				
	Heartland Regional Medical Center	  	Marion Hospital Corporation	  	IL	  	 3333 West DeYoung
 Marion, IL
62959

				
	McKenzie Regional Hospital	  	McKenzie Tennessee Hospital Company, LLC	  	DE	  	 161 Hospital Dr.
 McKenzie, TN
38201

				
	Mesa View Regional Hospital	  	MMC of Nevada, LLC	  	DE	  	 1299 Bertha Howe Avenue
 Mesquite, NV
89027

				
	Harris Hospital	  	National Healthcare of Newport, Inc.	  	DE	  	 1205 McLain
 Newport, AR 72112

				
	Plateau Medical Center	  	Oak Hill Hospital Corporation	  	WV	  	 430 Main Street
 Oak Hill, WV
25901

				
	Helena Regional Medical Center	  	Phillips Hospital Corporation	  	AR	  	 1801 Martin Luther King Drive
 (P.O. Box
788),
 Helena, AR 72342

  
 Schedules to Third
Omnibus Amendment 

							
	 Hospital Name
	  	 Legal Entity Name
	  	 Jurisdiction
	  	 Address

	Red Bud Regional Hospital	  	 Red Bud Illinois Hospital
 Company, LLC
	  	IL	  	 325 Spring Street
 Red Bud, IL
62278

				
	The Memorial Hospital of Salem County	  	Salem Hospital Corporation	  	NJ	  	 310 Woodstown Road
 Salem, NJ
08079

				
	Moses Taylor Hospital	  	Scranton Quincy Hospital Company, LLC	  	DE	  	 700 Quincy Ave.
 Scranton, PA
18510

				
	Sunbury Community Hospital	  	Sunbury Hospital Company, LLC	  	DE	  	 350 N. Eleventh Street
 (P. O. Box 737),

Sunbury, PA 17801

				
	Watsonville Community Hospital	  	Watsonville Hospital Corporation	  	DE	  	 75 Nielson Street
 Watsonville, CA
95076

				
	Martin General Hospital	  	Williamston Hospital Corporation	  	NC	  	 310 S. McCaskey Road
 Williamston, NC
27892

				
	Woodward Regional Hospital	  	Woodward Health System, LLC	  	DE	  	 900 17th Street
 Woodward, OK
73801

  
 Schedules to Third
Omnibus Amendment 

 Schedule II 

Condition Precedent Documents 

As required by Section 6 of the Amendment, each of the following items must be delivered to the Administrative Agent prior to the
effectiveness of the Amendment. Unless otherwise indicated, each of the documents below is dated as of March 31, 2014: 

Document/Action 
  

	1.	Amendment 

 Schedules to Amendment 

 

	 	Schedule I	Supplemental Originators 

  

	 	Schedule II	Condition Precedent Documents (Closing List) 

 Annexes to Amendment 

 

	 	Annex A	Form of Joinder Agreement 

  

	 	Annex B	Schedule I to Receivables Loan Agreement - Lenders 

  

	 	Annex C	Schedule VI to Receivables Loan Agreement - Specified Originators 

  

	 	Annex D	Schedule I to Sale Agreement - Originators 

  

	 	Annex E	Schedule III to Sale Agreement - Legal Name 

  

	 	Annex F	Schedule V to Sale Agreement - Specified Originators 

  

	2.	Originator Note for each Supplemental Originator that is a Specified Originator 

  

	3.	Second Amended and Restated Subordinated Note for Originators that are not Specified Originators 

  

	4.	Second Amended and Restated Deposit Account Notification Agreement (Government Healthcare Receivables) with Bank of America, N.A. 

  

	5.	Amended and Restated Deposit Account Notification Agreement (Government Healthcare Receivables) with Fifth Third Bank 

  

	6.	Joinder Agreement for Supplemental Originators 

  

	7.	Second Amended and Restated Fee Letter 

  

	8.	Officer’s Certificate of CHS concerning the requirements of Section 6.05(b)(ii) of the Parent Credit Agreement 

  

	9.	Officer’s Certificate of each of the Supplemental Originators certifying as to clauses (iii) and (v) of Section 9.14(a) of the Receivables Sale Agreement 

 

	10.	Officer’s Certificate of the Removed Originator pursuant to Section 9.14(b) of the Receivables Sale Agreement 

  
 Schedules to Third
Omnibus Amendment 

 Document/Action 
  

	11.	Secretary’s Certificate certifying and attaching (i) a copy of the certificate of incorporation or formation, as amended through the date hereof, certified by the applicable Secretary of State, (ii) a copy of the
operating agreement, by-laws or partnership agreement, as applicable, as amended through the date hereof, (iii) a copy of the resolutions adopted, (iv) the names and signatures of the officers authorized on its behalf to execute the agreements to be
delivered by it and (v) a copy of each good standing certificate and (if principal place of business is not the same as its jurisdiction of organization) certificates of foreign qualification from the applicable Secretary of State or other official,
dated as of a recent date (or, for any entity that is not a Supplemental Originator, certifying its good standing in its state of incorporation/organization, and its due qualification in every jurisdiction in which the nature of its business
requires it to be so qualified and the failure to do so could reasonably be expected to have a Material Adverse Effect), for each of: 

  

	 	(a)	Borrower 

  

	 	(b)	Collection Agent 

  

	 	(c)	Each of the Originators 

  

	 	(d)	CHS 

  

	12.	Opinion of Kirkland & Ellis LLP, counsel for the Borrower, Collection Agent, Originators (located in Delaware and Illinois), Nanticoke, CHS and Parent, as to existence and good standing, due authorization and
execution, non-contravention, governmental approvals, health care issues, enforceability and creation, perfection and priority of security interests 

  

	13.	Opinion of Kirkland & Ellis LLP, counsel for the Borrower, Collection Agent, Originators (located in Delaware and Illinois), Nanticoke, CHS and Parent, relating to issues of “true sale” (“first
step”) 

  

	14.	Opinion of Kirkland & Ellis LLP, counsel for the Borrower, Collection Agent, Originators (located in Delaware and Illinois), Nanticoke, CHS and Parent, relating to issues of “true sale” (“second
step”) 

  

	15.	Opinion of in-house counsel for Borrower, Collection Agent, Originators and CHS regarding additional corporate matters 

  

	16.	Opinion of Polsinelli Shughart PC, health care counsel for the Borrower, Collection Agent, Originators and CHS 

  

	17.	Opinion of Bradley Arant Boult Cummings LLP, Alabama local counsel for each of the Originators organized in such local counsel’s jurisdiction 

  
 Schedules to Third
Omnibus Amendment 

 Document/Action 
  

	18.	Opinion of Bradley Arant Boult Cummings LLP, Tennesee local counsel for each of the Originators organized in such local counsel’s jurisdiction 

 

	19.	Opinion of Liechty & McGinnis, LLP, Texas local counsel for each of the Originators organized in such local counsel’s jurisdiction 

 

	20.	Results of lien searches (including UCC and tax) from each of the relevant jurisdictions, dated as of a recent date, with respect to each of the Supplemental Originators 

 

	21.	Forms of UCC-1 Financing Statements (and UCC-3 Financing Statements as necessary) naming each Supplemental Originator, as debtor/seller, CHS, as secured party/purchaser, Borrower, as Assignee, and CA-CIB, as
Administrative Agent, as assignee of Borrower, which forms shall be filed on or prior to the Amendment Effective Date 

  

	22.	Forms of financing statements necessary to terminate or amend any financing statements filed in connection with the Parent Credit Agreement or any secured indenture covering the Receivables, Related Security or
Collections previously filed against CHS, any Existing Originator and any Supplemental Originator in such Person’s jurisdiction of organization, which forms shall be filed on or prior to the Amendment Effective Date 

 

	23.	Approval of Parent Credit Agreement Administrative Agent under Section 6.05(b)(ii) of the Parent Credit Agreement 

  

	24.	Bill of Sale between Borrower to CHS relating to receivables associated with Nanticoke Hospital Company, LLC 

  

	25.	Bill of Sale between CHS and Nanticoke Hospital Company, LLC relating to receivables associated with Nanticoke Hospital Company, LLC 

 

	26.	Delivery of the most recent monthly report on or before March 20, 2014 with respect to the February 2014 collection period 

  

	27.	Funding Request, dated March 28, 2014 (or such later date and at such later time than as provided in the Receivables Loan Agreement as may be approved by each Lender, in its respective sole discretion)

  

	28.	Second Amended and Restated Administrative Agent Fee Letter 

  

	29.	Payment of fees and expenses 

  
 Schedules to Third
Omnibus Amendment 

 Annex A 

FORM OF JOINDER AGREEMENT 
 This
JOINDER AGREEMENT, dated as of [            ], is made by each of the persons listed on Annex I hereto affiliated with CHS/Community Health Systems, Inc. (each a
“Supplemental Originator” and, jointly and severally, the “Supplemental Originators”), and Community Health Systems Professional Services Corporation, as Collection Agent and Authorized Representative, and
acknowledged and agreed by CHS/Community Health Systems, Inc., as Buyer, and Credit Agricole Corporate and Investment Bank, as Administrative Agent, and delivered pursuant to Section 9.14(a) of the Receivables Sale Agreement, dated as of
March 21, 2012, by Community Health Professional Services Corporation, as Collection Agent and Authorized Representative, CHS/Community Health Systems, Inc., as Buyer, and the Originators party thereto (as amended, restated, supplemented or
otherwise modified from time to time, the “Receivables Sale Agreement”). Capitalized terms used herein but not defined herein are used with the meanings given them in the Receivables Sale Agreement. 

PRELIMINARY STATEMENTS: 

WHEREAS, the parties to this Joinder Agreement wish to add the Supplemental Originators to the Receivables Sale Agreement in the manner
hereinafter set forth; and 
 WHEREAS, this Joinder Agreement is entered into pursuant to Section 9.14(a) of the Receivables Sale
Agreement. 
 NOW, THEREFORE, the parties hereto hereby agree as follows: 

By executing and delivering this Joinder Agreement, each Supplemental Originator, agrees to become, and upon satisfaction of the conditions
precedent contained in Section 9.14(a) of the Receivables Sale Agreement, does hereby become a party to the Receivables Sale Agreement as an Originator thereunder on the date hereof with the same force and effect as if originally named as an
Originator thereunder as of the date hereof. In furtherance of and without limiting the generality of the foregoing, each Supplemental Originator expressly assumes and agrees to be bound by all obligations and liabilities of an Originator
thereunder, including the obligation to sell Receivables, together with all of the Related Security relating to such Receivables and all Collections with respect to and other proceeds of such Receivables, in accordance with the terms thereof. 

Each of the undersigned Supplemental Originators hereby represents and warrants as to itself that, after giving effect to the supplementation
of the Schedules to the Receivables Sale Agreement as contemplated hereby, each of the representations and warranties contained in Article IV (Representations and Warranties) of the Receivables Sale Agreement applicable to it is true and correct on
and as the date hereof as if made on and as of such date. The information set forth in Annex II hereto is hereby added to the information set forth in Schedules I, III, and V of the Receivables Sale Agreement and such Schedules
shall be deemed to be supplemented by and with the information set forth in Annex II. 
 This Joinder Agreement shall be governed by
the laws of the State of New York. 

 This Joinder Agreement may be executed in any number of counterparts, each of which when so
executed shall be deemed to be an original and all of which when taken together shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page hereof by facsimile or by electronic mail attachment in portable
document format (.pdf) shall be effective as delivery of a manually executed counterpart of this Joinder Agreement. 
 [Signature pages
follow] 

 IN WITNESS WHEREOF, the undersigned have caused this Joinder Agreement to be duly executed and
delivered as of the date first above written. 
  

			
	 COLLECTION AGENT AND
 AUTHORIZED
REPRESENTATIVE:
  
 COMMUNITY HEALTH SYSTEMS

PROFESSIONAL SERVICES CORPORATION

		
	By:	 	 
	Name:
	Title:

  

			
	 SUPPLEMENTAL ORIGINATORS:
  

[SUPPLEMENTAL ORIGINATORS]

		
	By:	 	 
	Name:
	Title:

  
 [Signature Page to
Joinder Agreement] 

 Acknowledged and Agreed: 
  

			
	 BUYER:
  

CHS/COMMUNITY HEALTH SYSTEMS, INC.

		
	By:	 	 
		 	Name:
		 	Title:

 ADMINISTRATIVE AGENT: 
  

			
	 CRÉDIT AGRICOLE CORPORATE AND

INVESTMENT BANK

		
	By:	 	 
		 	Name:
		 	Title:

  

			
	By:	 	 
		 	Name:
		 	Title:

  
 [Signature Page to
Joinder Agreement] 

 ANNEX I 

Supplemental Originators 
  

							
	 Hospital Name
	  	 Legal Entity Name
	  	 Jurisdiction
	  	 Address

		  		  		  	
		  		  		  	

  
 Annexes to Third
Omnibus Amendment 

 ANNEX II 

Supplement to Schedules to Receivables Sale Agreement 

Schedule I: 
 Schedule III: 

Schedule V: 

  
 Annexes to Third
Omnibus Amendment 

 Annex B 

SCHEDULE I 
 LENDERS 

Commitments and Lender Groups 
  

									
	 Managing Agent
	  	 Conduit Lender,

if any
	  	 Committed Lender
	  	Committed Lender
Commitment	 
	 Credit Agricole Corporate and Investment Bank
	  	Atlantic Asset Securitization LLC	  	Credit Agricole Corporate and Investment Bank	  	$	270,000,000	  
	 The Bank of Nova Scotia
	  	Liberty Street Funding LLC	  	The Bank of Nova Scotia	  	$	180,000,000	  
	 The Bank of Tokyo-Mitsubishi UFJ, Ltd.
	  	Victory Receivables Corporation	  	The Bank of Tokyo-Mitsubishi UFJ, Ltd.	  	$	250,000,000	  

  
 Annexes to Third
Omnibus Amendment 

 Annex C 

SCHEDULE VI 
 SPECIFIED
ORIGINATORS 
  

					
	 Originator
	  	CHS %	 
	 1.      ARMC, L.P.
	  	 	87.58	  
	 2.      Augusta Hospital, LLC
	  	 	88.72	  
	 3.      Blue Ridge Georgia Hospital Company, LLC
	  	 	98.21	  
	 4.      Crestview Hospital Corporation
	  	 	96.5192	  
	 5.      Crestwood Healthcare, L.P.
	  	 	95.07	  
	 6.      Deaconess Health System, LLC
	  	 	97.168	  
	 7.      Greenbrier VMC, LLC
	  	 	96.0	  
	 8.      IOM Health System, L.P.
	  	 	86.30	  
	 9.      Jackson, Tennessee Hospital Company, LLC
	  	 	96.94	  
	 10.    Kirksville Missouri Hospital Co., LLC
	  	 	88.10	  
	 11.    Lake Wales Hospital Corporation
	  	 	94.7988	  
	 12.    Laredo Texas Hospital Company, L.P.
	  	 	95.012	  
	 13.    Lutheran Musculoskeletal Center, LLC
	  	 	60.00	  
	 14.    Mary Black Health System LLC
	  	 	98.1337	  
	 15.    McKenzie-Willamette Regional Medical Center Associates, LLC
	  	 	90.5	  
	 16.    Petersburg Hospital Company, LLC
	  	 	99.3	  
	 17.    Piney Woods Healthcare System, L.P.
	  	 	91.7823	  
	 18.    Porter Hospital, LLC
	  	 	91.17	  
	 19.    Rehab Hospital of Fort Wayne General Partnership
	  	 	86.30	  
	 20.    San Angelo Hospital, L.P.
	  	 	94.771	  
	 21.    St. Joseph Health System LLC
	  	 	86.30	  
	 22.    Sunbury Hospital Company, LLC
	  	 	73.26	  
	 23.    Warsaw Health System LLC
	  	 	99.07	  

  
 Annexes to Third
Omnibus Amendment 

 Annex D 

SCHEDULE I 
 ORIGINATORS 

 

	1.	Affinity Hospital, LLC 

  

	2.	Anna Hospital Corporation 

  

	3.	ARMC, L.P. 

  

	4.	Augusta Hospital, LLC 

  

	5.	Berwick Hospital Company, LLC 

  

	6.	Big Bend Hospital Corporation 

  

	7.	Big Spring Hospital Corporation 

  

	8.	Blue Ridge Georgia Hospital Company, LLC 

  

	9.	Bluefield Hospital Company, LLC 

  

	10.	Bluffton Health System LLC 

  

	11.	Brownwood Hospital, L.P. 

  

	12.	Bullhead City Hospital Corporation 

  

	13.	Carlsbad Medical Center, LLC 

  

	14.	Centre Hospital Corporation 

  

	15.	Cleveland Tennessee Hospital Company, LLC 

  

	16.	Clinton Hospital Corporation 

  

	17.	Coatesville Hospital Corporation 

  

	18.	College Station Hospital, L.P. 

  

	19.	Crestview Hospital Corporation 

  

	20.	Crestwood Healthcare, L.P. 

  

	21.	Deaconess Health System, LLC 

  

	22.	Deming Hospital Corporation 

  

	23.	DHSC, LLC 

  

	24.	Dukes Health System, LLC 

  

	25.	Dyersburg Hospital Corporation 

  

	26.	Emporia Hospital Corporation 

  

	27.	Evanston Hospital Corporation 

  

	28.	Fallbrook Hospital Corporation 

  
 Annexes to Third
Omnibus Amendment 

	29.	Foley Hospital Corporation 

  

	30.	Forrest City Arkansas Hospital Company, LLC 

  

	31.	Fort Payne Hospital Corporation 

  

	32.	Franklin Hospital Corporation 

  

	33.	Gadsden Regional Medical Center, LLC 

  

	34.	Galesburg Hospital Corporation 

  

	35.	Granbury Hospital Corporation 

  

	36.	Granite City Illinois Hospital Company, LLC 

  

	37.	Greenbrier VMC, LLC 

  

	38.	Greenville Hospital Corporation 

  

	39.	Hospital of Barstow, Inc. 

  

	40.	Hospital of Fulton, Inc. 

  

	41.	Hospital of Louisa, Inc. 

  

	42.	Hospital of Morristown, Inc. 

  

	43.	IOM Health System, L.P. 

  

	44.	Jackson, Tennessee Hospital Company, LLC 

  

	45.	Jourdanton Hospital Corporation 

  

	46.	Kay County Oklahoma Hospital Company, LLC 

  

	47.	Kirksville Missouri Hospital Company, LLC 

  

	48.	Lake Wales Hospital Corporation 

  

	49.	Lancaster Hospital Corporation 

  

	50.	Laredo Texas Hospital Company, L.P. 

  

	51.	Las Cruces Medical Center, LLC 

  

	52.	Lea Regional Hospital, LLC 

  

	53.	Lexington Hospital Corporation 

  

	54.	Longview Medical Center, L.P. 

  

	55.	Lutheran Musculoskeletal Center, LLC 

  

	56.	Marion Hospital Corporation 

  

	57.	Martin Hospital Corporation 

  

	58.	Mary Black Health System LLC 

  

	59.	McKenzie Tennessee Hospital Company, LLC 

  

	60.	McKenzie-Willamette Regional Medical Center Associates, LLC 

  

	61.	McNairy Hospital Corporation 

  

	62.	MCSA, L.L.C. 

  
 Annexes to Third
Omnibus Amendment 

	63.	MMC of Nevada, LLC 

  

	64.	Moberly Hospital Company, LLC 

  

	65.	National Healthcare of Leesville, Inc. 

  

	66.	National Healthcare of Mt. Vernon, Inc. 

  

	67.	National Healthcare of Newport, Inc. 

  

	68.	Navarro Hospital, L.P. 

  

	69.	Northampton Hospital Company, LLC 

  

	70.	Northwest Hospital, LLC 

  

	71.	Oak Hill Hospital Corporation 

  

	72.	Oro Valley Hospital, LLC 

  

	73.	Payson Hospital Corporation 

  

	74.	Petersburg Hospital Company, LLC 

  

	75.	Phillips Hospital Corporation 

  

	76.	Phoenixville Hospital Company, LLC 

  

	77.	Piney Woods Healthcare System, L.P. 

  

	78.	Porter Hospital, LLC 

  

	79.	Pottstown Hospital Company, LLC 

  

	80.	QHG of Enterprise, Inc. 

  

	81.	QHG of South Carolina, Inc. 

  

	82.	Red Bud Illinois Hospital Company, LLC 

  

	83.	Rehab Hospital of Fort Wayne General Partnership 

  

	84.	Roswell Hospital Corporation 

  

	85.	Ruston Louisiana Hospital Company, LLC 

  

	86.	Salem Hospital Corporation 

  

	87.	San Angelo Hospital, L.P. 

  

	88.	San Miguel Hospital Corporation 

  

	89.	Scranton Hospital Company, LLC 

  

	90.	Scranton Quincy Hospital Company, LLC 

  

	91.	Shelbyville Hospital Corporation 

  

	92.	Siloam Springs Arkansas Hospital Company, LLC 

  

	93.	Spokane Valley Washington Hospital Company, LLC 

  

	94.	Spokane Washington Hospital Company, LLC 

  

	95.	St. Joseph Health System LLC 

  

	96.	Sunbury Hospital Company, LLC 

  

	97.	Tomball Texas Hospital Company, LLC 

  
 Annexes to Third
Omnibus Amendment 

	98.	Tooele Hospital Corporation 

  

	99.	Victoria of Texas, L.P. 

  

	100.	Warren Ohio Hospital Company, LLC 

  

	101.	Warren Ohio Rehab Hospital Company, LLC 

  

	102.	Warsaw Health System LLC 

  

	103.	Watsonville Hospital Corporation 

  

	104.	Waukegan Illinois Hospital Company, LLC 

  

	105.	Weatherford Texas Hospital Company, LLC 

  

	106.	Wesley Health System LLC 

  

	107.	West Grove Hospital Company, LLC 

  

	108.	Wilkes-Barre Hospital Company, LLC 

  

	109.	Williamston Hospital Corporation 

  

	110.	Women & Children’s Hospital, LLC 

  

	111.	Woodward Health System, LLC 

  

	112.	Youngstown Ohio Hospital Company, LLC 

  
 Annexes to Third
Omnibus Amendment 

 Annex E 

SCHEDULE III 
 LEGAL NAME,
JURISDICTION OF ORGANIZATION, 
 ORGANIZATIONAL ID NUMBER, PRINCIPAL PLACE OF BUSINESS, 

CHIEF EXECUTIVE OFFICE, LOCATION OF RECORDS AND REGISTERED NAMES 

The chief executive office of each Originator is 4000 Meridian Blvd., Franklin, TN 37067. 

Each Originator keeps its Records at such Originator’s principal place of business, as well as at its chief executive office. 

The legal name, jurisdiction of organization, organization ID number and principal place of business for each Originator are as follows: 

 

									
	 	  	 Legal Name
	  	Jurisdiction
of
Organization	  	Organization
ID #	  	 Principal Place of Business

	  1.	  	Affinity Hospital, LLC	  	DE	  	4023245	  	 800 Montclair Rd,
 Birmingham, AL
35213

	  2.	  	Anna Hospital Corporation	  	IL	  	61552979	  	 517 North Main
 Anna, IL 62906

	  3.	  	ARMC, L.P.	  	DE	  	3561898	  	 6250 Highway 83/84
 Abilene, TX
79606

	  4.	  	Augusta Hospital, LLC	  	DE	  	4180037	  	 2260 Wrightsboro Road
 Augusta, GA
30904

	  5.	  	Berwick Hospital Company, LLC	  	DE	  	4447833	  	 701 E. 16th St,
 Berwick, PA 18603

	  6.	  	Big Bend Hospital Corporation	  	TX	  	0145339600	  	 2600 Highway 118 North
 Alpine, TX
79830

	  7.	  	Big Spring Hospital Corporation	  	TX	  	0133735500	  	 1601 West Eleventh Place
 Big Spring, TX
79720

	  8.	  	Blue Ridge Georgia Hospital Company, LLC	  	DE	  	4782030	  	 2855 Old Highway 5, North
 Blue Ridge, GA
30513

	  9.	  	 Bluefield Hospital Company, LLC
	  	DE	  	4812810	  	 500 Cherry St,
 Bluefield, WV
24701

  
 Annexes to Third
Omnibus Amendment 

									
	 	  	 Legal Name
	  	Jurisdiction
of
Organization	  	Organization
ID #	  	 Principal Place of Business

	10.	  	Bluffton Health System, LLC	  	DE	  	3089523	  	 303 S. Main Street,
 Bluffton, IN
46714

	11.	  	 Brownwood Hospital, L.P.
	  	DE	  	2967928	  	 1501 Burnet Dr.,
 Brownwood, TX
76801

	12.	  	 Bullhead City Hospital Corporation
	  	AZ	  	09397220	  	 2735 Silver Creek Rd,
 Bullhead City, AZ
86442

	13.	  	 Carlsbad Medical Center, LLC
	  	DE	  	2964276	  	 2430 W. Pierce,
 Carlsbad, NM
88220

	14.	  	 Centre Hospital Corporation
	  	AL	  	245-901	  	 400 Northwood Drive
 Centre, AL
35960

	15.	  	 Cleveland Tennessee Hospital Company, LLC
	  	DE	  	4589625	  	 2305 Chambliss Ave,
 Cleveland, TN
37311

	16.	  	 Clinton Hospital Corporation
	  	PA	  	3049114	  	 24 Cree Drive
 Lock Haven, PA
17745

	17.	  	 Coatesville Hospital Corporation
	  	PA	  	2987105	  	 201 Reeceville Rd,
 Coatesville, PA
19320

	18.	  	 College Station Hospital, L.P.
	  	DE	  	2967943	  	 1604 Rock Prairie,
 College Station, TX
77845

	19.	  	 Crestview Hospital Corporation
	  	FL	  	P93000087326	  	 151 Redstone Ave, S.E.,
 Crestview, FL
32539

	20.	  	 Crestwood Healthcare, L.P.
	  	DE	  	2616459	  	 One Hospital Drive SW
 Huntsville, AL
35801

	21.	  	 Deaconess Health System, LLC
	  	DE	  	3918793	  	 5501 N. Portland Ave,
 Oklahoma City, OK
73112

	22.	  	 Deming Hospital Corporation
	  	NM	  	1773365	  	 900 W. Ash Street
 Deming, NM
88030

	23.	  	 DHSC, LLC
	  	DE	  	3973263	  	875 Eighth Street, N.E. (P.O. Box 805), Massillon, OH 44648
	24.	  	 Dukes Health System, LLC
	  	DE	  	3575662	  	 275 West 12th Street,
 Peru, IN
46970

	25.	  	 Dyersburg Hospital Corporation
	  	TN	  	435828	  	 400 Tickle St,
 Dyersburg, TN
38024

  
 Annexes to Third
Omnibus Amendment 

									
	  
	  	 Legal Name
	  	Jurisdiction
of
Organization	  	Organization
ID #	  	 Principal Place of Business

	26.	  	Emporia Hospital Corporation	  	VA	  	0514489-4	  	 727 N. Main St,
 Emporia, VA 23847

	27.	  	 Evanston Hospital Corporation
	  	WY	  	1999-
000349020	  	 190 Arrowhead Drive
 Evanston, WY
82930

	28.	  	 Fallbrook Hospital Corporation
	  	DE	  	2921444	  	 624 East Elder
 Fallbrook, CA
92028

	29.	  	 Foley Hospital Corporation
	  	AL	  	208-366	  	 1613 N. McKenzie St,
 Foley, AL
36535

	30.	  	 Forrest City Arkansas Hospital Company, LLC
	  	AR	  	800076780	  	 1601 Newcastle Road
 Forrest City, AR
72335

	31.	  	 Fort Payne Hospital Corporation
	  	AL	  	245-903	  	 200 Medical Center Drive (P.O. Box 680778),

Fort Payne, AL 35968

	32.	  	 Franklin Hospital Corporation
	  	VA	  	0529059-8	  	 100 Fairview Dr.,
 Franklin, VA
23851

	33.	  	 Gadsden Regional Medical Center, LLC
	  	DE	  	4275573	  	 1007 Goodyear Ave,
 Gadsden, AL
35903

	34.	  	 Galesburg Hospital Corporation
	  	IL	  	63372153	  	 695 N. Kellogg St,
 Galesburg, IL
61401

	35.	  	 Granbury Hospital Corporation
	  	TX	  	0142527600	  	 1310 Paluxy Rd,
 Granbury, TX
76048

	36.	  	 Granite City Illinois Hospital Company, LLC
	  	IL	  	00585904	  	 2100 Madison Ave,
 Granite City, IL
62040

	37.	  	 Greenbrier VMC, LLC
	  	DE	  	3249745	  	 202 Maplewood Ave,
 Ronceverte, WV
24970

	38.	  	 Greenville Hospital Corporation
	  	AL	  	168-429	  	 29 L.V. Stabler Drive
 Greenville, AL
36037

	39.	  	 Hospital of Barstow, Inc.
	  	DE	  	2318485	  	 820 East Mountain View Street
 Barstow, CA
92311

	40.	  	 Hospital of Fulton, Inc.
	  	KY	  	0299733	  	 2000 Holiday Lane (P.O. Box 866)
 Fulton, KY
42041

	41.	  	 Hospital of Louisa, Inc.
	  	KY	  	0314079	  	 2483 Highway 644 (P.O. Box 769)
 Louisa, KY
41230

  
 Annexes to Third
Omnibus Amendment 

									
	 	  	 Legal Name
	  	Jurisdiction
of
Organization	  	Organization
ID #	  	 Principal Place of Business

	42.	  	 Hospital of Morristown, Inc.
	  	TN	  	264618	  	 726 McFarland St,
 Morristown, TN
37814

	43.	  	 IOM Health System, L.P.
	  	IN	  	LP95090037	  	 7950 W. Jefferson Blvd.,
 Fort Wayne, IN
46804

	44.	  	 Jackson, Tennessee Hospital Company, LLC
	  	TN	  	435835	  	 367 Hospital Blvd,
 Jackson, TN
38305

	45.	  	 Jourdanton Hospital Corporation
	  	TX	  	0800001865	  	 1905 Hwy 97 E.,
 Jourdanton, TX
78026

	46.	  	 Kay County Oklahoma Hospital Company, LLC
	  	OK	  	3512092198	  	 1900 North 14th Street,
 Ponca City, OK
74601

	47.	  	 Kirksville Missouri Hospital Co., LLC
	  	MO	  	LC0043450	  	 315 S. Osteopathy
 Kirksville, MO
63501

	48.	  	 Lake Wales Hospital Corporation
	  	FL	  	P02000099846	  	 410 S. 11th St,
 Lake Wales, FL
33853

	49.	  	 Lancaster Hospital Corporation
	  	DE	  	2436981	  	 800 W. Meeting Street,
 Lancaster, SC
29720

	50.	  	 Laredo Texas Hospital Company, L.P.
	  	TX	  	0800237874	  	 1700 E. Saunders,
 Laredo, TX
78041

	51.	  	 Las Cruces Medical Center, LLC
	  	DE	  	3306969	  	 4311 E. Lohman Ave,
 Las Cruces, NM
88011

	52.	  	 Lea Regional Hospital, LLC
	  	DE	  	2964402	  	 5419 N. Lovington Hwy,
 Hobbs, NM
88240

	53.	  	 Lexington Hospital Corporation
	  	TN	  	000435830	  	 200 West Church St.
 Lexington, TN
38351

	54.	  	 Longview Medical Center, L.P.
	  	DE	  	2964553	  	 2901 N. Fourth St,
 Longview, TX
75605

	55.	  	 Lutheran Musculoskeletal Center, LLC
	  	DE	  	4463811	  	 7952 W. Jefferson Blvd.
 Fort Wayne, IN
46804

	56.	  	 Marion Hospital Corporation
	  	IL	  	58955876	  	 3333 West DeYoung
 Marion, IL
62959

	57.	  	 Martin Hospital Corporation
	  	TN	  	435833	  	 161 Mt. Pelia Rd,
 Martin, TN
38237

  
 Annexes to Third
Omnibus Amendment 

									
	  
	  	 Legal Name
	  	Jurisdiction
of
Organization	  	Organization
ID #	  	 Principal Place of Business

	58.	  	 Mary Black Health System, LLC
	  	DE	  	2623318	  	 1700 Skylyn Dr,
 Spartanburg, SC
29307

	59.	  	 McKenzie Tennessee Hospital Company, LLC
	  	DE	  	4455045	  	 161 Hospital Dr.
 McKenzie, TN
38201

	60.	  	 McKenzie-Willamette Regional Medical Center Associates, LLC
	  	DE	  	3699827	  	 1460 G St,
 Springfield, OR 97477

	61.	  	 McNairy Hospital Corporation
	  	TN	  	435832	  	 705 Poplar Ave,
 Selmer, TN 38375

	62.	  	 MCSA, LLC
	  	AR	  	100129761	  	 700 W. Grove St,
 El Dorado, AR
71730

	63.	  	 MMC of Nevada, LLC
	  	DE	  	3540578	  	 1299 Bertha Howe Avenue
 Mesquite, NV
89027

	64.	  	 Moberly Hospital Company, LLC
	  	DE	  	4447851	  	 1515 Union Ave,
 Moberly, MO 65270

	65.	  	 National Healthcare of Leesville, Inc.
	  	DE	  	2101020	  	 1020 Fertitta Blvd,
 Leesville, LA
71446

	66.	  	 National Healthcare of Mt. Vernon, Inc.
	  	DE	  	2063507	  	 #8 Doctor’s Park Rd,
 Mt. Vernon, IL
62864

	67.	  	 National Healthcare of Newport, Inc.
	  	DE	  	2062708	  	 1205 McLain
 Newport, AR 72112

	68.	  	 Navarro Hospital, L.P.
	  	DE	  	2964396	  	 3201 W. Hwy 22,
 Corsicanna, TX
75110

	69.	  	 Northampton Hospital Company, LLC
	  	DE	  	4442353	  	 250 S. 21st,
 Easton, PA 18042

	70.	  	 Northwest Hospital, LLC
	  	DE	  	2964436	  	 6200 N. LaCholla Blvd,
 Tucson, AZ
85741

	71.	  	 Oak Hill Hospital Corporation
	  	WV	  	46241	  	 430 Main Street
 Oak Hill, WV
25901

	72.	  	 Oro Valley Hospital, LLC
	  	DE	  	3575660	  	 1551 E. Tangerine Rd,
 Oro Valley, AZ
85755

	73.	  	 Payson Hospital Corporation
	  	AZ	  	08080240	  	 807 S. Ponderosa,
 Payson, AZ
85541

	74.	  	 Petersburg Hospital Company, LLC
	  	VA	  	S096843-0	  	 200 Medical Park Blvd,
 Petersburg, VA
23805

  
 Annexes to Third
Omnibus Amendment 

									
	 	  	 Legal Name
	  	Jurisdiction
of
Organization	  	Organization
ID #	  	 Principal Place of Business

	75.	  	 Phillips Hospital Corporation
	  	AR	  	100208457	  	1801 Martin Luther King Drive (P.O. Box 788), Helena, AR 72342
	76.	  	 Phoenixville Hospital Company, LLC
	  	DE	  	3796044	  	 140 Nutt Rd,
 Phoenixville, PA
19460

	77.	  	 Piney Woods Healthcare System, L.P.
	  	DE	  	2964618	  	 505 S. John Redditt Dr,
 Lufkin, TX
75904

	78.	  	 Porter Hospital, LLC
	  	DE	  	4296736	  	 814 LaPorte Avenue,
 Valparaiso, IN
46383

	79.	  	 Pottstown Hospital Company, LLC
	  	DE	  	3657514	  	 1600 E. High St,
 Pottstown, PA
19464

	80.	  	 QHG of Enterprise, Inc.
	  	AL	  	176-166	  	 400 N. Edwards St,
 Enterprise, AL
36330

	81.	  	 QHG of South Carolina, Inc
	  	SC	  	N/A	  	 805 Pamplico Highway,
 Florence, SC 29505,

and
 2829 E Hwy 76,

Mullins, SC 295741

	82.	  	 Red Bud Illinois Hospital Company, LLC
	  	IL	  	00556424	  	 325 Spring Street
 Red Bud, IL
62278

	83.	  	 Rehab Hospital of Fort Wayne General Partnership
	  	DE	  	N/A	  	 7970 West Jefferson Blvd.,
 Fort Wayne, IN
46804

	84.	  	 Roswell Hospital Corporation
	  	NM	  	1913540	  	 405 West Country Club Road,
 Roswell, NM
88201

	85.	  	 Ruston Louisiana Hospital Company, LLC
	  	DE	  	4270657	  	 401 E. Vaughn Ave,
 Ruston, LA
71270

	86.	  	 Salem Hospital Corporation
	  	NJ	  	0100863665	  	 310 Woodstown Road
 Salem, NJ
08079

	87.	  	 San Angelo Hospital, L.P.
	  	DE	  	2964591	  	 3501 Knickerbocker Rd,
 San Angelo, TX
76904

  

	1 	These addresses represent the physical location of Carolinas Health System and Marion Regional Hospital, respectively. Records for Receivables are kept separately for each hospital at each of their respective physical
locations. 

  
 Annexes to Third
Omnibus Amendment 

									
	 	 	 Legal Name
	  	Jurisdiction
of
Organization	  	Organization
ID #	  	 Principal Place of Business

	88.	 	 San Miguel Hospital Corporation
	  	NM	  	2027670	  	 104 Legion Dr,
 Las Vegas, NM
87701

	89.	 	 Scranton Hospital Company, LLC
	  	DE	  	4927796	  	 746 Jefferson Avenue,
 Scranton, PA
18510

	90.	 	 Scranton Quincy Hospital Company, LLC
	  	DE	  	5005530	  	 700 Quincy Ave.
 Scranton, PA
18510

	91.	 	 Shelbyville Hospital Corporation
	  	TN	  	494640	  	 2835 Hwy 231 N.,
 Shelbyville, TN
37160

	92.	 	 Siloam Springs Arkansas Hospital Company, LLC
	  	DE	  	4617628	  	 205 E. Jefferson St,
 Siloam Springs, AR
72761

	93.	 	 Spokane Valley Washington Hospital Company, LLC
	  	DE	  	4447178	  	 12606 East Mission Avenue,
 Spokane Valley, WA
99216

	94.	 	 Spokane Washington Hospital Company, LLC
	  	DE	  	4436798	  	 800 W. 5th Avenue,
 Spokane, WA
99204

	95.	 	 St. Joseph Health System, LLC
	  	DE	  	2909376	  	 700 Broadway,
 Fort Wayne, IN
46802

	96.	 	 Sunbury Hospital Company, LLC
	  	DE	  	4442354	  	 350 N. Eleventh Street (P. O. Box 737),

Sunbury, PA 17801

	97.	 	 Tomball Texas Hospital Company, LLC
	  	DE	  	5017131	  	 605 Holderrieth,
 Tomball, TX
77375

	98.	 	 Tooele Hospital Corporation
	  	UT	  	1424668-
0142	  	 2055 N. Main,
 Tooele, UT 84074

	99.	 	 Victoria of Texas, L.P.
	  	DE	  	2949026	  	 101 Medical Dr,
 Victoria, TX 77904,

and
 506 E. San Antonio St.,

Victoria, TX 779012

	100.	 	 Warren Ohio Hospital Company, LLC
	  	DE	  	4856127	  	 1350 E. Market St.,
 Warren, OH
44484

  

	2 	These addresses represent the physical location of DeTar Hospital North, and DeTar Hospital Navarro, respectively. [Records for Receivables are kept separately for each hospital at each of their respective
physical locations.] 

  
 Annexes to Third
Omnibus Amendment 

									
	 	  	 Legal Name
	  	Jurisdiction
of
Organization	  	Organization
ID #	  	 Principal Place of Business

	101.	  	 Warren Ohio Rehab Hospital Company, LLC
	  	DE	  	4856131	  	 8747 Squires Lane Northeast,
 Warren, OH
44484

	102.	  	 Warsaw Health System, LLC
	  	DE	  	2987604	  	 2101 East DuBois Drive,
 Warsaw, IN
46580

	103.	  	 Watsonville Hospital Corporation
	  	DE	  	2872860	  	 75 Nielson Street
 Watsonville, CA
95076

	104.	  	 Waukegan Illinois Hospital Company, LLC
	  	IL	  	01715232	  	 1324 N. Sheridan Rd,
 Waukegan, IL 60085,

and
 2615 Washington Street,

Waukegan, IL 600853

	105.	  	 Weatherford Texas Hospital Company, LLC
	  	TX	  	800718224	  	 713 E. Anderson Street,
 Weatherford, TX
76086

	106.	  	 Wesley Health System, LLC
	  	DE	  	2770969	  	 5001 Hardy St,
 Hattiesburg, MS
39402

	107.	  	 West Grove Hospital Company, LLC
	  	DE	  	4442356	  	 1015 W. Baltimore Pike,
 West Grove, PA
19390

	108.	  	 Wilkes-Barre Hospital Company, LLC
	  	DE	  	4617619	  	 575 North River Street,
 Wilkes-Barre, PA
18764

	109.	  	 Williamston Hospital Corporation
	  	NC	  	0466901	  	 310 S. McCaskey Road
 Williamston, NC
27892

	110.	  	 Women & Children’s Hospital, LLC
	  	DE	  	2964655	  	 4200 Nelson Rd,
 Lake Charles, LA
70605

	111.	  	 Woodward Health System, LLC
	  	DE	  	2964411	  	 900 17th Street
 Woodward, OK
73801

	112.	  	Youngstown Ohio Hospital Company, LLC	  	DE	  	4848328	  	 500 Gypsy Lane,
 Youngstown, OH
44501

  

	3 	These addresses represent the physical location of Vista Medical Center and Vista Medical Center West, respectively. [Records for Receivables are kept separately for each hospital at each of their respective physical
locations.] 

  
 Annexes to Third
Omnibus Amendment 

 All currently registered trade names, fictitious names, assumed names or “doing business
as” names or other names under which it is doing business for each Originator are set forth on the following table: 
  

							
	 	 	  	 Parties
	 	 Names

			
	 	1.	  	  	Affinity Hospital, LLC	 	 - Montclair Baptist Medical Center
 - Lab
First
 - Trinity Medical Center

			
	 	2.	  	  	Anna Hospital Corporation	 	 - Union County Hospital
 - Union County Hospital
Long Term Care
 - Convenient Care Clinic

			
	 	3.	  	  	ARMC, L.P.	 	 - David M. Collins WellHealth Center
 -
ARMC-Surgery Center
 - Abilene Regional Medical Center

			
	 	4.	  	  	Augusta Hospital, LLC	 	 - Premier Care of Augusta
 - Trinity Hospital of
Augusta

			
	 	5.	  	  	Berwick Hospital Company, LLC	 	 - Berwick Hospital Center
 - Berwick Recovery
Systems
 - Berwick Retirement Village Nursing Home
 - Berwick
Family Medicine and Obstetrics
 - Berwick Hospital CRNA Group

- Berwick Orthopedics

			
	 	6.	  	  	Big Bend Hospital Corporation	 	 - Big Bend Regional Medical Center
 - Big Bend
Regional Medical Center Home Health Agency
 - Alpine Rural Health Clinic

- Presidio Rural Health Clinic
 - Marfa Rural Health Clinic

- All five d/b/a filed w/county of residence for Registered Agent

			
	 	7.	  	  	Big Spring Hospital Corporation	 	- Scenic Mountain Medical Center
			
	 	8.	  	  	Blue Ridge Georgia Hospital Company, LLC	 	 - Fannin Regional Hospital
 - Fannin Regional
M.O.B
 - Tri-County Diagnostic Center
 - Medical Specialities
of Ellijay

			
	 	9.	  	  	Bluefield Hospital Company, LLC	 	- Bluefield Regional Medical Center
			
	 	10.	  	  	Bluffton Health System LLC	 	 - Bluffton Regional Medical Center
 - Wells
Community Hospital
 - Caylor-Nickel Medical Center

			
	 	11.	  	  	Brownwood Hospital, L.P.	 	 - Brownwood Regional Medical Center
 - Brownwood
Regional Rehab and Fitness Zone
 - Brownwood Surgery Center
 -
Brownwood Regional Medical Center—Geriatric Psychiatric Unit
 - Brownwood Regional Medical Center—Skilled Nursing Facility

- Brownwood Regional Medical Center—Rehab Unit
 - One Source
Health Center—San Saba
 - One Source Health Center—Early

- One Source Health Center—Lake Brownwood
 - One Source
Health Center—Comanche
 - One Source Health Center—Cross Plains

- One Source Health Center—Rising Star
 - Brownwood Regional
Medical Center Outpatient Imaging and Breast Center

  
 Annexes to Third
Omnibus Amendment 

					
	 	  	 Parties
	 	 Names

			
	12.	  	Bullhead City Hospital Corporation	 	 - Western Arizona Regional Medical Center
 -
W.A.R.M.C. Imaging Center
 - W.A.R.M.C. Outpatient Rehabilitation Center

			
	13.	  	 Carlsbad Medical Center, LLC
	 	- Carlsbad Medical Center
			
	14.	  	 Centre Hospital Corporation
	 	- Cherokee Medical Center
			
	15.	  	 CHS Receivables Funding, LLC
	 	N/A
			
	16.	  	 CHS/Community Health Systems, Inc.
	 	N/A
			
	17.	  	 Cleveland Tennessee Hospital Company, LLC
	 	 - SkyRidge Medical Center
 - SkyRidge Medical
Center Westside Campus
 - Pine Ridge Treatment Center

			
	18.	  	 Clinton Hospital Corporation
	 	 - Lock Haven Hospital
 - Haven Skilled
Rehabilitation and Nursing
 - Haven Wound Care Clinic, an Affiliate of Lock Haven Hospital

- Haven Diagnostic Sleep Lab
 - Haven Occupational Health

- Haven Medical Center

			
	19.	  	 Coatesville Hospital Corporation
	 	 - Brandywine Hospital
 - Brandywine Health
System
 - Brandywine School of Nursing
 - Brandywine Hospital
Home Health
 - Brandywine Hospital Hospice
 - Brandywine
Hospital Women’s Health-New Garden
 - Brandywine Hospital Cardiothoracic Surgery

- Brandywine Behavioral Health Pavilion

			
	20.	  	 College Station Hospital, L.P.
	 	 - College Station Medical Center
 - The Heart
Institute at College Station Medical Center
 - College Station Orthopaedic Center

			
	21.	  	 Community Health Systems Professional Services Corporation
	 	 - CHS Professional Services Corporation (AL)
 -
Community Health Systems PSC, Inc. (WA)
 - Trademark: Community Health Systems, (TN)

- CH Aviation (TN)

			
	22.	  	 Crestview Hospital Corporation
	 	 - North Okaloosa Medical Center
 - Hospitalist
Services of Okaloosa County
 - Bluewater Bay Medical Center
 -
North Okaloosa Medical Center—Transitional Care Unit
 - Gateway Medical Clinic

- Gateway Medical Clinic—Laurel Hill
 - Baker Clinic

- Baker Medical Clinic
 - Gateway Medical Clinic—Baker

- North Okaloosa Medical Center Surgery Center

			
	23.	  	 Crestwood Healthcare, L.P.
	 	 - Crestwood Medical Center
 - Columbia Homecare
Huntsville
 - Columbia Medical Center of Huntsville

			
	24.	  	 Deaconess Health System, LLC
	 	 - Deaconess Hospital
 - Deaconess Surgery
Center
 - Deaconess Wound Care North & South
 - Deaconess
Outreach Services

  
 Annexes to Third
Omnibus Amendment 

							
	 	 	  	 Parties
	 	 Names

			
	 	25.	  	  	 Deming Hospital Corporation
	 	 - Mimbres Valley Home Health
 - Mimbres Valley
Hospice
 - Mimbres Valley Home Health & Hospice
 - Mountain
View Home Health

			
	 	26.	  	  	 DHSC, LLC
	 	 - Affinity Medical Center
 - Affinity Medical
Center—Massillon Campus
 - MCH Occupational Health
 -
Doctors Hospital of Stark County
 - Affinity Medical Center—Doctors Campus

			
	 	27.	  	  	 Dukes Health System, LLC
	 	- Dukes Memorial Hospital
			
	 	28.	  	  	 Dyersburg Hospital Corporation
	 	 - Dyersburg Regional Medical Center
 - Riverside
Surgery Center

			
	 	29.	  	  	 Emporia Hospital Corporation
	 	 - Greensville Memorial Hospital
 - Southern
Virginia Regional Medical Center
 - South Central Virginia Pain Center

- Southern Virginia Pain Management Center
 - Southern Virginia
CompCare

			
	 	30.	  	  	 Evanston Hospital Corporation
	 	 - Evanston Regional Hospital
 - Evanston
Regional Hospital Home Care
 - Evanston Dialysis Center
 -
Uinta Family Practice
 - Evanston Regional Hospice

			
	 	31.	  	  	 Fallbrook Hospital Corporation
	 	 - Fallbrook Hospital
 - Fallbrook Hospital
Skilled Nursing
 - Center for Advanced Sinus Care at Fallbrook Hospital

- Center for Advanced Orthopedic Care at Fallbrook Hospital

			
	 	32.	  	  	 Foley Hospital Corporation
	 	 - South Baldwin Regional Medical Center
 - South
Baldwin Regional Home Health

			
	 	33.	  	  	 Forrest City Arkansas Hospital Company, LLC
	 	 - Forrest City Medical Center
 - Forrest City
Emergency Medicine Associates

			
	 	34.	  	  	 Fort Payne Hospital Corporation
	 	- DeKalb Regional Medical Center
			
	 	35.	  	  	 Franklin Hospital Corporation
	 	 - Southampton Memorial Hospital
 - New
Outlook
 - Southampton Memorial Hospital Skilled Nursing Facility

- Southampton Memorial Hospital East Pavilion Nursing Facility
 -
Southampton Primary Care
 - Southampton Surgical Group
 -
Boykins Family Practice

			
	 	36.	  	  	 Gadsden Regional Medical Center, LLC
	 	- Gadsden Regional Medical Center
			
	 	37.	  	  	 Galesburg Hospital Corporation
	 	 - Galesburg Cottage Hospital
 - Galesburg
Cottage Hospital Skilled Nursing Unit;
 - Galesburg Emergency Physicians Associates

- Galesburg Nurse Anesthetists Associates

			
	 	38.	  	  	 Granbury Hospital Corporation
	 	 - Lake Granbury Medical Center
 - Lake Granbury
Home Health
 - Lake Granbury Sleep Disorders Center
 - Lake
Granbury Open MRI
 - Lake Granbury Physical Therapy
 - Lake
Granbury Fitness
 - Lake Granbury Imaging Center

  
 Annexes to Third
Omnibus Amendment 

											
	 	 	  	 Parties
	 	  
	 	  
	 	 Names

					
	 	39.	  	  	 Granite City Illinois Hospital Company, LLC
	 		 		 	 - Gateway Regional Medical Center
 - Gateway
Regional Medical Center Occupational Health
 - Gateway Regional Medical Center Outpatient Pharmacy

- Gateway Pharmacy

					
	 	40.	  	  	 Greenbrier VMC, LLC
	 		 		 	 - Greenbrier Valley Medical Center
 - Greenbrier
Valley Anesthesia
 - Greenbrier Thoracic and Vascular Surgery

- Jefferson Cardiology and Internal Medicine

					
	 	41.	  	  	 Greenville Hospital Corporation
	 		 		 	 - L.V. Stabler Memorial Hospital
 - L.V. Stabler
Memorial Home Health

					
	 	42.	  	  	 Hospital of Barstow, Inc.
	 		 		 	- Barstow Community Hospital
					
	 	43.	  	  	 Hospital of Fulton, Inc.
	 		 		 	 - Orthopedics of Southwest Kentucky
 - South
Fulton Family Clinic
 - Tri-Cities EMS; Parkway Orthopedics and Spine

					
	 	44.	  	  	 Hospital of Louisa, Inc.
	 		 		 	- Three Rivers Medical Center
					
	 	45.	  	  	 Hospital of Morristown, Inc.
	 		 		 	 - Lakeway Regional Hospital
 - Morristown
Professional Building
 - Lakeway Regional Women’s Imaging Center

					
	 	46.	  	  	 IOM Health System, L.P.
	 		 		 	 - Lutheran Hospital of Indiana
 - Lutheran Heart
Center
 - Lutheran Hospital Neurospine Center

					
	 	47.	  	  	 Jackson, Tennessee Hospital Company, LLC
	 		 		 	 - Regional Hospital of Jackson
 - Sleep
Diagnostics of Jackson

					
	 	48.	  	  	 Jourdanton Hospital Corporation
	 		 		 	 - South Texas Home Health
 - South Texas
Regional Anesthesia

					
	 	49.	  	  	 Kay County Oklahoma Hospital Company, LLC
	 		 		 	- Ponca City Medical Center
					
	 	50.	  	  	 Kirksville Missouri Hospital Company, LLC
	 		 		 	 - Northeast Regional Medical Center
 - Northeast
Home Health Services
 - Northeast Regional Health and Fitness Center

- Northeast Regional Health System
 - Family Health Center of
Edina
 - A.T. Still Rehabilitation Center
 - Missouri’s
Choice Home Care
 - Northeast Regional Heart Center
 -
Northeast Regional Vein Center
 - Northeast Regional Medical Group

					
	 	51.	  	  	 Lake Wales Hospital Corporation
	 		 		 	- Lake Wales Medical Center
					
	 	52.	  	  	 Lancaster Hospital Corporation
	 		 		 	 - Springs Memorial Hospital
 - Lancaster
Recovery Center
 - Kershaw Family Medicine Center
 - Springs
Business Health Services
 - Lancaster Rehabilitation
 - Springs
Wound Treatment Center
 - Springs Healthcare
 - Rock Hill
Rehabilitation
 - Lancaster County

  
 Annexes to Third
Omnibus Amendment 

					
	 	  	 Parties
	  	 Names

			
	53.	  	 Laredo Texas Hospital Company, L.P.
	  	 - Laredo Medical Center
 - LMC Outpatient
Diagnostic Center
 - LMC Lamar Bruni Vergara Rehabilitation Center

- LMC Child Care Center
 - LMC Outpatient Diagnostic
Center—South
 - Zapata Minor Care Center
 - Zapata EMS

- Zapata Medical Center
 - LMC Surgery and Diagnostic Center

- LMC North
 - Hebbronville Family Care Center

			
	54.	  	 Las Cruces Medical Center, LLC
	  	- Mountain View Family Wellness Center
			
	55.	  	 Lea Regional Hospital, LLC
	  	- Lea Regional Medical Canter
			
	56.	  	 Lexington Hospital Corporation
	  	 - Henderson County Community Hospital
 -
Henderson County ER Group
 - Henderson County Medical Group RHC

- Lexington Family Physicians RHC

			
	57.	  	 Longview Medical Center, L.P.
	  	 - Longview Regional Medical Center
 -
Longview Regional Medical Park Imaging Center
 - The Heart and Vascular Institute of Longview

- The Heart and Vascular Institute of Longview Regional
 - The
Vein Center of Longview Regional
 - Longview Regional Quickcare

- Family Care by Longview Regional

			
	58.	  	 Lutheran Musculoskeletal Center, LLC
	  	- The Orthopaedic Hospital of Lutheran Health Network
			
	59.	  	 Marion Hospital Corporation
	  	 - Heartland Regional Medical Center
 -
Heartland Regional Medical Center Home Health Agency

			
	60.	  	 Martin Hospital Corporation
	  	- Volunteer Community Hospital
			
	61.	  	 Mary Black Health System, LLC
	  	- Mary Black Memorial Hospital
			
	62.	  	 McKenzie Tennessee Hospital Company, LLC
	  	- McKenzie Regional Hospital
			
	63.	  	 McKenzie-Willamette Regional Medical Center Associates, LLC
	  	 - McKenzie-Willamette Medical Center
 -
McKenzie Heart Center
 - McKenzie Heart
 - Lung and Vascular
Center,
 - McKenzie Wound Center
 - McKenzie Cardiac
Rehabilitation

			
	64.	  	 McNairy Hospital Corporation
	  	 - McNairy Regional Hospital
 - Medical
Associates of McNairy Regional Hospital

			
	65.	  	 MCSA, L.L.C.
	  	- Medical Center of South Arkansas
			
	66.	  	 MMC of Nevada, LLC
	  	- Mesa View Regional Hospital
			
	67.	  	 Moberly Hospital Company, LLC
	  	 - Moberly Regional Medical Center,
 - Moberly
Rural Health Clinic

			
	68.	  	 National Healthcare of Leesville, Inc.
	  	 - Byrd Regional Hospital
 - Memorial
Hospital
 - Leesville Diagnostic Center
 - Byrd Regional
Hospital Outpatient Surgery Center

			
	69.	  	 National Healthcare of Mt. Vernon, Inc.
	  	- Crossroads Community Hospital

  
 Annexes to Third
Omnibus Amendment 

					
	 	  	 Parties
	 	 Names

			
	70.	  	 National Healthcare of Newport, Inc.
	 	 - Harris Hospital
 - Nightengale Home Health
Agency
 - Harris Anesthesia Associates

			
	71.	  	 Navarro Hospital, L.P.
	 	- Navarro Regional Hospital
			
	72.	  	 Northampton Hospital Company, LLC
	 	 - Easton Hospital
 - Outlook House

- Easton Hospital Imaging

			
	73.	  	 Northwest Hospital, LLC
	 	 - Northwest Medical Center
 - The
Women’s Health Center at Northwest Medical Center
 - La Cholla Day Surgery at Northwest Medical Center

- La Paloma Urgent Care
 - Healthy Beginnings

- The Wound Care Center at Northwest
 - Continental Reserve Urgent
Care
 - Northwest Urgent Care at Duval Mine Road
 - Northwest
Urgent Care at Orange Grove
 - Northwest Balance Therapy Center

			
	74.	  	 Oak Hill Hospital Corporation
	 	- Plateau Medical Center
			
	75.	  	 Oro Valley Hospital, LLC
	 	 - Oro Valley Hospital
 - Northwest Vein
Center at Oro Valley Hospital
 - The Sleep Centers of Oro Valley Hospital

			
	76.	  	 Payson Hospital Corporation
	 	 - Payson Regional Medical Center;
 - Payson
Regional Medical Center Outpatient Treatment Center

			
	77.	  	 Petersburg Hospital Company, LLC
	 	 - Southside Regional Medical Center
 -
Southside Regional Medical Center—Renal Services
 - Southside Rehabilitation Services

- Southside Behavioral Health Services
 - Southside Industrial
Medicine
 - Southside Regional Medical Center School of Nursing

- Southside Regional Medical Center School of Radiation Sciences

- Southside Regional Medical Center Professional Schools

			
	78.	  	 Phillips Hospital Corporation
	 	 - Helena Regional Medical Center
 - Helena
Regional Medical Center Home Health Agency
 - Marvell Medical Clinic

- Helena Surgical, P.A.

			
	79.	  	 Phoenixville Hospital Company, LLC
	 	 - Phoenixville Hospital
 - Phoenixville
Hospital Therapy & Fitness
 - Limerick Medical Center
 -
Cardiothoracic Surgical Specialists
 - The Surgery Center of the Main Line

- Blue Bell Surgery Center
 - Surgery Center at
Limerick

			
	80.	  	 Piney Woods Healthcare System L.P.
	 	 - Woodland Heights Medical Center
 - The
Surgery at Center at Gaslight Medical Park
 - PW Healthcare System, L.P.

- Gaslight Imaging Center

  
 Annexes to Third
Omnibus Amendment 

					
	 	  	 Parties
	 	 Names

			
	81.	  	 Porter Hospital, LLC
	 	 - Porter, DeMotte Medical Center
 - Porter,
Valparaiso Hospital
 - Porter, Portage Hospital
 - Porter,
Valparaiso Outpatient Center
 - Porter, Chesterton Medical Center

- Porter, Valparaiso Therapy Services
 - Porter, Hebron Medical
Center
 - Porter, Glendale Medical Center
 - Porter, Northwest
Indiana PET/CT Center
 - Porter, Portage Outpatient Center
 -
Endo Labs at Porter; Shoreline Surgery Center
 - Porter Regional Hospital

- Porter Regional Hospital Health at Work

			
	82.	  	 Pottstown Hospital Company, LLC
	 	 - Pottstown Memorial Medical Center
 - Pottstown
Memorial Medical Center Transitional Care Unit
 - Pottstown Memorial Medical Center Renal Care Unit

- Tri-County Medical Laboratory
 - Schuylkill Valley Health
System
 - Pottstown Obstetrical Associates;
 - Pottstown
Oncology Associates

			
	83.	  	 QHG of Enterprise, Inc.
	 	- Medical Center Enterprise
			
	84.	  	 QHG of South Carolina, Inc.
	 	 - Carolinas Rehabilitation Hospital
 - Carolinas
Hospital System;
 - Physicians’ Surgery Center of Florence

- Carolinas Hospital System—Marion
 - Mullins Nursing
Center
 - Carolinas Neurology
 - Carolinas
Oncology

			
	85.	  	 Red Bud Illinois Hospital Company, LLC
	 	 - Red Bud Regional Hospital
 - Older Adult
Health Center
 - Red Bud Regional Care
 - Red Bud Health
Clinic

			
	86.	  	 Rehab Hospital of Fort Wayne General Partnership
	 	N/A
			
	87.	  	 Roswell Hospital Corporation
	 	- Eastern New Mexico Medical Center
			
	88.	  	 Ruston Louisiana Hospital Company, LLC
	 	 - Northern Louisiana Medical Center
 - Northern
Louisiana Oncology Associates

			
	89.	  	 Salem Hospital Corporation
	 	 - The Memorial Hospital of Salem County
 - Salem
Medical Center
 - South Jersey Physical Therapy and Back Rehabilitation Center

- Beckett Diagnostic Center
 - Salem Medical Imaging

- Salem Surgical Weight Loss Center
 - Salem Physical Therapy and
Rehabilitation

			
	90.	  	 San Angelo Hospital, L.P.
	 	 - San Angelo Community Medical Center
 -
Community Surgery Center

			
	91.	  	 San Miguel Hospital Corporation
	 	- Alia Vista Regional Hospital

  
 Annexes to Third
Omnibus Amendment 

					
	 	  	 Parties
	 	 Names

			
	 92.
	  	 Scranton Hospital Company, LLC
	 	 - Commonwealth Healthcare Network
 -
Commonwealth Health Network
 - Commonwealth Health System
 -
Commonwealth Health Plan
 - Regional Hospital of Scranton
 -
Regional Hospital Surgery Center

			
	 93.
	  	 Scranton Quincy Hospital Company, LLC
	 	 - Moses Taylor Hospital
 - Moses Taylor
Apothecary
 - Commonwealth Health Carbondale Outpatient Center

- Advanced Imaging Specialists

			
	 94.
	  	 Shelbyville Hospital Corporation
	 	- Heritage Medical Center
			
	 95.
	  	 Siloam Springs Arkansas Hospital Company, LLC
	 	- Siloam Springs Memorial Hospital
			
	 96.
	  	 Spokane Valley Washington Hospital Company, LLC
	 	- Valley Hospital
			
	 97.
	  	 Spokane Washington Hospital Company, LLC
	 	- Deaconess Hospital
			
	 98.
	  	 St. Joseph Health System LLC
	 	 - St. Joseph Hospital
 - Dupont Ambulatory
Surgery Center
 - Northeast Indiana Rehabilitation Institute

			
	 99.
	  	 Sunbury Hospital Company, LLC
	 	 - Sunbury Community Hospital
 - Sunbury
Community Hospital Behavioral Health

			
	 100.
	  	 Tomball Texas Hospital Company, LLC
	 	 - Tomball Regional Medical Center
 - Texas
Sports Medicine Center
 - Tomball Regional Cancer Center
 -
Tomball Regional Heart and Vascular Center
 - Tomball Regional Surgery Center

- Tomball Regional Skilled Nursing
 - Tomball Regional Medical
Center Spring Creek Imaging

			
	 101.
	  	 Tooele Hospital Corporation
	 	 - Mountain West Medical Center
 - Mountain West
Ambulance Service
 - Mountain West Medical Center Physical Therapy and Wellness Center

- Mountain West Private Care Agency

			
	 102.
	  	 Victoria of Texas, L.P.
	 	 - DeTar Hospital
 - DeTar Hospital Navarro

- DeTar Hospital North;
 - DeTar Healthcare System

- DeTar Hospital After Hours Center

			
	 103.
	  	 Warren Ohio Hospital Company, LLC
	 	 - TMH Center for Rehabilitation
 - TMH
Diagnostic Center
 - TMH Center for Radiology
 - TMH Center for
Surgery
 - Trumbull Memorial Hospital
 - Trumbull Memorial
Hospital Cancer Care Center
 - TMH Sleep Center

			
	 104.
	  	 Warren Ohio Rehab Hospital Company, LLC
	 	- Hillside Rehabilitation Hospital

  
 Annexes to Third
Omnibus Amendment 

					
	 	  	 Parties
	 	 Names

			
	105.	  	 Warsaw Health System LLC
	 	 - Walnut Street Family Healthcare
 -
Provident Family Healthcare
 - Center of Hope
 - Warsaw
Surgical Specialties
 - Sessa Family Medicine
 - North Webster
Medical Clinic
 - Northern Lakes Family Medicine
 - Mentone
Family Medicine
 - Pierceton Community Health Clinic
 -
Pediatric Healthcare
 - Akron Family Medicine
 - Higbee Street
Healthcare
 - Kosciusko Community Hospital
 - The Center of
Hope Cancer Center
 - Northern Lakes Internal Medicine

			
	106.	  	 Watsonville Hospital Corporation
	 	 - Watsonville Community Hospital
 - The
Monterey Bay Wound Treatment Center
 - Monterey Bay Senior Clinic; Monterey Bay Diabetes Center

- Acclaim Urgent Care

			
	107.	  	 Waukegan Illinois Hospital Company, LLC
	 	 - Vista Medical Center East
 - Vista Medical
Center West
 - Lindenhurst Surgery Center
 - Vista Treatment
Center
 - Vista MRl Institute
 - Vista Imaging Center

- Vista Physical Medicine & Rehab
 - Vista Work Power
Center
 - Vista Health System
 - Lindenhurst Free Standing
Emergency Center

			
	108.	  	 Weatherford Texas Hospital Company, LLC
	 	- Weatherford Regional Medical Center
			
	109.	  	 Wesley Health System LLC
	 	- Wesley Medical Center
			
	110.	  	 West Grove Hospital Company, LLC
	 	 - Jennersville Regional Hospital
 -
HealthTech
 - Jennersville Pediatrics
 - Jennersville OB
Associates
 - Home Health of Brandywine;
 - Hospice of
Brandywine

			
	111.	  	 Wilkes-Barre Hospital Company, LLC
	 	 - Wilkes-Barre General Hospital
 -
Commonwealth Health Laboratory Services
 - Commonwealth Health School of Nurse Anesthesia

- Center for Same Day Surgery at Wilkes-Barre General Hospital
 -
Center for Diagnostic Imaging; Center for Advanced Surgery
 - Wellspring

- Wilkes-Barre General Hospital Sleep Disorder Center
 - Center
for Advanced Rehabilitation

			
	112.	  	 Williamston Hospital Corporation
	 	 - Martin General Hospital
 - Northeastern
Primary Care Group
 - University Family Medicine Center
 -
Roanoke Women’s Healthcare
 - Martin General Health System

			
	113.	  	 Women & Children’s Hospital, LLC
	 	- Lake Area Medical Center

  
 Annexes to Third
Omnibus Amendment 

							
	 	 	  	 Parties
	 	 Names

			
	 	114.	  	  	 Woodward Health System, LLC
	 	 - Woodward Regional Hospital
 - Woodward
Rehab
 - Woodward Works

			
	 	115.	  	  	 Youngstown Ohio Hospital Company, LLC
	 	 - Northside Medical Center
 - Austintown
Rehabilitation Services
 - Center for Breast Health
 -
ValleyCare Health System (OH and PA)
 - ValleyCare Health System of Ohio (OH and PA)

- Austintown Imaging Center
 - MRI at Northside Medical
Center

  
 Annexes to Third
Omnibus Amendment 

 Annex F 

SCHEDULE V 
 SPECIFIED ORIGINATORS

  

									
	 	 	  	 Originator
	  	CHS %	 
	 	1.	  	  	ARMC, L.P.	  	 	87.56	  
	 	2.	  	  	Augusta Hospital, LLC	  	 	88.72	  
	 	3.	  	  	Blue Ridge Georgia Hospital Company, LLC	  	 	98.21	  
	 	4.	  	  	Crestview Hospital Corporation	  	 	96.5192	  
	 	5.	  	  	Crestwood Healthcare, L.P.	  	 	95.07	  
	 	6.	  	  	Deaconess Health System, LLC	  	 	97.168	  
	 	7.	  	  	Greenbrier VMC, LLC	  	 	96.0	  
	 	8.	  	  	IOM Health System, L.P.	  	 	86.30	  
	 	9.	  	  	Jackson, Tennessee Hospital Company, LLC	  	 	96.94	  
	 	10.	  	  	Kirksville Missouri Hospital Co., LLC	  	 	88.10	  
	 	11.	  	  	Lake Wales Hospital Corporation	  	 	94.7988	  
	 	12.	  	  	Laredo Texas Hospital Company, L.P.	  	 	95.012	  
	 	13.	  	  	Lutheran Musculoskeletal Center, LLC	  	 	60.00	  
	 	14.	  	  	Mary Black Health System LLC	  	 	98.1337	  
	 	15.	  	  	McKenzie-Willamette Regional Medical Center Associates, LLC	  	 	90.5	  
	 	16.	  	  	Petersburg Hospital Company, LLC	  	 	99.3	  
	 	17.	  	  	Piney Woods Healthcare System, L.P.	  	 	91.7823	  
	 	18.	  	  	Porter Hospital, LLC	  	 	91.17	  
	 	19.	  	  	Rehab Hospital of Fort Wayne General Partnership	  	 	86.30	  
	 	20.	  	  	San Angelo Hospital, L.P.	  	 	94.771	  
	 	21.	  	  	St. Joseph Health System LLC	  	 	86.30	  
	 	22.	  	  	Sunbury Hospital Company, LLC	  	 	73.26	  
	 	23.	  	  	Warsaw Health System LLC	  	 	99.07	  

  
 Annexes to Third
Omnibus Amendment

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00229-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00229-of-00352.parquet"}]]